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Abstract	Fossil	 fuels	 are	 a	 finite	 resource	 and	 sustainable	 alternative	methods	 of	 producing	 fuel	molecules	and	the	numerous	chemical	products	derived	from	fossil	fuels	need	to	be	found.	Genetically	 engineered	 cyanobacteria	 represent	 one	 promising	 ‘green’	 platform	 for	 the	production	 of	 biofuels	 and	 high-value	 chemicals.	 As	 photosynthetic	 prokaryotes,	cyanobacteria	are	able	to	fix	atmospheric	carbon	dioxide	using	sunlight	and	channel	that	carbon	 into	organic	products.	Manipulation	of	 these	biochemical	pathways	 should	allow	the	 hyper-accumulation	 of	 certain	 products	 or	 the	 synthesis	 of	 novel	 compounds.	Compared	 to	 other	 phototrophic	 platforms	 (plants	 and	 eukaryotic	 algae),	 cyanobacteria	are	much	easier	 to	 grow	and	easier	 to	manipulate	 genetically.	Nevertheless,	 the	 current	genetic	tools	to	engineer	cyanobacteria	are	not	as	advanced	as	those	developed	for	E.	coli	and	S.	cerevisiae,	and	there	is	a	need	for	new	technologies	in	this	area.	The	work	presented	in	 this	 thesis	 therefore	aimed	 to	develop	novel	 tools	 for	 cyanobacteria	and	demonstrate	their	use	as	a	platform	for	the	production	of	new	compounds.		The	research	focussed	on	the	model	organism	Synechocystis	sp.	PCC	6803	–	the	availability	of	 a	 sequenced	 and	 annotated	 genome	 and	 the	 ability	 to	 integrate	 DNA	 via	 natural	transformation	 at	 a	 specific	 locus	 by	 homologous	 recombination	 making	 it	 ideal	 for	genetic	 engineering.	 A	 new	 method	 was	 developed	 in	 Synechocystis	 for	 creating	transformants	that	no	longer	contain	an	antibiotic	resistance	marker,	and	improvements	to	 transcription	 and	 translation	 of	 transgenes	 investigated.	 The	 expression	 of	 GFP	 and	limonene	 synthase	 were	 tested	 under	 various	 promoters,	 and	 several	 native	 and	 non-native	integenic	regions,	containing	ribosomal	binding	sites,	were	functionally	tested	in	a	two-gene	operon	containing	GFP	as	a	reporter	gene.	The	production	of	limonene	and	(S)-styrene	 oxide,	 a	 chiral	 compound	 used	 as	 a	 building	 block	 for	 pharmaceuticals,	 was	attempted	in	Synechocystis	using	the	newly	developed	tools.		 	
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1.1 Cyanobacteria	
1.1.1 Overview	Cyanobacteria	 (formerly	 known	 as	 blue-green	 algae)	 are	 photoautotrophic	 bacteria	capable	 of	 oxygenic	 photosynthesis.	 It	 is	 thought	 that	 cyanobacteria	 were	 the	 first	organisms	 capable	 of	 oxygenic	 photosynthesis	 and	 played	 a	 major	 role	 in	 altering	 the	earth’s	 reducing	 atmosphere	 into	 the	 oxygenic	 atmosphere	 that	 is	 present	 today	(Rasmussen	et	al.,	2008).	The	oldest	fossils	date	cyanobacteria	at	3.5	billion	years	old	and	were	discovered	 in	western	Australia	 (Schopf	 and	Packer,	 1987).	 The	 chloroplasts	 from	plants	 and	 algae	 are	 also	 widely	 thought	 to	 have	 descended	 from	 cyanobacteria	 via	endosymbiosis	 (McFadden,	 2001).	 Cyanobacteria	 still	 play	 an	 important	 role	 today;	marine	cyanobacteria	have	a	huge	part	to	play	in	the	carbon	cycle	and	strains	capable	of	nitrogen	fixation	play	an	important	role	in	the	nitrogen	cycle	(Capone,	2001).	The	 morphology	 of	 cyanobacteria	 varies,	 with	 certain	 species	 being	 unicellular	 or	filamentous	and	some	capable	of	 forming	heterocysts	and	of	 fixing	nitrogen	(Figure	1.1).	Cyanobacteria	 do	 not	 have	 flagella,	 but	 some	 strains	 are	 able	 to	 glide.	 Cyanobacteria	represent	 a	 diverse	 phylum	of	 bacteria,	 and	 this	 is	 reflected	by	 the	wide	distribution	 of	environments	they	inhabit.	They	have	been	found	almost	everywhere,	from	oceans	to	hot	springs	and	deserts	to	the	Antarctic	(Ruffing,	2011).	The	cyanobacteria	that	are	capable	of	surviving	 in	 some	 of	 these	 harsh	 environments	 have	 adapted	 in	 order	 to	 do	 so.	 Cell	division	occurs	by	binary	fission	in	cyanobacteria	(Ikeuchi	and	Tabata,	2001).	Cyanobacteria	 are	 classified	 as	 Gram-negative	 bacteria,	 with	 a	 cell	 wall	 made	 up	 of	 a	plasma	membrane,	peptidoglycan	layer	and	outer	membrane	(Liberton	et	al.,	2006).	Also,	most	 cyanobacteria	 contain	 thylakoid	 membranes,	 an	 internal	 membrane	 system	 that	follows	 the	 periphery	 of	 the	 cell	 (Figure	 1.2)	 (Vermaas,	 2001).	 Both	 the	 photosynthetic	and	 respiratory	 electron	 transport	 chains	 are	 located	 in	 the	 thylakoid	 membrane	(Vermaas,	2001).		
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Figure	1.1	Microscopy	images	of	various	cyanobacteria	strains.	
(A)	Synechocystis	sp.	PCC	6803,	(B)	Gleotrichia	echinulata	colony,	(C)	Microcystis	sp.,	(D)	
Planktothrix	 suspense,	 (E)	 Lyngbya	 sp.,	 (F)	 Synechococcus	 elongatus	 PCC	 7942.	Photographs	from	(Ruffing,	2011).			
Figure	removed	
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Figure	1.2	Diagram	of	a	cyanobacteria	cell.	Showing	 the	 internal	 membrane	 system,	 thylakoid	 membrane	 present	 within	cyanobacteria.	 Diagram	 taken	 from	http://cronodon.com/BioTech/Cyanobacteria.html.	In	 cyanobacteria	 the	 photosynthetic	 electron	 transport	 chain	 is	 very	 similar	 to	 plants,	containing	both	photosystem	II	(PSII)	and	photosystem	I	(PSI)	(Figure	1.3).	Unlike	plants,	most	cyanobacteria	contain	phycobilisomes	-	an	antennae	protein	complex	attached	to	the	thylakoid	membrane	made	up	of	phycobiliproteins.	Allophycocyanin	and	phycocyanin	and	depending	 on	 the	 species,	 phycoerythrin,	 phycoerythrocyanin	 are	 the	 phycobiliproteins	that	make	up	the	phycobilisome	(Bryant,	1982;	Grossman	et	al.,	1993).	The	phycobilisome	absorbs	 light	at	different	wavelengths	 from	the	chlorophylls	and	carotenoids	 in	order	 to	increase	the	spectral	range	of	light	harvested	(Figure	1.4)(Lea-Smith	et	al.,	2014).	 
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Figure	1.3	Schematic	representation	of	the	components	 involved	in	the	 light	reaction	of	
photosynthesis.		PSII	 uses	 light	 energy	 to	 split	 water	 and	 reduce	 the	 plastoquinone	 (PQ)	 pool;	 the	electrons	 are	 then	 transferred	 to	 the	 cytochrome	b6f	complex	 (cyt	 b6f	).	 Electrons	 are	then	 accepted	 by	 a	 soluble	 electron	 carrier,	 plastocyanin	 (PC),	 which	 reduces	 the	oxidised	 PS	 I	 reaction	 centre	 chlorophyll.	 The	 oxidised	 chlorophyll	 in	 PSI	 is	 formed	when	 light	 causes	 the	 transfer	 of	 an	 electron	 to	 ferredoxin	 (Fd),	which	 results	 in	 the	production	of	NADPH.	NADPH	is	used	along	with	ATP,	formed	from	the	proton	gradient	created	from	the	electron	transport	chains,	for	CO2	fixation.			
	
Figure	1.4	Absorbance	spectra	of	the	main	pigments	found	in	cyanobacteria		Phycoerythrin	 and	 phycocyanin	 cover	 different	 wavelengths	 to	 chlorophyll	 b	 (Chl	 b)	and	 chlorophyll	 a,	 (Chl	 a).	 Image	 taken	 from	 http://www.wur.nl/en/Show/Natural-food-colorants-from-microalgae-1.htm.		The	 production	 of	 NADPH	 and	 ATP	 from	 the	 light	 reaction	 drives	 the	 fixation	 of	atmospheric	 CO2,	 through	 the	 Calvin	 cycle	 and	 the	 pentose	 phosphate	 pathway.	 The	enzyme	 responsible	 for	 CO2	 fixation,	 ribulose	 1,5-bisphosphate	 carboxylase/oxygenase	
PSII	
Lu
m
en
	
Cy
to
pl
as
m
	
PSI	
Phycobillisome	
Th
yl
ak
oi
d	
M
em
br
an
e	
cyt	b6	f	
PC	
H2O	 O2+	H+	
Fdox	
H+	
Fdred	
NADP	NADPH	
ATP	synthase	
ATP	+	H2O	ADP	+	Pi	Light	
Light	
H+	
PQ	
e-	
Figure	removed	
	 25	
(RuBisCO)	 is	 present	 in	 the	 carboxysomes,	 which	 are	 bacterial	 compartments	 found	 in	cyanobacteria.	Carboxysomes	play	a	central	role	 in	 the	carbon	concentrating	mechanism	(CCM),	which	involves	the	uptake	of	inorganic	carbon	into	the	cell	and	the	accumulation	of	HCO3−.	 HCO3− is	 able	 to	 diffuse	 into	 the	 carboxysome,	 and	 is	 converted	 back	 to	 CO2	 by	carbonic	 anhydrase	 so	 that	 RuBisCO	 can	 use	 it	 as	 a	 substrate.	 The	 carboxysome	 was	thought	 to	 have	 evolved	 in	 order	 to	 minimise	 RuBisCO	 reacting	 with	 O2	 by	 creating	 a	barrier,	a	wasteful	reaction	that	competes	with	CO2	as	the	substrate,	(Kerfeld	and	Melnicki,	2016).	
1.1.2 Synechocystis	sp.	PCC	6803	
Synechocystis	 sp.	 PCC	 6803	 (Synechocystis	 from	 hereafter)	 is	 a	 species	 of	 cyanobacteria	found	ubiquitously	in	freshwater	that	is	unicellular	and	coccoid	in	shape	but	is	unable	to	fix	nitrogen	(Figure	1.5)	(Ikeuchi	and	Tabata,	2001).	The	strain	was	widely	used	to	study	photosynthesis	as	it	can	naturally	uptake	DNA	from	the	media	and	is	capable	of	growing	in	heterotrophic	conditions	using	glucose	(Grigorieva	and	Shestakov,	1982;	Williams,	1988).	In	 1996,	 Synechocystis	was	 the	 first	 photoautotroph	 and	 third	 prokaryote	 to	 have	 its	genome	 fully	 sequenced	 (Kaneko	et	al.,	1996).	The	genome	of	Synechocystis	 is	organised	into	the	main	chromosome	(3.57	Mbp)	and	seven	smaller	plasmids	and	has	an	average	GC	content	of	47.7%	(Kaneko	et	al.,	1996).	In	Synechocystis	it	has	been	reported	that	each	cell	has	8-12	copies	of	the	genome,	however	one	publication	suggested	that	the	copy	number	may	 be	much	 higher,	 with	 142	 copies	 of	 the	 genome	 present	 in	 the	 exponential	 phase	(Griese	 et	 al.,	 2011;	 Labarre	 et	 al.,	 1989).	 The	 most	 recent	 publication	 on	 ploidy	 in	
Synechocystis	suggests	that	at	an	OD:	0.1,	there	are	around	20	copies,	and	the	copy	number	varies	with	the	growth	stage	and	external	conditions	(Zerulla	et	al.,	2016).	A	database	was	created,	CyanoBase1,	to	easily	access	the	genome	of	Synechocystis	(Nakamura	et	al.,	1998).	The	database	has	been	annotated	and	so	far	3317	genes	have	been	identified	on	the	main	chromosome.	An	extension	of	CyanoBase	was	created	called	CyanoMutants2,	a	repository	for	genotypic	and	phenotypic	details	of	mutants	created	in	Synechocystis	(Nakamura	et	al.,	1999).		
Synechocystis	 sp.	 PCC	 6803	 was	 originally	 isolated	 from	 a	 freshwater	 pond	 in	 Oakland,	California	in	the	1970’s,	and	is	also	known	as	the	Berkeley	strain.	However	there	are	now	several	distinct	strains	that	originate	from	the	Berkeley	strain,	that	are	all	often	referred	to	as	Synechocystis	sp.	PCC	6803.	The	Berkeley	strain	branched	 into	a	motile	strain	(PCC	6803)	 and	 a	 non-motile	 strain	 (ATCC	 27184),	 which	 are	 both	 sensitive	 to	 glucose.	 A																																									 																					1	http://genome.microbedb.jp/cyanobase/sequence	2	http://genome.microbedb.jp/cyanobase/mutants/	
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glucose	 tolerant	 (GT)	 strain	 was	 created	 from	 ATCC	 27184	 (Ikeuchi	 and	 Tabata,	 2001;	Williams,	1988).	The	Kazusa	strain	used	to	obtain	the	genome	sequence	in	1996	is	derived	from	the	GT	strain	(Kaneko	et	al.,	1996).	The	PCC	strains	were	separated	based	on	their	phototactic	movement	 into	PCC-P	(positive	phototaxis)	and	PCC-N	(negative	phototaxis).	A	spontaneous	mutation	in	the	GT	strain	after	being	maintained	under	photoautotrophic	conditions	 led	 to	 a	 strain	 (WL)	 that	 was	 no	 longer	 able	 to	 grow	 under	 mixotrophic	conditions	 (Hihara	 and	 Ikeuchi,	 1997).	There	 is	 also	 a	GT	and	motile	 ‘Moscow’	 strain	of	
Synechocystis	called	PCC-M	(Trautmann	et	al.,	2012).			
Synechocystis	can	grow	in	the	absence	of	a	fixed	carbon	source	(photoautotrophic	growth)	but	 in	order	to	do	so,	PSII	and	PSI	must	be	functional.	 If	glucose	or	another	fixed-carbon	source	 is	present	Synechocystis	 is	also	capable	of	growing	with	either	a	 functional	PSI	or	PSII	(photoheterotrophic	growth)	or	with	both	PSI	and	PSII	functional	(photomixotrophic	growth)	 (Vermaas,	 1996).	 Synechocystis	 can	 also	 grow	 in	 light-activated	 heterotrophic	conditions,	which	means	that	it	can	grow	on	glucose	in	the	dark	as	long	as	it	is	pulsed	with	white	light	for	five	minutes	each	day	(Anderson	and	McIntosh,	1991).	Synechocystis	has	a	doubling	rate	of	8-12	hours	in	photoautotrophic	conditions	(Heidorn	et	al.,	2011;	Yu	et	al.,	2013).		
	
Figure	1.5	Images	of	Synechocystis	6803	(A)	Photograph	of	Synechocystis	culture	in	liquid	and	solid	medium	(taken	by	Michelle	Liberton,	 Washington	 University	 from	 http://www.enerzine.com/6/9788+produire-du-biocarburant-par-les-microorganismes-i+.html).	 (B)	 Light	 micrograph	 image	
Synechocystis	 6803	 from	 the	 Protist	 Information	 Server3	(C)	 Electron	 microscope	transmission	image	of	Synechocystis	(adapted	from	(Nickelsen	et	al.,	2011)).			
																																								 																					3	http://protist.i.hosei.ac.jp/pdb/Images/Prokaryotes/Chroococcaceae/Synechocystis/index.html	
Figure	removed	
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1.1.3 Other	model	organisms	of	cyanobacteria	Currently	there	are	39	genomes	of	different	cyanobacteria	species	on	CyanoBase	that	are	sequenced	 and	 annotated,	 however	 only	 a	 few	 species	 are	 widely	 used	 along	 with	
Synechocystis	 as	 model	 organisms	 representing	 cyanobacteria	 (Nakamura	 et	 al.,	 1998).	
Synechococcus	elongatus	PCC	7942	(Synechococcus	7942)	is	a	species	of	cyanobacteria	that	has	been	widely	used	to	study	circadian	rhythms	(Holtman	et	al.,	2005).	It	is	a	unicellular,	freshwater	strain	 like	Synechocystis,	 and	was	 the	 first	 strain	 to	be	naturally	 transformed	(Shestakov	and	Khyen,	1970).	The	genome	of	Synechococcus	has	also	been	sequenced.	The	filamentous,	heterocyst-forming	cyanobacteria,	Anabaena	sp.	strain	PCC	7120	(Anabaena	7120)	has	also	been	used	a	model	of	cyanobacteria	to	study	nitrogen	fixation	(Rice	et	al.,	1982).	Anabaena	7120	is	a	freshwater	strain	that	can	be	transformed	via	conjugation	with	
E.	coli	and	electroporation	and	was	fully	sequenced	in	2001	(Kaneko	et	al.,	2001;	Moser	et	al.,	1995;	Wolk	et	al.,	1984).		The	 thermophilic,	 unicellular,	 rod-shaped	 cyanobacterial	 strain,	 Thermosynechococcus	
elongatus	BP-1,	 has	 been	 used	 for	 protein	 structural	 studies	 as	 the	 proteins	 are	 more	stable	at	a	higher	temperature	and	thus	more	likely	to	give	rise	to	stable	crystals	suitable	for	 X-ray	 crystallography	 (Iwai	 et	 al.,	 2004;	 Onai	 et	 al.,	 2003).	 Thermosynechococcus	
elongatus	 BP-1	 has	 been	 sequenced	 and	 can	 be	 transformed	 naturally,	 and	 by	electroporation	and	conjugation	 (Mühlenhoff	 and	Chauvat,	1996;	Nakamura	et	al.,	2002;	Onai	et	al.,	2003)	
1.1.4 Applications	of	cyanobacteria		The	exploitation	of	engineered	cyanobacteria	originally	focused	on	their	ability	to	grow	in	certain	 environmental	 niches.	 For	 example,	 cyanobacteria	 were	 thought	 to	 be	 excellent	vectors	 to	 deliver	 mosquitocidal	 toxins,	 as	 they	 are	 found	 in	 the	 breeding	 grounds	 for	mosquitoes	and	are	eaten	by	the	larvae	(Ruffing,	2011).	Anabaena	7120	was	found	to	be	a	suitable	host	for	the	expression	of	mosquitocidal	toxins	for	mass	production;	it	is	capable	of	 expressing	mosquitocidal	 toxin	 genes	 from	Bacillus	 thuringiensis	subsp.	israelensis	and	was	shown	to	still	be	larvicidal	4	years	after	the	construction	of	the	strains	(Lluisma	et	al.,	2001).		Cyanobacteria	has	also	been	engineered	for	the	potential	use	as	biosensors	to	measure	the	major	 limiting	 nutrients	 such	 as	 iron,	 phosphorus	 and	 nitrate	 that	 lead	 to	 toxic	 algae	blooms,	in	order	to	predict	their	occurrence	(Ruffing,	2011).	The	biosensors	would	often	involve	the	expression	of	the	luxAB	reporter	genes	under	a	nutrient	responsive	promoter	such	as	the	isiAB	iron	sensitive	promoter	that	was	tested	in	Synechococcus	7942	to	detect	
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the	levels	of	iron	in	Lake	Huron,	Canada	(Porta	et	al.,	2003).	Cyanobacteria	has	also	been	engineered	 to	detect	herbicides	and	heavy	metals	using	 the	expression	of	 the	 luciferase,	
luc,	 gene	 from	 firefly	 as	 the	 reporter	 (Shao	 et	 al.,	 2002).	 One	 issue	 with	 using	cyanobacteria	as	a	biosensor	 is	 the	promoter	and	 the	concentration	 it	detects	 the	 target	compound.		More	recently,	there	has	been	a	lot	of	interest	in	engineering	cyanobacteria	for	production	of	small	molecule	organics	such	as	ethanol	and	iso-butanol	that	could	be	used	as	biofuels.	This	is	further	discussed	in	the	next	section.				
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1.2 Production	of	chemicals	using	modified	cyanobacteria	
1.2.1 Overview	The	 world	 is	 heavily	 dependent	 on	 fossil	 fuels	 with	 these	 accounting	 for	 81.2%	 of	 all	energy	production	(International	Energy	Agency,	2016a).	It	is	recognised	that	fossil	fuels	such	as	coal,	oil	and	gas	are	finite	resources.	However,	fossil	fuel	consumption	continues	to	increase.	With	the	global	energy	demand	predicted	to	increase	by	37%	by	2040	from	2014	levels	(International	Energy	Agency,	2014),	 there	 is	a	greater	urgency	to	 find	alternative	sources	of	energy	to	cope	with	demand	in	the	future.		Oil	is	the	most	used	fuel	and	accounts	for	32.9%	of	global	energy	consumption	(BP,	2016;	International	 Energy	 Agency,	 2016b).	 Although	 solar,	 wind	 and	 wave	 can	 be	 used	 to	provide	 a	 renewable	 source	 of	 electrical	 energy	 and	 can	 help	 to	 reduce	 greenhouse	 gas	emissions,	renewable	liquid	fuels	such	as	biofuels	are	considered	the	only	replacement	for	transport	 fuels	 (i.e.	petrol,	diesel	and	 jet	 fuel)	unless	 there	 is	a	complete	overhaul	of	 the	transport	infrastructure	(Machado	and	Atsumi,	2012;	Quintana	et	al.,	2011).	Of	all	the	oil	consumed	 in	 2013,	 63.8%	was	 used	 for	 transport	 and	 16.2%	was	 for	 non-energy	 uses	(International	Energy	Agency,	2015).	Most	chemical	feedstocks	used	for	the	production	of	everyday	 products	 such	 as	 plastics,	 polystyrene	 and	 pharmaceuticals	 are	 also	 derived	from	 oil.	 Therefore	 alternative	 and	 sustainable	 methods	 for	 the	 production	 of	 these	chemicals	 are	 also	 needed	 (Erickson	 et	 al.,	 2012).	 Engineered	 microorganisms	 could	provide	an	alternative	‘bio-manufacturing’	technology	for	synthesis	of	these	chemicals.	To-date,	 the	majority	 of	work	has	 focused	on	 the	model	 organisms	Escherichia	coli	 (E.	coli)	and	 Saccharomyces	 cerevisiae	 (S.	 cerevisiae),	 as	 their	 genetics	 are	 well-characterised,	 a	wide	 range	of	genetic	engineering	 tools	are	available	and	 they	are	 facultative	anaerobes	with	fast	growth	rates	(Lee	et	al.,	2008).	However,	one	of	the	biggest	issues	with	using	S.	
cerevisiae	and	E.	coli	is	that	they	both	require	a	carbon	source,	usually	sugar,	which	comes	from	plants.	These	plants	then	compete	directly	for	land	and	resources	with	crops	that	are	required	 for	 food.	 Sugars	 obtained	 from	 breaking	 down	 non-edible	 crop	 materials,	 i.e.	lignocellulose,	 could	 be	 utilised	 instead	 however	 a	 viable	method	 for	 the	 production	 of	low-value	chemicals	such	as	bioethanol	and	biomethane	has	not	yet	been	found	(Machado	and	Atsumi,	2012).	Photosynthetic	 microorganisms	 such	 as	 algae	 and	 cyanobacteria	 have	 also	 generated	interest	as	a	potential	platform	for	the	production	of	organic	chemicals,	due	to	their	ability	to	fix	atmospheric	CO2	using	sunlight.	Other	potential	advantages	to	using	photosynthetic	microorganisms	 is	 the	 removal	 of	 atmospheric	 CO2,	 one	 of	 the	 main	 greenhouse	 gases	
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responsible	for	global	warming,	and	the	ability	of	photosynthetic	microorganisms	to	grow	on	 non-arable	 land	 (Machado	 and	 Atsumi,	 2012;	 Ruffing,	 2011).	 They	 also	 grow	 much	faster	 than	 plants	 and	 per	 hectare	 are	 expected	 to	 produce	 a	 higher	 yield	 (Nozzi	 et	 al.,	2013;	Quintana	et	al.,	2011).	Algae	 are	 eukaryotic	 organisms	 and	 some	 species,	 when	 stressed,	 are	 capable	 of	producing	large	amounts	of	neutral	lipids	that	can	be	converted	into	biodiesel	(Mubarak	et	al.,	 2015).	 However	 the	 genetic	 engineering	 of	 algae	 for	 the	 production	 of	 novel	compounds,	 is	 much	 more	 difficult	 in	 comparison	 to	 cyanobacteria.	 As	 prokaryotes,	cyanobacteria	 have	 smaller	 genomes	 than	 eukaryotic	 algae,	 and	 their	 genomes	 lack	introns	 and	 extensive	 intergenic	 regions.	 For	 some	 cyanobacterial	 species	 there	 are	established	protocols	for	the	transfer	of	DNA,	together	with	characterised	plasmid	vectors,	selection	markers	and	gene	expression	systems	(Elhai,	1994;	Koksharova	and	Wolk,	2002;	Vioque,	2007).	Other	advantages	to	using	cyanobacterial	species	are	their	ability	to	grow	in	 extreme	 environments	 and	 their	 simple	 nutrient	 requirements	 (Ruffing,	 2011).	Furthermore,	N2-fixing	species	do	not	 require	costly	nitrogen	 fertilisers	 that	 crops	need,	which	are	a	known	source	of	nitrous	oxide,	which	is	a	greenhouse	gas	that	has	a	damaging	effect	on	the	ozone	layer	(Machado	and	Atsumi,	2012).		
1.2.2 Chemical	production	in	cyanobacteria	As	shown	in	Table	1.1,	cyanobacteria	have	been	genetically	modified	to	produce	a	number	of	chemicals	at	lab-scale	(Machado	and	Atsumi,	2012;	Ruffing,	2011).	The	majority	of	the	work	 has	 been	 achieved	 using	 Synechococcus	 7942	 and	 Synechocystis,	 due	 to	 the	availability	of	an	annotated	reference	genome,	and	well-established	molecular	techniques	for	genetic	manipulation	(Rosgaard	et	al.,	2012).	Both	species	are	naturally	transformable	and	will	readily	import	exogenous	DNA	into	the	cell	and	efficiently	integrate	the	DNA	into	the	 genome	 via	 homologous	 recombination	making	 genetic	 engineering	 quick,	 easy	 and	predictable	 (see	 section	1.3	 for	 further	details)	 (Koksharova	and	Wolk,	2002).	However,	these	 strains	were	 not	 selected	 for	 their	 ability	 to	 produce	 novel	 compounds	 and	 other	strains	with	superior	 traits	 including	 the	ability	 to	 fix	nitrogen,	produce	hydrogen,	grow	quickly	 and	 accumulate	 biomass,	 may	 be	 more	 suitable	 for	 the	 production	 of	 novel	compounds.	 Leptolyngbya	 sp.	 strain	 BL0802	 was	 identified	 as	 a	 strain	 with	 traits	 that	would	 make	 it	 ideal	 for	 commercial	 production,	 such	 as	 growth	 at	 a	 wide	 range	 of	temperatures	and	tolerance	to	high	levels	of	light	and	salt.	The	strain	was	also	capable	of	accumulating	lipids	and	monounsaturated	fatty	acids	as	a	biodiesel	feedstock	(Taton	et	al.,	2012).			
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Table	 1.1	 Biofuels	 and	 high-value	 products	 produced	 in	 engineered	 strains	 of	
cyanobacteria.	
Chemical	 Use	 Cyanobacteria	
strain	
Reference	
Ethanol	 Biofuels	 Synechocystis	6803	 (Dexter	and	Fu,	2009)	
Synechococcus	7942	 (Deng	 and	 Coleman,	1999)	
1-Butanol	 Biofuels	 Synechococcus	7942	 (Lan	and	Liao,	2011)	
Alkanes/	Alkenes	 Biofuels	 Synechocystis	6803	 (Tan	et	al.,	2011)	
Ethylene	 Platform	chemicals		 Synechococcus	7942	 (Sakai	 et	 al.,	 1997;	Takahama	et	al.,	2003)	
Synechocystis	6803	 (Ungerer	et	al.,	2012)	
Isobutanol	 Biofuel	 and	platform	chemical	 Synechococcus	7942	 (Atsumi	et	al.,	2009)	Synechocystis	6803	 (Varman	et	al.,	2013)	
Isobutyraldehyde	 Biofuel	 and	platform	chemical	 Synechococcus	7942	 (Atsumi	et	al.,	2009)	
Isoprene	 Biofuel	 and	platform	chemical	 Synechocystis	6803	 (Lindberg	et	al.,	2010)	
2,3-butanediol	 Biofuel	 and	platform	chemical	 Synechococcus	7942	 (Oliver	et	al.,	2013)	Synechocystis	6803	 (Savakis	et	al.,	2013)	
Fatty	acids		 Biofuel	 Synechocystis	6803	 (Liu	et	al.,	2011a)	
Synechococcus	7942	 (Kaiser	et	al.,	2013)	
Fatty	Alcohols	 Biofuel	 Synechocystis	6803	 (Tan	et	al.,	2011)	
Squalene	 Cosmetics,	vaccines,	 potential	feedstock	chemicals	
Synechocystis	6803	 (Englund	et	al.,	2014)	
Lactic	acid	 Biofuel	 and	platform	chemical	 Synechocystis	6803	 (Angermayr	et	al.,	2012)	Synechococcus	7942	 (Niederholtmeyer	 et	 al.,	2010)	
2-methyl-1-
butanol	
Biofuel	 Synechococcus	7942	 (Shen	and	Liao,	2012)	
	Sucrose	 Feedstock	 for	bioethanol	fermentation	 Synechocystis	6803	 (Du	et	al.,	2013)	Synechococcus	7942	 (Ducat	et	al.,	2012)	
Glycerol	 Platform	chemical	 Synechocystis	6803	 (Savakis	et	al.,	2015)	
β-carophyllene	 Fragrance	 and	cosmetics	 Synechocystis	6803	 (Reinsvold	et	al.,	2011)	
β-phellanderene	 Fragrance	 Synechocystis	6803	 (Bentley	et	al.,	2013a)	
Mannitol	 Food	 and	pharmaceutical	industry	 Synechococcus	 sp.	PCC	7002	 (Jacobsen	 and	 Frigaard,	2014)	
Isopropanol	 Platform	chemical	 Synechococcus	7942	 (Kusakabe	et	al.,	2013)	
1,2-Propanediol	 Antifreeze,	cosmetics,	plastics	 Synechococcus	7942	 (Li	and	Liao,	2013)	
1,3-Propanediol	 Platform	chemical	 Synechococcus	7942	 (Hirokawa	et	al.,	2016)	
Acetone	 Platform	chemical	 Synechocystis	6803	 (Zhou	et	al.,	2012)	
Cellulose	 Feedstock	 for	bioethanol	fermentation	 Synechococcus	leopoliensis	 strain	UTCC	100	 (Nobles	 and	 Brown,	2008)	
Synechococcus	 sp.	PCC	7002	 (Zhao	et	al.,	2015)	
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Chemical	 Use	 Cyanobacteria	
strain	
Reference	
Glycogen	 Feedstock	 for	bioethanol	fermentation	 Synechococcus	 sp.	PCC	7002	 (Aikawa	et	al.,	2014)	
Farnesene	 Biofuels	 and	fragrances/	cosmetics/	lubricants	
Anabaena	7120	 (Halfmann	et	al.,	2014a)	
3-
hydroxybutyrate	
(PHB)	
Plastic	 Synechococcus	7942	 (Suzuki	et	al.,	1996)		
Synechocystis	6803	 (Tyo	et	al.,	2009)	
Synechococcus	 sp.	MA19	 (Nishioka	et	al.,	2001)	
Synechococcus	 sp.	PCC	7002	 (Zhang	et	al.,	2015)	
	
1.2.2.1 Biofuels	and	biofuel	feedstocks	Biofuels	are	defined	as	fuels	that	are	derived	from	biomass,	including	any	organic	material	from	 life	 forms	 or	 its	 metabolic	 products	 (Quintana	 et	 al.,	 2011).	 Two	 commercially	available	biofuels	are	bioethanol,	produced	from	corn	starch	or	sugar	cane,	and	biodiesel	produced	 from	 vegetable	 oils	 and	 fats.	 However,	 both	 of	 these	 biofuels	 are	 not	 ideal	replacements	 for	 existing	 fuels,	 as	 bioethanol	 is	 difficult	 to	 transport,	 has	 only	 70%	 the	energy	density	of	petrol	and	is	hygroscopic	(Nozzi	et	al.,	2013;	Peralta-Yahya	et	al.,	2012).	Biodiesel	is	also	difficult	to	transport	due	to	problems	of	solidification	at	low	temperatures,	is	not	as	energy	dense	as	diesel	and	in	cold	weather	biodiesel	can	also	clog	up	fuel	lines	in	vehicles	(Peralta-Yahya	et	al.,	2012).		The	focus	for	‘next	generation	biofuels’	is	therefore	advanced	fuel	molecules	produced	by	genetically	 engineered	microorganisms	 such	 as	 cyanobacteria.	 These	 biofuels	 would	 be	hydrocarbons	 that	 have	 similar	 properties	 to	 petroleum-based	 fuels	 and	 can	 be	 used	directly	as	‘drop-in’	fuels	with	existing	engine	technologies.	Such	fungible	biofuels	include	compounds	such	as	butanol	and	higher	alcohols,	linear	and	cyclic	alkane	and	alkenes,	and	branched	isoprenoid	hydrocarbons	(Table	1.2).		
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Table	 1.2	 Table	 of	 the	 components	 present	 in	 current	 transport	 fuels,	 and	 the	 ideal	
properties	required	when	choosing	alternatives.	Table	from	(Lee	et	al.,	2008).	
	
	One	of	the	first	attempts	of	biofuel	production	in	cyanobacteria	was	in	1999	when	ethanol	was	produced	 in	Synechococcus	7942	after	 expressing	genes	 for	pyruvate	decarboxylase		(pdc)	 and	 alcohol	 dehydrogenase	 (adh)	 from	 Zymomonas	 mobilis	 (Deng	 and	 Coleman,	1999).	Since	then,	ethanol	has	also	been	produced	in	Synechocystis	by	expressing	the	same	genes	under	 the	 control	of	 the	psbAII	 promoter	 (Dexter	and	Fu,	2009).	A	number	of	 the	biofuels	produced	in	cyanobacteria	have	utilised	the	natural	metabolic	pathways	already	present,	only	requiring	the	additional	expression	of	a	few	genes	in	most	cases	(Figure	1.6)	(Ruffing,	 2011).	 Fatty	 acids,	 fatty	 alcohols,	 alkanes	 and	 alkenes	 are	 just	 a	 few	 potential	biofuels	that	been	produced	in	cyanobacteria	(Kaiser	et	al.,	2013;	Liu	et	al.,	2011a;	Tan	et	al.,	2011)	
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Figure	 1.6	 Metabolic	 pathways	 present	 in	 cyanobacteria	 utilised	 for	 the	 production	 of	
biofuels	and	other	high-value	products.		The	solid	arrows	indicate	enzymes	that	are	naturally	found,	whereas	the	dashed	arrow	requires	the	expression	of	a	recombinant	enzyme.	In	the	dashed	boxes	are	the	products	that	have	been	or	could	be	produced	in	cyanobacteria.	Figure	modified	from	(Ruffing,	2011).	 Abbreviation:	 GPP	 –	 geranyl	 diphosphate;	 IPP	 –	 isopentenyl	 pyrophosphate;	DMAPP	 –	 dimethylallyl	 pyrophosphate;	 HMBPP	 -	 1-hydroxy-2-methyl-2-butenyl-4-pyrophosphate;	 Me-CPP	 -	 4-diphosphocytidyl-2-C-methylerythritol;	 CDP-MEP	 -	 4-diphosphocytidyl-2-C-methyl-D-erythritol	 2-phosphate;	 CDP-ME	 -	 2-C-methyl-D-erythritol	 2,4-cyclodiphosphate;	 MEP	 -	 2-C-methylerythritol	 4-phosphate;	 DXP	 -	 1-deoxy-D-xylulose	 5-phosphate	 ;	 GAP	 -	 glyceraldehyde	 3-phosphate;	 3-PGA	 -	 	 3-phosphoglyceric	 acid;	 RuBP	 -	 ribulose-1,5-bisphosphate;	 F6P	 -	 fructose	 6-phosphate;	Glc	-	glucose;	PPP	-	pentose	phosphate	pathway;	PEP	–	phosphoenolpyruvic	acid;	PYR	–	Pyruvate;	 AA	 –	 amino	 acids;	 2-AL	 –	 2-acetolactate;	 2,3-DHIV	 -2,3-dihydroxy-isovalerate;	 2-KIV	 -	 2-ketoisovalerate;	 Val	 –	 valine;	 IBA-	 isobutyraldehyde	 ;	 IBOH	 -	isobutanol	 ;	 OAA	 -	 oxaloacetic	 acid;	 2-OG	 –	 2-oxoglutarate;	 acetyl-CoA	 –	 acetyl	coenzyme	A	;	acyl-ACP	–	acyl-acyl	carrier	protein	;	acyl-A	–	acyl-aldehyde	;	FFA	–	free	fatty	acids.		1-Butanol	production	in	Synechocystis	7942	was	successfully	achieved	by	expressing	five	genes,	 three	 of	 which	 are	 from	 Clostridium	 acetobutylicum,	 a	 bacterium	 capable	 of	naturally	producing	1-butanol	 (Lan	and	Liao,	 2011).	Butanol	 is	 thought	 to	be	 a	possible	
Figure	removed	
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replacement	 for	 gasoline,	 as	 it	 is	 more	 energy	 dense	 than	 ethanol	 and	 has	 low	hygroscopicity	(Lan	and	Liao,	2011).		Isobutyraldehyde	is	a	useful	chemical	feedstock	as	it	can	be	converted	 into	a	number	of	products	such	as	 isobutanol,	a	potential	 replacement	for	petrol	that	is	usually	derived	from	oil.	Both	isobutyraldehyde	and	isobutanol	have	been	successfully	 produced	 in	 Synechococcus	 7942.	 Isobutanol	 has	 also	 been	 produced	 in	
Synechocystis	 after	 expressing	 two	 genes,	 to	 produce	 a	 yield	 of	 298	 mg/L	 under	mixotrophic	culture	conditions	(Varman	et	al.,	2013).		The	 production	 of	 biofuel	 feedstocks	 in	 cyanobacteria	 has	 also	 been	 investigated.			Cellulose,	a	natural	product	of	plants,	can	be	used	as	a	 feedstock	 for	microorganisms	for	the	production	 of	 biofuels	 once	 it	 has	 been	broken	down	 into	 smaller	 sugars.	 The	 issue	with	plant-produced	cellulose	is	that	it	is	associated	with	lignin	and	hemicellulose,	making	it	difficult	to	break	down.	Cellulose	is	also	a	component	of	some	cyanobacterial	cell	walls	and	 its	 over-production	by	 genetic	 engineering	 yields	 lignin-free	 cellulose	 from	 sunlight	and	CO2	that	could	potentially	be	used	for	biofuels	and	other	biotechnological	applications	(Nobles	and	Brown,	2008;	Zhao	et	al.,	2015).	The	over-production	and	secretion	of	simple	sugars	such	as	sucrose,	glucose	and	fructose	that	are	naturally	made	in	cyanobacteria,	has	also	 been	 achieved	 and	 can	 be	 utilised	 as	 carbon	 source	 for	 other	 microbes	 for	 the	production	of	biofuels	(Du	et	al.,	2013;	Ducat	et	al.,	2012;	Niederholtmeyer	et	al.,	2010).		
1.2.2.2 High-value	chemicals		With	 the	 average	 price	 of	 oil	 in	 2015	 at	 its	 lowest	 level	 since	 2004	 (BP,	 2016),	 the	production	 of	 biofuels	 cannot	 compete	 with	 the	 low	 cost	 of	 oil.	 There	 are	 also	 major	questions	over	whether	 the	production	of	biofuels	 in	cyanobacteria	can	be	economically	feasible	 (Ducat	 et	 al.,	 2011a;	 Ruffing,	 2011).	 Therefore,	 the	 current	 focus	 is	 on	 the	production	 of	 high-value	 chemicals	 in	 cyanobacteria,	 whilst	 the	 technology	 for	 biofuels	continues	to	be	developed	(Ducat	et	al.,	2011a).	Some	of	the	high-value	products	that	have	been	produced	in	cyanobacteria	are	discussed	further	below.	An	early	attempt	was	made	in	Synechocystis	to	overexpress	native	genes	that	encode	enzymes	involved	in	carotenoid	biosynthesis	as	there	is	commercial	interest	in	the	use	of	these	natural	pigments	and	anti-oxidants	in	the	food,	cosmetic,	nutraceutical	and	pharmaceutical	 industry	(Lagarde	et	al.,	2000).		Ethylene	is	one	of	the	most	widely	used	chemicals;	it	is	used	for	the	production	of	plastics	such	 as	 polyethylene	 and	 polyester,	 and	 is	 used	 to	 produce	 industrial	 grade	 ethanol	(Ungerer	et	al.,	2012).	Ethylene	is	produced	from	steam	cracking	long	chain	hydrocarbons	from	petroleum	and	this	results	in	the	production	of	significant	amounts	of	CO2	waste.	The	
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production	of	 ethylene	was	achieved	 in	Synechococcus	7942	by	 introducing	 the	efe	 gene	from	Pseudomonas	syringae,	which	encodes	an	ethylene-forming	enzyme	that	converts	2-oxoglutarate	 into	 ethylene	 and	 carbon	 dioxide	 (Takahama	 et	 al.,	 2003).	 However,	 the	strain	 producing	 ethylene	 was	 not	 genetically	 stable	 (Takahama	 et	 al.,	 2003).	 Changes	were	 made	 to	 efe	 before	 the	 production	 of	 ethylene	 was	 achieved	 in	 Synechocystis	(Ungerer	et	al.,	2012).		Isoprene	is	a	platform	chemical	used	to	produce	a	number	of	other	high	value	chemicals.	It	can	be	polymerised	to	make	a	synthetic	rubber,	and	there	is	also	interest	 in	using	it	as	a	biofuel	 (Ducat	 et	 al.,	 2011a;	 Wang	 et	 al.,	 2012).	 Isoprene	 is	 produced	 in	 plants	 from	dimethylallyl	 pyrophosphate	 (DMAPP),	 which	 is	 synthesised	 via	 either	 the	methylerythritol	4-phosphate	(MEP)	pathway	or	the	mevalonate	(MVA)	pathway	(Figure	1.7).	 Like	 other	 prokaryotes,	 cyanobacteria	 contain	 only	 the	 MEP	 pathway,	 and	 by	introducing	an	 isoprene	synthase	 into	Synechocystis,	 isoprene	was	successfully	produced	(Lindberg	et	al.,	2010).	The	yield	of	isoprene	was	further	improved	2.5	fold,	by	introducing	a	heterologous	MVA	pathway	into	Synechocystis	(Bentley	et	al.,	2013b).		The	 success	 of	 isoprene	 production	 has	 drawn	 interest	 into	 the	 production	 of	 terpenes	and	 terpenoids	 in	 cyanobacteria.	 Terpenoids,	 often	 referred	 to	 as	 isoprenoids,	 are	modified	terpenes.	Terpenes	are	made	up	of	units	of	isoprene	(C5H8),	although	isopentenyl	pyrophosphate	(IPP)	and	DMAPP	are	the	building	blocks	for	terpenes.	IPP	like	DMAPP	is	produced	from	either	the	MEP	or	MVA	pathway.	Both	terpenes	and	terpenoids	have	useful	applications	 in	 medicines,	 fragrances,	 flavourings,	 cosmetics	 and	 as	 potential	 biofuels	(Pattanaik	 and	 Lindberg,	 2015).	 Squalene	 is	 a	 30-carbon	 isoprenoid	 that	 is	 used	 in	 the	cosmetic	 industry	 and	 has	 potential	 use	 as	 a	 replacement	 for	 petrol.	 It	 is	 naturally	produced	 in	Synechocystis,	 but	 is	usually	 converted	 to	hopene.	 	A	genetically	engineered	strain	 inactivating	 the	 gene	 predicted	 to	 encode	 squalene	 hopene	 cylase	 led	 to	 the	accumulation	of	squalene,	70	times	higher	than	levels	seen	in	wild-type	cells	(Englund	et	al.,	2014).			Poly-β-hydroxybutyrates	 (PHB)	 are	 thought	 to	 be	 promising	 replacements	 for	 plastics,	which	 are	 currently	 produced	 from	 fossil	 fuels	 (Ruffing,	 2011).	 One	 of	 the	 major	advantages	of	using	PHB	and	other	polyhydroxyalkanoates	as	replacements	for	plastic	 is	that	 they	 are	 biodegradable,	 making	 these	 materials	 a	 more	 environmentally	 friendly	product	 (Samantaray	 et	 al.,	 2014).	 PHB	 is	 naturally	 produced	 in	 some	 strains	 of	cyanobacteria	 and	 usually	 the	 yield	 is	 quite	 low.	 However,	 Synechococcus	 sp.	 MA19	naturally	accumulates	PHB	up	to	27%	of	dry	cell	weight	(Miyake	et	al.,	2000;	Panda	and	Mallick,	 2007).	 Attempts	 to	 increase	 the	 production	 of	 PHBs,	 by	 altering	 the	 culture	
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conditions	 demonstrated	 that	 growth	 in	 media	 deficient	 in	 nitrogen	 and	 phosphorus	resulted	in	increase	accumulation	(Panda	and	Mallick,	2007).		
	
Figure	1.7	MVA	and	MEP	pathway	present	in	plants.	Figure	 from	 (Vranová	 et	 al.,	 2013).The	 MVA	 pathway	 (in	 yellow)	 is	 not	 present	 in	cyanobacteria	but	 the	MEP	pathway	(in	green	 )	 is	present	and	can	be	utilised	 for	 the	production	of	terpenes	and	terpenoids.			
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1.2.3 Challenges	and	opportunities	Although	cyanobacteria	have	been	successfully	engineered	to	produce	biofuels	and	other	chemicals	at	 the	 lab-scale	 there	are	 still	 significant	 challenges	 that	need	 to	be	overcome	before	 commercialisation	 (Parmar	 et	 al.,	 2011).	 There	 are	 some	 technical	 challenges,	regarding	 cultivation	 and	 harvesting,	 and	 ecological	 challenges	 to	 ensure	 the	environmental	 benefits	 of	 using	 cyanobacteria	 are	 achieved.	 There	 are	 also	 economic	challenges	related	to	the	cost	of	scaling	up	production	(Parmar	et	al.,	2011).	This	section	will	 focus	 on	 some	 of	 the	 challenges	 faced	 by	 producing	 novel	 compounds	 in	cyanobacteria	 and	 the	 potential	 opportunities	 for	 improvement	 through	 genetic	engineering.			
1.2.3.1 Photosynthesis	As	 photosynthesis	 is	 driving	 the	 production	 of	 biofuels	 and	 high-value	 products	 in	cyanobacteria,	improving	the	photosynthetic	efficiency	when	growing	cells	in	dense,	large-scale	 monocultures	 has	 the	 potential	 to	 improve	 yield.	 Improving	 light	 harvesting	 CO2	fixation	and	the	CCM	in	cyanobacteria	are	all	strategies	that	have	been	investigated.			When	 attempting	 to	 produce	 large-scale	 cultures	 of	 cyanobacteria	 under	 phototrophic	growth	conditions,	the	light-harvesting	pigments	can	become	a	problem	due	to	excessive	photon	 capture	 by	 the	 cells	 at	 the	 surface	 that	 then	 block	 light	 availability	 to	 the	 cells	below	(Wang	et	al.,	2012).	The	absorbed	excess	light	energy	is	dissipated	as	heat	and	can	result	in	reduced	photosynthesis	by	photoinhibition,	due	to	damage	to	the	photosynthetic	proteins	 by	 high	 light	 (Ruffing,	 2011).	 Attempts	 have	 been	made	 to	 reduce	 the	 antenna	size	 (Cotton	 et	 al.,	 2015).	 However,	 Synechocystis	 strains	 that	 were	 engineered	 to	 be	deficient	 in	 phycobilisomes,	 were	 not	 useful	 for	 improving	 the	 production	 of	 biomass	unless	carbon	was	limited	(Lea-Smith	et	al.,	2014).		RuBisCO,	 the	enzyme	responsible	 for	 fixing	CO2	 is	 thought	 to	be	the	rate-limiting	step	to	carbon	 fixation	 (Jensen,	 2000).	 When	 isobutyraldehyde	 production	 from	 CO2	 was	successfully	 achieved	 in	 Synechococcus	 7942,	 the	 production	 was	 further	 increased	 by	expressing	the	rbcLS	genes	encoding	RuBisCO,	 from	the	related	strain	S.	elongatus	 strain	PCC6301	 (Atsumi	et	 al.,	 2009).	 In	 this	 case	 the	 rate	of	O2	produced	 from	photosynthesis	did	not	increase	so	the	increased	carbon	fixation	may	be	due	to	a	more	efficient	use	of	the	reducing	power	generated	 from	photosynthesis.	 In	Synechocystis,	 a	mutant	RuBisCO	was	introduced,	 that	 had	 an	 improved	 activity	 but	 less	 specificity	 for	 CO2	 over	 O2,	 however	there	was	no	growth	improvement	and	less	RuBisCO	was	present	in	the	cells	(Durão	et	al.,	2015).			
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1.2.3.2 Toxicity	One	of	the	major	problems	with	attempting	to	produce	biofuels	and	high	value	products	in	microorganisms	is	product	toxicity.	Therefore,	it	is	important	to	try	and	alleviate	any	toxic	effects	as	this	could	limit	production	(Dunlop,	2011).	Most	of	the	work	on	product	toxicity	has	 focussed	 on	 biofuel	 toxicity,	 particularly	 towards	 E.	 coli	 and	 S.	 cerevisiae	 (Dunlop,	2011).	Not	all	biofuels	are	toxic,	and	the	antimicrobial	effect	of	biofuels	is	thought	to	relate	to	 how	 hydrophobic	 the	 molecule	 is,	 as	 this	 determines	 how	much	 accumulates	 in	 the	cytoplasmic	membrane	(Brennan	et	al.,	2012;	Dunlop,	2011).	Most	biofuels	interfere	with	the	 cell	 membrane	 and	 result	 in	 increased	 permeability	 of	 the	 cell,	 which	 then	 affects	physiological	 processes.	 Some	 biofuels	 may	 interfere	 with	 membrane	 proteins,	 altering	the	 fluidity	 of	 the	 membrane,	 which	 then	 affects	 the	 stability	 and	 structure	 of	 the	 cell	(Dunlop,	2011).		Attempts	 have	 been	made	 to	 reduce	 the	 toxic	 effect	 of	 biofuels	with	 some	 success.	 The	heterologous	expression	of	an	efflux	pump	in	E.	coli	improved	survival	in	the	presence	of	limonene	and	also	increased	levels	of	production	(Dunlop	et	al.,	2011).	In	S.	cerevisiae,	the	toxic	effect	of	limonene	was	alleviated	using	non-toxic	solvents	such	as	dibutyl	phthalate,	dioctyl	phthalate,	 isopropyl	myristate	and	 farnesene	acting	as	an	organic	phase	over	 the	aqueous	medium	(Brennan	et	al.,	2012).	This	strategy	could	also	help	in	the	extraction	and	recovery	of	the	biofuels.	Overexpression	of	heat	shock	proteins	and	molecular	chaperones	that	prevent	protein	aggregation	during	heat	shock,	could	also	be	employed	to	reduce	the	toxic	effect	of	biofuels	(Dunlop,	2011).	
1.2.3.3 Improving	the	molecular	techniques	required	for	metabolic	engineering.	Product	 yields	 could	 be	 further	 improved	 in	 engineered	 cyanobacteria	 by	 applying	synthetic	 biology	 and	 systems	 biology	 approaches.	 This	 is	 discussed	 further	 in	 the	 next	section,	along	with	the	current	tools	that	are	available	in	cyanobacteria.		
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1.3 Genetic	engineering	of	cyanobacteria	As	detailed	in	the	previous	sections,	a	few	strains	of	cyanobacteria	have	been	genetically	engineered	 for	 the	 production	 of	 biofuels	 and	 high-value	 products.	 The	molecular	 tools	available	 to	 introduce	 foreign	 DNA	 into	 cyanobacteria	 and	 engineer	 changes	 in	endogenous	genes,	have	been	developed	for	a	number	of	model	strains	as	follows:		
1.3.1 Transformation	of	cyanobacteria	There	are	 three	methods	 that	 can	be	used	 to	 introduce	DNA	 into	 cyanobacteria;	natural	transformation,	electroporation	and	conjugation.		The	 ability	 of	 Synechocystis	 to	 naturally	 take	 up	 DNA	 from	 the	 medium	 and	 efficiently	integrate	 this	 DNA	 into	 the	 genome	 by	 homologous	 recombination	 is	 one	 of	 the	 main	reasons	why	 this	species	 is	used	as	a	model	organism	for	cyanobacteria	(Grigorieva	and	Shestakov,	 1982;	 Ikeuchi	 and	 Tabata,	 2001).	 Unicellular	 cyanobacteria	 such	 as	
Synechocystis,	 Synechococcus	 7942,	 Synechococcus	 PCC	 7002	 (Synechococcus	 7002)	 and	
Thermosynechococcus	elongatus	BP-1	are	just	some	of	the	strains	of	cyanobacteria	that	are	naturally	transformable.	With	natural	transformation,	DNA	(on	a	plasmid	or	as	linear	DNA)	is	naturally	taken	up	from	the	media.	DNA	can	then	integrate	into	the	genome	by	double	homologous	 recombination,	 which	 is	 favoured	 compared	 to	 single	 homologous	recombination	 (Figure	 1.8)	 (Heidorn	 et	 al.,	 2011).	 The	 mechanism	 of	 natural	transformation	 is	not	 clear,	 although	 it	 is	 thought	 to	 involve	DNA	 in	 its	 single	 stranded-form	in	Synechocystis	(Barten	and	Lill,	1995).	In	Synechocystis,	the	gene	slr0197	is	thought	to	encode	a	DNA-binding	protein	and	is	required	for	DNA	uptake	along	with	the	presence	of	 pili	 (Yoshihara	 et	 al.,	 2001).	 After	 finding	 homologs	 of	 pili	 and	 other	 genes	 vital	 for	natural	transformation	in	Synechocystis	present	in	Thermosynechococcus	elongatus	BP-1,	a	method	was	developed	for	naturally	transforming	this	strain	(Iwai	et	al.,	2004).			In	 Synechocystis,	 natural	 transformation	 was	 demonstrated	 to	 be	 the	 most	 efficient	method	 in	 comparison	 to	 conjugation	 and	 electroporation	 (Zang	 et	 al.,	 2007).	Transformation	success	was	improved	when	cells	were	transformed	during	mid	log	phase	and	when	 the	 cells	were	 incubated	with	DNA	 for	 5	 hours	 before	 plating	 onto	 antibiotic	free	media	to	allow	cells	to	recover	(Zang	et	al.,	2007).	Transformation	with	circular	DNA	was	also	found	to	be	more	successful	than	using	linearized	DNA	(Kufryk	et	al.,	2002).		
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Figure	 1.8	 Foreign	 DNA	 can	 be	 inserted	 into	 the	 cyanobacteria	 genome	 by	 (A)	 double	
homologous	recombination	or	(B)	single	homologous	recombination.		In	(A)	the	G.O.I.	replaces	the	WT	gene	and	in	(B)	the	entire	plasmid	integrates	into	the	genome.			Both	 conjugation	 and	 electroporation	 can	 be	 used	 to	 introduce	 DNA	 into	 cyanobacteria	strains	 that	 are	not	naturally	 transformable.	These	 two	methods	 can	also	be	used	when	single	recombination	is	required	or	when	introducing	a	replicative	plasmid	(Heidorn	et	al.,	2011).	
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Conjugation	 with	 E.	 coli	 is	 often	 used	 in	 filamentous	 cyanobacteria	 strains	 such	 as	
Anabaena	 and	 Nostoc	 strains	 and	 can	 be	 used	 in	 the	 unicellular	 strains	 Synechococcus	7942,	Synechococcus	PCC	6301	and	Synechocystis	(Flores	and	Wolk,	1985;	Mühlenhoff	and	Chauvat,	1996;	Tsinoremas	et	al.,	1994;	Wolk	et	al.,	1984).	Conjugation	usually	uses	 two	strains	of	E.	coli	(Figure	1.9).	One	strain	contains	the	conjugative	plasmid	that	carries	the	genes	that	enable	the	transfer	of	DNA.	The	other	strain	contains	the	cargo	plasmid	and	the	helper	 plasmid.	 The	 cargo	 plasmid	 contains	 the	 DNA	 to	 be	 introduced	 into	 the	cyanobacteria	and	also	the	oriT	site.	The	mob	gene	is	also	required	as	it	encodes	a	nickase	that	 recognises	 the	 oriT	 site	 and	 enable	 the	 transfer	 of	 the	 cargo	 plasmid	 into	cyanobacteria,	 although	 this	 can	be	provided	 in	trans	 on	 the	helper	plasmid.	The	helper	plasmid	also	contains	genes	for	DNA	methylases	that	protect	the	foreign	DNA	from	being	degraded	 by	 the	 host	 cyanobacteria’s	 restriction	 enzymes	 (Elhai,	 1994;	 Elhai	 and	Wolk,	1988;	Vioque,	2007).	The	cargo	plasmid	can	be	a	replicative	plasmid	or	contain	DNA	that	is	capable	of	integrating	by	recombination	or	transposition	(see	Plasmid	vectors	for	more	details).		
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Figure	1.9.	Triparental	mating	procedure	used	to	introduce	DNA	into	cyanobacterial	cells	
by	conjugation.		G.O.I.,	Gene	of	interest.	Figure	was	adapted	from	(Vioque,	2007).	In	Anabaena	PCC	7120,	double	recombination	events	using	conjugation	do	not	take	place	however	the	use	of	the	sacB	gene,	which	is	lethal	when	cells	are	grown	in	the	presence	of	sucrose,	 can	 eventually	 result	 in	 the	 production	 of	 double	 recombinants	 (Cai	 and	Wolk,	1990).		Electroporation	can	also	be	used	to	introduce	a	plasmid	into	some	strains	of	cyanobacteria,	such	 as	 Anabaena	 (Thiel	 and	 Poo,	 1989).	 Electroporation	 works	 by	 sending	 a	 pulse	 of	electricity	in	order	to	open	pores	in	the	cell	membrane	for	DNA	to	enter.	Electroporation	is	also	possible	for	freshwater	and	marine	Synechococcus	strains,	and	can	be	improved	with	CaCl2	treatment	(Matsunaga	and	Takeyama,	1994).	One	of	the	 issues	with	this	method	is	that	is	may	lead	to	mutations	in	the	genome	(Elhai,	1994).		
1.3.1.1 Segregation		Some	cyanobacteria	contain	multiple	copies	of	the	chromosome	in	each	cell	(Griese	et	al.,	2011;	 Labarre	 et	 al.,	 1989).	As	 aforementioned	 the	 copy	number	 in	Synechocystis	 varies	greatly	 depending	 on	 the	 growth	 phase	 and	 the	 environment	 (Zerulla	 et	 al.,	 2016).	 The	number	 of	 genome	 copies	 also	 varies	 in	 Synechococcus	dependent	 on	 the	 growth	 phase	
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(Watanabe	et	al.,	2015).	Therefore	when	foreign	DNA	is	inserted	into	a	copy	of	the	genome	by	 homologous	 recombination,	 continued	 rounds	 of	 selection	 may	 be	 required	 to	segregate	the	genome	to	the	homoplasmic	state,	where	all	copies	contain	the	insertion	and	no	wild-type	copies	remain.	Once	all	copies	of	the	genome	contain	the	gene,	the	selection	pressure	no	 longer	needs	 to	be	maintained.	 If	 complete	 segregation	 is	 not	 possible,	 and	copies	 of	 the	 insertion	 and	 the	 wild-type	 persist,	 this	 state	 is	 referred	 to	 as	 persistent	heteroplasmy,	and	suggests	that	the	wild-type	version	of	the	targeted	locus	is	essential	for	cell	viability	(Vermaas,	1996).	
1.3.2 Plasmid	vectors	There	are	two	types	of	plasmid	vector	that	are	used	to	introduce	DNA	into	cyanobacteria:	integrative	 and	 replicative	 vectors.	 Integrative	 vectors	 carry	 foreign	 DNA	 that	 can	 then	integrate	 into	 the	 cyanobacterial	 genome	 by	 homologous	 recombination,	 whereas	replicative	vectors	are	able	to	replicate	in	the	host	and	are	passed	onto	the	daughter	cells.	They	 are	 therefore	 able	 to	 maintain	 foreign	 DNA	 without	 integration	 into	 the	 main	chromosome	(Heidorn	et	al.,	2011).		1.3.2.1.1 Replicative	plasmids	Since	molecular	 cloning	 takes	place	 in	E.	coli,	 a	 shuttle	vector	 that	 is	 able	 to	 replicate	 in	both	E.	coli	and	the	cyanobacteria	host	is	required.	There	are	two	types	of	shuttle	vectors	that	 are	 used	 in	 cyanobacteria:	 those	 that	 contain	 a	 broad	host	 replicon,	 and	 those	 that	contain	an	E.	coli	cloning	plasmid	replicon	and	a	cyanobacteria-specific	replicon.	Examples	of	the	latter	type	are:	i)	pSCR119,	which	contains	the	replicon	pDC1	from	Nostoc	sp.	MAC	8009	and	the	pMB1	E.	coli	replicon;	ii)	pUC303,	which	contains	the	pUH24	replicon	from	
Synechocystis	7942	and	the	p15A	E.	coli	replicon	(Kuhlemeier	et	al.,	1983;	Summers	et	al.,	1995).	 Broad-host	 range	 plasmids	 usually	 contain	 the	 replicon	 derived	 from	 the	incompatibility	 group	 Q	 (IncQ)	 plasmid	 RSF1010.	 Shuttle	 vectors	 pFC1,	 pSL1211	 and	pPMQAK1	are	a	few	examples	of	replicative	plasmids	and	all	contain	the	RSF1010	replicon	(Wang	 et	 al.,	 2012).	 The	 pPMQAK1	 has	 been	 demonstrated	 to	 be	 functional	 in	
Synechocystis,	Anabaena	7120	 and	Nostoc	ATCC29133	 (Huang	 et	 al.,	 2010).	 To	maintain	the	presence	of	the	replicative	plasmids,	antibiotic	selection	is	required.	The	copy-number	of	 the	plasmid	needs	 to	be	 considered	when	 selecting	a	 suitable	plasmid.	Plasmids	with	the	RSF1010	replicon	have	been	demonstrated	as	having	10	copies	in	E.	coli	and	10	–	30	copies	in	Synechocystis	(Marraccini	et	al.,	1993;	Ng	et	al.,	2000).		When	expressing	genes	on	a	replicative	plasmid,	antibiotic	selection	 is	often	required	 to	maintain	the	presence	of	the	plasmid.	However,	maintaining	the	antibiotic	selection	for	a	
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large	culture	can	become	costly.	In	Synechococcus	7002,	a	method	was	established,	where	antibiotics	 would	 not	 need	 to	 be	 used,	 to	 maintain	 the	 replicating	 plasmid	 by	complementing	a	lethal	recA	null	mutant	with	an	E.	coli	recA	gene	present	on	the	plasmid	(Akiyama	et	al.,	2011).		1.3.2.1.2 Integrative	vectors	Integrative	 vectors	 are	 non-replicating	 plasmids	 and	 are	 therefore	 lost	 from	 the	cyanobacterial	 population	 during	 cell	 division,	 so	 the	 DNA	 needs	 to	 integrate	 into	 the	genome.	Any	plasmid	can	be	used	to	transfer	DNA	into	the	host	strain.	Integrative	vectors	insert	DNA	into	the	genome	at	a	specific	location	by	homologous	recombination.	DNA	can	integrate	by	single	or	double	homologous	recombination	depending	on	the	cyanobacteria	strain	 (Vioque,	2007).	The	host-homologous	DNA	elements	 flanking	 the	 introduced	DNA	determine	 the	 recombination	 site.	 The	 minimum	 length	 of	 these	 elements	 differs	 for	different	 strains	 of	 cyanobacteria,	 although	 it	 is	 generally	 thought	 that	 increasing	 the	flanking	region	increases	the	efficiency	of	recombination	(Zang	et	al.,	2007).		When	DNA	is	introduced	into	the	genome	the	target	site	chosen	is	often	a	neutral	site	that	does	not	negatively	affect	the	strain.	This	could	be	an	intergenic	site	or	could	involve	the	disruption	 (or	 replacement)	 of	 a	 non-essential	 gene.	 The	psbAII	gene	 is	 often	 used	 as	 a	neutral	site	in	Synechocystis	as	the	deletion	of	this	gene,	which	encode	a	photosystem	II	D1,	does	 not	 affect	 growth	 as	psbAIII,	 which	 encodes	 the	 same	 protein,	 is	 overexpressed	 to	compensate	 for	 the	deletion	 (Mohamed	et	 al.,	 1993).	The	psbAI	 gene	which	 encodes	 the	same	protein	has	also	been	used	as	a	neutral	site	(Varman	et	al.,	2013).	The	slr0168	gene	encodes	a	hypothetical	protein	 in	Synechocystis	 that	has	also	been	used	as	a	neutral	 site	(Bentley	et	al.,	2013b).	One	issue	with	using	intergenic	regions	is	that	they	may	actually	be	transcribed	 or	 have	 antisense	 function	 (Mitschke	 et	 al.,	 2011).	 More	 neutral	 sites	 in	
Synechocystis	are	being	discovered	to	enable	the	expression	of	heterologous	pathways	at	multiple	sites	(Ng	et	al.,	2015).		Transposons	have	also	been	used	in	some	strains	of	cyanobacteria	e.g.	Nostoc	ATCC29133	and	Synechococcus	7942	 in	 order	 to	 introduce	DNA	 into	 the	 genome	without	 the	 use	 of	recombination	(Elhai,	1994;	Heidorn	et	al.,	2011).		
1.3.3 Selectable	markers	Selection	 for	 successful	 transformants	 is	 usually	 made	 by	 introducing	 an	 antibiotic	resistance	gene	along	with	 the	G.O.I.	 and	choosing	 the	 transformants	 that	are	capable	of	growing	 in	 the	 presence	 of	 the	 antibiotic.	 Chloramphenicol,	 neomycin,	 streptomycin,	kanamycin,	spectinomycin,	ampicillin,	bleomycin	and	gentamycin	resistance	cassettes	can	
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all	 be	 used	 in	 different	 cyanobacteria	 for	 selection	 (Ruffing,	 2011).	 Antibiotics	 that	 are	light	sensitive	such	as	tetracycline	and	rifampicin	are	less	useful	in	cyanobacteria	as	they	are	 usually	 incubated	 under	 light	 (Koksharova	 and	Wolk,	 2002).	 A	method	 of	 selection	using	 herbicide	 resistance	 towards	 bialaphos	 and	 phosphinothricin	 has	 also	 been	developed	in	Synechocystis	and	Synechococcus	7942	(Chungjatupornchai,	1990;	Takahashi	et	al.,	1999).		
1.3.4 Reporters	Numerous	reporter	proteins	have	been	used	in	cyanobacteria	as	a	method	to	 investigate	gene	expression	and	protein	localisation.		In	Synechocystis	the	luxAB	genes,	from	Vibrio	harveyi	(V.	harveyi),	encoding	luciferase	have	been	 expressed	 along	 with	 luxCDE,	 also	 from	 V.	 harveyi,	 which	 produces	 the	 substrate	luciferase	aldehyde	that	 is	required	to	produce	light	(Peca	et	al.,	2008).	The	use	of	 luxAB	has	 also	been	utilised	 in	 cyanobacteria	without	 the	 expression	of	 the	 luxCDE,	where	 the	substrate	 is	provided	 in	 the	media	(Gillor	et	al.,	2003;	Muramatsu	and	Hihara,	2006).	As	mentioned	earlier,	 the	 luciferase,	 luc,	gene	 from	the	 firefly	Photinus	pyralis	has	also	been	utilised	in	Synechocystis	(Shao	et	al.,	2002).		Although	 the	 presence	 of	 photosynthetic	 pigments	 in	 cyanobacteria	 can	 interfere	 with	fluorescence	signals,	some	fluorescent	proteins	have	been	used	as	reporter	genes.	GFP	and	derivatives	 of	 GFP	 e.g.	 Cerulean,	 GFPmut3B	 and	 EYFP	 have	 all	 been	 used	 successfully	(Huang	et	al.,	2010),	although	one	of	the	issues	with	using	GFP	is	that	photobleaching	can	be	a	problem	(Koksharova	and	Wolk,	2002).		The	 lacZ	 gene,	 from	 E.	 coli,	 encodes	 β-galactosidase,	 which	 has	 also	 been	 used	 in	cyanobacteria	 as	 a	 reporter.	 The	 β-galactosidase	 activity	 assay	 in	 cyanobacteria	 is	performed	with	an	alternative	fluorescent	substrates	instead	of	Xgal,	as	the	blue	product	is	not	suitable	due	to	the	colour	of	cyanobacteria	(Scanlan	et	al.,	1990;	Thiel	et	al.,	1995).	The	
cat	 gene	 encodes	 chloramphenicol	 acetyl	 transferase,	 which	 result	 in	 chloramphenicol	resistance.	The	enzyme	transfers	the	acetyl	group	from	acetyl-coA	onto	chloramphenicol,	preventing	 it	 from	binding	 and	 inhibiting	 the	 ribosome.	 The	 expression	 of	 cat	 has	 been	used	 as	 a	 reporter	 in	 various	 strains	 of	 cyanobacteria	 by	 measuring	 resistance	 to	chloramphenicol	(Bauer	and	Haselkorn,	1995;	Marraccini	et	al.,	1993).		
1.3.5 Biological	parts	in	cyanobacteria	There	 is	 growing	 interest	 in	 applying	 synthetic	 biology	 principles	 to	 cyanobacteria,	 in	order	to	use	them	as	‘green’	platforms	for	the	production	of	biofuels,	foods,	feed	and	other	
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platform	chemicals	 (Lindblad	et	al.,	2012;	Wang	et	al.,	2012).	The	main	aim	of	 synthetic	biology	 is	 to	 try	 and	genetically	modify	organisms	 in	 a	predictive	way	by	designing	and	making	new	biological	parts,	devices	and	systems	(and	also	redesigning	existing	biological	systems),	for	the	production	of	useful	products	(Huang	et	al.,	2010).	Examples	of	biological	parts	are	promoters,	ribosome	binding	sites	(RBSs),	terminators	and	coding	sequences.	By	having	various	well-characterised	parts,	the	organism	can	be	easily	engineered	and	parts	can	be	swapped	in	and	out	if	necessary	to	optimise	the	yield	(Heidorn	et	al.,	2011).	So	far,	the	majority	 of	work	 on	 synthetic	 biology	 has	 focussed	 on	E.	 coli	however,	 some	 of	 the	parts	developed	in	E.	coli	do	not	function	in	the	same	way	in	cyanobacteria	(Heidorn	et	al.,	2011).	 This	 section	 describes	 some	 of	 the	 biological	 parts	 that	 have	 been	 developed	 in	some	of	 the	model	 strains	so	 far.	However,	 to	 further	utilise	 the	part-based	approach	 to	construct	 and	 control	 new	 metabolic	 pathways,	 more	 biological	 parts	 need	 to	 be	characterised	for	use	in	cyanobacteria.		
1.3.5.1 Promoters	Transcription	is	the	first	step	of	gene	expression	and	in	prokaryotes	it	is	a	step	involving	a	RNA	 polymerase	 (RNAP)	 holoenzyme,	 a	 complex	 that	 consist	 of	 a	 sigma	 (σ)	 subunit	 (σ	factor)	 and	 the	 core	RNAP	 enzyme	made	 up	 of	 the	 subunits	 α2	 (RpoA	 x	 2),	β	 (RpoB),	 β’	(RpoC)	 and	 ω	 (RpoZ).	 σ	 factors	 play	 an	 important	 role	 in	 controlling	 transcription,	 as	different	 σ	 factors	 will	 bind	 to	 the	 core	 enzyme	 depending	 on	 the	 environmental	conditions	and	different	σ	factors	recognise	different	classes	of	promoter.	In	cyanobacteria	the	RNAP	holoenzyme	and	 the	set	of	σ	 factors	are	different	 to	 that	seen	 in	E.	coli;	 the	β’	subunit	 is	split	 into	 two	different	subunits	RpoC1	(ϒ))	and	RpoC2	(β’),	which	has	a	DNA	binding	domain	at	the	C-terminus.	In	other	bacteria	the	σ	factors	belong	to	the	σ70	family	or	 the	 σ54	 family,	 however,	 in	 cyanobacteria	 σ	 factors	 in	 the	 σ54	 family	 are	 absent	(Imamura	and	Asayama,	2009).	 In	 cyanobacteria,	 both	 native	 and	 foreign	 promoters	 have	 been	 used	 to	 express	 foreign	genes	 (Table	 1.3).	 The	 native	 promoters	 used	 to	 express	 foreign	 genes	 constitutively	 in	cyanobacteria	 are	 often	 promoters	 of	 genes	 that	 are	 important	 for	 photosynthesis	 e.g.	PpsbAII	 (photosystem	II	D1	protein),	PrbcL	(Rubisco	 large	subunit),	Pcpc	 (c-phycocyanin	beta	subunit)	and	PpsaD	(photosystem	I	subunit	II)	(Wang	et	al.,	2012).	The	psbAII	promoter	is	seen	as	a	constitutive	promoter	 in	Synechocystis,	as	Synechocystis	 is	usually	grown	in	the	presence	of	light.	Expression	is	seen	in	low	light	however,	the	promoter	can	also	serve	as	an	inducible	promoter	as	expression	can	be	increased	when	grown	in	the	presence	of	high	light	 (500	 μmol	 photons/s/m2)	 (Lindberg	 et	 al.,	 2010).	 A	 super	 strong	 constitutive	promoter,	 Pcpc560,	 was	 recently	 discovered;	 made	 up	 of	 two	 cpcB	 promoters	 and	 14	
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predicted	 transcription	 factor	 binding	 sites	 (TFBSs).	 Using	 this	 promoter,	 expression	 of	heterologous	genes	were	reported	at	levels	achieved	in	E.	coli	(Zhou	et	al.,	2014).	
Table	1.3	Table	of	promoter	used	to	express	heterologous	genes	in	cyanobacteria	
Promoter	 Source	 Constitutive/	
Inducible	4	 Examples	 –	gene	 Host	 Reference	PpsbAII	 Synechocystis	 Constitutive	 ispS	 Synechocystis	 (Lindberg	 et	 al.,	2010)	PpsbAI	 Synechococcus	
7942	
Constitutive	 efe		 Synechococcus	
7942	 (Sakai	 et	 al.,	1997)	PpsbAIII	 Synechocystis	 Constitutive	 lhcB	 Synechocystis	 (He	et	al.,	1999)	Prbc	 Synechococcus	6301	 Constitutive	 luciferase	 Synechococcus	6301	 (Takeshima	 et	 al.,	1994)	
 Synechococcus	7942	 Constitutive	 pdc	 Synechococcus	7942	 (Deng	 and	Coleman,	1999)	
 Synechocystis	 Constitutive	 far	 Synechocystis	 (Tan	et	al.,	2011)	PrpnB	 Synechocystis	 Constitutive	 GFPmut3B	 Synechocystis	 (Huang	 et	 al.,	2010)		PnrsB	 Synechocystis	 Inducible	 holin	 Synechocystis	 (Liu	 and	 Curtiss,	2009)	Pcpc	 Synechocystis	 Constitutive	 accB	 and	
accC	
Synechocystis	 (Liu	 et	 al.,	2011b)1)	Pcpc560	 Synechocystis	 Constitutive	 ispS	 Synechocystis	 (Zhou	et	al.,	2014)	PpsaA	 Synechocystis	 Constitutive	 luxAB	 Synechocystis	 (Muramatsu	 and	Hihara,	2006)a)	PpsaD	 Synechocystis	 Constitutive	 luxAB	 Synechocystis	 (Muramatsu	 and	Hihara,	2007)	Pcmp	 Synechocystis	 Inducible	 fol	 Synechocystis	 (Liu	 et	 al.,	2011b)1)	Psbt	 Synechocystis	 Inducible	 gpl	 Synechocystis	 (Liu	 et	 al.,	2011b)1)	Plac	 E.	coli	 Inducible	 hydA	 Synechococcus	7942	 (Ducat	 et	 al.,	2011b)1)	Ptrc/	Ptac	 E.	coli	 Inducible	 petE	 Synechococcus	7942	 (Geerts	 et	 al.,	1995)		PcoaT	 Synechocystis	 Constitutive	(Repressed	in	presence	 of	Fe3+)	
efe		 Synechocystis	 (Guerrero	 et	 al.,	2012)	
PisiAB	 Synechocystis	 Inducible	 gfp	 Synechocystis	 (Kunert	 et	 al.,	2000)		Inducible	promoters	are	desirable	when	producing	a	 toxic	compound	 in	order	 to	reduce	the	 stress	 on	 the	 cell	 during	 growth.	Many	 of	 the	 native	 inducible	 promoters	 that	 have	been	 utilised	 are	 responsive	 to	 metal	 ions.	 One	 of	 the	 more	 responsive	 inducible	promoters	in	Synechocystis	is	PnrsB,	which	is	induced	by	Ni2+	or	Co2+	(García-Domínguez	et																																									 																					4	Grown	under	light	conditions	
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al.,	 2000).	 Additionally,	 PcoaT	 is	 a	 native	 promoter	 induced	 by	 Co2+	 or	 Zn2+	 found	 in	
Synechocystis	(Peca	et	al.,	2008).	Expression	under	PcoaT	is	not	strong,	but	in	the	absence	of	the	inducible	metal,	complete	repression	was	seen	(Guerrero	et	al.,	2012).	Finally,	the	PisiAB	promoter	 is	 expressed	 in	 the	 absence	 of	 Fe3+	 in	Synechocystis.	 The	 addition	of	 Fe3+	 then	leads	to	repression	of	expression,	although	there	is	some	leakage	of	expression	(Kunert	et	al.,	2000).		Foreign	promoters,	usually	from	E.	coli,	have	also	been	used	in	cyanobacteria	in	order	to	express	foreign	genes.	E.	coli	promoters	in	cyanobacteria	do	not	function	in	the	same	way,	as	 there	 are	 differences	 between	 the	 RNA	 holoenzyme	 and	 sigma	 factors	 in	 E.	 coli	compared	to	Synechocystis	(Heidorn	et	al.,	2011).	Ptet	and	Plac	are	commonly	used	in	E.	coli	but	function	weakly	in	cyanobacteria	(Huang	et	al.,	2010).	Modifications	have	been	made	to	 certain	E.	coli	promoters,	 e.g.	 Ptrc	 and	Plac,	 that	 have	 helped	 improve	 their	 function	 in	
Synechocystis	(Camsund	et	al.,	2014;	Huang	et	al.,	2010).	
1.3.5.2 Ribosome	binding	sites		Translation	in	bacteria	is	 initiated	when	the	ribosome	binds	to	mRNA	at	the	RBS.	Within	the	 RBS	 is	 the	 core	 Shine-Dalgarno	 (SD)	 sequence	 (5’-GGAGG-3’).	 The	 base	 pairing	between	the	RBS	with	the	anti-SD	sequence	(found	on	the	3’	end	of	the	16S	rRNA)	and	the	distance	between	the	SD	sequence	and	the	start	codon	affects	the	functioning	of	the	RBS	(Heidorn	et	al.,	2011).	The	effectiveness	of	the	RBS	is	also	affected	by	secondary	structures	that	might	arise	from	the	surrounding	nucleotide	sequences	(Salis	et	al.,	2009).	In	 Synechocystis	 the	 3’	 end	 of	 the	 16S	 rRNA	 is	 …AUCACCUCCUUU-3’,	 the	 optimal	complementary	sequence	is	therefore	AAAGGAGGUGAU	(SD	sequence	underlined)	and	the	ideal	 spacing	 between	 the	 central	 A	 in	 the	 SD	 sequence	 and	 the	 first	 base	 in	 the	 start	codon	is	nine	bases	(Heidorn	et	al.,	2011).	The	RBS	sequence	UAGUGGAGGU	based	on	the	optimal	 complementary	 sequence	 (with	 optimal	 spacing	 between	 the	 central	 A	 and	 the	start	 codon)	 was	 compared	 against	 three	 BioBrick	 RBS	 and	 gave	 two-fold	 higher	expression	than	the	RBS	sequence	AUUAAAGAGGAGAAA	(a	strong	RBS	in	E.	coli)	(Heidorn	et	al.,	2011).			
1.3.5.3 Codon	optimisation	Codon-optimisation	is	often	performed	when	introducing	a	gene	from	one	organism	into	another	 to	 try	 and	 improve	 the	 efficiency	 of	 translation,	 e.g.	 by	 removing	 rare	 codons	(Quax	et	 al.,	 2015).	 In	Synechocystis,	 a	 comparison	was	made	 to	 see	 the	 effect	 of	 codon-optimisation.	The	expression	of	the	gene	encoding	isoprene	synthase,	ispS,	from	Pueraria	
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Montana	 was	 approximately	 10	 times	 greater	 after	 codon-optimising	 the	 gene	 for	
Synechocystis	(Lindberg	et	al.,	2010).	
1.3.5.4 Degradation	Proteins	have	the	potential	 to	accumulate	 in	 the	cell	even	after	 the	promoter	controlling	the	expression	has	been	switched	off,	thereby	having	no	real	control	over	the	circuit.	In	E.	
coli,	degradation	tags	have	been	used,	as	proteases	recognise	the	proteins	that	have	been	tagged.	There	has	been	some	research	on	the	use	of	degradation	tags	in	cyanobacteria.	A	few	 non-native	 degradation	 tags	 were	 expressed	 and	 were	 functional	 in	 cyanobacteria	(Huang	et	al.,	2010).	In	Synechocystis,	a	range	of	cyanobacteria	and	E.	coli	degradation	tags	were	developed	and	tested	that	provide	a	range	of	turnover	levels	(Landry	et	al.,	2013).		
1.3.5.5 Marker-less	transformants		Transformant	 lines	 that	 do	 not	 carry	 an	 antibiotic	 resistance	 gene	 are	 desirable	 as	 this	eliminates	 the	risk	of	antibiotic	resistance	genes	being	 transferred	 to	microorganisms	 in	the	 environment	 when	 growing	 cultures	 in	 open	 systems.	 A	 marker-less	 strategy	 also	ensures	 that	 when	 performing	 multiple	 transformations	 on	 a	 strain,	 the	 number	 of	antibiotic	resistance	cassettes	that	are	available	does	not	limit	this.	In	some	cyanobacterial	strains	 the	 expression	 of	 the	 conditionally	 toxic	 sacB	 gene	 has	 been	 utilised	 to	 produce	marker-less	 transformants	 (Cai	 and	 Wolk,	 1990;	 Lagarde	 et	 al.,	 2000).	 In	 the	 first	transformation	 step,	 the	 sacB	 gene	 alongside	 an	 antibiotic	 resistance	 cassette	 is	introduced	 into	 the	 genome	and	 selection	 is	made	based	on	 antibiotic	 resistance.	 In	 the	second	 step,	 both	 the	 sacB	 gene	 and	 the	 antibiotic	 selection	 cassette	 are	 replaced,	 and	selection	 is	 made	 based	 on	 the	 loss	 of	 sacB	 in	 the	 toxic	 conditions	 (Ried	 and	 Collmer,	1987).		
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1.4 Summary	and	thesis	aims	Fossil	 fuel	 usage	 continues	 to	 increase	 despite	 limited	 reserves	 and	 the	 effect	 of	 global	warming.	 Renewable	 alternatives	 are	 required	 to	 produce	 the	 transport	 fuels	 and	chemicals	 that	 are	 normally	 derived	 from	 oil.	 Cyanobacteria	 as	 photosynthetic	 bacteria	have	 the	potential	 to	be	a	microbial	 factory	 for	 the	production	of	novel	compounds.	The	molecular	 tools	 currently	 available	 have	 allowed	 model	 strains	 of	 cyanobacteria	 to	 be	engineered	 to	 produce	 novel	 chemicals	 at	 the	 lab-scale,	 but	 these	 tools	 are	 rather	 basic	and	 lag	 behind	 the	metabolic	 engineering	 technologies	 and	 synthetic	 biology	 tools	 of	E.	
coli.	With	this	in	mind,	the	main	aims	of	the	following	studies	were:	
• Attempt	 the	 production	 of	 limonene,	 an	 essential	 oil	 produced	 in	 plants	 that	 is	used	 in	 fragrances	 and	 also	 has	 potential	 use	 as	 a	 jet	 fuel	 replacement,	 in	
Synechocystis	(Chapter	3).	
• Improve	 the	 molecular	 tools	 available	 to	 cyanobacteria	 in	 order	 to	 express	multiple-genes	 involved	 a	 metabolic	 pathway	 for	 the	 production	 of	 novel	chemicals	 as	 an	 operon	 (Chapter	 4),	 and	 create	 strains	 that	 are	 marker-less	(Chapter	5).			
• Utilise	 the	 molecular	 tools	 developed	 to	 validate	 their	 function	 and	 produce	another	novel	compound	in	Synechocystis	(Chapter	6).				 	
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Chapter	2 	Materials	and	methods	
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2.1 Bacterial	Strains,	media	and	culture	conditions	
2.1.1 Synechocystis	sp.	PCC	6803	
2.1.1.1 Strains	used	The	 wild-type	 (WT)	 Synechocystis	 sp.	 PCC	 6803	 (large	 cells	 and	 glucose	 tolerant)	 was	obtained	 from	Prof.	 Conrad	Mullineaux,	Queen	Mary	University	 of	 London.	The	 strain	 is	referred	to	as	WT	Synechocystis	hereafter.		Transgenic	 strains	 of	 Synechocystis	 sp.	 PCC	 6803	 created	 by	 previous	 members	 of	 the	Purton	 laboratory	 were	 also	 used	 in	 the	 study	 and	 are	 listed	 in	 Table	 2.1.	 Transgenic	strains	created	during	this	study	are	listed	in	the	Appendix.		
Table	2.1	Transgenic	strains	used	in	this	study	
Strain	name	(in	
this	study)	
Description	 Reference	
6803.AII	 The	psbAII	gene	is	replaced	by	no	gene-of-interest	under	the	control	of	the	PpsbAII	and	a	kanamycin	resistance	cassette.		
(Al-Haj,	2014)	
6803.nrsB	 The	psbAII	promoter	and	gene	is	replaced	by	no	gene-of-interest	under	the	control	of	the	PnrsB	and	a	kanamycin	resistance	cassette.	
	
(Al-Haj,	2014)	
6803.4op	 The	psbAII	and	gene	is	replaced	by	ble,	aadA,	aphA-6	and	gfp	under	the	control	of	the	PpsbAII.	Resistant	to	zeocin,	spectinomycin	and	kanamycin.			
(Mackrow,	2011)	
6803.cpc	 The	psbAII	promoter	and	gene	is	replaced	by	no	gene-of-interest	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.		
(Lau,	unpublished)	
6803.AII.GFP	 The	psbAII	gene	is	replaced	by	gfp	under	the	control	of	the	PpsbAII	and	a	kanamycin	resistance	cassette.		 (Lau,	unpublished)	
6803.cpc.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	gfp	under	the	control	of	Pcpc560	and	a	kanamycin	resistance	cassette.		
(Lau,	unpublished)	
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2.1.1.2 Media	
Synechocystis	was	grown	in	BG-11	(Blue	Green	11)	medium.	The	stock	solutions	used	for	the	preparation	of	BG-11	are	presented	in	Table	2.2.	To	prepare	1L	of	medium:	10	ml	of	100x	 BG-11	 stock,	 1	ml	 trace	 elements	 and	 1	ml	 iron	 stock	 are	 combined	with	 976	ml	water	 and	 autoclaved.	Once	 the	 solution	has	 cooled,	 1	ml	Phosphate	 stock,	 1	ml	Na2CO3	stock,	10	ml	NaHCO3	stock	and	10	ml	TES	Buffer	are	added.				
Table	2.2	Stock	solutions	for	the	preparation	of	BG-11	medium		
100	x	BG-11	 g/L	NaNO3	 149.6	MgSO4.7H2O	 7.49	CaCl2	 3.60	Citric	acid	 0.60	Na2EDTA	 1.12	ml	0.25M	solution,	pH	8.0	
Trace	Elements	 g/100ml	H3BO3	 0.286	MnCl2.4H2O	 0.181	ZnSO4.7H2O	 0.022	Na2MoO4.2H2O	 0.039	CuSO4.5H2O	 0.008	Co(NO3)2.6H2O	 0.005	
Iron	Stock	 g/100ml	Ferric	ammonium	citrate	 1.11	
Phosphate	stock	 g/100ml	K2HPO4	 3.05	
Na2CO3	stock	 g/100ml	Na2CO3	 2.0	
TES	Buffer	 g/100ml	TES	 22.9	
NaHCO3	stock	 g/100ml	NaHCO3	 8.401g		For	 the	preparation	of	 solid	medium,	2x	concentrated	BG-11	(including	3	g/L	of	 sodium	thiosulphate)	was	mixed	with	the	same	volume	of	molten	3%	Difco-agar	(w/v)	to	produce	1x	BG-11	and	1.5%	agar.	Antibiotics	(2.2)	were	added	to	the	media	just	before	pouring.		Initially	 BG-11	 agar	 supplemented	 with	 5%	 (w/v)	 sucrose	 was	 autoclaved	 with	 the	 2x	concentrated	BG-11	solution	that	also	contained	NaHCO3.	BG-11	agar	supplemented	with	5%	(w/v)	sucrose	was	then	prepared	without	the	addition	of	NaHCO3,	and	with	a	stock	of	50%	(w/v)	sucrose	solution	that	was	filter	sterilised	using	a	0.22	μm	filter.		To	prepare	BG-11	agar	supplemented	with	5-fluorocytosine	(5-FC),	a	10	mg/ml	stock	of	5-FC	in	2x	BG-11	was	prepared	before	adding	to	the	rest	of	the	2x	BG-11	medium.	
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2.1.1.3 Culture	conditions	2.1.1.3.1 Growth	of	Synechocystis	
Synechocystis	strains	were	grown	on	BG-11	agar	plates	incubated	at	30°C	in	an	illuminated	incubator	with	the	light	intensity	between	40–80	μmol/m2/s,	unless	stated	otherwise.		Liquid	 cultures	 of	 Synechocystis	 were	 grown	 in	 an	 illuminated	 incubator	 with	 a	 light	intensity	of	20–200	μmol/m2/s,	at	120	rpm	shaking	and	at	25°C,	unless	otherwise	stated.	Flasks	were	 inoculated	with	 a	 loop	 of	 cells	 from	 agar	 plates.	 Larger	 volumes	 of	 culture	were	sometimes	inoculated	from	a	smaller	pre-culture,	in	a	1	in	10	dilution.	2.1.1.3.2 Quantification	of	Synechocystis	To	 quantify	 the	 growth	 of	 Synechocystis,	 1ml	 of	 liquid	 culture	 was	 used	 to	 record	 the	optical	density	(OD)	at	730	nm	using	the	Unicam	UV/Vis	Spectrometer	(Thermo	Electron	Corporation,	USA).	
2.1.1.3.3 Growth	of	Synechocystis	in	automated	photobioreactor,	Algem®  In	 the	 Algem®	 Photobioreactor	 (Algenuity,	 UK),	 Synechocystis	 was	 grown	 in	 200	μmol/m2/s	white	 light,	 at	30°C	with	120	 rpm	shaking.	The	OD	at	750	nm	was	 recorded	every	30	minutes.	Cultures	were	prepared	in	500	ml	BG-11	medium,	and	inoculated	with	a	starter	culture	to	give	a	starting	OD750	~0.1.	Cultures	were	performed	in	duplicate,	unless	otherwise	stated	and	the	average	OD750	was	plotted	over	time.		To	calculate	the	growth	rate:	the	ln	(OD750)	between	the	exponential	phase,	OD750:	0.5	and	1.5,	was	plotted	on	a	graph.	The	gradient	of	 the	 line	of	best	 fit	 is	 the	growth	rate	and	 is	expressed	as	h-1.			2.1.1.3.4 Short-term	storage	of	Synechocystis	
Synechocystis	 strains	 were	 grown	 on	 BG-11	 agar	 plates,	 containing	 antibiotic	 (2.2)	 if	required	and	then	subsequently	stored	in	dim	light	conditions	of	5-10	μmol/m2/s	at	20°C.	Strains	were	transferred	to	a	fresh	plate	every	3-4	weeks.		2.1.1.3.5 Long-term	storage	of	Synechocystis	For	the	long-term	storage	of	Synechocystis	strains,	a	50	ml	liquid	culture	was	grown	to	an	OD730	between	1	and	3.	Cells	were	harvested	by	centrifugation	at	4500	g	for	6	minutes	at	room	temperature.	The	supernatant	was	poured	off	and	the	cell	pellet	resuspended	in	the	residual	medium.	The	volume	of	 the	cell	suspension	was	then	measured	and	mixed	with	
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0.24	volumes	of	80%	glycerol.	The	cells	were	stored	at	-80	°C.	The	cells	were	recovered	by	inoculating	BG-11	medium	with	a	thawed	stock.	
2.1.2 Escherichia	coli		
2.1.2.1 Strain	
Escherichia	coli	DH5α	(fhuA2,	Δ(argF-lacZ)U169,	phoA,	glnV44,	Φ80,	Δ(lacZ)M15,	gyrA96,	
recA1,	relA1,	endA1,	thi-1,	hsdR17)	was	the	strain	used.	Referred	to	as	E.	coli	hereafter.	
2.1.2.2 Media	
E.	coli	was	grown	in	LB	(Lysogeny	Broth)	medium	prepared	with	10	g/L	bacto-tryptone,	5	g/L	yeast	extract	and	10	g/L	NaCl.	For	the	preparation	of	solid	1.5%	Difco	agar	was	added	(15	g/L).	LB	medium	was	autoclaved	before	use.	Strains	of	E.	coli	carrying	a	zeocin	resistance	gene	were	grown	in	low-salt	LB	medium	and	5	g/L	NaCl	was	used	instead.		
2.1.2.3 Culture	conditions	2.1.2.3.1 Growth	of	E.	coli	
E.	 coli	 cultures	 were	 grown	 on	 LB	 agar	 plates	 at	 37°C,	 or	 in	 LB	 liquid	 medium	 under	constant	shaking	at	37°C.	Antibiotics	(2.2)	were	added	if	necessary.		
2.1.2.3.2 Long-term	storage	of	E.	coli	For	 long-term	 storage,	E.	coli	 cells	were	 stored	 as	25%	glycerol	 stock.	 Equal	 volumes	of	bacterial	culture	were	mixed	with	50%	autoclaved	glycerol.	The	mixture	was	then	briefly	vortexed	and	stored	at	–80	°C.		
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2.2 Antibiotics	and	other	selective	agents	A	list	of	the	antibiotics	(Table	2.3)	and	selective	agents	(Table	2.4)	used	in	this	study	are	presented	below.	Unless	otherwise	stating	the	working	concentration	in	these	tables	was	used.		
Table	2.3	List	of	antibiotics	used	in	this	study.	
Antibiotic	
Stock	
concentration	
(mg/ml)	
Working	concentration	
for	E.	coli	(μg/ml)	
Working	concentration	
for	Synechocystis	(μg/ml)	
Ampicillin	 75	in	H2O	 75	 N/A	Kanamycin	 50	in	H2O	 50	 200	Chloramphenicol	 34	in	100%	EtOH	 34	 34	Zeocin™	(Invivogen)	 100	in	H2O	 25	 7.5	Spectinomycin	 50	in	H2O	 50	 50	
Table	2.4	List	of	selective	agents	used	in	this	study	
Selective		agent	 Stock	concentration	 Working	concentration	for	Synechocystis	
5-	FC	 10mg/ml	in	2x	BG-11	medium	 0.5	mg/ml	Sucrose	 N/A	 5%	(w/v)	
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2.3 	Plasmids	Plasmids	created	by	others	used	in	this	study	are	listed	in	Table	2.5.	Plasmids	created	in	this	study	can	be	found	in	the	Appendix.	Plasmids	used	for	integration	in	Synechocystis	are	indicated	with	*.		
Table	2.5	Plasmids	used	in	this	study	
Plasmid	
name	
Source	 Usage	
4op*	 (Mackrow,	2011)	
Expression	vector	for	Synechocystis,	containing	ble,	aadA,	aphA-6	and	
gfpuv	under	the	control	of	the	psbAII	promoter	for	insertion	at	the	psbAII	locus.	
4op.Rev*	 (Mackrow,	2011)	
Expression	vector,	containing	ble,	
aadA,	aphA-6	and	gfp	under	the	control	of	the	psbAII	promoter	in	the	reverse	order	of	4op	for	insertion	at	the	psbAII	locus.	pARG1.3	 Saul	Purton’s	Collection	 Source	of	cat	cassette.	
pJET1.2	blunt		 ThermoFisher	ScientificTM	 Blunt	end	cloning	vector;	base	for	creating	expression	vectors	used	in	this	study.	
pLAH.AII*		 (Al-Haj,	2014)	
Expression	vector	for	Synechocystis,	containing	NdeI	and	BamHI	restriction	sites	to	insert	a	gene-of-interest	(G.O.I.)	under	the	control	of	the	psbAII	promoter	and	a	kanamycin	resistance	cassette	for	insertion	at	the	
psbAII	locus.	See	Appendix	for	a	diagram.	
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Plasmid	
name	
Source	 Usage	
pLAH.nrsB*	 (Al-Haj,	2014)		
Expression	vector	for	Synechocystis,	containing	NdeI	and	BamHI	restriction	sites	to	insert	a	G.O.I.	under	the	control	of	the	nrsB	promoter	and	a	kanamycin	resistance	cassette	for	insertion	at	the	psbAII	locus.	See	Appendix	for	a	diagram.	
pLAH.cpc*	 (Lau,	unpublished)	
Expression	vector	for	Synechocystis,	containing	NdeI	and	BamHI	restriction	sites	to	insert	a	G.O.I.	under	the	control	of	the	cpc560	promoter	and	a	kanamycin	resistance	cassette	for	insertion	at	the	psbAII	locus.	See	Appendix	for	a	diagram.	
pRY127d	 (Young	and	Purton,	2014)	 Source	of	synthetically	designed	codA	gene,	codon	optimised	for	
Chlamydomonas	reinhardtii.	
pUC4K	 (Taylor	and	Rose,	1988)	 Source	of	a	kanamycin	resistance	cassette	(KmR).		pUM24Cm		 (Ried	and	Collmer,	1987)	 Source	of	sacBR	–nptI	cassette.	pZΔES	 Saul	Purton’s	Collection	 Source	of	a	ble	cassette.	
pASapI-SplB	 (Larrea	Alvarez,	unpublished)	 Source	of	synthetically	designed	splB	gene,	codon	optimised	for	
Chlamydomonas	reinhardtii.	
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2.4 Molecular	genetic	methods	
2.4.1 PCR	PCR	 reactions	 were	 performed	 on	 a	 programmed	 thermocycler.	 The	 TC-3000X	 or	 TC-3000G	 thermocyclers	 were	 used	 (both	 from	 Techne),	 the	 latter	 one	 was	 also	 used	 for	gradient	PCR	reactions.	PCR	was	performed	using	Phusion®	high-fidelity	DNA	polymerase	from	New	England	Biolabs	(NEB);	the	components	and	conditions	used	for	PCR	reactions	are	in	Table	2.6.	The	annealing	temperature	varied	for	the	primers	used.		
Table	 2.6	 Component	 and	 cycling	 conditions	 for	 a	 25	 μl	 reaction	mix	 using	 Phusion	®	
high-fidelity	DNA	polymerase.	
Components	 Volume	(for	a	25	μl	reaction)	 Final	Concentration	5X	Phusion	Buffer	 5	 1x	Deoxynucleotide	Solution	Mix	(10	mM)	 0.5	 200	μM	Upstream	Primer	(100	μM)	 0.25	 1	μM	Downstream	Primer	(100	μM)	 0.25	 1	μM	Template	DNA	 Variable	 	Phusion	DNA	Polymerase	 0.25	 0.02	units/	μl	Nuclease	Free	Water	 Add	to	a	final	volume	of	25	μl	 	
Cycling	conditions	for	PCR	Reaction	
Stage	 Temperature		(°C)	 Time	Initial	Denaturation	 98	 1	minute	25	cycles	 Denaturation	 98	45-72	72	 10	seconds	20	seconds	15-30	seconds	per	kb	Annealing	Extension	Final	Extension	 72	 5	minutes	Storage	 10	 Hold		
2.4.2 Primers	All	primers	used	were	synthesised	by	MWG	Eurofins,	Germany.	For	a	 list	of	 the	primers	used	in	this	study	see	the	Appendix.		
2.4.3 Agarose	gel	electrophoresis	DNA	fragments	were	separated	on	a	1%	(w/v)	agarose	gel	made	with	1	x	TAE	Buffer	(40	mM	 Tris,	 1mM	 sodium	 EDTA,	 17.5	 mM	 acetic	 acid)	 and	 0.2	 μg/ml	 ethidium	 bromide.	Samples	were	mixed	with	6x	DNA	Loading	Dye	(Thermo	ScientificTM)	before	loading	into	a	gel	 that	was	 submerged	 in	 1	 x	 TAE	buffer	 in	 an	 electrophoresis	 tank.	 GeneRulerTM	DNA	Ladder	Mix	(Thermo	ScientificTM)	was	 loaded	alongside	the	samples	 in	order	to	estimate	the	size	of	the	DNA	fragments.	Electrophoresis	was	performed	at	90	V	for	30-90	minutes,	
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depending	on	the	size	of	the	expected	fragments.	DNA	fragments	were	visualised	using	a	UV	transilluminator	(UVP	Gel	Documentation	System).	
2.4.4 Plasmid	isolation	Plasmid	 isolation	 was	 performed	 using	 the	 GeneJET	 Plasmid	 Miniprep	 Kit	 (Thermo	ScientificTM)	according	to	the	manufacturer’s	instructions.	
2.4.5 DNA	purification	DNA	purification	of	PCR	products	and	DNA	fragments	were	performed	using	the	GeneJET	PCR	 Purification	 Kit	 (Thermo	 ScientificTM)	 for	 quantities	 of	 a	 plasmid	 up	 to	 20	 μg	according	to	the	manufacturer’s	instructions.	
2.4.6 Gel	extraction	To	 isolate	 DNA	 from	 an	 agarose	 gel,	 the	 DNA	 of	 interest	 was	 excised	 from	 the	 gel	illuminated	 with	 UV	 light.	 The	 DNA	 was	 purified	 from	 the	 gel	 using	 the	 GeneJET	 Gel	Extraction	Kit	(Thermo	ScientificTM)	following	the	manufacturer’s	instructions.		
2.4.7 Restriction	enzyme	digests	Restriction	 enzymes	 from	NEB	 or	 Thermo	 ScientificTM	were	 used	 to	 perform	 restriction	enzyme	digests	according	to	the	manufacturer’s	instructions.		
2.4.8 Dephosphorylation		To	 avoid	 the	 religation	 of	 digested	 vectors,	 dephosphorylation	 was	 sometimes	 used	 to	remove	the	5’	phosphate.	Dephosphorylation	was	performed	using	Antarctic	Phosphatase	(NEB).	To	30	μl	of	digested	DNA,	3	μl	of	10x	Antarctic	Phosphatase	Buffer	was	added	along	with	1	μl	of	Antarctic	Phosphatase.	After	incubating	the	reaction	mixture	for	30	minutes	at	37°C	the	reaction	was	heat	inactivated	at	65°C	for	5	minutes.		
2.4.9 Ligation	Ligation	was	performed	using	T4	DNA	ligase	(NEB)	following	the	manufacturer’s	protocol.	The	 ratio	 of	 vector	 to	 insert	 used	 for	 ligation	 varied	 from	1:3	 to	 1:5,	with	 50-100	ng	 of	vector	used.		
2.4.10 DNA	sequencing	DNA	 sequences	 of	 plasmids	 and	 PCR	 products	 were	 performed	 using	 the	 Scientific	Support	 Services	 of	 the	 Wolfson	 Institute	 for	 Biomedical	 Research,	 University	 College	
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London	or	using	Source	Biosciences,	Cambridge.	The	results	were	aligned	using	ClustalW2	or	MacVector	12.6.0	software.	
2.4.11 DNA	quantification	To	quantify	the	concentration	of	DNA	fragments	and	plasmids,	1	μl	was	used	for	analysis	on	a	Nanodrop	2000c	Spectrophotometer	(Thermo	ScientificTM).		
2.4.12 Cloning	in	E.	coli	
2.4.12.1 Preparation	of	competent	E.	coli	cells	DH5α	was	restreaked	from	a	frozen	glycerol	stock	onto	a	LB	plate	and	incubated	at	37°C	overnight.	 A	 single	 colony	 was	 picked	 and	 used	 to	 inoculate	 10	 ml	 of	 LB	 and	 grown	overnight	at	37°C	under	continuous	shaking.	From	this	culture,	1	ml	was	added	to	100	ml	LB	 and	 grown	 under	 continuous	 shaking	 at	 37°C	 for	 2-3	 hours.	 After	 incubation,	 the	culture	was	cooled	on	 ice	 for	15	minutes	and	was	spun	at	4500	rpm	 for	5	minutes.	The	supernatant	 was	 removed	 and	 for	 each	 25	 ml	 of	 E.	 coli	 spun	 down,	 the	 cells	 were	resuspended	 in	 10	ml	 cold	 50mM	CaCl2	 and	 kept	 on	 ice	 for	 30	minutes.	 The	 cells	were	spun	again	at	4500	rpm	for	5	minutes	and	the	CaCl2	decanted.	To	each	tube	1.5ml	of	fresh	CaCl2	was	added	and	the	cells	resuspended	and	pooled	into	a	single	tube.	To	the	cells	3.5	ml	 of	 sterile	 50%	 glycerol	was	 added.	 Aliquots	 containing	 400	 μl	 competent	 cells	were	prepared	and	stored	at	–80°C.		
2.4.12.2 Transformation	of	competent	E.	coli	by	heat-shock	An	aliquot	of	 competent	E.	coli	 cells	was	 thawed	on	 ice.	For	each	 transformation,	100	μl	was	used	and	1	μl	of	plasmid	(between	10	pg	–	100ng)	or	10-20	μl	of	ligation	product	was	added	to	the	cells.	A	control	mix,	with	no	DNA	was	also	prepared.	The	cells	were	incubated	on	ice	for	30	minutes,	at	42°C	for	1	minute	and	then	transferred	back	onto	ice.	To	the	heat-shocked	 cells,	 1	 ml	 of	 LB	 medium	 was	 added	 and	 they	 were	 incubated	 at	 37°C	 under	continuous	shaking	for	1	hour.	After	incubation,	100	μl	and	200	μl	of	the	cells	were	spread	onto	LB	plates	containing	the	appropriate	antibiotic	and	incubated	at	37°C	overnight.		
2.4.12.3 Isolation	and	analysis	of	E.	coli	To	check	whether	the	E.	coli	transformants	contained	the	expected	plasmid	either	a	colony	PCR	on	putative	transformants	was	performed,	or	a	restriction	digest	test	on	the	purified	plasmid.			To	perform	the	colony	PCR,	the	colony	picked	by	sterile	pipette	tip	is	used	as	the	template	DNA	 and	 is	 resuspended	 in	 the	 PCR	 mixture	 (2.4.1).	 A	 couple	 of	 colonies	 showing	 a	
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positive	PCR	result	were	picked	using	a	sterile	pipette	tip,	and	used	to	inoculate	5-10	ml	LB	 medium	 supplemented	 with	 the	 appropriate	 antibiotic,	 and	 grown	 at	 37°C	 under	continuous	 shaking	 overnight.	 Plasmid	 isolation	 (2.4.4)	 was	 performed	 and	 a	 glycerol	stock	was	prepared	(2.1.2.3.2).		To	test	the	plasmid	by	performing	a	restriction	digest	test,	individual	colonies	were	picked	using	 a	 sterile	 pipette	 tip,	 which	 were	 then	 used	 to	 inoculate	 5-10	 ml	 of	 LB	 medium	supplemented	 with	 the	 appropriate	 antibiotic.	 These	 cultures	 were	 then	 grown	 in	 a	continually	 shaking	 incubator	 set	 at	 37°C	 overnight.	 Plasmid	 isolation	 (2.4.4)	 was	performed	 to	 extract	 the	 plasmid.	 The	 plasmid	was	 digested	 using	 restriction	 enzymes,	and	the	product	run	on	an	agarose	gel.	A	glycerol	stock	of	a	successful	transformant	was	prepared.		
2.4.13 Transformation	of	Synechocystis	The	 transformation	method	used	was	 adapted	 from	 (Williams,	 1988)	 by	 (Al-Haj,	 2014).	BG-11	 liquid	 medium	 was	 inoculated	 with	 WT	 Synechocystis	 from	 a	 freshly	 restreaked	plate.	The	cells	were	grown	in	an	illuminated	shaking	incubator	at	25°C	at	a	light	intensity	of	40–100	μmol/m2/s	to	an	OD730	of	0.6–1.		X	ml	of	the	culture	was	taken	and	harvested	by	centrifugation	at	3000x	g	for	10	minutes.	X	ml	was	calculated	to	ensure	the	final	concentration	of	the	cells	was	4x108	cells/ml	before	the	DNA	was	added.	To	calculate	 initial	concentration	of	 the	culture	(cells/ml)	 the	OD730	value	was	multiplied	by	1.15x108	cells/ml	 (Bishop,	2002).	Cells	were	 ‘washed’	with	2	ml	fresh	BG-11	medium	and	spun	down	again	at	3000	xg	 for	5	minutes.	The	cell	pellet	was	resuspended	in	1ml	BG-11	medium	to	give	a	final	concentration	of	4x108	cells/ml.		For	each	transformation,	200	μl	was	aliquoted	into	1.5	ml	microfuge	tubes	and	0.4–2	μg	of	plasmid	 DNA	was	 added.	 A	 ‘no	 DNA’	 transformation	 was	 also	 prepared	 and	 acted	 as	 a	control.	The	cells	were	incubated	at	30°C	in	~40	μmol/m2/s	for	4-6	hours.	The	cells	were	spread	onto	BG-11	agar	plates	and	left	to	dry	before	incubation	in	a	30°C	incubator	for	2-3	days.	 The	 plates	 were	 then	 overlain	 with	 3	 ml	 of	 0.6%	 of	 agar	 supplemented	 with	 the	appropriate	 antibiotic	 and	 returned	 to	 the	 30°C	 incubator.	 Colonies	 would	 typically	appear	after	7	days.	
2.4.13.1 Isolation	and	analysis	of	Synechocystis	transformants	Single	colonies	were	picked	using	sterile	toothpicks	and	streaked	onto	BG-11	agar	plates	supplemented	with	the	appropriate	antibiotic.	Colonies	were	restreaked	between	0	and	4	times	 unless	 otherwise	 mentioned.	 Genomic	 DNA	 from	 Synechocystis	 was	 extracted	
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(2.4.13.2),	and	used	as	the	template	in	a	PCR	reaction	in	order	to	determine	whether	the	transformant	 genome	 was	 homoplasmic	 and	 all	 copies	 of	 the	 genome	 had	 successfully	integrated	 the	 DNA.	 If	 the	 PCR	 results	 indicated	 the	 transformant	 genome	 was	heteroplasmic	 and	 there	 was	 a	 mixture	 of	 the	 original	 genome	 and	 the	 transformed	genome,	 then	 further	 rounds	 of	 selection	 were	 carried	 out	 until	 homoplasmicity	 was	reached	by	restreaking	onto	BG-11	agar	containing	the	appropriate	antibiotic.	A	glycerol	stock	(2.1.1.3.5)	of	successful	transformants	was	prepared.	
2.4.13.2 Genomic	DNA	extraction	of	Synechocystis	for	PCR	analysis	To	 extract	 the	 genomic	 DNA	 the	 Chelex®-based	 method	 adapted	 from	 (Werner	 and	Mergenhagen)	was	used.	A	loopful	of	cells	from	a	plate	was	resuspended	in	20	μl	distilled	water.	 To	 the	 cells,	 20	 μl	 of	 absolute	 ethanol	 was	 added,	 after	 1	 min,	 200	 μl	 of	 a	 5%	suspension	 of	 Chelex®	 100	 Resin	 (Bio-Rad)	 was	 added.	 	 The	 tubes	 were	 then	 vortexed	briefly	and	boiled	for	5	minutes.	They	were	then	cooled	on	ice	and	the	cell	debris	pelleted	with	a	2	minutes	 spin	at	13000	 rpm.	The	 supernatant	 containing	 the	genomic	DNA	was	transferred	to	a	new	tube,	and	1	μl	of	supernatant	used	in	a	25	μl	PCR	reaction.	
2.4.14 The	codA-5-FC	method	for	the	production	of	marker-less	transformants	Strain	6803.IR706.codA	(see	section	5.2.3.2)	 from	a	 freshly	restreaked	plate	was	used	to	inoculate	 20-50	 ml	 BG-11	 medium.	 Cells	 were	 grown	 to	 an	 OD730	 of	 0.5-1.2,	 in	 an	illuminated	shaking	incubator	at	25°C	at	a	light	intensity	of	40-100	μmol/m2/s.		X	ml	of	the	liquid	culture	was	harvested,	washed	and	resuspended	in	1	ml	BG-11	medium,	using	the	same	method	as	in	2.4.13	to	ensure	the	final	concentration	of	the	cells	was	4x108	cells/ml.	For	each	 transformation,	10	μl	was	aliquoted	 into	a	30	ml	sterilin	 tube	and	1	μg	of	DNA	was	added.	A	transformation	mix	where	no	DNA	was	added	was	also	prepared	to	act	as	a	control.	The	cells	were	then	placed	at	30°C	in	~40	μmol/m2/s	with	no	shaking	for	5	hours.	To	each	tube,	2	ml	of	BG-11	was	added	and	the	cells	were	grown	in	an	illuminated	shaking	incubator	at	20°C	at	a	light	intensity	of	20-40	μmol/m2/s	for	96	hours.	1ml	and	0.5ml	were	then	plated	onto	BG-11	agar	plates	 supplemented	with	0.5	mg/ml	5-FC.	 Colonies	would	appear	 after	 7-12	 days,	 and	 were	 picked	 and	 restreaked	 onto	 BG-11	 agar	 plates	supplemented	with	0.5	mg/ml	5-FC.	Genomic	DNA	was	isolated	and	analysed	to	check	for	successful	transformants.		
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2.4.14.1 Growth	spot	tests	for	analysing	successful	marker-less	transformants	Growth	 spot	 tests	 were	 performed	 as	 a	 quicker	 method	 for	 selecting	 for	 successful	transformants.	 A	 pipette	 tip	 was	 used	 to	 pick	 colonies	 from	 the	 BG-11	 medium	supplemented	with	0.5	mg/ml	5-FC.	The	colony	was	then	resuspended	in	50	μl	of	BG-11,	10	μl	was	then	aliquoted	onto	BG-11	and	BG-11	supplemented	with	200	μg/ml	kanamycin.	Once	the	liquid	had	dried,	the	plates	were	incubated	at	30°C	incubator	in	~40	μmol/m2/s	light.	Photos	were	taken	of	the	plates	after	3-7	days.	
2.4.15 The	sacB-sucrose	method	for	the	production	of	marker-less	transformants		Strain	 6803.IR706.sacB	 (see	 section	 5.2.6.2)	 from	 a	 freshly	 streaked	 plate	 was	 used	 to	inoculate	20	ml	of	BG-11	medium	and	the	cells	were	grown	to	an	OD730	of	0.8.	The	same	protocol	used	to	successfully	obtain	transformants	using	the	codA-5-FC	method	was	used	(2.4.14)	 except	 6803.IR706.sacB	 was	 used	 instead	 of	 6803.IR706.codA	 and	 the	transformation	mix	was	plated	onto	BG-11	supplemented	with	5%	(w/v)	sucrose.	
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2.5 Protein	analysis	
2.5.1 Isolation	of	crude	whole	protein	extracts	of	Synechocystis	strains	A	flask	containing	50	ml	BG-11	was	inoculated	with	the	Synechocystis	strain	from	a	freshly	restreaked	plate	and	grown	to	an	OD730	of	0.6-1.2.	The	cells	were	harvested	by	spinning	the	cells	down	at	3000	xg	for	10	minutes.	The	cell	pellet	was	then	resuspended	in	X	ml	of	Solution	A,	(0.8	M	Tris-HCl	pH	8.3,	0.2	M	Sorbitol	and	1%	β-mercaptoethanol)	where	X	ml	is	 the	 OD730	 value.	 This	 was	 done	 to	 obtain	 samples	 with	 approximately	 the	 same	concentration.	Samples	were	stored	at	-20°C	for	up	to	two	months.		
2.5.2 Glass	 beads	 used	 to	 isolate	 crude	 whole	 protein	 extracts	 of	 Synechocystis	
strains	A	flask	containing	50	ml	BG-11	was	inoculated	with	the	Synechocystis	strain	from	a	freshly	restreaked	plate	and	grown	to	an	OD730	of	0.6-1.2.	The	cells	were	harvested	by	spinning	the	cells	down	at	3000	xg	for	10	minutes.	The	cell	pellet	was	then	resuspended	in	X	ml	of	enzyme	buffer	A/B	(see	below),	where	X	ml	is	the	OD730	value,	to	obtain	samples	with	the	same	 concentration.	 450	 μl	 (800	 μl	 for	 the	 enzyme	 assay)	 of	 the	 sample	 was	 then	transferred	 to	 a	 1.5	 ml	 microfuge	 tube	 and	 ~100	 μl	 of	 212-300	 μm	 acid	 washed	 glass	beads	 (Sigma),	 were	 added	 to	 the	 cells.	 The	 sample	 was	 then	 treated	 to	 5	 cycles	 of	vortexing	 for	2	minutes	 then	placing	on	 ice	 for	2	minutes.	Cells	were	 then	spun	at	3000	rpm	at	4°C	for	5	minutes.	The	supernatant	was	then	spun	down	further	at	13000	rpm	at	4°C	 for	20	minutes	 to	separate	 the	soluble	 fraction	and	the	 insoluble	 fraction	containing	the	membrane	proteins.		Enzyme	buffer	A:	50	mM	MnCl2,	500	mM	KCl,	1mM	Tris/HCl	(pH	7.5),	5	mM	dithiothreitol	(DTT),	0.05%	(w/v)	NaHSO3	and	10%	glycerol	(Bohlmann	et	al.,	1997).	Enzyme	buffer	B:	 15	mM	MOPS	 (pH	7.0),	 10mM	MgCl2,	 2	mM	DTT	 (GE	Healthcare),	 1	 x	cOmplete™,	EDTA-free	Protease	Inhibitor	Cocktail	tablet	per	50	ml	(Roche)	(Entova,	2013).	
2.5.3 Sodium	dodecyl	sulphate	polyacrylamide	gel	electrophoresis	(SDS-PAGE)	SDS-PAGE	was	carried	out	using	the	Mini-Protean®	Tetra	System	(Bio-Rad).	Gels	(80	x	83	x	1	mm	gels)	were	prepared	with	a	lower	resolving	gel,	either	10	or	12%	acrylamide,	and	a	5%	acrylamide	upper	stacking	gel	(Table	2.7)	To	prepare	 the	crude	protein	extracts	 in	solution	A	(2.5.1),	11	μl	of	10%	(w/v)	SDS	was	added	to	a	100	μl	aliquot	of	the	crude	protein.	The	samples	were	then	boiled	for	2	minutes	and	spun	at	14000	rpm	for	2	minutes	to	pellet	cell	debris.	
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To	prepare	samples	from	the	crude	protein	extracts	isolated	using	glass	beads	(2.5.2),	20	μl	 of	 5	 x	 Laemmli	 sample	 dye	 (see	 below)	 was	 added	 to	 an	 80	 μl	 aliquot	 of	 the	 crude	protein	sample	along	with	1	μl	β-mercaptoethanol.	Samples	were	then	boiled	at	99°C	for	2	minutes,	then	spun	at	13	000	rpm	for	2	minutes.	Laemmli	 sample	 dye:	 0.25	 M,	 40%	 (v/v)	 glycerol,	 8%	 (w/v)	 SDS,	 0.4%	 (w/v)	 Blue	Bromophenol	For	gels	with	10	wells,	25	μl	of	each	sample	was	 loaded	into	each	well.	Gels	were	run	 in	reservoir	 buffer	 (0.25	 M	 Tris,	 1.92	 M	 Glycine	 and	 1%	 SDS)	 at	 120	 V	 for	 2	 hours.	PageRulerTM	 Prestained	 Protein	 Ladder	 (Thermo	 ScientificTM)	 was	 loaded	 alongside	samples	in	order	to	estimate	protein	size.		
Table	2.7	Recipe	for	preparation	of	resolving	and	stacking	gels.		 Resolving	Gel	(Volume	for	1	gel)	 Stacking	gel	
(Volume	for	1	gel)	12%	 10%	H2O	 2.2	ml	 2.45	ml	 2.87	ml	40%	Acrylamide/	bis-acrylamide	solution,	37.5:1	 1.5	ml	 1.25	ml	 0.5	ml	1.5	M	Tris	(pH	8.8)	 1.3	ml	 1.3	ml	 0.5	ml	10%	SDS	 0.05	ml	 0.05	ml	 0.04	ml	10%	Ammonium	persulphate	(AMPS)	 0.05	ml	 0.05	ml	 0.04	ml	
N,	N,	N′,	N′-Tetramethylethane-1,	2-diamine	(TEMED)	 0.002	ml	 0.002	ml	 0.004	ml	
2.5.4 Western	blot	analysis	(Semi-dry)	After	electrophoresis,	the	gel	was	soaked	in	Towbin	buffer	(Table	2.8),	along	with	6	pieces	of	 3	 mm	 WhatmanTM	 chromatography	 paper	 and	 an	 AmershamTM	 HybondTM-ECL	nitrocellulose	membrane	(paper	and	membrane	both	cut	to	the	same	size	as	the	gel).	The	blotter	was	set	up	in	the	following	method,	with	3	pieces	of	chromatography	paper	at	the	bottom,	 then	 the	ECL	nitrocellulose	membrane,	 followed	by	 the	gel	and	 the	 remaining	3	pieces	of	chromatography	paper.	The	transfer	was	performed	using	a	Bio-Rad	Trans-Blot®	SD	Semi-Dry	Transfer	Cell	at	20	V	for	1	hour.		
2.5.5 Immuno-detection	Once	the	proteins	had	been	transferred	onto	the	membrane,	the	membrane	was	blocked	overnight	in	blocking	buffer:	5%	Skim	milk	powder	in	TBS	(Table	2.8)	at	4°C.	The	milk	was	 poured	 off	 and	 the	membrane	washed	 in	TBS	 for	 5-10	minutes.	 This	was	repeated	 three	 times,	with	 gentle	 shaking.	 The	membrane	was	 then	 incubated	with	 the	primary	antibody	(Table	2.9)	for	2-4	hours	with	gentle	shaking	at	room	temperature.	After	incubation	with	 the	 primary	 antibody,	 the	membrane	was	washed	with	 TBS-T	 for	 5-10	
	 68	
minutes	with	 gentle	 shaking.	 This	wash	 step	was	 repeated	 three	 times.	 The	membrane	was	 then	 incubated	with	 the	 secondary	 antibody	 (Table	 2.9)	 in	 5%	 Skim	milk	 powder-TBS-T	for	2	hours	with	gentle	shaking.	After	incubation,	the	membrane	was	washed	once	more	with	TBS-T.		When	 horseradish	 peroxidase-linked	 secondary	 (ECL)	 antibodies	 were	 used,	 the	membrane	 was	 incubated	 with	 SuperSignal®	 West	 Pico	 Chemiluminescence	 Substrate	(Thermo	 ScientificTM)	 for	 two	 minutes	 at	 room	 temperature.	 In	 a	 dark	 room,	 the	membrane	was	 exposed	 to	 a	 sheet	 of	 autoradiography	 Film	 –	AmershamTM	HyperfilmTM	ECL	 (GE	Healthcare)	 and	was	developed	using	 a	Xograph	automatic	 film	developer.	The	time	of	exposure	varied,	depending	on	the	strength	of	the	signal.		For	quantitative	Western	blot	analysis,	IRDye®	secondary	antibodies	(Dylight™800)	were	used	 as	 the	 secondary	 antibody.	 Before	 detection	 the	membrane	was	washed	with	TBS.	Detection	 was	 carried	 out	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 (Li-COR	Biosciences)	and	the	infrared	fluorescence	signal	was	excited	at	785	nm.	Image	Studio	Lite	2	 (Li-COR	 Biosciences)	 software	 was	 used	 to	 analyse	 the	 membrane	 and	 quantify	 the	proteins.		
Table	2.8	Buffer	and	solutions	used	for	Western	blot	analysis	
TBS	 	Tris	Base	 20	mM	NaCl	 137	mM	pH	to	7.6	with	HCl	 1M	
TBS	with	Tween-20	(TBS-T)		 	TBS	 As	above	Tween-20	 0.1%	(v/v)	
Towbin	Buffer	 	Tris	 25mM	Glycine	 192	mM	Methanol	 20%	(v/v)	
2.5.6 Quantification	of	Western	blot	analysis	The	 IR	 fluorescent	 signals	 of	 the	 bands	 detected	 from	 the	 Western	 blot	 analysis	 were	measured	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 (Li-COR	 Biosciences)	 and	 were	analysed	using	Image	Studio	Lite	2,	looking	at	the	signals	of	the	proteins	from	the	800	nm	channel.	The	background	value	was	defined	by	drawing	a	 rectangle	onto	 the	membrane	where	no	band	was	present.	To	quantify	 the	signal,	 rectangles	were	drawn	around	each	band	 to	 define	 the	 region	 for	 quantification;	 the	 background	 signal	 was	 automatically	subtracted.		
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When	 normalising	 the	 target	 sample	 to	 the	 loading	 control,	 the	 infrared	 signal	 of	 the	loading	control	was	quantified.	Each	loading	control	value	was	divided	by	a	single	loading	control,	to	give	a	proportional	value.	The	target	signal	was	then	divided	by	their	respective	loading	control	to	give	a	normalised	IR	fluorescent	signal.		Antibodies	Table	2.9	shows	a	list	of	the	primary	and	secondary	antibodies	used	in	this	study.		
Table	2.9	Antibodies	used	in	this	study	for	Western	blot	analysis.	
Antibodies	 Source	 Dilution	
Primary	antibodies	Anti-HA	(polyclonal,	produced	in	rabbit)	 Sigma-Aldich	 1:2000	Anti-GFP	(polyclonal,	produced	in	rabbit)	 Thermo-Fisher	ScientificTM	 1:2000	Anti-RbcL	(polyclonal,	produced	in	rabbit)	 Gift	from	P.	Nixon,	Imperial	College	London,	UK	 1:8000	Anti-PsaD	(polyclonal,	produced	in	rabbit)	 Gift	from	J.	Gray,	University	of	Cambridge,	UK	 1:1000	
Secondary	Antibodies	ECL	anti-Rabbit	IgG,	horseradish	peroxidase-linked	whole	antibody	(from	donkey)	
Amersham,	GE	Healthcare	 1:5000	
Anti-Rabbit	IgG	(H&L)	DyLightTM	800	conjugated	(from	goat)	 Thermo	ScientificTM	 1:15000	
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2.6 Activity	assays	
2.6.1 Growth	spot	tests	to	assay	expression	of	selectable	markers	Cells	either	from	a	small	 loopful	resuspended	in	100	μl	of	BG-11	or	from	a	liquid	culture	grown	to	an	OD730	of	0.6-1	were	used	for	growth	spot	tests.	A	10-fold	serial	dilution	was	performed	 on	 the	 strains	 and	 10	 μl	 of	 each	 dilution	 was	 applied	 onto	 solid	 medium	containing	BG-11	supplemented	with	the	appropriate	selective	agent.	The	plate	was	then	left	 to	dry	and	 then	 incubated	 in	 the	30°C	 incubator	 in	~40	μmol/m2/s	 light.	The	plates	were	inspected	every	day	and	photographs	were	taken	after	3-7	days.	
2.6.2 Induction	of	PnrsB	using	Ni2+	A	6.4	mM	NiCl2.H2O	stock	solution	was	prepared,	and	used	for	induction.	Unless	otherwise	stated,	the	final	concentration	for	induction	was	6.4	μM.	When	incubating	in	liquid	media,	samples	were	induced	for	4	hours,	unless	otherwise	stated,	before	harvesting	the	samples	for	further	analysis.	
2.6.3 Detection	of	GFP	using	a	luminescence	spectrometer	To	detect	 the	emission	of	GFP	 from	various	Synechocystis	 strains	expressing	 the	protein,	liquid	cultures	of	the	various	strains	were	grown	to	a	similar	OD730.	For	analysis	4ml	was	used	in	the	PerkinElmer	LS	55	Luminescence	Spectrometer.	 	The	emission	spectrum	was	recorded	 from	 420	 nm	 to	 700	 nm,	 with	 excitation	 at	 395	 nm	 and	 a	 scan	 speed	 of	500nm/min.	The	peak	at	509	nm	representing	GFP	was	analysed.		In	later	studies	using	the	luminescence	spectrometer,	50	ml	of	BG-11	was	inoculated	from	a	 freshly	 restreaked	plate,	 to	give	a	 starting	OD730:	~0.05.	Cells	were	 then	grown	 in	 low	light,	20-40	μmol/m2/s	at	25°C,	with	shaking	at	120	rpm	until	the	OD730	reached	~0.6-0.8.	X	ml	 of	 the	 cultures	were	 then	 harvested	 and	 resuspended	 in	 4	ml	 of	 BG-11.	 X	ml	was	calculated	 (see	 section	 2.4.13)	 to	 ensure	 the	 final	 concentration	 of	 the	 cells	 was	 4x108	cells/ml.	
2.6.4 GC-MS	
2.6.4.1 Ethyl	acetate	extraction	The	 strains	were	 inoculated	 in	25	ml	 of	BG-11	 and	were	 grown	 to	 an	OD730	 of	~1.4.	 To	perform	 the	 ethyl	 acetate	 extraction,	 1	ml	was	 centrifuged	 at	 13000	 rpm	 for	5	minutes.		The	supernatant	was	removed	and	transferred	into	another	1.5	ml	microfuge	tube.	To	the	pellet	 and	 the	 supernatant,	 500	 μl	 ethyl	 acetate	 (HPLC	 grade)	was	 added.	 The	 samples	
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were	then	heated	at	50°C	for	10	minutes	before	transferring	the	ethyl	acetate	layer	to	a	GC	vial.	The	vials	were	stored	at	-20°C.		
2.6.4.2 Two-phase	dodecane	extraction	The	strains	were	used	to	inoculate	50	ml	of	BG-11,	which	were	then	overlaid	with	5	ml	n-dodecane	 (dodecane)	 (99+%,	Alfa	Aesar).	 The	 liquid	 cultures	were	 then	 incubated	 until	they	grew	to	an	OD730	of	~1.2.	The	dodecane	layer	was	then	transferred	into	a	GC	vial	and	stored	at	-20°C.	
2.6.4.3 GC-MS	conditions	and	analysis	Limonene	standards	were	prepared	with	analytical	standard	(S)-Limonene	(Sigma	Aldrich)	in	dodecane	or	ethyl	acetate.	All	samples	in	dodecane	were	diluted	1:20	with	ethyl	acetate	before	loading	onto	the	GC-MS	GC-MS	 was	 performed	 on	 an	 Agilent	 7890A/5975C	 GC-MS.	 One	 μl	 of	 each	 sample	 was	injected	and	separated	using	a	HP-5MS	column	(35	m ✕	0.25mm; 0.25	μm	film	thickness).	The	 analytical	 conditions	 were	 as	 follows:	 He	 (1.5	 ml/min)	 as	 the	 carrier	 gas,	 splitless	injection,	 and	 the	 oven	 program	 was	 set	 at	 45°C	 for	 1	 min	 then	 40°C/min	 to	 320°C.	Scanning	method	was	used	to	obtain	a	library	match	and	the	SIM	method	was	the	used	at	68	m/z.	The	internal	standard	used	was	1-octanol.	
2.6.5 Limonene	-	DPPH	assay	The	 DPPH	 solutions	 were	 freshly	 prepared	 in	 dodecane	 before	 use.	 Spectroscopy	 was	performed	 using	 the	 FLUOstar	 Omega	 microplate	 reader	 (BMG	 LABTECH)	 at	 25°C.	Standards	 were	 prepared	 by	 dissolving	 limonene	 in	 dodecane	 (100	 μl,	 various	concentrations)	 and	were	 added	 to	 100	 μl	 of	 0.2	mM	DPPH	 into	 polypropylene	 96-well	plates	 (Grenier	bio-one).	For	 the	enzyme	assay	 (2.6.5.1),	100	μl	of	 the	dodecane	overlay	was	added	to	100	μl	of	0.2	mM	DPPH.	A	200	μl	aliquot	of	dodecane	was	used	to	blank	the	plate	reader	and	replicates	of	each	sample	performed.	Samples	were	shaken	at	500	rpm	before	 each	 cycle	 reading	 in	 orbital	 shaking	mode	 and	 absorbance	 readings	 at	 510	 nm	were	 taken	every	minute	 for	180	minutes.	Reaction	rates	calculated	 ignored	 the	 first	10	minutes,	as	this	region	was	noisy.		
2.6.5.1 Enzyme	assay	To	 prepare	 the	 enzyme	 for	 the	 enzyme	 assay,	 105ml	 of	 BG-11	 was	 inoculated	 from	 a	freshly	streaked	plate	and	grown	to	an	OD730:	~1.1.	Glass	beads	were	used	to	isolate	whole	protein	(2.5.1),	and	the	samples	were	resuspended	in	0.5	x	X	ml	enzyme	buffer	B	and	800	
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μl	of	resuspended	cells.	After	using	the	glass	beads,	40	μl	from	the	upper	fraction	and	40	μl	from	 the	 lower	 fraction	were	used	 for	Western	blot	analysis,	 to	 confirm	 the	presence	of	the	enzyme.		A	100	μl	aliquot	of	the	upper	fraction,	containing	the	soluble	proteins,	was	then	used	for	the	enzyme	assay	and	was	transferred	to	a	GC	vial,	containing	300	μl	of	either	0	/1/	1.5	mM	 GPP	 (Echelon	 Biosciences)	 in	 15	 mM	 MOPs,	 10	 mM	 MgCl2,	 2	 mM	 DTT.	 A	 layer	 of	dodecane	of	250	μl	was	then	overlaid	on	top	of	the	cell	extract	with	GPP.	Samples	were	left	at	25°C	 for	24	hours	before	vortexing	 the	sample	 to	 terminate	 the	assay.	To	 test	 for	 the	presence	of	limonene,	a	100	μl	sample	was	used	in	the	FLUOstar	Omega	microplate	reader	with	100	μl	of	0.2	mM	DPPH	(2.6.5).		
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2.7 Synechocystis	toxicity	tests	
2.7.1 	Toxicity	tests	with	limonene	A	liquid	culture	of	Synechocystis	was	grown	to	an	OD730	of	~0.8,	unless	otherwise	stated,	and	25	ml	was	added	to	each	flask.		Either	(R)-(+)-limonene	(97%,	Sigma	Aldrich)	or	(S)-(−)-limonene	(96%,	Sigma	Aldrich)	was	added	to	individual	flasks	to	a	final	concentration	of	0,	0.02,	0.1,	0.2,	0.4	or	1%	(v/v).	The	cultures	were	then	grown	at	25°C	in	50	μmol/m2/s	light.	Photographs	were	taken	after	the	addition	of	limonene	after	0,	2,	4,	6	and	24	hours	to	record	the	viability	of	the	culture.		
2.7.1.1 Growth	on	solid	media	after	24	hours	24	hours	after	 the	addition	of	 (R)-(+)-limonene,	a	200	μl	aliquot	was	spread	onto	BG-11	medium	and	grown	at	 30°C	 in	~40	μmol/m2/s	 for	4-6	hours.	 Photographs	of	 the	plates	were	taken	after	7	and	16	days.		
2.7.2 Toxicity	test	with	limonene	and	dodecane	A	 liquid	culture	of	Synechocystis	was	grown	 to	an	OD730	of	0.7,	 and	25	ml	was	aliquoted	into	12	flasks.	For	six	of	the	flasks	5	ml	of	n-dodecane	(Alfa	Aesar)	was	added	to	the	cells.	Different	volumes	of	 (R)-(+)-limonene	 (Sigma	Aldrich)	was	added	 to	 the	 flasks	with	and	without	dodecane	to	give	the	following	final	concentrations	of	limonene:	0,	0.02,	0.1,	0.2,	0.4	and	1%	(v/v).	Photographs	were	taken	at	0,	2,	18,	24,	and	then	every	24	hours	after	the	addition	of	limonene	to	record	the	viability	of	the	culture.		
2.7.3 Toxicity	tests	with	styrene,	trans-cinnamic	acid	and	styrene	oxide	To	prepare	the	trans-Cinnamic	acid	(tCa),	a	stock	of	100	g/L	tCa	(99+%,	Alfa	Aesar)	was	prepared	 in	 95%	 ethanol.	 A	 liquid	 culture	 of	 BG-11	 was	 inoculated	 with	 wild-type	
Synechocystis	and	was	grown	to	an	OD730	of	either	~0.8	or	~0.1.	For	each	flask,	25	ml	of	the	 liquid	 culture	was	 added	along	with	different	 volumes	of	 styrene	 (99%,	Alfa	Aesar),	tCa	and	styrene	oxide	(98+%,	Alfa	Aesar).	A	culture	without	styrene,	tCa	or	styrene	oxide	present	acted	as	 the	control.	 	Photographs	were	 taken	 immediately	after	 the	addition	of	the	three	chemicals	and	twice	a	day	thereafter	to	record	the	viability	of	the	cells.	
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2.8 Construction	of	two-gene	operons	
2.8.1 Construction	of	two-gene	operon	containing	ble	and	gfp	The	 PCR	 product,	 Ble_IG2	 (0.4kb),	was	 amplified	 via	 PCR	 using	 Ble_Fw	 and	 Ble_IG2_Re.	The	 PCR	 product,	 IG2_GFP	 (0.7	 kb),	 was	 also	 amplified	 via	 PCR,	 using	 GFP_Re	 and	GFP_IG2_Fw.	A	PCR	was	then	performed	using	Ble_IG2	and	IG2_GFP	as	the	template	with	Ble_Fw	 and	 GFP_Re	 to	 create,	 ble_IG2_GFP	 (1.1	 kb).	 The	 same	 PCR	 reactions	 were	performed	 with	 different	 primers	 (Table	 2.10)	 to	 create	 Ble_IG4_GFP,	 Ble_IG5_GFP,	Ble_IG0bp_GFP	and	Ble_IG1bp_GFP	(all	1.1	kb).		
Table	2.10	Primers	used	to	create	the	PCR	products	of	the	two-gene	operons	
	Each	 Ble_IGX_GFP	 PCR	 fragment	was	 then	 digested	with	 AseI	 and	 BglII	 and	 cloned	 into	pLAH.cpc	between	the	NdeI	and	BamHI	site.	The	insertion	of	Ble_IGX_GFP	into	pLAH.cpc	to	produce	various	pLAH.cpc.ble.IGX.GFP	expression	plasmids	was	 confirmed	by	PCR	using	Ben.ups.F	and	C.Frag.BR.	Sequencing	with	primers	Pcpc_ins_F,	ble_Fw	and	Out_GFP_R	also	confirmed	the	results	of	the	PCR.		
2.8.2 Construction	of	two-gene	operon	containing	ble	and	splB	Primers	used	to	transcriptionally	couple	splB	and	gfpuv	were	designed	in	a	similar	manner	to	those	used	to	amplify	ble	when	the	intergenic	region	was	zero	base	and	one	base	(Table	2.11).		
Template Forward	Primer Reverse	Primer PCR	product
pZΔES	 Ble_Fw Ble_IG2_Re ble_IG2
4op GFP_IG2_Fw GFP_Re IG2_GFP
ble_IG2	and	IG2_GFP Ble_Fw GFP_Re ble_IG2_GFP
pZΔES	 Ble_Fw Ble_IG4_Re ble_IG4
4op GFP_IG4_Fw GFP_Re IG4_GFP
ble_IG4	and	IG4_GFP Ble_Fw GFP_Re ble_IG4_GFP
pZΔES	 Ble_Fw Ble_IG5_Re ble_IG5
4op GFP_IG5_Fw GFP_Re IG5_GFP
ble_IG5	and	IG5_GFP Ble_Fw GFP_Re ble_IG5_GFP
pZΔES	 Ble_Fw Ble_IG0bp_Re ble_IG0bp
4op GFP_IG0bp_Fw GFP_Re IG0bp_GFP
ble_IG0bp	and	IG0bp_GFP Ble_Fw GFP_Re ble_IG0bp_GFP
pZΔES	 Ble_Fw Ble_IG1bp_Re ble_IG1bp
4op GFP_IG1bp_Fw GFP_Re IG1bp_GFP
ble_IG1bp	and	IG1bp_GFP Ble_Fw GFP_Re ble_IG1bp_GFP
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Table	2.11	Table	containing	the	primers	used	to	create	the	PCR	products	containing	the	
two-gene	operon	with	splB	and	gfpuv.	
	The	 PCR	 products,	 splB_IG0bp_GFP	 and	 splB_IG1bp_GFP,	 were	 digested	 with	 AseI	 and	BglII,	 and	 cloned	 into	 pLAH.cpc	 at	 the	 NdeI	 and	 BamHI	 restriction	 sites	 to	 produce	pLAH.splB.0bp.GFP	 and	 pLAH.splB.1bp.GFP.	 Construction	 of	 these	 plasmids	 was	confirmed	 by	 performing	 a	 test	 digest	 using	 EcoRV	 and	NdeI.	 Sequencing	with	 primers	pcpc_ins_fw	 and	 GFP_Fw_0bp/GFP_Fw_1bp	 confirmed	 the	 presence	 of	 the	 insert	 in	pLAH.splB.IG0bp.GFP	and	pLAH.splB.IG1bp.GFP.		
Template Forward	Primer Reverse	Primer PCR	product
pASapI-SplB splB_F splB_IG0bp_R splB_IG0bp
4op GFP_0bp_F GFP_Re IG0bp_GFP	(splB)
splB_IG0bp	and	IG0bp_GFP	(splB)

splB_F GFP_Re splB_IG0bp_GFP
pASapI-SplB splB_F splB_IG1bp_R splB_IG1bp
4op GFP_1bp_F GFP_Re IG1bp_GFP	(splB)
splB_IG1bp	and	IG1bp_GFP	(splB)

splB_F GFP_Re splB_IG1bp_GFP
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2.9 Bioinformatics	Alignment	and	sequence	analysis	was	performed	using	MacVector	12.6.0.	Table	2.12	 list	the	following	free	online	tools	also	used	in	this	study.		
Table	2.12	List	of	databases	and	websites	used	in	this	study.	
Protein	and	DNA	sequences	Database	
Sequence	for	
Synechocystis	genome	
http://genome.microbedb.jp/cyanobase/Synechocystis	
NCBI	 http://www.ncbi.nlm.nih.gov/	
Bioinformatics	tools	
Primer	design	 http://www.basic.northwestern.edu/biotools/oligocalc.html	
Reverse	complement	 http://www.bioinformatics.org/sms/rev_comp.html	
Sequence	alignment	 http://www.ebi.ac.uk/Tools/msa/clustalw2/	
Restriction	digest	 http://nc2.neb.com/NEBcutter2/	
Calculate	MW	of	
Proteins	
http://web.expasy.org/protparam/	
Ligation	calculator	 http://www.insilico.uni-duesseldorf.de/Lig_Input.html	
Intergenic	sequences	
search	
http://meta.microbesonline.org/operons/gnc1148.html	
Translation	tool	 http://www.attotron.com/cybertory/analysis/trans.htm	
BPROM	 http://www.softberry.com/berry.phtml?topic=bprom&group=programs&
subgroup=gfindb	
BLAST	®	 http://blast.ncbi.nlm.nih.gov/Blast.cgi	
Operon	Predictor	 http://www.microbesonline.org/operons/gnc1148.html	
Codon	optimisation	for	
SO	operon	for	
Synechocystis	
https://www.idtdna.com/CodonOpt	
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Chapter	3 	Expression	 of	 limonene	 synthase	 in	
Synechocystis	
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3.1 Introduction	
3.1.1 Limonene	Limonene	is	a	C10	cyclic	monoterpene	that	is	produced	as	an	essential	oil	in	plants.	Many	plants	 naturally	 produce	 limonene	 as	 a	 pollinator	 attractant	 and	 a	 defence	 mechanism	against	herbivores	(Maruyama	et	al.,	2001).		Recently	 there	has	been	growing	 interest	 in	 limonene	and	 its	derivatives	as	 they	can	be	used	in	a	wide	range	of	applications	(Figure	3.1).	Limonene	could	be	used	as	an	alternative	aviation	fuel	as	it	was	demonstrated	to	have	properties	(e.g.	freezing	point,	volatility	and	viscosity)	that	were	comparable	to	Jet	A-1,	one	of	the	most	commonly	used	aviation	fuels	in	 the	world	 (Chuck	 and	Donnelly,	 2014).	 Limonene	 in	 the	 hydrogenated	 form	 also	 has	favourable	properties	 for	use	 as	 a	 jet	 fuel	 (e.g.	 high	 energy	density,	 immiscible	 in	water	and	a	 low	 freezing	point)	 (Alonso-Gutierrez	 et	 al.,	 2013)	 and	as	 a	diesel	 fuel	 additive	 to	enhance	 cold	weather	 performance	 (Tracy	 et	 al.,	 2009).	 Limonene	 has	 a	 pleasant	 smell,	and	 is	 often	 used	 as	 a	 fragrance	 in	 perfumes	 and	 cosmetics	 and	 is	 present	 in	 cleaning	products.	 The	 oxygenated	 forms	 such	 as	 carvone	 and	 perillyl	 alcohol	 are	 also	 useful	chemicals	with	applications	in	the	pharmaceutical,	food	and	cosmetic	industries	(Alonso-Gutierrez	et	al.,	2013;	Carter	et	al.,	2003).		Limonene	is	usually	obtained	as	a	by-product	from	the	orange	juice	industry,	however	the	process	 of	 extracting	 limonene	 (mechanical	 pressurising	 and	 distillation)	 is	 energy	intensive	 and	 costly,	 making	 it	 unsustainable	 for	 biofuel	 production	 (Halfmann	 et	 al.,	2014b).	Both	the	d-	and	l-	enantiomers	of	 limonene	exist,	due	to	the	presence	of	a	chiral	centre,	and	have	different	properties	and	uses.	The	limonene	produced	from	citrus	fruits	is	often	70-98%	of	the	d-enantiomer	(also	called	(+)-	and	R-limonene)	which	has	a	citrus	smell	and	is	the	enantiomer	used	as	a	flavour/fragrance	ingredient	(Jongedijk	et	al.,	2016).	The	 l-limonene	(also	called	(−)-limonene	and	S-limonene)	has	a	piney,	 turpentine	odour.	Both	 (−)-perillyl	 alcohol	 and	 (−)-carvone	are	produced	 from	 the	 l-limonene	enantiomer.	Limonene	 is	 sold	at	9-10	$/kg,	whereas	 the	derivatives	of	 limonene	are	 sold	at	a	higher	price;	(−)-menthol	costs	15-20	$/kg	and	(−)-carvone	costs	15-20	$/kg	(Lange,	2015).		
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Figure	3.1	Applications	of	limonene	and	derivatives	of	limonene	1.	Limonene;	2.	carveol;	3.	carvone;	4.	perillyl	alcohol;	5.	p-mentha-2,8-diene-1-ol;	6.	p-mentha-1,8-dien-4-ol;	 7.	 p-menth-8-ene-1,2-diol;	 8.	 terephthalic	 acid;	 9.	menthol;	 10.		dehydrocarvone,	 11.	 	 polylimonene;	 12.	 limonene	 monoepoxide;	 13.	 limonene	 di-epoxide;	 14.	 	 product	 of	 thiol	 di-addition	 (R1	 and	 R2	 are	 thiol-side	 groups	 e.g.,	 2-mercaptoethanol,	 methyl	 thioglycolate,	 or	 thioglycerol;	 15.	 1-isopropyl-4-methylcyclohexane;	 16.	 m-cymene;	 17.	 menthone.	 +	 and	 –	 indicate	 where	 a	 single	enantiomer	 is	 used;	 +/−	means	 either	 enantiomer	 can	be	used,	 but	 not	 as	 a	mixture.	Figure	from	(Jongedijk	et	al.,	2016).	
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In	 plants,	 limonene	 and	 other	monoterpenes	 are	 produced	 from	 the	 common	precursor	geranyl	 diphosphate	 (GPP).	 Two	 isoprene	 units	 DMAPP	 and	 IPP	 are	 produced	 from	 the	MEP	 pathway	 or	 the	MVA	 pathway	 and	 are	 combined	 by	 geranyl	 diphosphate	 synthase	(GPPS)	to	produce	GPP	(Figure	1.7).	Limonene	is	then	produced	from	GPP	using	limonene	synthase	(LS).	Some	plant	species	produce	one	enantiomer,	whereas	others	produce	both	in	varying	ratios	(Maruyama	et	al.,	2001).		
3.1.2 Limonene	production	in	microorganisms	Successful	 attempts	 have	 been	 made	 to	 produce	 limonene	 in	 E.	 coli	 and	 S.	 cerevisiae	(Alonso-Gutierrez	et	al.,	2013;	Behrendorff	et	al.,	2013;	Carter	et	al.,	2003;	Jongedijk	et	al.,	2015;	Willrodt	et	al.,	2014).	In	E.	coli	limonene	production	from	sugar	was	achieved	after	expressing	GPPS	 from	Grand	 fir	 (Abies	grandis)	and	LS	 from	spearmint	 (Mentha	spicata)	(Carter	 et	 al.,	 2003).	 The	 yield	 of	 limonene	 production	 was	 further	 improved	 by	expressing	heterologous	genes	from	S.	cerevisiae	to	introduce	the	MVA	to	work	alongside	the	 MEP	 pathway	 and	 produce	 more	 IPP	 and	 DMAPP	 (Alonso-Gutierrez	 et	 al.,	 2013;	Willrodt	et	al.,	2014).	The	production	of	 limonene	has	also	been	achieved	in	S.	cerevisiae	by	 expressing	 LS	 from	 lemons	 (Citrus	 limon),	 beefsteak	 plants	 (Perilla	 frusctascens)	 and	spearmint	(Behrendorff	et	al.,	2013;	Jongedijk	et	al.,	2015).	
3.1.3 Aims	and	objectives	At	 the	 time	of	 starting	 the	project,	 the	production	of	 limonene	 in	 cyanobacteria	had	not	been	achieved.	The	main	aim	of	the	work	in	this	chapter	was	to	attempt	the	synthesis	of	limonene	in	Synechocystis	through	genetic	engineering,	and	to	increase	the	production	of	limonene	by	making	further	genetic	modifications	to	the	metabolic	pathway.	As	GPP	(the	substrate	 for	LS)	 is	produced	 from	 the	MEP	pathway	 in	Synechocystis,	 the	production	of	limonene	was	attempted	by	expressing	a	LS	gene	under	various	promoters	 (Figure	3.2).	Alongside	this	work,	attempts	were	made	to	increase	the	pool	of	GPP	for	LS,	by	knocking	out	 pathways	 downstream	 of	 GPP.	 The	 toxicity	 of	 limonene	 towards	 Synechocystis	 was	also	 investigated,	 as	 the	 toxicity	 of	 limonene	 towards	 other	 microorganisms	 has	 been	demonstrated.			
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Figure	 3.2	 Native	 MEP	 pathway	 for	 isoprenoid	 synthesis	 and	 engineered	 limonene	
pathway	in	Synechocystis		Schematic	 showing	 the	 methyerythritol	 phosphate	 (MEP)	 pathway.	 Native	
Synechocystis	genes	in	blue	and	non-native	pathway	in	red.	Abbreviations	used:	G3P	=	glyceraldehyde	 3-phosphate,	 DXP	 =	 1-deoxy-d-xylulose	 5-phosphate,	 MEP	 =	methylerythritol-4-phosphate,	 IPP	=	 isopentenyl	diphosphate,	DMAPP	=	dimethylallyl	diphosphate,	GPP	=	geranyl	diphosphate,	LS	=	limonene	synthase.		
Pathway	-	showing	the	MEP	pathway	-	then	the	subsequent	
pathway	and	the	introduc8on	of	limonene	synthase.		
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3.2 Results	
3.2.1 Toxicity	of	limonene	towards	Synechocystis	One	 of	 the	 main	 problems	 with	 producing	 novel	 compounds	 in	 cyanobacteria	 is	 the	problem	with	 toxicity.	Monoterpenes	such	as	 limonene	are	 thought	 to	 interfere	with	 the	cell	 membrane	 (Brennan	 et	 al.,	 2012).	 The	 external	 addition	 of	 limonene	 proved	 to	 be	toxic,	at	low	concentrations,	for	E.	coli	(0.025%	(v/v))	and	S.	cerevisiae	(~0.0075%	(v/v)),	(Brennan	 et	 al.,	 2012;	 Dunlop	 et	 al.,	 2011).	 Although	 E.	 coli	 has	 been	 engineered	 to	produce	 limonene,	 the	 levels	of	production	were	not	yet	 toxic	 to	 the	cells	 (Dunlop	et	al.,	2011).	 Therefore	 toxicity	 tests	 were	 performed	 by	 adding	 limonene	 exogenously	 to	cultures	 of	 Synechocystis	 to	 determine	 the	 potential	 effects	 of	 introducing	 a	 limonene	production	pathway	into	Synechocystis.		
3.2.1.1 Initial	toxicity	tests	with	limonene	An	initial	toxicity	test	was	performed	on	WT	Synechocystis	with	different	amounts	of	(R)-limonene	added	to	the	cultures	(Figure	3.3A).	After	two	hours	the	cultures	supplemented	with	 limonene	 appeared	unhealthy	 in	 comparison	 to	 the	 control	 strain	 that	 had	no	 (R)-limonene	added.	After	24	hours,	the	same	cultures	appeared	colourless,	which	suggested	the	 cells	 had	 died,	 so	 a	 sample	 of	 each	 culture	 was	 taken	 and	 grown	 onto	 solid	 BG-11	medium	(Figure	3.3B).	After	16	days,	no	colonies	were	observed	on	the	plates	that	had	1%	or	0.4%	(v/v)	of	limonene	added	to	the	cells;	colonies	were	present	on	some	of	the	plates	when	0.02%,	0.1%	and	0.2%	were	added	to	the	cultures,	with	fewer	colonies	obtained	as	the	 concentration	 increases.	 These	 results	 confirm	 that	 limonene	 is	 toxic	 towards	
Synechocystis	 at	 concentrations	 as	 low	 as	 0.02%	 (v/v),	 and	 therefore	 production	 of	 the	compound	in	the	cyanobacterium	should	ideally	be	inducible	(see	section	3.2.2	below)	so	that	biomass	can	be	produced	prior	to	inducing	synthesis	of	limonene.	
	 83	
	
Figure	 3.3	 Photographs	 of	 toxicity	 tests	 taken	 after	 the	 addition	 of	 (R)-limonene	 to	 a	
culture	of	WT	Synechocystis	with	a	starting	OD730	of	0.83.		(A)	 Photographs	 of	 the	 cultures	 were	 taken	 after	 2,	 4,	 14	 and	 49	 hours	 after	 the	addition	of	(R)-Limonene.	(B)	i)	culture	at	24	hours,	grown	in	BG-11	medium	ii)	plating	on	solid	BG-11,	photograph	taken	after	16	days.		
3.2.1.2 Mitigate	toxicity	of	limonene	with	dodecane	From	the	previous	results,	limonene	appears	to	be	toxic	towards	Synechocystis.	Two-phase	culture	 systems	 with	 various	 solvents	 have	 been	 effective	 in	 reducing	 the	 toxicity	 of	limonene	 towards	 S.	 cerevisiae	 (Brennan	 et	 al.,	 2012).	 Dodecane	 has	 been	 used	 as	 the	solvent	 in	a	 two-phase	system	and	was	effective	 in	 reducing	 the	 toxicity	of	geraniol	and	farnesene	towards	Synechocystis	(Al-Haj,	2014).		As	 before,	 different	 concentrations	 of	 (R)-limonene	 were	 added	 to	 a	 culture	 of	
Synechocystis,	 but	 in	 this	 case	 with	 and	 without	 a	 layer	 of	 20%	 (v/v)	 dodecane	 to	determine	whether	 this	 immiscible	 hydrocarbon	 layer	 could	mitigate	 the	 toxic	 effect	 of	limonene	by	 sequestering	 it	 (Figure	3.4).	 Similar	 results	 to	 those	 seen	 in	 section	3.2.1.1	were	obtained	in	the	absence	of	dodecane	after	48	hours,	and	limonene	was	confirmed	to	be	 toxic	at	 concentrations	as	 low	as	0.02%	(v/v)	 limonene.	However,	 in	 the	 initial	 tests,	the	 cultures	 were	 only	 observed	 for	 49	 hours,	 whereas	 in	 this	 case	 the	 culture	 was	observed	for	a	longer	period	of	time	and	after	72	hours,	the	culture	of	Synechocystis	in	the	presence	 of	 0.02%	 (v/v)	 limonene	 appeared	 slightly	 green	 and	 started	 to	 recover.	 This	recovery	 is	also	seen	after	228	hours	when	0.1%	(v/v)	 limonene	was	added	to	 the	cells.	This	may	be	due	 the	degradation	or	 loss	of	 the	volatile	 limonene	 from	 the	medium,	and	recovery	of	a	few	‘survivor’	cells,	or	the	adaptation	of	a	few	cells	to	the	limonene.	
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As	shown	in	Figure	3.4,	growth	of	Synechocystis	 is	unaffected	by	an	overlay	of	dodecane.	More	significantly,	the	dodecane	allowed	growth	in	the	presence	of	limonene,	even	at	the	highest	concentration	tested	–	1%	(v/v).	This	 illustrates	that	the	toxic	effect	of	 limonene	build	up	 in	 the	medium	could	be	mitigated	by	 the	use	of	an	overlay.	Furthermore,	 if	we	assume	 that	 limonene	 can	 be	 excreted	 from	 engineered	 cells	 then	 the	 removal	 of	 the	compound	in	the	media	into	the	overlay	could	extend	the	lifetime	of	a	limonene-producing	culture	(Alonso-Gutierrez	et	al.,	2013).	
	
Figure	 3.4	 Toxicity	 tests	 following	 the	 addition	 of	 (R)-limonene	 to	 a	 culture	 of	 WT	
Synechocystis	with	a	starting	OD730	of	0.7,	without	and	with	a	20%	(v/v)	overlay	of	dodecane.	Photographs	 taken	after	2	hours,	 then	every	24	hours.	 (Note:	not	all	photographs	are	shown).	
3.2.1.3 Toxicity	test	with	(S)-limonene	The	 toxicity	 of	 the	 (S)-limonene	 enantiomer	was	 also	 tested	 to	 determine	 the	 effect	 on	
Synechocystis	(Figure	3.5).	(S)-Limonene	was	added	to	a	culture	of	Synechocystis	grown	to	OD730:	 0.5	 and	 showed	 similar	 results	 to	 the	 addition	 of	 (R)-limonene.	 The	 cells	 are	affected	by	the	presence	of	0.02%	(v/v)	limonene	after	24	hours,	but	the	cells	recover	at	0.02%	(v/v)	after	72	hours,	which	was	also	seen	with	(R)-limonene.		
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Figure	 3.5	 Toxicity	 tests	 after	 the	 addition	 of	 (S)-limonene	 to	 a	 culture	 of	 WT	
Synechocystis	with	a	starting	OD730:	0.4.3.	Photographs	taken	every	24	hours.		
3.2.2 Expression	of	limonene	synthase	in	Synechocystis	Interest	in	cyanobacteria	has	grown	over	the	past	few	years,	due	to	their	ability	to	produce	novel	 compounds	 directly	 from	 CO2	 using	 light	 energy	 and	 to	 grow	 on	 non-arable	 land	(Machado	and	Atsumi,	2012;	Ruffing,	2011).	Limonene	and	its	derivatives	have	a	number	of	 applications,	 including	 potential	 use	 in	 jet	 fuels	 (Jongedijk	 et	 al.,	 2016).	 Limonene	production	 has	 not	 yet	 been	 attempted	 in	 cyanobacteria,	 although	 the	 substrate	 for	 LS,	GPP,	 is	produced.	Therefore,	 the	production	of	 limonene	was	attempted	 in	Synechocystis	by	the	heterologous	introduction	of	LS.		
3.2.2.1 Design	of	a	synthetic	limonene	synthase	gene	In	order	to	select	a	suitable	LS	sequence	for	gene	design,	the	 literature	was	searched	for	well	 characterised	 enzymes.	 LS	was	 found	 to	 be	 characterised	 from	 a	 number	 of	 plants	such	 as	 Perilla	 frutescens,	 Schizonepeta	 tenuifolia,	 Agastache	 rugosa,	 Citrus	 limon,	 Abies	
grandis	and	Mentha	spicata	(Bohlmann	et	al.,	1997;	Colby	et	al.,	1993;	Lücker	et	al.,	2002;	Maruyama	et	 al.,	 2001,	2002;	Yuba	et	 al.,	 1996).	The	 (-)-4S-Limonene	 synthase	 found	 in	spearmint	(Mentha	spicata)	(Accession	number:	L13459),	which	principally	produces	the	
S-limonene,	was	selected	as	it	has	been	successfully	expressed	in	E.	coli	for	the	production	of	limonene	and	has	been	characterised	in	more	detail	than	the	other	LSs.	Other	researchers	had	reported	that	expression	of	the	full-length	LS	led	to	the	formation	of	inclusion	bodies	in	E.	coli,	but	a	truncated	version	of	LS	from	Mentha	spicata	lacking	an	N-terminal	 transit	 sequence	 was	 shown	 to	 be	 functional	 in	 E.	 coli	 and	 S.	 cerevisiae	(Behrendorff	 et	 al.,	 2013;	 Williams	 et	 al.,	 1998)	 The	 first	 57	 amino	 acids	 up	 to	 the	
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conserved	RRX8W	motif	were	removed,	as	they	make	up	the	cleavable	transit	peptide	for	plastid	 localisation	 in	 plants,	 and	 therefore	 were	 not	 required	 for	 expression	 in	cyanobacteria	 (Lücker	 et	 al.,	 2002).	 The	 threonine	 and	 glutamate	 residues	 just	 before	RRX8G	were	retained	to	provide	stability	to	the	enzyme	(Varshavsky,	1997).	For	our	gene	design,	 the	 C-terminal	 end	 of	 the	 various	 LSs	 were	 compared,	 before	 a	 HA-epitope	sequence	 (-YPYDVPDYA*)	was	 added	 to	 enable	 the	 detection	 of	 LS	 (Figure	 3.6).	 The	 LS	sequence	gene	was	codon-optimised	for	Synechocystis	and	designed	with	an	NdeI	at	the	5’	end	of	the	gene	and	a	BamHI	site	at	the	3’	end	of	the	gene.	The	NdeI	start	site	also	provides	the	 start	 codon	 for	 the	 truncated	 LS	 gene.	 The	 designed	 gene,	 ls,	 was	 synthesised	 by	GeneArt	and	provided	on	plasmid	ls_pMA-RQ	(See	Appendix).		
	
Figure	3.6	Alignment	of	the	full	length	Mentha	spicata	limonene	synthase	(Ms_LS)	aligned	
with	the	modified	limonene	synthase	(ls)	truncated	at	the	N-terminus	and	a	HA-tag	at	the	C-
terminus.		The	first	55	amino	acids	are	removed	from	the	full-length	LS	sequence.			
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3.2.2.2 Creation	 of	 a	 transgenic	 strain	 of	 Synechocystis	 containing	 limonene	
synthase	under	the	control	of	the	nickel	inducible	promoter	As	limonene	was	shown	to	be	very	toxic	towards	Synechocystis,	the	expression	of	LS	under	the	 control	of	 the	nickel	 inducible	promoter,	PnrsB,	was	 initially	attempted.	To	create	 the	transgenic	strains	of	Synechocystis	expressing	LS	under	the	control	of	PnrsB,	the	expression	plasmid	 pLAH.nrsB.LS	 was	 created	 to	 introduce	 ls	 at	 the	 psbAII	 site	 (Figure	 3.7).	 The	
psbAII	 gene	 encodes	 the	 D1	 protein	 in	 PSII,	 and	 deletion	 of	 this	 gene	 does	 not	 affect	growth	as	the	psbAIII	gene	expresses	the	D1	protein	in	its	absence	(Mohamed	et	al.,	1993)	.	
	
Figure	3.7	Diagram	of	the	expression	plasmid	pLAH.nrsB.LS	The	 ls	 gene	 digested	 from	 ls_pMA-RQ	 was	 cloned	 into	 pLAH.nrsB	 to	 create	pLAH.nrsB.LS,	to	enable	the	integration	of	ls	under	the	control	of	PnrsB	at	the	psbAII	site.		Using	 NdeI	 and	 BamHI,	 ls	 was	 digested	 from	 ls_pMA-RQ	 and	 cloned	 into	 the	 NdeI	 and	BamHI	 sites	 of	 pLAH.nrsB	 to	 create	 pLAH.nrsB.LS.	 A	 restriction	 digest	 with	 NdeI	 and	sequencing	analysis	confirmed	the	insertion	of	ls	into	pLAH.nrsB.	WT	 Synechocystis	 was	 transformed	 with	 pLAH.nrsB,	 and	 after	 selection	 for	 kanamycin	resistance,	colonies	appeared	after	seven	days.	Eight	colonies	were	picked	after	8	rounds	of	 selection	 on	 kanamycin	 and	 PCR	 analysis	 was	 performed	 to	 screen	 for	 putative	transformants	 of	 6803.nrsB.LS.	 Three	 clones	 contained	 the	 ls	 gene	 at	 the	 psbAII	 locus	confirming	 the	 successful	 creation	of	6803.nrsB.LS	 strains.	As	 there	are	no	copies	of	 the	WT	genome	detected	by	the	PCR	analysis,	all	strains	were	considered	to	be	homoplasmic	for	the	engineered	genome	(Figure	3.8).		
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Figure	 3.8	 PCR	 confirmation	 of	 successful	 transformants	 of	 Synechocystis	 containing	 ls	
under	the	control	of	PnrsB.	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis,	 pLAH.nrsB.LS	 expression	 plasmid	 and	 successful	 6803.nrsB.LS	transformants.	 (B)	 PCR	 screening	 of	 putative	 transformants.	 	WT	Synechocystis	 (WT)	and	 pLAH.nrsB.LS	 (+C)	 were	 used	 as	 controls.	 The	 single	 band	 at	 4.5	 kb	 confirmed	homoplasmic	strains	were	produced.		
3.2.2.3 Expression	of	limonene	synthase	under	the	control	of	the	nickel	promoter	LS	 was	 designed	 with	 an	 HA-epitope	 tag	 at	 the	 C-terminus	 to	 enable	 detection	 of	expression	in	Synechocystis	by	using	commercially	available	anti-HA	antibodies.		Three	transformants	of	6803.nrsB.LS	were	grown	to	an	OD730:	0.8-1	before	induction	with	6.4	μM	Ni2+	for	4	hours.		The	Ni2+	concentration	was	chosen	as	it	has	been	used	previously	to	induce	PnrsB	and	is	thought	to	induce	the	maximal	response	in	PnrsB	(Peca	et	al.,	2008).	Western	 blot	 analysis	 was	 performed	 with	 anti-HA	 antibodies	 on	 the	 crude	 extract	 of	these	 transformants	 on	 6803.nrsB.LS	 using	 horseradish	 peroxidase-linked	 secondary	antibodies	to	measure	the	chemiluminescence	on	photographic	film.	The	expression	of	LS	was	detected	in	all	three	transformants	of	6803.nrsB.LS	when	induced	with	Ni2+	but	in	the	absence	of	Ni2+	the	expression	of	LS	was	not	detected	(Figure	3.9).	These	results	confirm	the	creation	of	a	strain	of	Synechocystis,	6803.nrsB.LS,	which	expresses	LS	under	the	PnrsB.		
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Figure	 3.9	 Western	 blot	 analysis	 showing	 the	 presence	 of	 HA-tagged	 LS	 in	 successful	
6803.nrsB.LS	transformants	that	have	been	induced	with	Ni2+.	Western	 blot	 analysis	 was	 performed	 on	 samples	 of	 6803.nrsB.LS	 that	 were	 either	uninduced	(−)	or	 induced	(+)	with	6.4	μM	Ni2+	 for	4	hours.	The	ECL	method	to	detect			recombinant	 LS	 with	 anti-HA	 antibodies	 and	 ECL	 anti-rabbit	 IgG	 antibodies.	Transformant	line	6803.nrsB	was	used	as	a	negative	control.	The	expected	band	size	of	LS	(65	kDa)	was	seen	in	the	6803.nrsB.LS	transformants	following	induction	with	Ni2+.		
3.2.2.3.1 Investigating	different	induction	conditions	Western	blot	analysis	using	anti-HA	antibodies	was	performed	on	a	single	transformant	of	6803.nrsB.LS_8	using	 the	Odyssey®	Infrared	 Imaging	System,	 to	 investigate	 the	effect	of	the	length	of	induction	and	the	concentration	of	Ni2+	used	on	the	expression	of	LS	(Figure	3.10).	To	test	the	length	of	induction	a	culture	of	6803.nrsB.LS_8	was	grown	to	an	OD730:	0.8	 and	 divided	 into	 four	 flasks.	 Each	 flask	 induced	 with	 6.4	 μM	 Ni2+	 and	 cells	 were	harvested	after	2,	4,	8	and	24	hours.	By	increasing	the	length	of	induction	the	expression	of	LS	was	seen	to	increase.		To	test	the	effect	of	the	concentration	of	nickel,	a	culture	of	6803.nrsB.LS_8	was	grown	to	an	OD730:	 0.8,	 and	divided	 into	 five	 flasks,	with	different	 concentrations	 of	Ni2+	 used	 for	induction.	The	expression	of	LS	with	0.4	μM	Ni2+	was	weak	in	comparison	to	the	use	of	3.2,	6.4,	 12.8,	 and	 19.2	 μM	 Ni2+.	 The	 expression	 of	 LS,	 when	 induced	 with	 higher	concentrations	of	Ni2+	(12.8,	and	19.2	μM),	did	not	appear	to	be	significantly	greater	than	when	3.2	and	6.4	μM	Ni2+	are	used.	This	suggests	that	 increasing	the	Ni2+	beyond	3.2	µM	had	limited	influence	on	the	expression	level.			
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Figure	 3.10	 Western	 blot	 analysis	 comparing	 the	 expression	 of	 HA-tagged	 LS	 in	
6803.nrsB.LS	 transformants	 induced	 with	 different	 times	 of	 induction	 and	 different	
concentrations	of	Ni2+.	Western	blot	analysis	was	performed	with	whole	cell	extracts	with	anti-HA	antibodies	using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 Samples	 were	 run	 on	 a	12%	 SDS-PAGE	 gel.	 Protein	 size	 was	 determined	 using	 the	 PageRulerTM	 Prestained	Protein	ladder	(Thermo	Scientific).	Samples	of	6803.nrsB.LS	were	induced	with	6.4		μM	Ni2+	for	2,	4,	8	and	24	hours	and	samples	of	6803.nrsB.LS	were	induced	with	0,	0.4,	3.2,	12.8,	and	19.2	μM	Ni2+	for	4	hours.		To	try	and	quantify	the	effect	of	using	different	concentrations	of	Ni2+	on	the	expression	of	LS,	Western	blot	 analysis	 (methods)	was	performed	using	anti-HA	antibodies	and	PsaD-antibodies,	which	acted	as	a	loading	control	and	binded	to	the	endogenous	PSI	subunit.		Expression	was	tested	using	6803.nrsB.LS	grown	to	an	OD730	of	0.8,	split	into	seven	flasks,	and	 induced	 for	 4	 hours	 with	 different	 concentrations	 of	 Ni2+	(Figure	 3.11).	 The	 result	confirmed	 that	 expression	of	LS	 is	weak	after	 induction	with	0.4	and	0.8	μM	Ni2+,	but	 is	increased	when	3.2,	6.4	and	12.8	μM	Ni2+	is	used	for	induction.	Quantitative	analysis	using	PsaD	as	 the	standard,	confirmed	that	 this	was	the	case	(Figure	3.11B).	Expression	peaks	when	 3.2	 μM	 Ni2+	 was	 used	 for	 induction	 and	 levels	 start	 to	 decrease	 at	 higher	concentrations,	 possibly	 because	 of	 the	 inhibitory	 effect	 on	 growth	 of	 high	 nickel	concentrations.	 To	 confirm	 this,	 another	Western	 blot	 was	 run	 with	 the	 same	 samples	(including	an	extra	sample	induced	with	1.6	μM	Ni2+	in	duplicate	(Figure	3.12).	However,	the	 quantitative	 analyses	 from	both	 blots	were	 not	 entirely	 in	 agreement	 (Figure	 3.12).	The	first	blot	suggests	that	the	expression	peaked	when	3.2	μM	Ni2+	was	used,	however,	in	the	second	blot	the	expression	peaked	when	6.4	μM	Ni2+.	This	demonstrates	the	difficulty	of	 using	 band	 quantification	 following	 Western	 blot	 analysis	 to	 accurately	 determine	expression.	Nevertheless,	the	study	revealed	that	a	range	of	between	3.2	and	6.4	μM	Ni2+	is	suitable	to	induce	maximal	levels	of	LS.		
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Figure	 3.11	Western	 blot	 analysis	 comparing	 the	 effect	 different	 concentrations	 of	Ni2+	
has	on	the	expression	of	LS	under	the	control	of	PnrsB.	(A)	 Western	 blot	 performed	 with	 whole	 cell	 extracts	 and	 anti-HA	 and	 anti-PsaD	antibodies,	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	 samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	for	LS	is	65	kDa	and	20	kDa	for	 PsaD,	 which	 acted	 as	 a	 loading	 control.	 Protein	 size	 was	 determined	 using	 the	PageRulerTM	Prestained	Protein	 ladder	(Thermo	Scientific).	The	strain,	6803.nrsB	was	used	as	negative	control.	 (B)	LS	was	quantified	using	 the	Odyssey®	Infrared	 Imaging	System.	The	LS	IR	fluorescence	signal	was	normalised	against	the	IR	fluorescence	signal	of	PsaD.		
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Figure	3.12	Western	blot	analysis,	repeating	the	Western	blot	in	Figure	3.11,	comparing	
the	effect	different	concentrations	of	Ni2+	has	on	 the	expression	of	LS	under	 the	control	of	
PnrsB.	(A)	and	(C)	Western	blot	performed	with	whole	cell	extracts	and	anti-HA	and	anti-PsaD	antibodies,	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	 samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	for	LS	is	65	kDa	and	20	kDa	for	 PsaD,	 which	 acted	 as	 a	 loading	 control.	 Protein	 size	 was	 determined	 using	 the	PageRulerTM	Prestained	Protein	 ladder	(Thermo	Scientific).	The	strain,	6803.nrsB	was	used	as	a	negative	control.	(B)	and	(D)	LS	was	quantified	using	the	Odyssey®	Infrared	Imaging	 System.	 The	 LS	 IR	 fluorescence	 signal	 was	 normalised	 against	 the	 IR	fluorescence	signal	of	PsaD.		
3.2.2.3.2 Growth	analysis	on	the	effect	of	nickel	on	6803.nrsB.LS	and	6803.nrsB		The	 results	 of	 the	 toxicity	 tests	 suggest	 that	 a	 low	 concentration	 of	 limonene	 is	 toxic	towards	 Synechocystis	 when	 added	 exogenously.	 If	 the	 same	 toxic	 effect	 is	 seen	 when	limonene	 is	 produced	 within	 the	 cell,	 the	 growth	 of	 Synechocystis	 strains	 producing	limonene	will	be	affected.	When	preparing	the	cultures	for	Western	blot	analysis	(section	3.2.2.3.1),	after	the	addition	of	Ni2+,	the	OD730	would	decrease	slightly	in	the	6803.nrsB.LS	strains.	To	determine	whether	 this	effect	was	due	to	Ni2+	or	 the	production	of	 limonene,	the	growth	of	6803.nrsB	was	compared	to	the	growth	of	6803.nrsB.LS	before	and	after	the	addition	of	Ni2+	(methods)	(Figure	3.13).	6803.nrsB	without	the	addition	of	Ni2+	was	also	grown	alongside	as	a	control	strain.	The	slower	growth	rate	of	6803.nrsB	in	the	absence	of	
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Ni2+	was	due	 to	problems	with	 the	 incubator,	 and	was	grown	at	 around	26°C	 instead	of	30°C.		The	results	indicate	that	the	addition	of	nickel	does	have	a	negative	effect	on	the	growth	of	
Synechocystis,	 as	both	 strains	are	affected	by	 the	addition	of	Ni2+	whereas	 the	growth	of	the	 control	 strain	 is	 unaffected.	 After	 the	 addition	 of	 6.4	 μM	 Ni2+,	 photographs	 of	 the	cultures	were	taken	at	68.5	hours	and	confirmed	the	decrease	in	growth	after	the	addition	of	Ni2+.	Clumps	appeared	in	cultures	where	Ni2+	was	added.	Transition	metal	ions	such	as	Ni2+	 are	 required	 by	 enzymes	 to	 provide	 the	 catalytic	 activity.	 The	 nrsBACD	 and	 nrsRS	operon	present	in	Synechocystis,	where	the	nrsB	promoter	originates	from,	is	responsible	for	 maintaining	 Ni2+	 homeostasis	 (García-Domínguez	 et	 al.,	 2000;	 López-Maury	 et	 al.,	2002).	 However,	 Ni2+	 can	 inhibit	 photosynthesis	 and	 respiration	 at	 high	 concentrations	(Kleiner,	1978;	Rai	et	al.,	1994).	
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Figure	 3.13	 Comparison	 of	 cell	 growth	 between	 6803.nrsB.LS	 and	 6803.nrsB	 after	
induction	with	Ni2+.	(A)	The	 growth,	measured	by	 the	A750,	 of	 strains	6803.nrsB.LS	 and	6803.nrsB.LS	 and	6803.nrsB	was	monitored	in	the	Algem	photobioreactor	(200	μmol/m2/s	white	light,	at	30°C	and	120	rpm	shaking)	before	and	after	induction	with	6.4	μM	Ni2+	after	43	hours	(+).	 The	 strain	 6803.nrsB	 was	 also	 grown	 without	 the	 addition	 of	 Ni2+	 (−).	 (B)	Photographs	were	taken	after	68.5	hours.			
A"er	68.5	hours	
6803.nrsB.LS	 6803.nrsB	 6803.nrsB	
+	 +	 -	
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
1.4	
1.6	
1.8	
0.0	 10.0	 20.0	 30.0	 40.0	 50.0	 60.0	 70.0	 80.0	 90.0	
A 7
50
	n
m
		 	
Time	(hours)	
6803.nrsB.LS	(+)	
6803.nrsB	(+)	
6803.nrsB	(-)	
Addi?on	of	Ni2+	
(B)	
(A)	
	 95	
3.2.2.4 Creation	 of	 transgenic	 strains	 of	 Synechocystis	 containing	 the	 limonene	
synthase	gene	under	the	control	of	the	PpsbAII	promoter	The	induction	of	LS	resulted	in	the	accumulation	of	the	protein	(Figure	3.10)	but	did	not	result	in	the	death	of	the	culture,	seen	when	limonene	was	added	to	the	medium	(Figure	3.3),	 suggesting	 that	 any	 LS	 activity	 produced	 in	 the	 transformant	 cells	 is	 below	 toxic	levels.	 It	 was	 therefore	 decided	 to	 further	 increase	 the	 production	 of	 LS	 in	 the	 cell,	 by	putting	the	gene	under	the	control	of	the	stronger	promoter,	PpsbAII.		As	before,	ls	was	digested	from	ls_pMA-RQ	using	NdeI	and	BamHI	and	cloned	into	the	NdeI	and	 BamHI	 site	 of	 expression	 vector	 pLAH.AII	 (see	 section	 2.3	 for	 details)	 to	 create	pLAH.AII.LS	(Figure	3.14).	
	
Figure	3.14	Diagram	of	the	expression	plasmid,	pLAH.AII.LS	The	 ls	gene	digested	from	ls_pMA-RQ	was	cloned	into	pLAH.AII	to	create	pLAH.AII.LS,	to	enable	the	integration	of	ls	under	the	control	of	PpsbAII	at	the	psbAII	site.		The	 plasmid	 was	 checked	 both	 by	 restriction	 digest	 and	 sequencing,	 and	 then	 used	 to	transform	WT	Synechocystis.	 After	 selection	with	kanamycin,	 eight	 colonies	were	picked	for	 four	 rounds	 of	 selection	 on	 kanamycin-containing	 media.	 PCR	 was	 performed	 on	putative	6803.AII.LS	transformants	(Figure	3.15).	All	eight	putative	transformants	tested	showed	 the	 integration	 of	 ls	 under	 PpsbAII	 at	 the	 psbAII	 site,	 and	 were	 judged	 to	 be	homoplasmic.		
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Figure	 3.15	 PCR	 screening	 for	 successful	 transformants	 of	 Synechocystis	 containing	 ls	
under	the	control	of	PpsbAII.	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis,	 pLAH.AII.LS	 expression	 plasmid	 and	 successful	 6803.AII.LS	transformants.	(B)	Colony	PCR	screening	of	putative	transformants	of	6803.AII.LS.		WT	
Synechocystis	(WT),	no	DNA	(-C)	and	pLAH.AII.LS	(+C)	were	used	as	controls.	The	single	band	at	3.7	kb	confirmed	homoplasmic	strains	were	produced.		
3.2.2.5 Expression	of	limonene	synthase	under	the	control	of	the	PpsbAII	Western	 blot	 analysis	 was	 performed	 with	 anti-HA	 antibodies	 on	 the	 crude	 extract	 of	three	transformants	of	6803.AII.LS	using	the	Odyssey®	Infrared	Imaging	System	to	detect	the	expression	of	LS	(Figure	3.16).	Also	 included	were	samples	of	6803.nrsB.LS	that	had	been	induced	for	4h	with	different	concentrations	of	Ni2+.	The	expression	of	LS	was	seen	in	all	three	6803.AII.LS	transformants,	and	all	6803.nrsB.LS	samples,	that	were	induced	with	Ni2+.	From	the	Western	blot,	the	expression	of	LS	under	the	PnrsB,	at	all	concentrations,	 is	seen	to	be	significantly	weaker	than	the	expression	of	LS	under	the	control	of	PpsbAII.		
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Figure	 3.16	 Western	 blot	 analysis	 confirming	 the	 expression	 of	 HA-tagged	 LS	 in	
6803.AII.LS.		Western	blot	 analysis	was	performed	with	whole	 cell	 extracts	with	anti-HA	and	anti-PsaD	 antibodies	 using	 the	Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 Samples	were	run	on	a	12%	SDS-PAGE	gel.	Protein	size	was	determined	using	the	PageRulerTM	Pre-stained	 Protein	 ladder	 (L)	 (Thermo	 ScientificTM).	 The	 expression	 of	 three	transformants	 of	 6803.AII.LS	 was	 compared	 against	 the	 expression	 of	 6803.nrsB.LS	induced	with	different	concentrations	of	Ni2+.	The	expected	band	size	for	LS	was	65	kDa	and	20	kDa	for	PsaD,	which	acted	as	a	loading	control.		
3.2.2.6 Limonene	extraction	and	GC-MS	analysis	To	 test	whether	 strains	 of	 6803.AII.LS	were	 able	 to	 successfully	 produce	 limonene,	 two	methods	were	used	to	recover	any	limonene	produced	from	the	strains.	One	method	used	ethyl	 acetate	 to	 extract	 limonene	 directly	 from	 cells	 and	 the	 other	method	 used	 a	 two-phase	 extraction	 with	 a	 10%	 (v/v)	 overlay	 of	 dodecane	 over	 a	 growing	 culture	 of	6803.AII.LS.	 Limonene	 standards	 of	 S-limonene	 prepared	 in	 ethyl	 acetate	 and	 dodecane	were	also	prepared.	GC	 Analysis	 was	 performed	 on	 the	 two	 extracts.	 Limonene	 was	 readily	 detected	 when	using	 the	 standard	 (50	 mg/L	 S-limonene	 in	 ethyl	 acetate),	 as	 a	 single	 peak	 at	 3.773	minutes,	 and	 gave	 peak	 fragments	 at	 136,	 121,	 93	 and	 68	m/z	 as	 found	 in	 the	 library	standard	of	limonene	(Figure	3.17).	However,	limonene	could	not	be	detected	in	any	of	the	6803.AII.LS	samples	(Figure	3.18).			
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Figure	3.17	GC-MS	analysis	of	5	mg/L	limonene	in	dodecane		(A)	 The	mass	 spectra	 of	 the	 compound	 found	 at	 3.773	 retention	 time	 has	 the	 same	characteristic	 peaks	 of	 at	 68,	 93,	 121	 and	 136	m/z	 as	 the	 (B)	 library	 standard	mass	spectra	of		(-)-limonene	from	(Byun-McKay	et	al.,	2006).	
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Figure	 3.18	 GC-MS	 analyses	 of	 dodecane	 overlay-extracted	 from	 6803.AII.LS	 and	 ethyl	
acetate	extraction	of	6803.AII.LS.	MS	chromatogram	(ion	overlay	at	68	m/z)	of	 the	samples	extracted	 from	6803.AII.LS	by	 using	 dodecane	 and	 ethyl	 acetate.	 The	 peak	 at	 3.773	minutes	 indicates	 limonene	presence	 and	 the	 peak	 at	 ~3.94	 minutes	 is	 the	 internal	 standard,	 1-octanol.	 No	limonene	is	detected	in	any	of	the	6803.AII.LS	samples.		
3.2.2.7 Glass	beads	method	for	extraction	One	 possible	 explanation	 for	 the	 lack	 of	 limonene	 detection	 may	 be	 that	 the	 ls	 gene	designed	did	not	result	in	a	functional	gene	product.	To	assess	whether	this	was	the	case,	an	 enzyme	 assay	 testing	 the	 recombinant	 LS	 was	 attempted.	 In	 order	 to	 perform	 an	enzyme	assay	using	crude	cell	extracts,	it	was	first	necessary	to	find	an	alternative	method	
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of	breaking	open	the	cells	without	using	heat,	which	can	damage	the	enzyme.	To	extract	the	 crude	 protein	 extract,	 the	 samples	 are	 usually	 boiled	 to	 break	 open	 the	 cells	 when	using	the	‘Heat’	method	(see	2.5.1	and	2.5.3	for	details).	Glass	beads	could	also	be	used	as	an	 alternative	method	of	 breaking	 the	 cells	 open	 (see	2.5.2	 and	2.5.3	 for	 details).	When	using	 this	method,	 the	 soluble	 proteins	 can	 be	 separated	 from	 the	membrane	 proteins,	present	in	the	lower	fraction.		A	 Western	 blot	 analysis	 was	 performed	 on	 extracts	 from	 single	 transformant	 of	6803.AII.LS	(grown	to	an	OD730:	0.603)	and	6803.nrsB.LS	(grown	to	an	OD730:	0.481),	after	they	were	prepared	using	the	two	methods	(Figure	3.19).	As	seen	in	the	figure,	glass	beads	are	 an	 effective	 method	 of	 breaking	 the	 cells	 open,	 with	 LS	 detected	 mostly	 in	 the	supernatant	(although	some	LS	is	detected	in	the	pellet	where	the	membrane	proteins	are	expected	 to	 be	 present).	 When	 ls	 is	 expressed	 under	 PpsbAII,	 the	 amount	 of	 LS	 in	 the	supernatant	was	similar	to	the	total	amount	of	LS	recovered	following	the	heating	method.	The	 results	 also	 confirm	 that	 the	 expression	 of	 LS	 under	 the	 control	 of	 PpsbAII	 is	 much	greater	than	under	the	control	of	PnrsB	following	a	4	hour	induction	with	6.4	μM	Ni2+.	
	
Figure	3.19	Western	blot	analysis	confirming	 the	detection	of	LS	using	Glass	beads	as	a	
method	of	cell	disruption	on	strains	6803.AII.LS	and	6803.nrsB.LS.		Western	 blot	 analysis	was	 performed	 on	 extracts	 of	 6803.AII.LS	 and	 6803.nrsB	 cells	broken	with	 glass	 beads	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	Samples	were	run	on	a	12%	SDS-PAGE	gel.	The	upper	layer	of	extract	when	using	glass	beads	was	referred	to	as	the	supernatant	(GB_S)	and	the	lower	layer	the	pellet	(GB_P).	Protein	 size	 was	 determined	 using	 the	 PageRulerTM	 Pre-stained	 Protein	 ladder	(Thermo	Scientific).	The	detection	of	LS	using	heat	(H)	as	the	method	of	cell	disruption	acted	as	the	positive	control.	
3.2.2.8 Creation	 of	 transgenic	 strains	 of	 Synechocystis	 containing	 limonene	
synthase	under	the	control	of	the	Pcpc560	As	presented	in	detail	in	Chapter	4,	the	promoter	Pcpc560	is	stronger	than	PpsbAII,	therefore	the	 expression	of	 ls	 under	 the	Pcpc560	was	 attempted	 in	Synechocystis	 to	 further	 increase	expression	and	thereby	improve	the	chances	of	detecting	LS	activity.	
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The	ls	gene	was	again	digested	from	ls_pMA-RQ	using	NdeI	and	BamHI,	and	cloned	into	the	NdeI	 and	 BamHI	 restriction	 sites	 of	 pLAH.cpc	 (see	 2.3	 for	 more	 details)	 to	 create	pLAH.cpc.LS	 (Figure	 3.20).	 The	 creation	 of	 pLAH.cpc.LS	 was	 confirmed	 by	 restriction	digest	and	sequencing	analysis.	
	
Figure	3.20	Diagram	of	the	expression	plasmid,	pLAH.cpc.LS	The	 ls	 gene	 digested	 from	 ls_pMA-RQ	 was	 cloned	 into	 the	 pLAH.cpc	 to	 create	pLAH.cpc.LS,	to	enable	the	integration	of	ls	under	the	control	of	Pcpc560	at	the	psbAII	site.		WT	 Synechocystis	 was	 transformed	 with	 pLAH.cpc.LS.	 After	 selection	 with	 kanamycin,	colonies	 appeared	 after	 10	 days	 and	 eight	 colonies	 were	 picked	 for	 another	 round	 of	selection	 on	 kanamycin-containing	media.	 All	 putative	 transformants	 were	 screened	 by	PCR	 and	 confirmed	 the	 insertion	 of	 ls	 under	 the	 control	 of	 Pcpc560	 at	 the	 psbAII	 site,	 to	produce	6803.cpc.LS	 (Figure	3.21).	All	 transformants	were	homoplasmic	as	 all	 copies	of	
psbAII	have	been	replaced	with	ls.	
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Figure	 3.21	 PCR	 screening	 for	 successful	 transformants	 of	 Synechocystis	 containing	 ls	
under	the	control	of	Pcpcp560.	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis,	6803.cpc	and	successful	6803.cpc.LS	transformants.	(B)	PCR	screening	of	putative	 transformants	 of	 6803.cpc.LS.	 	 WT	 Synechocystis	 (WT),	 no	 DNA	 	 (–C)	 and	6803.cpc	(+C)	were	used	as	controls.	The	single	band	at	4.2	kb	confirmed	homoplasmic	strains	of	6803.cpc.LS.		
3.2.2.9 Expression	of	limonene	synthase	under	the	control	of	the	Pcpc560	The	 expression	 of	 LS	 under	 the	 Pcpc560	 promoter	 in	 three	 strains	 of	 6803.cpc.LS	 was	confirmed	by	Western	blot	analysis,	using	anti-HA	antibodies	and	the	Odyssey®	Infrared	Imaging	 System	 for	 detection	 (Figure	 3.22).	 Expression	 of	 LS	 under	 the	 control	 of	 the	Pcpc560	appeared	to	be	greater	than	expression	under	the	control	of	the	PpsbAII	(Figure	3.22).	
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Although	the	level	of	LS	is	hard	to	quantify	because	the	blot	appears	to	have	moved	during	blotting	or	exposure,	the	amount	of	LS	does	appear	to	be	higher	when	the	gene	is	under	the	Pcpc560	promoter.	
	
Figure	 3.22	Western	 blot	 analysis	 confirming	 the	 expression	 of	 LS	 in	 6803.cpc.LS	 and	
comparing	the	expression	with	6803.AII.LS		Western	blot	 analysis	was	performed	with	whole	 cell	 extracts	with	anti-HA	and	anti-PsaD	 antibodies	 using	 the	Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 Samples	were	run	on	a	12%	SDS-PAGE	gel.	Protein	size	was	determined	using	the	PageRulerTM	Pre-stained	 Protein	 ladder	 (L)	 (Thermo	 Scientific).	 The	 expression	 of	 three	transformants	 of	 6803.cpc.LS	 was	 compared	 against	 three	 transformants	 of	6803.AII.LS.	The	expected	band	size	for	LS	is	65	kDa	and	20	kDa	for	PsaD,	which	acted	as	a	loading	control.	6803.AII	and	6803.cpc	were	loaded	as	negative	controls.		
3.2.2.9.1 Growth	analysis	comparing	6803.cpc.LS	and	6803.cpc	As	 the	expression	of	LS	was	greater	when	under	 the	 control	of	 the	Pcpc560	promoter,	 the	growth	of	6803.cpc	and	6803.cpc.LS	was	compared	to	see	whether	the	greater	expression	of	 LS	 and	 the	 production	 of	 limonene	 had	 an	 effect	 on	 growth.	 A	 growth	 curve	 was	performed	 in	 an	 Algem	 photobioreactor	 and	 the	 growth	 rates	 of	 6803.cpc.LS	 with	6803.cpc	 (Figure	 3.23)	 were	 also	 calculated.	 Both	 strains	 were	 grown	 in	 the	 same	conditions	in	duplicate.	Although	the	6803.cpc.LS	strain	showed	a	longer	lag	phase	in	this	particular	 experiment,	 both	 6803.cpc	 and	 6803.cpc.LS	 had	 an	 equivalent	 growth	 rate	 of	0.01	h-1	and	both	reached	a	similar	OD	at	stationary	phase.	The	expression	of	LS	therefore	has	no	effect	on	growth	of	6803.cpc.LS.	If	limonene	is	being	produced	then	it	is	not	being	produced	to	a	high	enough	concentration	to	have	a	toxic	effect	on	the	cell.			
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Figure	3.23	Comparison	of	cell	growth	between	6803.cpc	and	6803.cpc.LS	The	growth,	measured	by	the	A750,	of	strains	6803.cpc	and	6803.cpc.LS	were	monitored	using	 the	 Algem	 photobioreactor	 (200	 μmol/m2/s	 white	 light,	 at	 30°C	 and	 120	 rpm	shaking).	
3.2.2.10 Enzyme	assay	and	DPPH	assay	for	limonene	production	As	the	production	of	limonene	was	not	detected	in	6803.AII	by	GC-MS	analysis,	an	enzyme	assay	on	LS	expressed	from	6803.cpc.LS	was	performed.	To	try	and	detect	the	production	of	 limonene	 without	 using	 GC-MS,	 the	 2,2-Diphenyl-1-picrylhydrazyl	 (DPPH)	 assay	 was	used	to	detect	limonene	production	in	S.	cerevisiae	with	some	modifications	(Behrendorff	et	al.,	2013).	The	assay	uses	DPPH,	a	stable	radical	that	produces	a	strong	absorbance	at	517	nm,	and	at	510	nm	when	DPPH	is	dissolved	in	dodecane.	When	DPPH	loses	a	radical	in	 exchange	 for	 a	 proton	 from	 limonene,	 the	 absorbance	 at	 510	 nm	 decreases	proportionately,	 and	 DPPH	 in	 dodecane	 goes	 from	 purple	 to	 yellow	 (Figure	 3.24)	(Behrendorff	 et	 al.,	 2013).	 As	 the	 DPPH	 assay	 is	 performed	 in	 dodecane,	 a	 dodecane	overlay	was	used	in	the	enzyme	assay	to	trap	any	limonene	produced	by	6803.cpc.LS.		
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Figure	3.24	DPPH	Reaction		DPPH	exhibits	strong	absorbance	at	517nm	(Purple)	but	when	it	loses	its	radical	for	a	proton,	 its	 absorbance	 decreases	 proportionally	 and	 becomes	 yellow.	 Figure	 from	(Behrendorff	et	al.,	2013)		
3.2.2.10.1 Establish	the	DPPH	assay	The	 DPPH	 assay	 was	 capable	 of	 detecting	 limonene	 at	 200	 μM,	 so	 initial	 tests	 were	performed	 to	 try	 and	 emulate	 the	 assay	 (Behrendorff	 et	 al.,	 2013).	 Using	 the	 FLUOstar	Omega	plate	reader	the	maximum	absorbance	of	DPPH	dissolved	in	dodecane	was	seen	as	a	single	peak	at	510	nm	and	there	was	a	slight	decrease	over	time.	To	establish	the	lowest	concentration	of	limonene	that	can	be	detected	by	the	plate	reader,	the	difference	between	the	 A510	 nm/min	 of	 DPPH	 in	 dodecane	 was	 compared	 to	 different	 concentrations	 of	limonene	in	DPPH	(Figure	3.25).	A	threshold	was	employed	using	an	unpaired	Student’s	t-test,	 when	 p<0.01(n=4),	 between	 the	 DPPH	 in	 dodecane	 and	 limonene	 in	 DPPH	(Behrendorff	et	al.,	2013).	Using	this	threshold,	limonene	was	significantly	detected	at	0.8	mM;	 making	 the	 assay	 in	 our	 hands	 less	 sensitive	 as	 it	 is	 four-times	 higher	 than	 the	detection	 level	seen	by	Behrendorff	et	al	(Behrendorff	et	al.,	2013).	This	could	be	due	to	oxidation	 of	 the	 limonene	 standards,	 as	 this	 decreases	 the	 proportion	 of	 limonene	available	to	react	with	DPPH.		
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Figure	3.25	Detection	of	limonene	after	incubation	with	DPPH.		The	reaction	rates	between	0.1	mM	DPPH	and	varying	concentrations	of	limonene	were	calculated	between	10-180	min	 (n=4	 for	 each	 concentration,	mean	±	1	 SD).	Reaction	rates	 for	 DPPH	 limonene	 standards	were	 compared	 to	 the	 relevant	 control	 using	 an	unpaired	Student’s	t-test.			
3.2.2.10.2 Enzyme	assay	with	6803.cpc.LS	using	DPPH	assay	for	detection	The	 enzyme	 assay	was	 designed	 to	 be	 performed	 using	 crude	 protein	 extract	 from	 the	supernatant	of	6803.cpc.LS	with	cells	broken	using	 the	glass	bead	method.	Western	blot	analysis	confirmed	the	presence	of	LS	in	the	supernatant	of	6803.cpc.LS,	to	be	used	in	the	enzyme	 assay	 (Figure	 3.26).	 GPP,	 the	 substrate	 of	 LS,	 would	 then	 be	 added	 to	 the	supernatant	 and	 a	 layer	 of	 dodecane	 would	 then	 trap	 any	 limonene	 produced.	 The	dodecane	would	 then	 be	 used	 in	 the	DPPH	 assay	 to	 see	 if	 limonene	was	 produced.	 The	DPPH	assay	was	 also	performed	with	 limonene	 standards	 of	 different	 concentrations	 in	0.1	mM	DPPH.		The	 results	 of	 the	 DPPH	 assay	 suggests	 that	 the	 difference	 in	 the	 ΔA510	nm/min	 for	 the	control	strain,	6803.cpc,	is	actually	higher	than	the	6803.cpc.LS	strain	when	1	mM	and	1.5	mM	GPP	are	added	to	the	cells	(Figure	3.27).	This	suggests	that	limonene	is	not	produced	by	6803.cpc.LS	strains	to	a	detectable	 level	using	this	assay.	As	duplicates	of	the	enzyme	assay	were	not	performed	 the	ΔA520	nm/min	of	 6803.cpc	 and	6803.cpc.LS	 (+0,	 1,	 1.5	mM	GPP)	were	compared	to	the	standards	run	alongside	the	enzyme	assay	(Figure	3.27).	The	ΔA520	nm/min	values,	from	the	enzyme	assay	were	all	below	the	values	seen	when	0.8	mM	limonene	 is	 present,	 the	 threshold	 for	 limonene	 detection	 by	 the	 plate	 reader.	 This	
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confirms	 that	 the	ΔA520	nm/min	values	 seen	 in	 the	enzyme	assay	were	not	 caused	by	 the	production	of	limonene.		
	
Figure	 3.26	 Western	 blot	 analysis	 confirming	 the	 expressing	 of	 LS	 in	 the	 supernatant	
used	in	the	enzyme	assay.	Western	blot	 analysis	was	performed	with	whole	 cell	 extracts	with	anti-HA	and	anti-PsaD	 antibodies	 using	 the	Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 Samples	were	run	on	a	12%	SDS-PAGE	gel.		Protein	size	was	determined	using	the	PageRulerTM	Pre-stained	 Protein	 ladder	 (Thermo	 Scientific).	 LS	 was	 detected	 in	 the	 supernatant	(GB_S)	and	pellet	(GB_P)	of	6803.cpc.LS.	The	expected	band	size	for	LS	is	65	kDa	and	20	kDa	for	PsaD,	which	acted	as	a	loading	control.			
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Figure	3.27	Reaction	 rates	 of	 the	dodecane	 layer	 from	 the	 enzyme	assay	 and	 limonene	
standards	after	incubation	with	DPPH.		(A)	 Reaction	 rates	 of	 the	 dodecane	 layer	 from	 the	 enzyme	 assay	 performed	 on	 the	supernatant	of	6803.cpc	and	6803.cpc.LS	with	0,	1	 and	1.5	mM	GPP,	 after	 incubation	with	 0.1	 mM	 DPPH.	 (B)	 Reaction	 rates	 between	 0.1	 mM	 DPPH	 and	 varying	concentrations	 of	 limonene	 were	 calculated	 between	 10-180	 min	 (n=3	 for	 each	concentration	(except	1.6	mM	n=2),	mean	±	1	SD).	Reaction	rates	 for	DPPH	limonene	standards	were	compared	to	the	relevant	control	using	an	unpaired	Student’s	t-test.			
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3.2.3 Increasing	limonene	production:	deletion	of	sds		One	possible	explanation	for	the	lack	of	detectable	limonene	in	the	transformants	despite	the	presence	of	the	LS	enzyme	is	that	the	pool	of	available	GPP	substrate	is	low	in	the	cell	or	inaccessible	to	the	LS.	An	attempt	was	therefore	made	to	increase	the	pool	of	GPP	for	LS	by	 deleting	 a	 gene	 downstream	 of	 GPP	 in	 the	 pathway	 for	 the	 terpenoid	 backbone	synthesis.	 The	 KEGG	 pathway	 of	 Synechocystis	 –	 ‘terpenoid	 backbone	 synthesis’	 –	 was	reviewed	 when	 finding	 possible	 genes	 downstream	 of	 GPP	 that	 could	 be	 deleted.	 One	identified	 gene	 (sds:	 gene	 slr0611)	 was	 that	 encoding	 solanesyl	 diphosphate	 synthase	(SDS),	 which	 produces	 solanesyl	 diphosphate,	 a	 precursor	 of	 the	 side	 chains	 in	ubiquinone-9	 (UQ-9)/plastoquinone-9	 (PQ-9)	 (Figure	 3.28)	 (Kanehisa	 and	 Goto,	 2000;	Okada	et	 al.,	 1997;	 Sadre	 et	 al.,	 2012).	According	 to	 the	on-line	database	CyanoBase	 the	deletion	of	slr0611	has	been	achieved	by	inserting	a	kanamycin	resistance	cassette	at	the	SmaI	site	within	the	gene,	and	this	resulted	in	no	phenotypic	change	in	(Nakamura	et	al.,	1999).	Based	on	this	evidence,	sds	was	chosen	for	deletion	in	Synechocystis,	in	an	attempt	to	increase	the	pool	of	GPP	for	LS.			
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Figure	3.28	MEP	pathway	and	pathway	downstream	of	GPP	for	the	production	of	PQ-3.		Schematic	showing	the	methyerythritol	4-phosphate	(MEP)	pathway	PQ-3	pathway	in	
Synechocystis.	Native	 genes	 in	 Synechocystis	 in	 blue	 and	 non-native	 pathway	 in	 red.	Abbreviations	 used:	 G3P	 =	 glyceraldehyde	 3-phosphate,	 DXP	 =	 1-deoxy-d-xylulose	 5-phosphate,	 MEP	 =	 methylerythritol	 4-phosphate,	 IPP	 =	 isopentenyl	 diphosphate,	DMAPP	 =	 dimethylallyl	 diphosphate,	 GPP	 =	 geranyl	 diphosphate,	 LS	 =	 limonene	synthase,	PQ-9	=	Plastoquinone-9.		
3.2.3.1 Creation	of	an	expression	plasmid	to	knockout	sds	in	Synechocystis		To	knockout	sds,	the	expression	plasmid,	pJET.sds::Km	was	created	(Figure	3.29).		
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Figure	3.29	Diagram	showing	to	creation	of	pJET.sds::km	and	confirmation	of	its	creation	
by	restriction	digest.		Schematic	 showing	 the	 creation	 of	 the	 expression	 plasmid,	 pJET.sds::km,	 with	 the	kanamycin	resistance	cassette	in	two	different	orientation.		Primers,	 slr0611F	and	slr0611R	were	designed	and	successfully	used	 to	amplify	sds	 and	approximately	 500-800	 bp	 upstream	 and	 downstream	 of	 sds	 from	 the	 genome	 of	
Synechocystis	 via	 PCR.	 The	 PCR	 product	 was	 cloned	 into	 the	 blunt	 cloning	 site	 of	pJET1.2/blunt	 (see	 appendix)	 to	 produce	 pJET.sds.	 A	 restriction	 digest	 with	 HincII	 and	SmaI	 and	 sequencing	 results	with	primers,	 pJETR	and	pJETF,	 confirmed	 the	 insertion	of	
sds	and	creation	of	pJET.sds.			A	 kanamycin	 resistance	 cassette,	 KmR,	was	 digested	 from	 pUC4K	 (see	 appendix),	 using	HincII,	 and	 cloned	 into	 pJET.sds	 at	 the	 SmaI	 and	 HincII	 blunt	 restriction	 sites	 to	successfully	 create	 pJET.sds::Km.	 A	 restriction	 digest	 with	 XhoI	 confirmed	 the	construction	of	pJET.sds::Km.	Two	variations	of	pJET.sds::Km	were	created,	pJET.sds::Km3	and	 pJET.sds::Km6,	 as	 KmR	was	 inserted	 in	 the	 two	 possible	 orientations	 at	 the	 blunt-ended	restriction	sites	(Figure	3.29).	Sequencing	with	FO.kmF	and	FO.kmR,	confirmed	the	insertion	of	the	KmR	into	pJET.sds,	in	the	two	different	orientations.	
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3.2.3.2 Attempts	to	knockout	sds	in	Synechocystis	WT	Synechocystis	was	transformed	with	pJET.sds::Km3	and	after	selection	on	kanamycin-containing	media,	 four	colonies	were	picked	after	14	days.	After	four	rounds	of	selection	on	medium	supplemented	with	kanamycin	a	PCR	was	performed	using	primers,	slr0611F	and	slr0611R.	All	four	transformants	appeared	to	have	the	KmR	gene	integrated	at	the	sds	locus,	however	all	 transformants	still	appeared	to	have	copies	of	 the	wild-type	sds.	After	four	 more	 rounds	 of	 selection	 on	 kanamycin,	 the	 strain	 remained	 heteroplasmic,	 and	copies	of	WT	sds	remained	in	the	genome.	The	putative	transformants	were	then	streaked	onto	 BG-11	 medium	 with	 and	 without	 the	 antibiotic,	 to	 see	 whether	 the	 strain	 would	revert	 back	 to	WT	 in	 the	 absence	 of	 selection	 for	KmR.	 After	 10	 rounds	 of	 selection	 on	kanamycin,	 the	 sds	 gene	 still	 remained,	 indicating	 that	 the	 gene	 is	 essential	 for	
Synechocystis	 to	 grow	 (Figure	 3.30B).	 However,	 after	 removing	 kanamycin	 from	 the	medium,	the	KmR	gene	also	remained,	suggesting	that	the	integration	was	relatively	stable.		WT	Synechocystis	was	also	transformed	with	pJET.sds::Km6	to	see	whether	the	orientation	of	the	KmR	gene	had	an	effect	on	the	genes	flanking	sds,	as	sds	may	not	be	essential	but	one	of	 the	genes	 flanking	sds	may	be	essential	 instead.	After	 selection	with	kanamycin,	eight	putative	 transformants	were	 picked.	 After	 eight	 rounds	 of	 selection	 on	 kanamycin,	 PCR	was	 performed	 as	 before.	 Similarly	 to	 the	 previous	 PCR,	 these	 new	 transformants	 also	retained	copies	of	both	KmR	and	sds	(Figure	3.30C).	When	restreaked	onto	BG-11	medium,	after	10	rounds	without	selection,	the	KmR	gene	was	eventually	lost	(results	not	shown).		
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Figure	3.30	PCR	screening	of	putative	transformants	of	Synechocystis	containing	the	KmR	
cassette	replacing	the	sds	gene.		(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis	 and	 successful	 6803.sds::Km	 transformants.	 (B)	 PCR	 screening	 of	putative	 transformants	of	6803.sds::km3.	WT	Synechocystis	 (WT)	was	used	a	 control.	Heteroplasmic	strains	are	present	after	restreaking	10	(RS10)	times	onto	BG-11	media	supplemented	with	 kanamycin	with	 two	bands	 at	 2.3	 and	3	 kb.	 (C)	PCR	 screening	of	putative	transformants	of	6803.sds::km6.	WT	Synechocystis	and	no	DNA	(-C)	was	used	a	control.	 	 Heteroplasmic	 strains	 are	 still	 present	 after	 restreaking	 8	 (RS8)	 times	 onto	BG-11	medium	supplemented	with	kanamycin	with	two	bands	at	2.3	and	3	kb.				
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3.3 Discussion	and	future	work	In	summary,	the	research	presented	in	this	chapter	demonstrates	that	exogenous	addition	of	 limonene	is	toxic	to	Synechocystis	at	concentrations	as	 low	as	0.02%	(v/v)	but	using	a	dodecane	overlay	can	mitigate	this	toxicity.	The	expression	in	Synechocystis	of	a	synthetic	gene	encoding	a	plant	LS	was	successfully	achieved	using	three	separate	promoters	(PnrsB,	PpsbAII	 and	 Pcpc560);	 however	 the	 production	 of	 limonene	 in	 these	 lines	 could	 not	 be	demonstrated.	Attempts	were	also	made	to	delete	the	sds	gene	to	increase	the	pool	of	GPP;	however	this	gene	was	found	to	be	essential.			During	the	course	of	this	work,	three	separate	reports	were	published	(Davies	et	al.,	2014;	Halfmann	 et	 al.,	 2014b;	 Kiyota	 et	 al.,	 2014)	 that	 describe	 the	 successful	 production	 of	limonene	in	three	different	engineered	strains	of	cyanobacteria,	including	Synechocystis.		
3.3.1 Toxicity	tests	Both	limonene	enantiomers	were	toxic	towards	Synechocystis	at	concentrations	as	low	as	of	0.02%	(v/v);	however	this	toxicity	can	be	mitigated	by	phase	extraction	with	an	organic	layer	of	dodecane	as	limonene	is	poorly	soluble	in	water	but	miscible	in	organic	solvents.	However	 since	 limonene	 was	 added	 exogenously,	 the	 results	 obtained	 may	 not	 be	 the	same	as	when	limonene	is	produced	inside	the	cell,	but	the	tests	can	give	an	indication	of	the	effect	 limonene	production	may	have	on	Synechocystis.	The	recovery	of	Synechocystis	around	 72	 hours	 after	 limonene	 was	 added	 might	 be	 explained	 by	 the	 volatility	 of	limonene.	As	the	results	from	Figure	3.3	showed,	after	24	hours	some	cells	in	the	presence	of	limonene	at	0.02,	0.1,	and	0.2	%	(v/v)	survived	and	as	limonene	is	known	to	be	volatile,	it	may	have	evaporated	and	no	longer	be	present	at	an	inhibitory	level	in	the	culture.	In	E.	coli	there	is	a	correlation	between	toxicity	of	the	solvent	and	its	logKO/W	value	(Ramos	et	 al.,	 2002).	 The	 octanol-water	 partition	 coefficient	 (reported	 as	 logKO/W)	 of	 organic	solvents	often	correlates	with	the	antimicrobial	activity	of	the	solvent;	therefore	it	is	used	as	 an	 indicator	 of	 solvent	 toxicity	 towards	 bacteria.	 The	 reported	 logKO/W	 for	 limonene	was	4.40.	If	the	value	is	between	1	and	5	then	the	product	is	expected	to	be	hydrophobic	and	toxic	towards	the	cell.	This	was	the	case	for	limonene	towards	Synechocystis,	although	the	mechanism	of	toxicity	is	not	clear.	Hydrophobic	aromatics	like	limonene	are	thought	to	accumulate	within	the	cytoplasmic	membrane,	disrupting	its	integrity	causing	ions	to	leak,	and	a	change	in	pH	and	in	the	proton	gradient	(Ramos	et	al.,	2002).	However,	recently	the	toxicity	of	d-limonene	towards	S.	cerevisiae	was	found	to	have	an	effect	on	the	cell	wall,	not	the	cell	membrane	as	previously	thought	(Brennan	et	al.,	2013).	The	toxicity	of	limonene	in	E.	coli	was	thought	to	be	due	to	the	common	oxidation	product	limonene	hyperperoxide	
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not	 limonene	itself,	and	could	be	alleviated	by	a	point	mutation	in	an	alkyl	hyperoxidase	(Chubukov	et	al.,	2015).		Dodecane	does	not	have	a	toxic	effect	towards	Synechocystis	and	the	toxicity	of	limonene	is	mitigated	 by	 the	 presence	 of	 a	 20%	 (v/v)	 dodecane	 overlain	 on	 top	 of	 the	 culture.	Dodecane	 has	 been	 used	 to	 trap	 the	 production	 of	 limonene	 in	 engineered	 strains	 of	
Saccharomyces	cerevisiae	and	E.	coli	(Alonso-Gutierrez	et	al.,	2013;	Jongedijk	et	al.,	2015).	Dodecane	 also	 has	 been	 demonstrated	 to	 increase	 the	 yield	 and	 recovery	 of	 amorpha-4,11-diene,	 a	 volatile	 sesquiterpene,	 production	 in	 E.	 coli	 (Newman	 et	 al.,	 2006).	 The	addition	 of	 the	 dodecane	 layer	 was	 used	 to	 increase	 the	 yield	 in	 limonene-producing	strains	of	Synechococcus	7002,	by	trapping	limonene	that	would	most	likely	have	been	lost	through	 evaporation	 (Davies	 et	 al.,	 2014).	 In	 Synechococcus	 7002,	 the	 presence	 of	 a	dodecane	overlay	did	not	interfere	with	the	ability	of	atmospheric	CO2	to	diffuse	into	the	cultures	 (Davies	 et	 al.,	 2014).	 As	 the	 growth	 rate	 of	 6803.cpc.LS	was	 unaffected	 by	 the	expression	of	LS,	if	LS	is	functional	then	the	amount	of	limonene	produced	is	not	toxic	to	the	cells.	It	might	also	be	the	case	that	the	production	of	limonene	inside	the	cells	is	not	as	toxic	towards	the	cells	as	the	exogenous	addition	of	limonene.		
3.3.2 Limonene	production	in	cyanobacteria	
Synechocystis	 strains	 expressing	 LS,	 under	 the	 control	 of	 various	 promoters,	 were	successfully	produced	although	synthesis	of	limonene	could	not	be	demonstrated.	During	the	 course	of	 this	work,	 the	 successful	 production	of	 limonene	 in	Synechocystis	 and	 two	other	 cyanobacteria	 strains	was	 published	 (Davies	 et	 al.,	 2014;	 Halfmann	 et	 al.,	 2014b;	Kiyota	et	al.,	2014).	The	differences	in	the	strategies	used	are	discussed	below.	
3.3.2.1 Extraction	and	GC-MS	The	 production	 of	 limonene	was	 not	 detected	 in	 6803.AII.LS	 strains	 after	 extraction	 by	ethyl	 acetate	 and	 recovery	 using	 a	 dodecane	 layer	 for	 two-phase	 extraction.	 Both	 the	pellet	and	supernatant	after	ethyl	acetate	extraction	did	not	yield	any	detectable	product	and	may	not	be	the	most	suitable	method	for	extracting	limonene.	As	discussed	previously	the	use	of	dodecane	not	only	mitigates	the	possible	toxic	effect	of	limonene,	but	it	can	also	be	used	as	a	method	to	trap	limonene	and	has	been	used	in	strains	of	E.	coli,	S.	cerevisiae	and	 Synechococcus	 (Alonso-Gutierrez	 et	 al.,	 2013;	 Davies	 et	 al.,	 2014;	 Jongedijk	 et	 al.,	2015).	In	Synechococcus,	 limonene	was	produced	after	the	introduction	of	just	the	(-)-4S-LS	 gene	 from	 Mentha	 spicata,	 that	 was	 codon-optimised	 for	 Synechococcus,	 had	 the	chloroplast	 transit	 peptide	 removed	 and	 was	 under	 the	 control	 of	 Pcpc	 promoter	 from	
Synechocystis	(Davies	et	al.,	2014).	This	method	was	not	too	dissimilar	to	the	6803.AII.LS	
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used	 for	 GC-MS	 analysis,	 although	 the	 ls	 gene	 was	 under	 the	 control	 of	 the	 weaker	promoter,	PpsbAII,	and	a	different	strain	of	cyanobacteria	was	used.	To	avoid	the	possibility	of	the	reverse	solvent	effect,	the	dodecane	from	the	overlaid	sample	was	diluted	by	ethyl	acetate.	 This	 was	 not	 done	 for	 the	 dodecane	 extract	 from	 the	 limonene	 producing	
Synechococcus,	 therefore	 if	 the	 dodecane	 overlaying	 6803.AII.LS	 managed	 to	 trap	 any	limonene,	then	it	may	have	been	below	the	level	of	detection	by	the	GC-MS	(Davies	et	al.,	2014).	In	S.	cerevisiae,	the	detection	of	limonene	was	improved	by	trapping	the	volatile	limonene	produced	in	the	headspace	of	the	culture	and	more	limonene	was	detected	via	this	method	than	when	dodecane	was	used	(Jongedijk	et	al.,	2015).	Detection	of	 limonene	production	was	also	achieved	in	Anabaena	by	trapping	limonene	in	the	culture	headspace	(Halfmann	et	 al.,	 2014b).	 In	 limonene	 producing	 Synechocystis,	 limonene	 was	 detected	 in	 the	 cells	using	chloroform	and	from	the	cultures	using	a	gas-stripping	system	to	collect	the	volatile	limonene	 (Kiyota	 et	 al.,	 2014).	 These	 alternative	methods	 could	 also	 be	 used	 to	 try	 and	trap	volatile	limonene	produced	from	the	Synechocystis	strains	produced	in	this	chapter.		Other	 than	 the	 method	 of	 extraction,	 a	 lack	 of	 available	 substrate	 or	 a	 non-functional	enzyme	could	also	potentially	explain	why	limonene	was	not	detected	in	Synechocystis.		
3.3.2.2 LS	assay	and	detection	using	the	DPPH	assay		In	the	ls	gene	designed	for	insertion	into	Synechocystis,	the	codons	for	the	threonine	(T56)	and	glutamate	(E57)	residues	just	before	RRX8G	motif	were	retained	to	provide	stability	to	the	enzyme.	The	Mentha	spicata	ls	gene	expressed	was	truncated	for	expression	in	E.	coli	just	 before	 RRX8G	 and	 in	 Synechococcus	7002	 before	 the	 glutamate	 residue	 before	 the	RRX8G	 motif	 (Alonso-Gutierrez	 et	 al.,	 2013;	 Davies	 et	 al.,	 2014).	 Truncated	 versions	 of	
Mentha	spicata	LS	at	 the	glutamate	residue	(E57)	preceding	 the	RRX8W	motif	and	at	 the	glutamine	(Q53)	have	been	shown	to	be	functional	(Williams	et	al.,	1998).	The	presence	of	the	 HA-tag	 at	 the	 C-terminus	 of	 LS	 could	 have	 an	 effect	 on	 the	 correct	 folding	 of	 the	enzyme,	although	a	FLAG2-tag	was	fused	to	the	C-terminus	of	the	LS	from	Picea	sitchensis	that	was	successfully	used	to	produce	limonene	in	Anabaena	sp.	PCC	7120	(Halfmann	et	al.,	2014b).	This	suggests	that	these	design	features	are	unlikely	to	render	LS	non-functional.		To	see	whether	the	enzyme	expressed	in	6803.cpc.LS	was	functional,	an	enzyme	assay	was	performed	 using	 a	 DPPH	 assay;	 however,	 no	 limonene	 production	was	 detected.	 As	 the	assay	was	only	attempted	once,	and	no	positive	control	was	available,	the	lack	of	limonene	detected	may	be	due	to	 flaws	 in	 the	assay	procedure	rather	 than	the	non-function	of	LS.	Significantly,	the	DPPH	assay,	was	unable	to	detect	limonene	at	less	than	0.8	mM,	which	is	
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a	high	threshold.	If	this	experiment	were	to	be	repeated,	the	dodecane	extracted	from	the	enzyme	 assay	 should	 be	 analysed	 by	 GC-MS	 as	 it	 is	 much	 more	 sensitive	 and	 would	provide	a	clearer	answer	to	whether	the	enzyme	is	functional.		
3.3.3 Further	metabolic	engineering	of	Synechocystis		The	unsuccessful	attempt	to	replace	all	copies	of	the	sds	gene	with	a	kanamycin	resistance	cassette,	 suggest	 that	 SDS	 is	 essential	 for	 Synechocystis	 and	 therefore	 its	 inactivation	cannot	be	used	to	increase	the	pool	of	GPP.	One	of	the	main	factors	for	choosing	to	delete	
sds	was	the	claim	on	CyanoBase,	that	sds	had	been	deleted	and	no	mutant	phenotype	was	seen.	 The	 results	 obtained	 in	 this	 chapter	 and	 further	 reading	 of	 the	 literature	 suggests	that	this	is	not	the	case.	The	solanesyl	diphosphate	is	produced	through	the	condensation	reaction	of	isopentenyl	diphosphate	(IPP)	to	GPP	or	geranylgeranylpyrophosphate	(GGPP)	(Kanehisa	and	Goto,	2000).	Solanesyl	diphosphate	forms	the	side	chain	of	plastoquinone-9	(PQ-9)	 (Sadre	et	al.,	2012).	 	Further	 research	 into	 the	 literature	 indicated	PQ-9	plays	an	essential	 role	 in	 the	 electron	 transport	 chain	 and	 although	 plastoquinones	with	 shorter	side	chains	can	also	be	synthesised,	sds	appears	to	be	essential	to	Synechocystis	(Sadre	et	al.,	2012).		An	alternative	strategy	to	increase	the	pool	of	GPP	is	to	increase	the	flux	to	the	pool	rather	than	 reduce	 the	 flux	 from	 the	 pool.	 In	 other	 microorganisms	 engineered	 to	 produce	limonene,	the	pathway	upstream	of	LS	has	been	modified	to	increase	the	amount	of	GPP.		For	 example,	 in	 several	 engineered	 strains	 a	 second	 copy	 of	 GPPS	 has	 been	 introduced	(Alonso-Gutierrez	 et	 al.,	 2013;	 Halfmann	 et	 al.,	 2014b;	 Kiyota	 et	 al.,	 2014),	 and	 in	
Synechocystis	 an	 extra	 copy	 of	 the	 native	 genes	 found	 in	 the	 MEP	 pathway	 dxs	(deoxyxylulose-1-phosphate	 synthase),	 crtE	 (GPP	 synthase)	 and	 ipi	 (isopentenyl	pyrophosphate	 isomerase)	were	 inserted	to	 increase	the	yield	of	 limonene	(Kiyota	et	al.,	2014).	 In	 Anabaena,	 the	 same	 enzymes	 were	 expressed	 to	 increase	 yield,	 however	 the	native	genes	were	not	used;	instead	dxs	from	E.	coli,	ipphp1	from	Haematococcus	pluvialis	and	GPPS	from	Mycobacterium	tuberculosis	were	expressed	(Halfmann	et	al.,	2014b).	 If	a	lack	 of	 substrate	was	 the	 reason	why	 limonene	was	 not	 produced	 to	 a	 detectable	 level,	then	the	 introduction	of	native/non-native	genes	from	the	MEP	pathway	or	a	non-native	MVA	pathway	along	with	GPPS	would	all	help	 to	 increase	 the	 flux	 to	GPP	and	provide	a	larger	substrate	pool	for	LS.	Finally,	the	introduction	of	an	efflux	pump	has	been	shown	to	increase	the	yield	of	limonene	in	a	microbial	host,	and	is	believed	to	function	by	relieving	toxicity	and	preventing	production	inhibition	(Dunlop	et	al.,	2011).			 	
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Chapter	4 	Molecular	tools	for	trans-operon	expression	in	
Synechocystis	
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4.1 Introduction	For	cyanobacteria	to	fulfil	their	potential	as	‘green’	cell	factories	it	is	important	to	be	able	to	control	gene	expression.	 In	order	 to	optimise	 the	synthesis	of	biofuels	and	high-value	chemicals	in	cyanobacteria	the	expression	levels	of	each	gene	within	a	metabolic	pathway	need	 to	 be	 balanced	 to	 avoid	 the	 accumulation	 of	 any	 toxic	 products	 and	 remove	 any	potential	bottlenecks.	The	development	of	molecular	tools	that	are	able	to	tightly	regulate	the	level	of	transcription	and	translation	is	vital	to	optimise	a	metabolic	pathway	for	the	production	of	novel	compounds.		
4.1.1 Transcriptional	control	tools	-	Promoters	In	 cyanobacteria,	 a	 range	 of	 native	 and	 foreign	 promoters	 have	 been	 used	 to	 express	heterologous	genes.	Commonly,	native	promoters	used	 to	express	 trans-genes	are	 taken	from	key	photosynthetic	genes	e.g.	PpsbAII	(photosystem	II	D1	protein),	PrbcL	(Rubisco	large	subunit),	Pcpc	(c-phycocyanin	beta	subunit)	and	PpsaD	(photosystem	I	subunit	II)	(Wang	et	al.,	2012).	Inducible	promoters	are	desirable	when	attempting	to	produce	a	toxic	chemical,	and	 one	 such	 endogenous	 promoter	 that	 has	 been	 exploited	 is	 the	 nickel-inducible	promoter	PnrsB	 (Liu	and	Curtiss,	2009).	Foreign	promoters	 from	E.	coli	 (Plac,	Ptrc/Ptac,	Ptet)	have	 also	 been	 used	 in	 various	 cyanobacteria,	 however	 they	 are	 not	 always	 effective	 in	
Synechocystis	 (Huang	 et	 al.,	 2010).	 Differences	 in	 the	 RNA	 polymerase	 holoenzyme	between	E.	coli	and	Synechocystis	may	explain	why	E.	coli	promoters	function	differently	in	
Synechocystis	 (Heidorn	 et	 al.,	 2011).	 Although,	 modifications	 made	 to	 certain	 E.	 coli	promoters	 have	 helped	 improve	 their	 function	 in	 Synechocystis	 (Camsund	 et	 al.,	 2014;	Huang	et	al.,	2010).	
4.1.1.1 PpsbAII	The	 PpsbAII	 promoter	 is	 considered	 to	 be	 a	 constitutive	 promoter,	 but	 higher	 levels	 of	transcripts	 can	 be	 seen	 in	 high	 light	 conditions	 (Lindberg	 et	 al.,	 2010;	 Liu	 and	 Curtiss,	2009).	 PpsbaII	 is	 also	 a	 strong	 promoter	 and	 has	 been	 used	 to	 drive	 the	 production	 of	ethanol,	 isoprene	and	fatty	acids	(Chen	et	al.,	2014;	Dexter	and	Fu,	2009;	Lindberg	et	al.,	2010).	
4.1.1.2 Nickel-inducible	promoter,	PnrsB		The	nickel-inducible	promoter,	PnrsB,	originates	from	the	Ni2+	sensing/response	system	in	
Synechocystis	(García-Domínguez	et	al.,	2000).	The	Ni2+	sensing/response	system	is	made	up	of	 the	nrsBACD	 operon	and	a	 two-component	 signal	 transduction	system	made	up	of	
nrsR	 and	 nrsS,	 found	 upstream	 of	 the	 operon.	 The	 nrsBACD	 operon	 is	 involved	 in	 Ni2+	
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resistance	whereas	 the	 nrsR	 and	 nrsS	genes	 detect	 the	 presence	 of	 Ni2+	 and	 induce	 the	transcription	of	the	operon.	The	presence	of	Ni2+	is	thought	to	stimulate	the	kinase	activity	of	 NrsS,	 which	 phosphorylates	 NrsR.	 NrsR	 then	 binds	 to	 the	 intergenic	 region	 between	
nrsRS	 and	 nrsBACD,	which	 activates	 the	 transcription	 of	 nrsBACD	 (López-Maury	 et	 al.,	2002).	PnrsB	has	been	used	as	a	nickel	 inducible	promoter	to	express	heterologous	genes.	Liu	and	Curtiss	expressed	various	lysin	genes	under	PnrsB,	made	up	of	the	nrsB	promoter,	along	with	nrsRS	to	create	a	nickel-inducible	lysis	system	in	Synechocystis	(Liu	and	Curtiss,	2009).	Within	the	Purton	group	the	expression	vector	pLAH.nrsB	(created	by	Lamya	Al-Haj	–	see	appendix)	has	been	employed	to	express	foreign	genes	under	the	nickel-inducible	system.	The	PnrsB	 in	pLAH.nrsB,	differs	to	the	one	used	by	Liu	and	Curtiss	as	 it	 is	made	up	of	 the	
nrsB	promoter	and	nrsR,	but	does	not	contain	nrsS	(Liu	and	Curtiss,	2009).	Nickel-induced	expression	of	several	genes	under	the	PnrsB	has	been	demonstrated	in	Synechocystis	(Al-Haj,	2014;	Stoffels,	2014).		
4.1.1.3 	‘Super-strong’	promoter,	Pcpc560	Recently,	 Zhou	 et	 al.	 published	 details	 of	 a	 ‘super-strong’	 promoter,	 Pcpc560	 capable	 of	producing	functional	proteins	at	very	high	expression	levels	(15%	of	total	soluble	proteins	in	 Synechocystis)	 (Zhou	 et	 al.,	 2014).	 The	 Pcpc560	 is	 composed	 of	 two	 promoters	 and	 14	transcription	factor	binding	sites	(TFBSs)	 found	upstream	of	the	cpcB	gene	encoding	the	beta	 subunit	 of	 c-phycocyanin	 and	 is	 responsible	 for	 expressing	 the	 cpc	 operon	 which	encodes	 the	phycocyanin	and	 linker	polypeptides	present	 in	phycobilisomes.	The	TFBSs	region	 in	 the	 cpc560	 promoter	 was	 demonstrated	 to	 be	 essential	 for	 high	 expression	(Zhou	et	al.,	2014).	Such	a	strong	promoter	could	be	utilised	 in	 industrial	biotechnology	when	using	cyanobacterial	for	over-production	of	key	enzymes	or	as	a	protein	expression	platform.		
4.1.2 Translational	control	tools	–	ribosomal	binding	sites	As	 aforementioned	 in	 the	 introduction,	 translation	 in	 bacteria	 is	 initiated	 when	 the	ribosome	 binds	 to	 mRNA	 at	 the	 RBS.	 The	 effectiveness	 of	 RBS	 is	 affected	 by	 the	 SD	sequence,	the	presence	of	distance	between	the	SD	sequence	and	the	start	codon	and	the	secondary	 structures	 that	 may	 develop	 due	 to	 the	 surrounding	 nucleotide	 sequence	(Heidorn	 et	 al.,	 2011).	 In	 Synechocystis,	 an	 RBS	 sequence	 UAGUGGAGGU	 based	 on	 the	optimal	complementary	sequence,	based	on	the	complementary	base	pairing	to	the	3’	end	of	the	16S	rRNA	and	with	the	ideal	spacing	between	the	central	A	and	the	start	codon,	was	
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compared	against	three	BioBrick	RBSs.	Expression	with	the	optimal	Synechocystis	RBS	was	greater	than	the	BioBrick	RBSs	(Heidorn	et	al.,	2011).			
4.1.2.1 Intergenic	regions	containing	RBS	in	operons	Operons	 are	 naturally	 found	 in	 bacteria	 and	 are	 a	 useful	 method	 of	 arranging	 related	genes	 under	 the	 control	 of	 the	 same	 promoter.	 The	 presence	 of	 RBSs	 in	 the	 intergenic	region	 (IG)	 between	 each	 gene	 can	 initiate	 translation	 of	 each	 gene	 in	 the	 operon.	Although	not	much	is	known	about	RBSs	in	Synechocystis,	genome	analysis	comparing	the	
Synechocystis	genome	with	other	bacterial	genomes	indicated	the	IGs	within	an	operon	in	
Synechocystis	were	much	longer	(median	distance	between	genes	in	a	conserved	pair	was	56)	 than	 expected	 especially	 compared	 to	 other	 prokaryotes	 (Moreno-Hagelsieb	 and	Collado-Vides,	2002;	Price	et	al.,	2005;	Rogozin	et	al.,	2002).	
4.1.3 Background	work		Within	the	group,	two	expression	plasmids,	pLAH.nrsB	and	pLAH.AII,	are	routinely	used	to	express	genes	inserted	into	the	genome	at	the	psbAII	locus,	under	the	control	of	the	PnrsB	and	the	PpsbAII,	respectively.	Another	expression	plasmid,	pLAH.cpc,	created	by	Aaron	Lau,	was	produced	to	express	genes	at	the	psbAII	locus	under	the	Pcpc560	promoter,	designed	by	(Zhou	et	 al.,	 2014).	The	pLAH.cpc	 expression	vector	was	 created	 to	 compare	Pcpc560	with	PpsbAII.	 Two	 transgenic	 strains	 of	 Synechocystis,	 6803.cpc.GFP	 and	 6803.AII.GFP,	 were	created	 by	 Aaron	 Lau	 with	 gfpuv	 expressed	 under	 the	 Pcpc560	 and	 PpsbAII,	 respectively	(Figure	4.1).	
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Figure	 4.1	 GFPuv	 expressing	 strains	 of	 Synechocystis	 and	 the	 corresponding	 control	
strain	created	by	Aaron	Lau.	The	 diagram	 shows	 the	 transgene	 arrangement	 in	 the	 strains	 created	 to	 test	 the	expression	of	GFP	under	the	control	of	the	two	promoters,	Pcpc560	and	PpsbAII.	A	control	strain,	 6803.cpc	 was	 also	 created	 with	 the	 Pcpc560	 replacing	 the	 psbAII	 gene	 and	promoter.	An	expression	plasmid	termed	“4op”	was	created	by	Ben	Mackrow	in	the	Purton	group	to	express	a	four-gene	operon	(containing	three	antibiotic	resistance	genes	and	the	gene	for	GFP)	 at	 the	 Synechocystis	psbAII	 site	 under	 the	 control	 of	 PpsbAII.	 To	 design	 4op,	 various	native	IGs	thought	to	contain	RBSs	were	used	to	separate	the	coding	regions	and	ensure	the	 translation	 of	 each	 gene	 in	 the	 operon.	 Short,	 native	 IGs	 were	 found	 within	 the	
Synechocystis	 genome	 by	 searching	 for	 sequences	 between	 known	 operons	 (using	‘MicrobesOnline’	database)	(Alm	et	al.,	2005).	As	the	IGs	would	be	incorporated	into	PCR	primers	used	to	assemble	the	operon,	the	size	of	the	chosen	IGs	was	limited	to	less	than	40	bp.	IG1,	IG2	and	IG3	were	selected	to	separate	the	genes	in	4op	(Table	4.1).	A	transgenic	strain	(strain	6803.4op),	containing	the	four-gene	operon	was	created	(Figure	4.2).	In	this	strain	 expression	of	 the	 first	 three	 genes	was	 confirmed	by	phenotype	 testing,	 however	expression	of	 the	 fourth	 gene	was	not	 seen.	A	 second	 expression	plasmid,	 4op.Rev,	was	created	in	which	the	order	of	the	IG’s	was	kept	the	same	but	the	gene	order	was	reverse	(Figure	 4.2).	 Again	 phenotype	 tests	 showed	 that	 the	 final	 gene	 was	 not	 expressed,	suggesting	that	IG3	was	not	functional.	
6803.AII.GFP	
6803.cpc.GFP	
psbAII	downstream	
element	
psbAII	upstream	
element	
gfpuv	
gfpuv	 KmR	
KmR	
PpsbAII	
Pcpc560	
Figure	X.	GFP	expressing	strains	of	Synechocys/s	created	by	
Aaron	Lau	
The	diagram	shows	the	two	strains	containing	GFPuv	at	the	
psbAII	site	in	Synechocys/s.	The	6803.AII.GFP,	strain	has	the	
GFPuv	under	the	control	of	the	psbAII	promoter	and	in	the	
6803.cpc.GFP	strain,	GFPuv	is	under	the	control	of	the	cpc560	
promoter.		
	
6803.cpc	 KmR	
Pcpc560	
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Table	4.1	IGs	used	in	the	4op	and	4op.Rev	operons	The	 IGs	 used	 to	 separate	 the	 genes	 in	 the	 4op	 and	 4op.Rev	 operons	 created	 by	 Ben	Mackrow.	 The	 location	 of	 the	 IG	 region	 is	 found	 between	 the	 two	 genes	 in	 the	
Synechocystis	genome.	The	pOp	value	is	the	estimated	probability	that	the	gene	pair	are	in	the	same	operon,	values	that	are	closer	to	1	or	0	are	confident	predictions	that	the	two	 genes	 are	 in	 the	 same	 operon,	 whereas	 values	 near	 0.5	 are	 low-confidence	predictions.		
		
Name	of	
Intergenic	
(IG)	region	
Loca3on		 Sequence		 Length	
(bp)	
pOp	
value	
	
IG1	 sll1030-
sll1029	
ttttccctataaattttgagcccaattaagcc ! 33	 0.849	
IG2	 sll1032-
sll1031	
taattactagttgaccagccccccggattttgcc! 35	 0.919	
IG3	 sll1324-
sll1323	
gtgccctatagatctagttgccatt! 26	 0.993	
	 124	
	
Figure	 4.2	 Expression	 plasmids	 used	 to	 create	 the	 transgenic	 strains	 of	 Synechocystis	
expressing	a	4-gene	operon	under	the	control	of	PpsbAII.	The	 diagram	 shows	 4op,	 the	 expression	 plasmid	 used	 to	 create	 the	 strain	 6803.4op.	The	4-gene	operon	shows	the	antibiotic	resistance	genes	ble,	aadA	and	aphA-6,	which	confer	resistance	to	zeocin,	spectinomycin	and	kanamycin,	and	gfpuv	separated	by	IG1,	IG2	and	IG3,	under	the	control	of	PpsbAII.	Also	shown	is	the	expression	plasmid	4op.Rev	(gene	order	reversed	relative	to	4op),	used	to	create	the	strain	6803.4op.Rev.	
4.1.4 Aims	and	objectives	The	overall	aim	of	the	work	presented	in	this	chapter	was	to	develop	further	the	necessary	tools	for	efficient	trans-operon	expression	in	Synechocystis.		This	builds	on	the	work	previously	carried	out	in	the	lab.	The	expression	of	the	multi-gene	operon	(designed	by	Ben	Mackrow)	was	 tested	under	 the	control	of	 the	nickel	 inducible	promoter,	 to	 investigate	 whether	 an	 inducible	 promoter	 such	 as	 PnrsB	 can	 regulate	individual	genes	within	an	operon.	A	further	promoter,	Pcpc560	was	studied	and	compared	with	PpsbAII	using	the	transgenic	strains	6803.cpc.GFP	and	6803.AII.GFP	(created	by	Aaron	Lau).	 Finally,	 continuing	 on	 from	 the	 work	 started	 by	 Ben	 Mackrow,	 more	 intergenic	regions	containing	potential	RBSs	were	 found	and	 tested	within	a	 two-gene	operon	 that	used	as	GFP	as	the	reporter,	to	test	the	functionality	of	each	intergenic	region.		
IG1	 IG3	
psbAII	upstream	
element	
psbAII	downstream	
element	
4op	
Ori	
PpsbAII	
IG2	ble	 aadA	 apha-6	 gfpuv	
IG1	 IG3	
psbAII	upstream	
element	
psbAII	downstream	
element	
4op.REV	
Ori	
PpsbAII	
IG2	 ble	aadA	apha-6	gfpuv	
Figure	X.	Expression	
plasmids	created	by	Ben	
Mackrow	used	to	create	
the	transgenic	strains	of	
Synechocys6s	containing	
the	4-gene	operon.	
	
The	diagram	…	
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4.2 Results	
4.2.1 Expression	of	the	multi-gene	operon	under	nrsB	promoter	To	 determine	 whether	 an	 inducible	 trans-operon	 system	 could	 be	 established	 for	
Synechocystis,	part	of	the	multi-gene	operon	in	4op	was	used	to	create	a	transgenic	strain	containing	a	multi-gene	operon	under	the	control	of	the	native	nickel	inducible	promoter,	PnrsB.		The	operon	was	composed	of	three	antibiotic	resistance	genes:	ble,	aadA	and	aphA-6,	that	 confer	 resistance	 to	zeocin,	 spectinomycin	and	kanamycin	 (zsk),	 respectively	and	 is	therefore	 referred	 to	 as	 the	 zsk	 operon.	 Intergenic	 regions	 IG1	 and	 IG2	 were	 used	 to	separate	the	genes	in	the	operon.		
4.2.1.1 Creation	of	 transgenic	 strain	expressing	 the	 zsk	operon	under	 the	nickel-
inducible	promoter	To	 create	 the	 expression	 plasmid,	 pLAH.nrsB.zsk	 (Figure	 4.3)	 used	 to	 transform	
Synechocystis;	the	ble-IG1-aadA-IG2-aphA-6	region	was	amplified	from	4op	and	cloned	into	a	modified	pLAH.nrsB	expression	vector,	pLAH.nrsB_cat.	The	pLAH.nrsB_cat	plasmid	was	created	 in	 order	 to	 remove	 the	 KmR	 cassette	 present	 between	 the	 psbAII	 elements	 and	insert	a	cat,	a	chloramphenicol	resistance	gene,	into	the	backbone	to	enable	selection	in	E.	
coli.			
	
Figure	 4.3	 Diagram	 of	 the	 expression	 plasmid	 used	 to	 create	 transgenic	 strains	 of	
Synechocystis	expressing	the	zsk	operon	under	the	PnrsB	at	the	psbAII	site	in	the	genome.	The	 zsk	 operon	 was	 ligated	 into	 the	 pLAH.nrsB_cat	 vector	 in	 order	 to	 create	pLAH.nrsB.zsk.	The	region	was	amplified	using	AL.ZnR.4op.F	and	AL.KanR.4op.R,	and	produced	NdeI	and	Acc65I	 restriction	 sites	 at	 the	 5’	 and	 3’	 end	 of	 the	 PCR	 product,	 respectively.	 The	 PCR	fragment	 containing	 the	 multi-gene	 operon	 was	 initially	 cloned	 into	 the	 pJET1.2/blunt	vector	to	create	pJET.zsk,	and	then	excised	using	NdeI	and	Acc65I	and	cloned	in	the	NdeI	and	 Acc65I	 site	 of	 pLAHnrsB_cat	 to	 create	 pLAH.nrsB.zsk.	 Restriction	 analysis	 and	sequencing	 using	 primers	 nrsB.seqF	 and	 Out.GFP.R	 verified	 the	 construction	 of	
psbAII	upstream	
element	
psbAII	downstream	
element	
pLAH.nrsB.zsk	
PnrsB	
Ori	cat	
IG1	 IG2	ble	 aadA	 apha-6	
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pLAH.nrsB.zsk.	 However,	 when	 sequenced	 with	 nrsB.seqF,	 a	 single	 base	 deletion	 is	observed	 towards	 the	end	of	 the	ble	 gene,	 leading	 to	a	 frame	shift	 (Table	4.2).	 Since	 the	growth	of	the	cell	line	was	seen	in	the	presence	of	Zeocin,	the	mutation	does	not	appear	to	have	an	effect	on	the	function	of	the	Ble	protein.	These	results	also	showed	a	single	base	deletion	in	IG1,	in	the	region	where	the	SD	sequence	in	likely	to	be	present	this	may	have	an	effect	on	the	expression	levels	of	aadA	(Table	4.2).		
Table	4.2	Deletion	mutations	in	ble	and	IG1	present	in	pLAH.nrsB.zsk	Table	shows	 the	expected	and	actual	 sequence	of	 the	end	of	ble	 (in	blue)	and	 IG1	(in	black)	and	the	start	of	GFP	(in	green).	The	expected	and	actual	amino	acid	sequence	of	the	C-terminal	end	of	Ble	is	also	shown.	The	chromatogram	received	from	sequencing	pLAH.nrsB.zsk	with	nrsB.seqF	shows	the	missing	bases	in	ble	and	IG1	
	
WT	Synechocystis	was	transformed	with	pLAH.nrsB.zsk,	to	create	a	transgenic	strain	with	the	zsk	operon.	To	select	for	transformants,	the	cells	were	supplemented	with	6.4	μM	Ni2+	to	 induce	 the	 expression	 of	 the	 antibiotic	 resistance	 genes.	 Colonies	 were	 selected	 on	Zeo7.5	+	 Spec30	+	Km30	 for	 resistance	 to	 all	 three	antibiotics.	 16	 colonies	were	 restreaked	onto	plates	containing	Zeo7.5	+	Spec30	+	Km30+	6.4	μM	Ni2+.	Of	the	16	colonies,	10	grew	and	PCR	using	Ben.ups.F	and	C.Frag.BR	primers	was	performed	on	the	genomic	DNA	extracted	from	these	putative	 transformants.	A	single	 transformant	 (6803.nrsB.zsk_7)	appeared	 to	have	 the	 operon	 integrated	 at	 the	 psbAII	 locus	 (Figure	 4.4).	 A	 further	 16	 putative	transformants	were	tested,	and	from	this	two	additional	transformants	(6803.nrsB.zsk_D	and	6803.nrsB.zsk_M)	appeared	 to	have	successfully	 integrated	 the	operon	at	 the	psbAII	
Expected	pLAH.nrsB.zsk	sequence	 …GTGGCCGAGGAGCAGGACTGAttttccctataaattttgagcccaattaagccATGGCTCGTGAAG…!
Expected	amino	acid	sequence	
	
… V  A  E  E  Q  D  * !
Consensus	Sesquence	 …GTGGCCGAGGA-CAGGACTGAttttccctataaattttgagccca-ttaagccATGGCTCGTGAAG…!
	
Actual	pLAH.nrsB.zsk	sequence		
	
…GTGGCCGAGGACAGGACTGAttttccctataaattttgagcccattaagccATGGCTCGTGAAG…!
	
Actual	amino	acid	sequence	 … V  A  E  D  R  T  D  F  P  Y  K  F  *!
Chromatogram	of		
nrsB.seq.F	on	pJAH.nrsB.zsk		
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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site	 (Figure	4.4).	All	 successful	 transformants	were	 judged	 to	be	homoplasmic	based	on	the	absence	of	the	smaller	PCR	product	from	the	WT	locus	(Figure	4.4).	The	unusually	high	number	 of	 false	 transformants	 seen	 in	 this	 transformation	 may	 be	 due	 to	 the	 low	antibiotic	 concentrations	 used,	 which	 may	 have	 enabled	 so	 many	 strains	 to	 become	resistant	and	grow.			
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Figure	 4.4	 PCR	 screen	 of	 successful	 transformants	 in	 Synechocystis	 containing	 the	 zsk	
operon	under	the	control	of	PnrsB	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragment	 sizes	 for	 WT	
Synechocystis	and	successful	6803.nrsB.zsk	transformants.	(B)	PCR	screens	of	putative	transformants	 of	 6803.nrsB.zsk.	 WT	 Synechocystis	 (WT),	 pLAH.nrsB.zsk	 (+C)	 and	 no	DNA	(-C)	were	used	as	controls.	Successful	transformants	7,	D	and	M	all	have	a	band	at	3.6	kb	and	are	homoplasmic.				
L
3.5		
3.0		
2.0		
kb	
1.5	
-C	 7*	 2	1	 3	 4	 7	5	 15	9	 16	10	 WT	 +C	
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4.0	
kb	
3.5		
3.0		
2.0		
1.5	
4.0	
Fig	X.	PCR	screen	for	successful	transformants	in	Synechocys)s	
containing	ble,	aadA	and	apha-6	under	the	control	of	the	nrsB	
promoter.		
(A)	SchemaUc	showing	the	binding	sites	and	expected	f agment	
sizes	for	WT	Synechocys)s	and	successful	6803.con2.zsk	strains.	
(B)	and	(C)	Colony	PCR	screens	of	putaUve	transformants	of	
6803.con2.zsk.	WT	Synechocys)s,	WT	and	a	plasmid	preparaUon	
of	pLAH.nrsB.zsk,	+C,	(3.6	kb)	were	used	as	controls.	Successful	
transformants	7,	D	and	M	all	have	a	band	at	3.6	kb	and	are	
homoplasmic.		
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4.2.1.2 Testing	the	expression	of	the	antibiotic	resistance	genes	within	the	operon	A	growth	‘spot’	test	was	performed	to	assess	whether	the	nickel-inducible	promoter	was	able	to	control	the	expression	of	the	zsk	operon	such	that	the	transformants	would	show	sensitivity	to	the	antibiotics	in	the	absence	of	added	nickel,	but	resistance	when	nickel	was	added	to	the	medium.	The	three	biological	replicates	of	6803.nrsB.zsk	were	grown,	alongside	WT	Synechocystis	and	 6803.4op	 (used	 as	 controls)	 on	 BG-11	 medium	 containing	 zeocin/	 spectinomycin/	kanamycin	and	with/without	6.4	μM	Ni2+	(Figure	4.5).	After	 four	days,	 the	6803.nrsB.zsk	transformants	7	and	D	showed	a	clear	phenotype	of	growth	on	zeocin	and	spectinomycin	in	the	presence	of	nickel,	but	not	in	its	absence.	This	demonstrates	that	the	expression	of	
ble	 and	aadA	 are	nickel–induced	and	under	 the	 control	of	PnrsB.	 For	 transformant	M,	 the	induction	appears	much	weaker	suggesting	a	possible	mutation	in	the	promoter	element.	However,	 all	 three	 6803.nrsB.zsk	 transformants	 were	 able	 to	 grow	 in	 the	 presence	 of	kanamycin	even	when	Ni2+	was	absent	(Figure	4.5).	The	expression	of	aphA-6	is	therefore	not	 induced	by	Ni2+,	and	 is	not	under	 the	control	of	PnrsB.	A	possible	explanation	 for	 this	constitutive	expression	is	given	in	section	4.2.1.3.	
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Figure	4.5	Growth	‘spot’	test	assessing	the	expression	of	the	zsk	operon	in	6803.nrsB.zsk	
transformants	in	the	absence	(−)	and	presence	(+)	of	Ni2+.	Photo	 taken	 after	 4	 days.	 Three	 6803.nrsB.zsk	 transformants	 were	 grown	 alongside	WT	 Synechocystis	 (WT	 6803)	 and	 6803.4op	 (used	 as	 the	 controls).	 WT	 6803	 was	unable	to	grow	on	any	of	the	antibiotics	and	grew	only	on	BG-11	as	expected	whereas	6803.4op	(expressing	ble,	aadA	and	aphA-6	under	PpsbAII)	was	able	to	grow	on	all	plates.	Growth	of	6803.nrsB.zsk	on	zeocin	and	spectinomycin	was	induced	by	the	presence	of	Ni2+	but	6803.nrsB.zsk	was	able	to	grow	on	kanamycin	even	when	Ni2+	was	absent.			As	 6803.nrsB.zsk	 is	 resistant	 to	 spectinomycin,	 this	suggests	 that	 the	 intergenic	 region	IG1*	 (IG1	 with	 the	 1bp	 deletion),	 is	 functional	 allowing	 translation	 of	 the	 aadA	 coding	region.	However,	after	7	days,	all	 three	6803.nrsB.zsk	started	to	grow	on	spectinomycin,	even	when	Ni2+	was	absent	(Figure	4.6).	This	probably	reflects	leaky	expression	from	PnrsB	either	due	 to	 the	 low	concentration	of	zinc	 in	 the	medium	or	 the	very	weak	constitutive	promoter	in	PnrsB	(further	examined	in	the	discussion).		
WT	6803	
6803.nsrB.zsk	7	
6803.nrsB.zsk	D	
6803.nsrB.zsk	M	
6803.4op	
BG-11	 BG-11	+	Km50	BG-11	+	Spec50	 BG-11	+	Zeo7.5	
+	Spec30	+	Km30	
BG-11	+	Zeo25	
+	-	 +	-	 +	-	 +	-	 +	-	
Figure	X.	Growth	‘sp t’	t st	assessing	the	expressi n	of	the	3-ge e	
operon	in	6803.nrsB.zsk	transformants	in	the	absence	(-)	and	
presence	(+)	of	Nickel.		
Three	6803.con2.zsk	transformants	were	grown	alongside	WT	
Synechocys)s	(WT	6803)	and	6803.4op.	WT	6803	was	unable	to	grow	
in	the	presence	of	anTbioTcs	and	6803.4op	was	able	to	grow	on	all	
plates	as	expected.	The	expression	of	ble	and	aadA	are	under	the	
control	of	the	nrsB	promoter,	but	apha-6	does	not	appear	to	be.		
Ni2+	
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Figure	 4.6	 Growth	 ‘spot’	 test	 assessing	 the	 expression	 of	 aadA	 in	 6803.nrsB.zsk	
transformants.	Photos	 taken	 4	 and	 9	 days	 after	 ‘spotting’	 onto	 medium	 containing	 spectinomycin.	Three	 6803.nrsB.zsk	 transformants	 were	 grown	 alongside	 WT	 Synechocystis	 (WT	6803)	 and	 6803.4op	 (used	 as	 the	 controls).	WT	 6803	was	 unable	 to	 grow	 on	 plates	containing	 spectinomycin	 as	 expected	 and	 6803.4op	 (expressing	 aadA	 under	 PpsbAII)	was	able	 to	grow	 in	 the	presence	of	 spectinomycin.	The	6803.nrsB.zsk	 transformants	showed	weak	growth	after	9	days.		
4.2.1.3 Investigating	the	presence	of	a	possible	cryptic	promoter	As	 the	 expression	 of	aphA-6	 occurs	 readily	 in	 the	 absence	 of	 nickel,	 a	 cryptic	 promoter	could	be	present	in	aadA	or	IG2	that	enables	expression.		Using	the	E.	coli	promoter	prediction	software,	BPROM	the	aadA	gene	and	IG2	upstream	of	
aphA-6	 was	 analysed	 and	 two	 predicted	 promoters	 were	 found.	 One	 promoter	 was	predicted	 to	 be	 in	 the	 middle	 of	 the	 spectinomycin	 resistance	 gene	 and	 the	 other	 one	towards	 the	end	of	 the	aadA,	with	 the	predicted	 -10	box	 region	 formed	 from	both	aadA	and	IG2	(Figure	4.7).	The	finding	that	such	cryptic	promoters	can	confound	the	intended	phenotype	highlights	one	of	the	challenges	of	synthetic	biology	–	namely,	the	difficulty	of	predicting	 and	 avoiding	 such	 ‘off-target’	 effects	 from	 unintended	 cis	 elements	 within	transgene	constructs.	Nonetheless,	the	expression	of	AphA-6	demonstrates	that	IG2	is	also	functional	in	terms	of	mediating	efficient	translation.	
WT	6803	
6803.nsrB.zsk	7	
6803.nrsB.zsk	D	
6803.nsrB.zsk	M	
6803.4op	
BG-11	+	Spec50	
9	4	
Day		
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Figure	4.7	Sequence	of	the	end	of	aadA,	IG2,	and	the	starts	of	aphA-6	in	6803.nrsB.zsk.	The	–10	box	and	–35	box	of	the	cryptic	promoter	predicted	to	be	in	the	middle	of	the	
aadA	gene	and	at	the	end	of	the	gene	are	underlined.		
4.2.2 Expression	of	GFP	under	the	cpc	promoter	
To	compare	 the	expression	of	genes	under	 the	Pcpc560	and	PpsbAII	promoter	elements,	and	test	the	claims	of	Pcpc560	being	a	super-strong	promoter,	the	expression	of	gfp	was	tested	in	the	two	transgenic	strains	6803.cpc.GFP	and	6803.AII.GFP.	Western	blot	analysis	and	the	fluorescence	 of	 GFPuv	 were	 used	 to	 compare	 the	 expression	 of	 GFPuv	 under	 the	 two	promoters.		
Comparing	 the	 expression	 of	 GFPuv	 under	 the	 control	 of	 the	 psbAII	 promoter	 and	 the	
cpc560	promoter.		To	compare	the	expression	of	GFPuv	under	the	two	promoters	the	following	cultures	were	grown	 in	BG-11:	 three	 biological	 replicates	 of	 6803.cpc.GFP	 (#1,	 5,	 7)	 and	6803.AII.GFP	(#1,	2,	7)	with	6803.cpc	and	6803.AII	(see	appendix)	as	the	two	control	strains.	Once	the	cultures	were	grown	to	an	OD730	of	~0.9,	the	cells	were	used	for	Western	blot	analysis	and	fluorescence	measurements.		For	Western	blot	analysis,	 samples	were	probed	with	anti-GFP	antibodies	and	anti-RbcL	antibodies	as	a	loading	control,	and	the	Odyssey	Infrared	Imaging	System	was	used	for	the	quantification	 of	GFP	protein	 levels.	 The	 expression	 of	gfp	was	 seen	 in	 all	 6803.cpc.GFP	
AAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTG
GCCTCGCGCGCAGATCAGTTGGAAGAATTTGTCCACTACGT
GAAAGGCGAGATCACTAAGGTAGTTGGCAAATAATAATTAC
TAGTTGACCAGCCCCCCGGATTTTGCCATGACCATGGAATT !
!
aadA!
apha-6!
IG2!
-10 box!
-35 box!
ATGGCTCGTGAAGCGGTTATCGCCGAAGTATCAACTCAACTATCAGAGGTAGTTGGCGTCAT
CGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCG
GCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACA
ACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGAT
TCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAG
CTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAG
CCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGC
CTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGG
CGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAAT
GTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGA
TGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAG
CTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAA
GAATTTGTCCACTACGTGAAAGGCGAGATCACTAAGGTAGTTGGCAAATAATAATTACTAGT
TGACCAGCCCCCCGGATTTTGCCATGACCATGGAATTACCAAAT!
!
aadA!
apha-6!
IG2!
-10 box!
-35 box!
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and	6803.AII.GFP	lines	with	a	band	at	27	kDa.	This	band	is	absent	in	both	control	strains	(Figure	 4.8A).	 Western	 blot	 confirms	 expression	 of	 gfp	 under	 both	 Pcpc560	 and	 PpsbAII	promoters.	
	
Figure	4.8	Western	blot	analysis	confirms	and	compares	GFPuv	expression	under	Pcpc560	
and	PpsbAII	in	transformants	of	Synechocystis.		(A)	Western	 blot	 analysis	 was	 performed	with	whole	 cell	 extracts	 and	 anti-GFP	 and	anti-RbcL	 antibodies,	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	Samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	 for	GFP	is	27	kDa	and	 52.5	 kDa	 for	 RbcL,	which	 acted	 as	 loading	 control.	 Protein	 size	was	 determined	using	 the	PageRulerTM	prestained	protein	 ladder	(Thermo	Scientific).	Strains	6803.AII	and	6803.cpc	acted	as	negative	controls.	(B)	The	GFPuv	signal	was	quantified	using	the	Odyssey®	Infrared	Imaging	System.	The	GFPuv	IR	fluorescence	signal	was	normalised	against	 the	 signal	 of	 RbcL.	 The	 average	 normalised	 IR	 signal	 for	 all	 the	 three	6803.cpc.GFP	strains	was	compared	to	6803.AII.GFP.	Error	bars	are	±	one	SD.	The	IR	fluorescence	signal	of	GFPuv	and	RbcL	was	quantified	using	the	Odyssey	Infrared	Imaging	System.	As	seen	 in	Figure	4.8	 the	 level	of	GFPuv	appears	 to	be	at	 least	 two-fold	greater	under	the	control	of	Pcpc560	than	PpsbAII,	supporting	the	reported	finding	that	Pcpc560	can	serve	as	a	very	strong	promoter	(Zhou	et	al.,	2014).	
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GFP	 fluorescence	 was	 measured	 using	 a	 luminescence	 spectrometer.	 	 However,	 the	emission	maximum	for	GFP	at	509	nm	is	obscured	by	endogenous	emissions	with	a	peak	at	455	nm	that	arises	from	the	light-harvesting	pigments	present	in	cyanobacteria	(Figure	4.9)	(Spence	et	al.,	2003).		In	 order	 to	 remove	 the	 effect	 of	 the	 peak	 at	 455nm,	 the	 absorbance	 units	 for	 each	wavelength	 was	 normalised	 to	 the	 absorbance	 value	 at	 455	 nm.	 The	 spectrum	 of	 the	control	 strain	 was	 then	 subtracted	 from	 the	 test	 strain	 and	 plotted.	 The	 peaks	 of	6803.cpc.GFP_5	 and	 6803.cpc.GFP_7	 are	 higher	 than	 the	 6803.AII.GFP	 transformants.	6803.cpc.GFP_1	appears	to	be	an	anomaly,	with	a	small	peak	in	comparison	to	the	others	transformants.	Ignoring	6803.cpc.GFP_1,	the	results	using	the	luminescence	spectrometer	match	the	results	of	the	Western	blot	analysis;	the	expression	of	GFP	is	greater	under	the	control	of	Pcpc560	(Figure	4.10).		
	
Figure	4.9	The	absorbance	spectra	of	Synechocystis	(black	line).		The	 green	 line	 represents	 the	 emission	 peak	 at	 approximately	 509nm	 of	 GFP,	which	overlaps	 with	 part	 of	 the	 absorption	 peak	 seen	 in	 Synechocystis.	 This	 absorption	 of	
Synechocystis	 may	 interfere	 with	 detection	 of	 GFP.	 Modified	 image	 from	http://2010.igem.org/Project_usu.html.			
Figure	removed	
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Figure	 4.10	 GFPuv	 Fluorescence	 measured	 under	 the	 control	 of	 promoter,	 Pcpc560	 and	
PpsbAII	in	transformants	of	Synechocystis.			Cultures	of	similar	OD730	were	excited	at	395	nm	and	the	emission	spectrum	between	450	–	600	nm	was	plotted.	The	absorbance	of	each	wavelength	was	normalised	to	the	absorbance	 value	 at	 455	 nm	 and	 the	 spectrum	 of	 the	 control	 strain	 (6803.cpc	 or	6803.AII)	 was	 then	 subtracted	 from	 these	 values.	 The	 emission	 peak	 at	 509	 nm	 is	GFPuv.		
4.2.3 Testing	intergenic	regions	(containing	RBS)	in	a	two-gene	operon	Continuing	 from	 the	 work	 carried	 out	 by	 Ben	 Mackrow	 in	 the	 Purton	 group,	 more	 IGs	(containing	 RBS)	 for	 insertion	 in	 an	 operon	 were	 identified	 from	 the	 genome	 of	 WT	
Synechocystis.	Various	IGs	were	then	tested	by	placing	these	between	the	coding	regions	of	
ble	and	gfpuv,	in	a	two-gene	operon,	under	the	control	of	Pcpc560	at	the	psbAII	site	(Figure	4.11).	The	expression	of	gfpuv	was	used	to	check	the	functionality	of	the	IGs.		
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Figure	4.11	Two-gene	operon	created	to	test	various	IGs.	Diagram	shows	the	two-gene	operon,	made	up	of	ble	and	gfpuv	separated	by	the	IG,	to	test	the	function	of	the	IG.		
4.2.3.1 Search	and	identification	of	IGs	to	test	As	IG2	(Figure	4.5)	has	already	been	shown	to	be	functional,	IG2	was	chosen	for	use	in	the	two-gene	operon.	 In	addition,	a	non-native	 IG	region,	 IG4,	was	designed	 that	utilises	 the	optimal	RBS,	RBS*	designed	by	Heidorn	et	al.	(2011),	and	extra	bases	were	added	to	make	the	 IG	 22	 bases	 in	 length.	 More	 native	 IGs	 were	 initially	 identified	 by	 searching	 the	‘Microbes	Online’	database’	 for	pairs	of	genes	that	were	predicted	to	 lie	within	the	same	operon	and	had	a	pOp	value	(estimated	probability	that	the	pair	were	in	the	same	operon)	that	was	 close	 to	1	or	0	as	 this	gives	more	 confident	predictions	 that	 the	 two	genes	are	within	 an	 operon,	 whereas	 values	 near	 0.5	 are	 low-confidence	 predictions.	 The	 IG	sequences	between	the	coding	pairs	were	then	chosen	for	pairs	that	were	also	less	than	40	bases	apart	using	CyanoBase	(Table	4.3).	From	the	list	of	IGs,	the	IG	between	sll0939	and	
sll0938	was	renamed	IG5	and	was	chosen	for	testing.	
KmR	
Pcpc560	
psbAII	downstream	
element	
psbAII	upstream	
element	
IGX	ble	 GFPuv	
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Table	4.3	List	of	 the	native	 intergenic	regions	 found	 in	Synechocystis	 genome	that	were	
between	20	and	40	bases.		The	 sequence	 for	 the	 IG	 was	 obtained	 for	 each	 gene	 pair.	 The	 function	 of	 the	 gene	products	 in	 the	 gene	 pairs	 was	 found	 using	 CyanoBase.	 Highlighted	 in	 blue	 is	 IG5,	which	was	chosen	for	testing.	
	In	 order	 to	 test	 whether	 an	 IG	 was	 actually	 required	 for	 translation	 of	 a	 downstream	cistron,	the	expression	of	gfpuv	was	also	tested	without	the	addition	of	any	IG	so	the	start	codon	of	gfpuv	was	placed	immediately	after	the	ble	stop	codon	(construct	named	IG0bp).	Similarly,	the	expression	was	also	tested	with	a	single	base	between	the	stop	codon	of	ble	and	the	start	codon	of	gfpuv	(named	IG1bp).		A	list	of	the	IGs	used	to	test	in	the	two-gene	operon	is	given	in	Table	4.4.		
Figure	IG	region	shortlist	-	
Highlight	the	chosen	one	and	
include	another	list	of	the	ﬁnal	IG	
regions	chosen	-	have	this	as	two	
separate	ﬁgures.			-	highlight	RB	
sites???	
Gene	Pair	 Func?on	of	Genes	 Length	(bp)	 Sequence	5’	to		3’	
pOp	
value	
sll1204/	
sll1203	 similar	to	macrolide	eﬄux	protein/	hypothe?cal	protein	 17	 TTAATTTACAAAAATAA! 0.965	
sll1062/	
sll1061	 unknown	protein/	unknown	protein	 26	 ACCCTCTTAAAAAAATCTAAAAAACT!0.956	
sll0710/
sll0709	 unknown	protein/	puta?ve	endonuclease	 40	
TCTAAGTTTTCTTTTCATTGAATAGTT
TTATTTACATATT! 0.922	
slr0722/	
slr0723	 hypothe?cal	protein/	hypothe?cal	protein	 20	 TTTTTTTGGCCCTTTTCCCT! 0.938	
slr0250/	
slr0251	
hypothe?cal	protein/	ATP-binding	protein	of	ABC	
transporter	 24	 GCTGTGGGATACTAACGGCATTCG! 0.952	
sll0218/	
sll0217	 hypothe?cal	protein/	ﬂavoprotein	 26	 GTTCACCTTCTACCTGGGATTTTCTC!0.962	
slr1103/	
slr1104	 hypothe?cal	protein/	hypothe?cal	protein	 28	
CTTAGAATTAATAGATCCCAGATTCTC
T! 0.911	
sll1680/	
sll1679	 hypothe?cal	protein/periplasmic	protease	HhoA	 33	
GTTTCCCGTACCTCACCCATCCAAACT
TTAACC! 0.844	
sll0939/	
sll0938	 hypothe?cal	protein/aspartate	transaminase	 24	 ACTAAAAGGCAAAGGAATAAAACT! 0.772	
sll0933/	
ssl1784	 hypothe?cal	protein/	30S	ribosomal	protein	S15	 17	 GTTTTTGCATTTTTCCC! 0.967	
slr0984/	
slr0985	
CDP-glucose	4,6-dehydratase/dTDP-4-
dehydrorhamnose	3,5-epimerase	 18	 AACAAAAACCCAGCAAAA! 0.966	
slr1617/	
slr1618	 similar	to	UDP-glucose	4-epimerase/	unknown	protein	 12	 GAAAGCAAGCAA! 0.847	
slr1618/	
slr1619	 unknown	protein/	hypothe?cal	protein	 28	
TTAACTTATTCAATTAAGAGGTAATTC
A! 0.75	
slr1063/	
slr1064	
probable	glycosyltransferase/	probable	
glycosyltransferase	 21	 AACTAGTTTACGTTTCATAAT! 0.928	
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Table	4.4	List	of	the	IGs	tested	in	the	two-gene	operon	containing	ble	and	gfpuv	IG	regions	to	be	tested,	both	IG2	and	IG5	are	native	IG	regions.	IG4	has	been	designed	to	complement	the	16S	rRNA.	IG0bp	represent	no	IG	between	the	stop	codon	of	the	first	gene	and	the	start	codon	of	the	second	gene.	With	IG1bp	there	is	a	single	base	between	the	stop	codon	of	the	first	gene	and	the	start	codon	of	the	second	gene.	The	pOp	value	is	the	estimated	probability	that	the	gene	pairs	are	in	the	same	operon.	
	
4.2.3.2 Creation	of	transgenic	strains	expressing	the	two-gene	operon	To	 construct	 the	 expression	 plasmids	 required	 to	 create	 the	 transgenic	 strains,	 first	ble	and	gfp	were	individually	amplified	to	each	have	the	IG	region	in	place.	The	PCR	products	(ble_IGX	and	IGX_GFP)	were	then	used	as	a	template	to	perform	an	overlap	PCR	to	join	the	two	 genes	 together	 (ble_IGX_GFP).	 The	 resulting	 PCR	 product	 was	 then	 cloned	 into	pLAH.cpc,	 to	 produce	 pLAH.ble_IGX_GFP,	 (for	 further	 details	 see	 2.8.1).	 Figure	 4.12	demonstrates	the	creation	of	the	transgenic	strain	containing	the	two-gene	operon,	when	IG2	is	used,	but	the	same	method	was	used	for	all	the	strains	tested.		
Name	of	
Intergenic	
(IG)	region	
Gene	pair	 Sequence	5’-3’	 Length	(bp)	
pOp	
value	
IG2	 sll1032-sll1031	 TAATTACTAGTTGACCAGCCCCCCGGATTTTGCC! 35	 0.919	
IG4	 N/A	 TGGCAATAGTGGAGGTAATCGA!! 22	 N/A	
IG5	 sll0939-sll0938		 ACTAAAAGGCAAAGGAATAAAACT! 24	 0.772	
IG0bp	 N/A	 N/A! 0	 N/A	
IG1bp	 N/A	 G! 1	 N/A	
Underlinin ?	Not	sure	about	for	t e	
others	
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Figure	4.12	Schematic	showing	the	construction	of	transgenic	strains	expressing	the	two-
gene	operon	Example	showing	the	construction	of	6803.ble.IG2.GFP,	but	the	process	applies	 for	all	strains.	The	primers	used	to	amplify	ble	from	pZΔES	(See	appendix)	were	designed	so	that	 the	 forward	 primer	 would	 have	 an	 AseI	 restriction	 site	 at	 the	 5’	 end	 and	 the	reverse	primer	designed	to	have	the	entire	intergenic	region	after	the	stop	codon	of	ble.	To	amplify	gfpuv	 from	4op,	 the	 forward	primer	was	designed	so	 the	entire	 intergenic	region	is	upstream	of	the	start	codon	of	gfpuv	and	the	reverse	primer	was	designed	to	have	 a	 BglII	 restriction	 site	 after	 the	 stop	 codon.	 This	 was	 the	 case	 for	 when	 the	intergenic	region	was	IG2,	IG4	and	IG5,	but	when	the	intergenic	region	was	0bp	or	1bp,	the	reverse	primer	for	amplifying	ble	was	designed	so	that	after	the	end	of	ble	the	start	of	gfpuv	was	present	after	the	0bp	or	1	bp	(G)	space	after	ble.	The	forward	primer	for	amplifying	 gfpuv	 was	 designed	 so	 that	 before	 the	 start	 of	 gfpuv,	 the	 end	 of	 ble	 was	present	before	the	0bp	or	1	bp	(G)	space.			WT	 Synechocystis	was	 then	 transformed	 with	 the	 various	 pLAH.ble.IGX.GFP	 expression	plasmids	to	create	the	transgenic	lines.	After	selection	on	kanamycin	supplemented	media,	six	 putative	 transformants	 of	 6803.ble.IG2.GFP,	 6803.ble.IG4.GFP	 and	 6803.ble.IG5.GFP	were	 tested.	 PCR	 performed	with	 Ben.ups.F	 and	 C.Frag.BR,	 on	 genomic	DNA,	 confirmed	the	successful	integration	of	the	two-gene	operon	at	the	psbAII	site	(Figure	4.13).	PCR	was	also	 performed	 on	 three	 putative	 transformants	 of	 6803.ble_IG0bp_GFP	 and	
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6803.ble_IG1bp_GFP,	and	confirmed	the	successful	 integration	of	the	two-gene	operon	at	the	 psbAII	 site	 to	 create	 6803.ble.IG0bp.GFP	 and	 6803.ble.IG1bp.GFP	 (Figure	 4.14).	 All	6803.ble.IG2.GFP,	 6803.ble.IG4.GFP,	 6803.ble.IG5.GFP,	 6803.ble.IG0bp.GFP	 and	6803.ble.IG1bp.GFP	strains	that	showed	a	transformant	band	were	homoplasmic.		
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Figure	4.13	PCR	screen	of	successful	transformants	in	Synechocystis	containing	the	two-
gene	operon	with	the	various	IGs	(IG2,	IG4,	IG5)	under	the	control	of	Pcpc560	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragment	 sizes	 for	 WT	
Synechocystis	 and	 successful	 6803.ble.IGX.GFP	 strains.	 (B)	 PCR	 screens	 of	 putative	transformants	 of	 6803.ble.IGX.GFP	 strains.	WT	 Synechocystis	 (WT),	 no	DNA	 (-C)	 and	pLAH.ble.IG2.GFP	 (+C),	 expected	 to	 give	 a	 band	 at	 3.6	 kb,	 were	 used	 as	 controls.	Transformants	with	a	band	at	3.6	kb	and	no	visible	band	at	1.9	kb	are	presumed	to	be	homoplasmic.				
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Figure	4.14	PCR	screen	of	successful	transformants	in	Synechocystis	containing	the	two-
gene	operon	with	either	IG0bp	or	IG1bp.	Colony	 PCR	 screens	 of	 putative	 transformants	 of	 6803.ble.IGX.GFP	 strains.	 WT	
Synechocystis,	WT	and	no	DNA	template	(-C),	were	used	as	controls.		
4.2.3.3 Testing	GFP	expression	and	IG	function	As	in	the	preceding	studies,	Western	blot	analysis	and	fluorescence	of	GFPuv	were	used	to	compare	the	expression	of	gfpuv	when	linked	to	the	various	IGs.		Three	 biological	 replicates	 of	 each	 6803.ble_IG2_GFP,	 6803.ble_IG4_GFP	 and	6803.ble_IG5_GFP	were	grown	alongside	6803.cpc	and	6803.cpc.GFP,	used	as	negative	and	positive	 controls	 respectively,	 to	 an	 OD730	 of	 ~0.7.	 	 For	 Western	 blot	 analysis	 samples	were	 probed	with	 anti-GFP	 and	 anti-RbcL	 antibodies	 (loading	 control)	 and	 the	Odyssey	Infrared	 Imaging	 System	 was	 used	 for	 the	 quantification	 of	 GFP	 (Figure	 4.15).	 The	preliminary	 results	 confirmed	 the	 expression	 of	 GFP	with	 a	 band	 at	 27	 kDa	 in	 all	 three	6803.ble_IG2_GFP,	6803.ble_IG4_GFP	and	6803.ble_IG5_GFP	strains.	The	band	is	present	in	the	 positive	 control	 6803.cpc	 and	 absent	 in	 6803.cpc	 as	 expected.	 IG2,	 IG4	 and	 IG5	 are	therefore	able	to	support	the	translation	of	gfpuv	mRNA	when	co-transcribed	with	ble.		Quantification	 of	 GFP	 suggested	 that	 expression	 using	 IG4	 is	 greater	 than	 IG5,	which	 in	turn	is	greater	than	IG2,	which	had	very	low	expression	(Figure	4.15).	GFP	 fluorescence	 was	 measured	 using	 a	 luminescence	 spectrometer	 and	 plotted	 in	 the	same	way	as	Figure	4.10	in	section	4.2.2	to	remove	the	effect	of	the	peak	at	455nm	(Figure	4.16).	The	expression	of	GFP	after	IG4	is	greater	than	IG5	and	IG2	and	matches	the	results	seen	in	the	Western	blot	analysis.	
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Figure	 4.15	Western	 blot	 analysis	 confirms	 and	 compares	 GFPuv	 expression	 after	 IG2,	
IG4	and	IG5	in	Synechocystis	strains	expressing	the	two-gene	operons.		(A)	Western	blot	analysis	was	performed	with	whole	cell	extracts	with	anti-RbcL	and	anti-GFP	 antibodies	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	 for	GFP	 is	27	kDa	and	 52.5	 kDa	 for	 RbcL,	which	 acted	 as	 loading	 control.	 Protein	 size	was	 determined	using	 the	 PageRulerTM	 prestained	 protein	 ladder.	 Three	 biological	 replicates	 of	6803.ble.IG2.GFP,	 6803.ble.IG4.GFP	 and	 6803.ble.IG5.GFP	 were	 tested.	 Strains	6803.cpc.	 and	 6803.cpc.GFP	 acted	 as	 negative	 and	 positive	 controls,	 respectively.	 (B)	The	GFPuv	 signal	was	 quantified	 using	 the	Odyssey®	 Infrared	 Imaging	 System.	 	 The	GFPuv	 IR	 fluorescence	 signal	was	normalised	against	 the	 signal	of	RbcL.	The	average	normalised	IR	signal	was	plotted.	Error	bars	are	±	one	SD.			
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Figure	 4.16	 GFPuv	 fluorescence	 measured	 after	 various	 IGs	 (IG2,	 IG4,	 IG5)	 under	 the	
control	of	promoter,	Pcpc560	in	transformants	of	Synechocystis.			Cultures	of	similar	OD730	were	excited	at	395	nm	and	the	emission	spectrum	between	450	–	600	nm	was	plotted.		The	absorbance	of	each	wavelength	was	normalised	to	the	absorbance	value	at	455	nm	and	the	spectrum	of	the	control	strain	(6803.cpc)	was	then	subtracted	from	these	values.	The	emission	peak	at	509	nm	is	GFPuv.		Interestingly,	 preliminary	 data	 comparing	 6803.ble.IG0bp.GFP	 and	 6803.ble.IG1bp.GFP	confirmed	that	gfpuv	could	be	expressed	without	an	IG	to	give	readily	detectable	levels	of	the	protein	(Figure	4.17).	Quantification	of	the	GFP	does	not	show	a	statistically	significant	difference	between	a	zero	base	gap	and	a	one	base	gap	between	the	ble	and	gfpuv	coding	sequences.		
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Figure	4.17	Western	blot	analysis	confirms	and	compares	GFPuv	expression	after	IG0bp	
and	IG1bp	in	the	Synechocystis	expressing	the	two-gene	operons.		(A)	Western	blot	analysis	performed	with	whole	cell	extracts	with	anti-RbcL	and	anti-GFP	 antibodies	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	 for	GFP	 is	27	kDa	and	 52.5	 kDa	 for	 RbcL,	which	 acted	 as	 loading	 control.	 Protein	 size	was	 determined	using	 the	 PageRulerTM	 prestained	 protein	 ladder.	 Three	 biological	 replicates	 of	6803.ble.IG0bp.GFP	 and	 6803.ble.IG1bp.GFP	 were	 tested.	 Strains	 6803.cpc	 and	6803.cpc.GFP	 acted	 as	 negative	 and	 positive	 controls,	 respectively.	 (B)	 The	 GFPuv	signal	 was	 quantified	 using	 the	 Odyssey®	 Infrared	 Imaging	 System.	 The	 GFPuv	 IR	fluorescence	signal	was	normalised	against	the	signal	of	RbcL.	The	average	normalised	IR	signal	was	plotted.	Error	bars	are	±	one	SD.		When	 all	 the	 IGs	 are	 compared	 again	by	Western	blot	 analysis,	 a	 ranked	order	 of	 IG4	>	{IG0bp,	IG1bp,	IG5}	>	IG2	can	be	produced	(Figure	4.18).	
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Figure	 4.18	Western	 blot	 analysis	 confirms	 and	 compares	 GFPuv	 expression	 after	 IG2,	
IG4,	IG5,	IG0bp	and	IG1bp	in	the	Synechocystis	expressing	the	two-gene	operon.		(A)	Western	blot	analysis	performed	with	whole	cell	extracts	with	anti-RbcL	and	anti-GFP	 antibodies	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	samples	were	run	on	a	12%	SDS-PAGE	gel.	The	expected	band	size	 for	GFP	 is	27	kDa	and	 52.5	 kDa	 for	 RbcL,	which	 acted	 as	 loading	 control.	 Protein	 size	was	 determined	using	 the	 PageRulerTM	 prestained	 protein	 ladder.	 A	 representative	 of	6803.ble.IG0bp.GFP,	 6803.ble.IG1bp.GFP,	 6803.ble.IG2.GFP,	 6803.ble.IG4.GFP	 and	6803.ble.IG5.GFP	 were	 tested.	 Strains	 6803.cpc.	 and	 6803.cpc.GFP	 acted	 as	 negative	and	 positive	 controls,	 respectively.	 (B)	 The	 GFPuv	 signal	 was	 quantified	 using	 the	Odyssey®	Infrared	Imaging	System.	The	GFPuv	IR	fluorescence	signal	was	normalised	against	the	signal	of	RbcL	and	plotted.			
4.2.3.4 Further	creation	of	transgenic	strains	From	the	results	in	the	previous	section,	the	expression	of	gfpuv	was	seen	after	a	0/1	base	space	between	 the	ble	 stop	 codon	and	 the	 start	 of	gfpuv.	 This	 begs	 the	question	of	 how	
68
03
.c
pc
.G
FP
	
68
03
.c
pc
	
RbcL	(52.5	kDa)	
GFPuv	(27	kDa)	
68
03
.b
le
.IG
0b
p.
GF
P	
68
03
.b
le
.IG
1b
p.
GF
P	
68
03
.b
le
.IG
2.
GF
P	
68
03
.b
le
.IG
4.
GF
P	
68
03
.b
le
.IG
5.
GF
P	
0	
200	
400	
600	
800	
1000	
1200	
1400	
1600	
1800	
2000	
N
or
m
al
is
ed
	IR
	F
lu
or
es
ce
nc
e	
Si
gn
al
	(A
.U
)	
(A)	
(B)	
	 147	
translation	of	gfpuv	is	achieved	in	the	absence	of	a	known	RBS.	Further	inspection	of	the	
ble	 sequence	 suggests	 that	 there	may	be	a	 cryptic	RBS	 (Table	4.5)	at	 the	end	of	ble	 that	enables	the	ribosome	to	bind	and	initiate	translation	of	gfpuv.		
Table	4.5	3’	end	of	ble	with	the	potential	RBS		The	sequence	of	ble	compared	to	the	optimal	sequence	for	the	RBS	with	the	3’	end	of	the	splB	sequence.	
	To	see	whether	the	putative	RBS	in	ble	had	an	effect	on	the	expression	of	gfpuv,	the	two-gene	operon	was	redesigned	so	that	the	gene	preceding	it	did	not	have	a	SD-like	sequence.		From	genes	that	were	easily	accessible	within	the	lab,	splB,	a	Staphylococcus	aureus	gene	codon	optimised	for	Chlamydomonas	reinhardtii	that	encodes	a	serine	proteasewas	chosen	(Table	4.5).		Primers	used	to	transcriptionally	couple	splB	and	gfpuv	were	designed	in	a	similar	manner	to	those	used	to	amplify	ble	when	the	intergenic	region	was	zero	base	and	one	base	(for	further	details	see	2.8.2).		WT	Synechocystis	was	 transformed	with	pLAH.splB.IG0bp.GFP	and	pLAH.splB.IG1bp.GFP,	to	 create	 strains	 6803.splB.IG0bp.GFP	 and	 6803.splB.IG1bp.GFP,	 respectively.	 After	selection	 for	 kanamycin	 resistance,	 four	 putative	 transformants	 of	 6803.splB.IG0bp.GFP	and	6803.splB.IG1bp.GFP	were	checked	by	PCR.	All	putative	transformants	tested	contain	the	splB_IGX_GFP	operon	at	 the	psbAII	 site	and	all	appear	homoplasmic	(i.e.	all	 copies	of	the	WT	genome	have	been	lost	from	the	transformants)	(Figure	4.19).		
Op#mal	Complementary	SD	
(5’-3’)	
__________________AAAGGAGGUGAU__		
3’	end	of	ble	(5’-3’)	 GCGTGCACTTCGTGGCCGAGGAGCAGGACTGA !
3’	end	of	splB	(5’-3’)	 AATACCCATACGATGTTCCAGATTACGCTTAA !
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Figure	 4.19	 PCR	 screen	 of	 putative	 transformants	 in	 Synechocystis	 containing	 the	 two-
gene	operon	of	splB	and	gfpuv	with	IG0bp/IG1bp	under	the	control	of	Pcpc560	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragment	 sizes	 for	 WT	
Synechocystis	 and	 6803.splB.IGX.GFP	 strains.	 (B)	 PCR	 analysis	 of	 putative	transformants	of	6803.splB.IGX.GFP	strains.	WT	Synechocystis	 (WT)	and	no	DNA	(-C)	were	 used	 as	 controls.	 Transformants	were	 confirmed	with	 a	 band	 at	 4.0	 kb	 and	 all	appear	homoplasmic	as	they	lack	any	detectable	WT	band	at	1.9	kb.		
4.2.3.5 Testing	levels	of	GFP	in	the	new	splB-gfpuv	configurations	To	 determine	 GFP	 fluorescence	 levels,	 two	 transformants	 of	 6803.splB.IG0bp.GFP	 and	three	 transformants	 of	 6803.splB.IG1bp.GFP	were	 grown	 along	with	 6803.cpc	 (negative	control)	and	6803.ble_IG4_GFP	(positive	control).	In	an	attempt	to	reduce	the	peak	at	455	nm	from	obscuring	the	GFP	peak	at	509	nm,	cells	were	grown	in	low	light	(methods)	and	the	 cells	 were	 harvested	 and	 resuspended	 to	 the	 same	 cell	 concentration,	 but	 were	analysed	in	same	manner	as	(4.2.3.3).	The	results	show	translation	of	gfpuv	still	occurs	in	the	presence	of	a	single	base	between	ble	and	gfpuv	or	no	IG	region	(Figure	4.20).	The	level	of	GFP	produced	appears	to	be	greater	when	there	is	a	single	base	in	comparison	to	a	zero	base	gap	(Figure	4.20).		
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Figure	 4.20	 GFPuv	 fluorescence	 measured	 after	 splB	 and	 IG0bp	 or	 IG1bp	 under	 the	
control	of	promoter	Pcpc560	in	transformants	of	Synechocystis.			The	emission	peak	at	509	nm	is	from	GFPuv.	Cultures	were	prepared	to	the	same	cell	concentration,	 excited	 at	 395	nm	and	 the	 emission	 spectrum	between	450	–	600	nm	was	 plotted.	 	 The	 absorbance	 of	 each	wavelength	was	 normalised	 to	 the	 absorbance	value	at	455	nm	and	the	spectrum	of	the	control	strain	(6803.cpc)	was	then	subtracted	from	these	values.	6803.ble.IG4.GFP	acted	as	the	positive	control.		To	 compare	 all	 the	 IGs	were	 grown	 6803.cpc	 (negative	 control),	 6803.cpc.GFP	 (positive	control),	6803.splB.0bp.GFP,	6803.splB.1bp.GFP,	6803.ble.IG0bp.GFP,	6803.ble.IG1bp.GFP,	6803.ble.IG2.GFP,	 6803.ble.IG4.GFP	 and	 6803.ble.IG5.GFP.	 The	 cultures	 cells	 were	prepared	 as	 described	 when	 testing	 6803.splB.IG0bp.GFP	 and	 6803.splB.IG1bp.GFP	 (in	low	 light).	 The	 positive	 control,	 6803.cpc.GFP,	 gave	 the	 highest	 level	 of	 expression,	followed	by	 IG4,	1bp	(ble),	 IG5,	0bp	(ble),	1bp	(splB),	0bp	(splB)	 then	 IG2	(Figure	4.21).	The	expression	of	GFPuv	after	ble	when	there	is	a	0/1	bp	gap	is	greater	that	after	splB.	This	suggests	the	sequence	preceeding	gfpuv	does	have	an	effect	on	its	expression	when	there	is	no	IG	present.		Although	 the	 results	 have	 not	 been	 validated	 by	Western	 blot	 analysis,	 IG4	 consistently	gives	the	highest	level	of	GFP,	whilst	IG5	and	IG2	gave	very	low	levels.	The	expression	of	
gfpuv	after	IG5,	IG0bp	and	IG	1bp	(after	ble)	are	similar.		
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Figure	 4.21	 GFPuv	 fluorescence	measured	 in	 all	 strains	 under	 the	 control	 of	 promoter	
Pcpc560	in	transformants	of	Synechocystis.			The	emission	peak	at	509	nm	is	from	GFPuv.	Cultures	were	prepared	to	the	same	cell	concentration	 and	 excited	 at	 395	nm	and	 the	 emission	 spectrum	between	450	–	600	nm	was	plotted.		The	absorbance	of	each	wavelength	was	normalised	to	the	absorbance	value	 at	 455	 nm	 and	 spectrum	 of	 the	 control	 strain	 (6803.cpc)	was	 then	 subtracted	from	these	values.	6803.cpc	was	used	as	positive	control.			
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4.3 Discussion	and	future	work	
4.3.1 Transcriptional	controls	
4.3.1.1 Nickel	inducible	promoter	The	 metabolic	 engineering	 of	 a	 microorganism	 such	 as	 Synechocystis	 requires	 the	coordinated	 expression	 of	multiple	 transgenes.	 Furthermore,	 that	 expression	 should	 be	tightly	controllable	since	the	synthesis	of	novel	metabolites	can	typically	place	a	metabolic	burden	 on	 the	 cell,	 and	 in	 the	 worst-case	 scenarios	 prove	 toxic.	 The	 nickel-inducible	promoter,	PnrsB,	represents	one	possible	tool	for	control	of	multiple	transgenes	assembled	as	an	operon.	The	results	presented	here	show	that	the	expression	of	the	reporter	genes	
ble	and	aadA	can	be	controlled	by	Ni2+	concentration.	However,	the	work	also	highlighted	two	potential	issues.	Firstly,	under	the	low	Ni2+	conditions	used,	the	promoter	appears	not	to	be	completely	‘off’	as	slow	growth	on	spectinomycin-containing	medium	was	observed	after	 nine	 days.	 This	 could	 also	 be	 a	 result	 of	 weak	 expression	 from	 a	 separate	 cryptic	promoter	 upstream	 of	 the	 aadA	 gene.	 From	 the	 literature	 the	 nrsBACD	 promoter	 is	thought	 to	 have	 two	 promoters,	 one	 is	 induced	 by	 presence	 of	 Ni2+,	 and	 the	 other	 is	constitutive,	 found	 further	upstream,	 and	 is	 present	 in	PnrsB	 in	 the	pLAH.nrsB	 construct,	that	produces	very	 low	 levels	of	 transcripts	 (López-Maury	et	 al.,	 2002).	After	nine	days,	the	 low	 levels	 of	 transcript	 may	 express	 enough	 AadA	 to	 grow	 in	 the	 presence	 of	spectinomycin.		The	 second	 issue	 is	 certainly	 the	 result	 of	 a	 cryptic	 promoter,	 with	 the	 Ni2+–regulated	expression	of	the	third	gene	in	the	operon,	aphA-6,	being	‘over-ridden’	by	expression	from	another	 promoter	 somewhere	 upstream	of	aphA-6,	 but	 downstream	of	 the	 translational	start	of	aadA.	 Two	potential	 cryptic	promoters	were	 found	upstream	of	aphA-6,	 in	aadA	and	 IG2,	 and	 one	 or	 both	 are	 likely	 responsible	 for	 the	 transcription	 of	 aphA-6	 in	 the	absence	 of	 added	Ni2+.	 Although	 transcription	 in	E.	 coli	differs	 to	 Synechocystis,	 BPROM,	the	software	used	to	predict	the	cryptic	promoter,	searched	for	σ70	promoters,	which	are	also	found	in	Synechocystis	(Imamura	and	Asayama,	2009).	One	of	the	potential	promoter	regions	 covers	 part	 of	 the	 aadA	 gene	 and	 IG2.	 To	 determine	 whether	 this	 potential	promoter	 that	 is	 responsible	 for	 the	 expression	 aphA-6,	 the	 intergenic	 region	 could	 be	swapped	for	another	and	the	expression	of	aphA-6	could	be	again	tested	in	the	presence	of	kanamycin	with	and	without	nickel.		
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4.3.1.2 Comparison	of	the	cpc560	promoter	to	the	commonly	used	psbAII	promoter	The	expression	of	the	GFP	gene	was	found	to	be	approximately	3-fold	greater	under	Pcpc560	than	 PpsbAII,	making	 this	 new	promoter	 element	 a	 useful	 DNA	part	 in	 the	 cyanobacterial	‘toolkit’.	However,	expression	under	Pcpc560	was	less	than	expected	considering	expression	of	two	other	genes,	as	reported	by	Zhou	et	al.	(2014),	resulted	in	the	recombinant	protein	being	 approximately	 15%	 of	 the	 total	 soluble	 protein	 and	 clearly	 visible	 on	 an	 stained	SDS-polyacrylamide	gel.		The	 construction	 of	 the	 strains	 presented	 in	 this	 chapter	 and	 the	 difference	 in	 growth	conditions	may	have	 contributed	 to	 the	modest	 levels	of	 expression	 seen	with	Pcpc560.	 In	the	work	described	by	Zhou	et	al.	(2014),	the	rbc	terminator	sequence	was	used	after	the	two	test	genes	(Ter	and	DldhE),	and	the	genes	were	also	 integrated	at	 the	pta	 locus	 that	encodes	phosphotransacetylase	rather	 than	 the	psbAII	 locus.	The	pta	 gene	 is	 involved	 in	the	 acetate	 synthetic	pathway	and	knocking	out	pta	 does	not	 affect	 growth	 (Zhou	et	 al.,	2014).	These	differences	along	with	differing	growth	conditions	could	all	have	an	effect	on	transcription	 levels.	 To	make	 a	 true	 comparison	 the	method	 used	 by	 Zhou	 et	 al.	 would	have	to	be	attempted.	In	particular,	it	would	be	interesting	to	see	the	effect	of	higher	light	levels	on	each	promoter,	as	transcription	from	both	promoters	is	induced	by	light	(Gill	et	al.,	2002;	Lindberg	et	al.,	2010).		
4.3.2 Translational	control	within	an	operon	The	expression	of	GFP	was	detected	 for	all	 the	 IGs	 tested	 in	 the	 two-gene	operon	under	the	control	of	Pcpc560.	The	IG	that	gave	the	highest	expression	was	IG4,	which	was	designed	to	 contain	 a	 RBS	 site	 that	 was	 complementary	 to	 the	 16S	 rRNA	 of	 Synechocystis.	Expression	was	also	found	to	be	possible	even	when	there	was	no	bases	or	a	single	base	between	 the	 stop	 codon	 of	 the	 first	 gene	 and	 the	 start	 codon	 of	 the	 second	 gene,	suggesting	 that	 a	 process	 of	 translational	 coupling	 might	 be	 operating	 in	 which	 the	ribosome	is	able	to	associate	with	the	start	codon	of	the	second	gene	once	it	reaches	the	stop	codon	of	the	first	gene.	IG4	has	the	best-matched	SD	sequence	out	of	the	intergenic	regions	tested	and	as	such	was	expected	 to	 give	 the	 highest	 level	 of	 GFP	 expression.	 In	 prokaryotes,	 highly	 expressed	genes	 are	more	 likely	 to	 have	 a	 strong	 SD	 sequence	 (Ma	 et	 al.,	 2002).	 The	 next	 best	 IG	region	 was	 IG5.	 This	 IG	 region	 is	 found	 between	 a	 hypothetical	 protein	 (sll0939)	 and	aspartate	 transaminase	 (sll0938).	 IG2	 gave	 the	 lowest	 level	 of	 GFP	 expression	 but	 was	selected	because	 IG2	had	been	previously	 shown	 to	work.	 IG2	 is	 found	between	 sll1032	
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(ccmN)	and	sll1031	(ccmM)	part	of	 the	gene	cluster	ccmKLMN,	which	encodes	genes	that	assemble	the	shell	of	the	carboxysome	(Cot	et	al.,	2008). An	 interesting	observation	 from	 the	work	 is	 the	 finding	 that	 omission	of	 an	 IG	between	two	coding	sequences	still	results	in	translation	of	the	downstream	sequence.	In	the	case	of	the	ble-gfpuv	pairing	the	translation	of	gfpuv	could	be	accounted	for	by	the	finding	of	a	cryptic	SD	sequence	at	end	of	ble.	However,	translation	of	gfpuv	is	still	seen	when	ble	was	replaced	 by	 splB,	 which	 was	 chosen	 specifically	 as	 it	 did	 not	 contain	 an	 obvious	 SD	sequence.	Significantly,	only	26%	of	all	genes	in	the	Synechocystis	genome	contain	the	core	SD	sequence,	whereas	in	E.	coli	this	figure	is	57%	(Ma	et	al.,	2002).	Abe	et	al	looked	briefly	at	 the	 SD	 sequence	 of	 genes	 involved	 in	 photosynthesis,	 and	 found	psbA	 and	 cpcB	 both	have	SD-like	sequences	in	their	5’	UTRs,	AGGA	and	AGGAG,	respectively	(Abe	et	al.,	2014).	This	suggests	that	many	genes	in	Synechocystis	do	not	need	an	SD	sequence	for	translation,	although	expression	may	be	more	effective	for	those	genes	that	do.		Ideally	the	work	initiated	here	would	be	extended	to	more	IGs.	These	could	be	quantified	in	terms	of	GFP	fluorescence	levels	achieved	using	the	strategy	developed	to	provide	a	list	of	 IGs	 that	 can	 be	 inserted	 between	 genes	when	 designing	 a	 transgenic	 operon,	 so	 that	translation	of	each	gene	can	be	balanced	to	optimise	the	yield.	 	 	
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Chapter	5 	Developing	a	new	method	for	the	production	of	
marker-less	transformants	in	Synechocystis.		
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5.1 	Introduction	
5.1.1 Marker-less	transformants	Selectable	markers,	often	bacterial	antibiotic	resistance	genes,	are	used	to	select	for	rare	transformants	 amongst	 a	 large	 population	 of	 treated	 cells.	 However,	 once	 such	transformant	lines	have	been	recovered,	the	selectable	marker	serves	no	further	purpose	and	 its	 presence	 within	 the	 transformant	 genome	 becomes	 superfluous.	 A	 selection	system	 that	 results	 in	 marker-less	 transformants	 is	 valuable	 since	 it	 avoids	 biosafety	concerns	 relating	 to	 the	 potential	 horizontal	 gene	 transfer	 of	 these	 resistance	 genes	 to	other	 bacteria	 (Tan	 et	 al.,	 2013).	 In	 addition,	 there	 is	 a	 reduced	 ‘metabolic	 load’	 on	 the	transformant	 line	 as	 it	 is	 not	 required	 to	 replicate	 and	 express	 an	 unnecessary	 gene.	Finally,	 multiple	 cycles	 of	 transformation	 of	 a	 strain	 are	 not	 limited	 by	 the	 number	 of	selectable	markers	available	(Cheah	et	al.,	2013;	Viola	et	al.,	2014).		The	 current	 methods	 of	 producing	 marker-less	 transformants	 in	 different	 strains	 of	cyanobacteria	are	discussed	below.	
5.1.2 Production	of	marker-less	transformants	using	the	expression	of	sacB		The	 sacB	 gene	 from	 Bacillus	 subtilis	 encodes	 levansucrase,	 a	 secreted	 enzyme.	 The	expression	of	sacB	is	regulated	by	a	cis-acting	regulatory	locus,	sacR,	and	is	induced	in	the	presence	 of	 sucrose	 (Steinmetz	 et	 al.,	 1985).	 Levansucrase	 transfers	 fructosyl	 residues	from	sucrose	via	hydrolysis	to	different	acceptors	such	as	levans;	other	acceptors	include	water	and	other	sugars	(Steinmetz	et	al.,	1985).	Levans	are	branched	polymers	made	up	of	fructosyl	residues	that	are	added	to	further	by	levansucrase	(Steinmetz	et	al.,	1985).	The	expression	of	sacB	 in	the	presence	of	sucrose	in	Gram-negative	bacteria	such	as	E.	coli	 is	lethal	to	the	cell.	The	mechanism	of	toxicity	is	not	clear,	it	might	be	due	to	the	transfer	of	the	 fructosyl	 residue	 to	 metabolically	 important	 acceptors	 or	 it	 might	 be	 due	 to	 the	accumulation	of	levans	in	the	periplasm	that	cannot	be	cleaved	or	exported	out	of	the	cell	(Gay	et	al.,	1983).	As	the	peripheral	cell	structure	of	Gram-negative	bacteria	 is	similar	to	cyanobacteria,	the	sacB-sucrose	method	was	established	in	Anabaena	sp.	Strain	PCC	7120	and	Synechocystis	(Cai	and	Wolk,	1990;	Lagarde	et	al.,	2000).		The	 sacB	 –	 sucrose	method	 is	 one	 of	 the	more	 commonly	 used	methods	 for	 producing	marker-less	 transformants	 in	 Synechocystis	 and	 is	 described	 in	 Figure	 5.1.	 Usually	 the	method	 requires	 two	 transformation	 steps	 and	 two	 transforming	 plasmids,	 however	 a	method	has	recently	been	developed	where	only	a	single	transforming	plasmid	is	required	(Viola	et	al.,	2014).		
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Figure	 5.1	 Pipeline	 for	 the	 production	 of	 marker-less	 transformants	 using	 the	 sacB–	
sucrose	method.	In	 the	 first	 transformation	 step,	 sacB	 alongside	 an	 antibiotic	 resistance	 gene	 (in	 this	case	 nptI,	 a	 gene	 conferring	 resistance	 to	 kanamycin)	 is	 integrated	 by	 homologous	recombination	 into	 the	 genome	 of	 Synechocystis.	 The	 creation	 of	 the	 chassis	 strain	containing	 sacB	 is	 selected	 for	on	kanamycin.	The	gene-of-interest,	G.O.I,	 replaces	 the	
sacB/nptI	 gene	 cassette	 in	 the	 second	 transformation,	 with	 the	 marker-less	transformants	selected	on	sucrose	for	the	loss	of	sacB.			
5.1.3 Other	methods	used	in	cyanobacteria	to	produce	maker-less	transformants	Although	 a	 number	 of	methods	 have	 been	 developed	 for	 the	 production	 of	marker-less	transformants	 (Table	 5.1),	 there	 are	 three	 distinct	 strategies	 used.	 One	 strategy	 uses	counter-selection	 and	 is	 used	 by	 the	 sacB	 –	 sucrose	 method.	 Initially	 an	 antibiotic	resistance	 gene,	 e.g.	 nptI,	 is	 introduced	 into	 the	 genome	 alongside	 a	 conditionally	 toxic	
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gene,	e.g.	sacB.	The	toxic	gene	is	then	expressed,	so	only	the	transformants	that	no	longer	contain	the	toxic	gene	and	the	antibiotic	resistance	gene	are	able	to	survive.		
Table	5.1	Overview	of	the	various	methods	used	to	produce	marker-less	transformants	
in	cyanobacteria.		Adapted	 from	(Branco	dos	Santos	et	al.,	2014).	Counter	selection	systems	(in	blue),	site-specific	 recombinase	 systems	 (in	 green)	 and	 a	mutant-complementation-based	system	(in	white)	have	been	used	 to	produce	marker-less	 transformants	 in	various	strains	of	cyanobacteria.		
Method	 Strain	tested	 Reference	
sacB	-	sucrose	 Synechocystis	sp.	PCC	6803	
Anabaena	sp.	strain	PCC	7120	 (Lagarde	et	al.,	2000)	(Cai	and	Wolk,	1990)	
sacB	-	sucrose	(one-step)	 Synechocystis	sp.	PCC	6803	 (Viola	et	al.,	2014)	
mazF	-	nickel	 Synechocystis	sp.	PCC	6803	 (Cheah	et	al.,	2013)	
acsA	-	acrylate	 Synechococcus	sp.	PCC	7002	 (Begemann	et	al.,	2013)	
upp	–	5-fluorouracil	 Synechococcus	elongatus	PCC	7942	
Synechocystis	sp.	PCC	6803	
Synechococcus	sp.	PCC	7002	
(Aikens	and	Turner,	2013)		(Aikens	and	Turner,	2013)	(Xu	and	Green,	2012)	
rps12	-	streptomycin	 Synechococcus	elongatus	PCC	7942	 (Matsuoka	et	al.,	2001)	Cre/	loxP	 Anabaena	sp.	PCC	7120	 (Zhang	et	al.,	2007)	Flp/	FRT	 Synechocystis	sp.	PCC6803	
Synechococcus	elongatus	PCC	7942	
(Tan	et	al.,	2013)	(Tan	et	al.,	2013)	
		The	mazF	–	nickel	method	uses	the	same	strategy	and	was	developed	in	Synechocystis	to	be	 used	 in	 other	 cyanobacteria	 strains	 that	 can	 integrate	 DNA	 by	 homologous	recombination	 but	 are	 unable	 to	 use	 the	 sacB	 –	 sucrose	method,	 as	 they	 cannot	 uptake	sucrose	 (Cheah	 et	 al.,	 2013).	 The	 E.	 coli	mazF	 gene	 encodes	 an	 endoribonuclease	 that	cleaves	mRNA	at	the	ACA	triplet	sequence	thereby	inhibiting	all	protein	synthesis	(Cheah	et	al.,	2013).	Expression	of	mazF	under	the	control	of	a	nickel	inducible	promoter	acts	as	
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the	conditionally	 lethal	gene,	 therefore	marker-less	 transformants	are	selected	on	nickel	for	the	loss	of	mazF	(Cheah	et	al.,	2013).		Acrylate	inhibits	Synechococcus	sp.	PCC	7002,	however,	the	loss	of	function	of	acsA,	which	encodes	acetyl-CoA	ligase,	was	shown	to	overcome	this	inhibition	(Begemann	et	al.,	2013).	Marker-less	 transformants	 can	 therefore	 be	 produced	 by	 selecting	 for	 the	 loss	 of	 acsA,	introduced	 alongside	 an	 antibiotic	 resistance	 cassette,	 in	 the	 presence	 of	 acrylate.	 This	method	uses	a	similar	strategy	to	the	sacB	–	sucrose	method;	however,	 the	original	acsA	gene	 needs	 to	 be	 knocked	 out	 before	 the	 strain	 can	 be	 used	 to	 produce	 marker-less	transformants.	 Similarly,	 the	 upp	 –	 5-fluorouracil	 method,	 used	 in	 Synechocystis,	
Synechococcus	7942	and	Synechococcus	7002,	has	the	same	issue	and	requires	the	deletion	of	 upp	 (Aikens	 and	 Turner,	 2013;	 Xu	 and	 Green,	 2012).	 The	 upp	 gene	 encodes	 uracil	phosphoribosyltransferase,	an	enzyme	that	usually	converts	uracil	into	UMP	but	can	also	accept	5-fluorouracil	 to	produce	5-fluoro-UMP	which	 results	 in	 the	 inhibition	of	 protein	synthesis	and	leads	to	cell	death.		Another	 strategy	 uses	 a	 strain	 of	 Synechococcus	 sp.	 PCC	 7942	 that	 is	 resistant	 to	streptomycin	 due	 to	 a	 single	 mutation	 in	 a	 ribosomal	 S12	 protein	 encoded	 by	 rps12	(Matsuoka	et	al.,	2001).	The	reintroduction	of	WT	rps12	alongside	an	antibiotic	resistance	gene	 makes	 the	 strain	 sensitive	 to	 streptomycin.	 Marker-less	 transformants	 are	 then	selected	on	streptomycin	(Matsuoka	et	al.,	2001).	Unlike	the	sacB	–	sucrose	method,	there	are	two	rounds	of	positive	selection,	which	is	advantageous,	however	the	resulting	strain	has	a	mutation	in	a	ribosomal	protein	and	this	might	compromise	translational	efficiency	and	therefore	the	‘fitness’	of	the	engineered	strain.		The	 third	 strategy	 uses	 site-specific	 recombinases	 such	 as	 Cre	 from	 the	 E.	 coli	bacteriophage	 P1	 and	 FLP	 from	 S.	 cerevisiae.	 Site-specific	 recombinases	 catalyse	recombination	 between	 two	 site-specific	 recombinase	 recognition	 sites.	 Cre	 recognises	the	locus	of	crossover	in	phage	P1	(loxP)	and	FLP	recognises	FLP	recognition	target	(FRT).	Flanking	a	 selectable	marker	with	 the	specific	 recognition	sites,	 and	expressing	 the	site-specific	recombinases,	removes	the	selectable	marker	(Tan	et	al.,	2013).	Cre-loxP	has	been	used	 in	Anabaena	 7120	 and	 the	 FLP-FRT	method	 has	 been	 developed	 for	 Synechocystis	and	Synechococcus	7942	(Zhang	et	al.,	2007;	Tan	et	al.,	2013).	Using	this	method	does	have	some	disadvantages:	a	scar	sequence	remains	and	multiple	uses	of	this	strategy	can	result	in	unexpected	and	undesirable	crossover	events.	
	 159	
5.1.4 Could	the	expression	of	codA	be	used	to	produce	marker-less	transformants	
in	Synechocystis?	Cytosine	 deaminase	 is	 an	 enzyme	 involved	 in	 converting	 cytosine	 and	water	 into	 uracil	and	 ammonia	 (Figure	 5.2)	 (Danielsen	 et	 al.,	 1992).	 Cytosine	 deaminase	 is	 found	 in	prokaryotes,	 fungi	 and	 some	 eukaryotic	 microorganisms	 but	 is	 not	 present	 in	 higher	plants	(Danielsen	et	al.,	1992;	Serino	and	Maliga,	1997).	In	some	cases	cytosine	deaminase	can	 also	 accept	 5-fluorocytosine	 (5-FC)	 as	 a	 substrate	 to	 produce	 5-fluorouracil,	 a	compound	 that	 leads	 to	 cell	 death	 by	 inhibition	 of	 DNA	 and	 protein	 synthesis	 (Figure	5.2)(Vermes	et	al.,	2000).	This	has	led	to	the	use	of	5-FC	as	a	negative-selectable	marker	in	a	number	of	organisms	(Stougaard,	1993;	Kobayashi	et	al.,	1995;	Serino	and	Maliga,	1997;	Dubeau	et	al.,	2009;	Young	and	Purton,	2014).	
	
Figure	5.2	Pathway	and	mode	of	action	of	5-fluorocytosine		Adapted	 from	 (Vermes	et	 al.,	 2000).	Abbreviations:	5-FC,	5-fluorocytosine;	5-FU,	5-fluorouracil;	 FUMP,	 5-fluorouridine	 monophosphate;	 FUDP,	 5-fluorouridine	diphosphate;	 FUTP,	 5-fluorouridine	 triphosphate;	 FdUMP,	 5-fluorodeoxyuridine	monophosphate.	Since	codA	and	5-FC	can	be	used	as	a	method	of	negative	selection,	it	could	potentially	be	used	 to	 produce	marker-less	 transformants	 in	 Synechocystis	 in	 a	 similar	method	 to	 the	
sacB	–	sucrose	method.		
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5.1.5 Aims	and	objectives		The	initial	objective	was	to	introduce	sacB	at	a	neutral	site	in	the	genome	of	Synechocystis	in	 order	 to	 produce	 a	 chassis	 strain	 that	 could	 be	 used	 to	 introduce	 genes	 and	operons	without	the	presence	of	an	antibiotic	resistance	marker	using	the	sacB	-	sucrose	method.	Attempts	 to	use	 the	 sacB	–	 sucrose	method	were	 initially	unsuccessful	 so	 an	 alternative	method	 using	 the	 expression	 of	 a	 non-native	 codA	 gene	 in	 the	 presence	 of	 5-FC	 was	developed.	The	work	presented	in	this	chapter	describes	the	attempts	of	using	the	sacB	–	sucrose	 method	 and	 the	 codA-5-FC	 method	 for	 the	 production	 of	 marker-less	transformants	in	Synechocystis.		
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5.2 Results	and	discussion	
5.2.1 Creation	of	chassis	strains	containing	sacB	gene	To	produce	marker-less	 transformants	at	a	neutral	site	 in	Synechocystis	using	 the	sacB	–	sucrose	method,	it	was	decided	to	use	the	strategy	presented	in	Figure	5.1.	Once	a	neutral	site	was	selected,	the	various	expression	plasmids	would	be	created.	Initially	the	cat	gene	encoding	chloramphenicol	resistance	was	chosen	as	the	G.O.I.	The	strategy	used	to	construct	each	expression	plasmid	is	shown	in	Figure	5.3.	
5.2.1.1 Identification	of	a	neutral	site	To	create	a	standard	chassis	strain	for	metabolic	engineering	it	 is	necessary	to	identify	a	region	of	the	genome	where	transgenes	can	be	targeted	without	affecting	the	expression	of	 any	native	genes.	CyanoBase	was	used	 to	 search	 the	genome	of	Synechocystis	 sp.	PCC	6803	 for	potential	neutral	 sites.	Non-coding	regions	greater	 than	400	bp	between	genes	that	are	oriented	in	a	divergent	or	convergent	orientation,	and	which	also	contain	a	unique	restriction	 enzyme	 site	 suitable	 for	 cloning	 (that	 is	 also	 absent	 from	 the	 pJET1.2/blunt	cloning	 vector)	 approximately	 half	 way	 into	 the	 non-coding	 region,	 were	 shortlisted	 as	potential	neutral	sites.		The	 705	 bp	 non-coding	 region	 between	 slr1340	 and	 sll1255	 (genes	 organised	 in	 a	convergent	 orientation),	 containing	 the	 blunt-ended	 HpaI	 and	 sticky-ended	 NheI	restriction	sites,	was	chosen	as	the	neutral	site.	According	to	CyanoBase,	the	gene	slr1340,	encodes	an	unknown	protein,	and	sll1255,	encodes	a	putative	transposase.	
5.2.1.2 Creation	of	pIR706	Plasmid	pIR706,	containing	a	clone	of	 the	neutral	 site,	was	created	 to	 introduce	DNA	by	homologous	recombination	at	this	site.	Gradient	PCR	using	IR706F	and	IR706R	(annealing	temperature	 58,	 60,	 68°C)	 was	 used	 to	 amplify	 the	 chosen	 neutral	 site	 and	 part	 of	 the	
slr1340	and	sll1255	coding	region	to	ensure	the	region	of	homology	either	side	of	the	NheI	restriction	 site	was	 approximately	500	bp.	 The	 fragment	was	 cloned	 into	pJET1.2/blunt	cloning	vector	to	produce	pIR706.	The	creation	of	pIR706	was	verified	by	PCR	performed	with	IR706F	and	IR706R	and	by	sequencing.	
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Figure	5.3	Schematic	of	the	plasmids	constructed	for	the	production	of	marker-less	transformants	in	Synechocystis	using	the	sacB	–	sucrose	method	
at	a	neutral	site.		The	neutral	site	was	cloned	from	the	genome	of	Synechocystis	and	used	to	construct	pIR706	(in	the	purple	box).	This	expression	vector	provided	the	regions	of	homology	required	to	 introduce	sacB	 (in	 the	red	box),	via	pIR706.sacB.nptI	and	pIR706.sacB.nptI’,	and	cat	 (in	 the	blue	box),	via	pIR706.cat,	into	the	genome	of	Synechocystis.				
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5.2.1.3 Creation	of	pIR706.cat	In	 order	 to	 create	 the	 test	 plasmid	 carrying	 the	 cat	 G.O.I.,	 the	 expression	 cassette	containing	the	cat	marker	was	isolated	from	pARG1.3	(Debuchy	et	al.,	1989)	by	digestion	with	 EcoRV	 and	 ZraI,	 and	 cloned	 into	 pIR706	 at	 the	 HpaI	 site.	 PCR	 with	 IR706F	 and	IR706R	and	sequencing	confirmed	the	creation	of	pIR706.cat.		
5.2.1.4 Creation	of	pIR706.sacB.nptI	and	pIR706.sacB.nptI’	The	pIR706.sacB.nptI	and	pIR706.sacB.nptI’	plasmids	were	created	in	order	to	 introduce	
sacB,	 along	with	 sacR,	 alongside	nptI,	 a	 kanamycin	 resistance	gene,	 into	Synechocystis	 to	produce	 the	 chassis	 strain	 (Figure	 5.3).	 In	 pIR706.sacB.nptI’	 a	 section	 of	 DNA	 between	
sacB	and	nptI	was	removed.	This	section	of	DNA,	a	possible	transposon	that	is	likely	to	be	an	artefact	from	cloning,	remains	present	in	pIR706.sacB.nptI.		The	 sacB/nptI	 gene	 cassette	 used	 to	 create	 pIR706.sacB.nptI	 and	 pIR706.sacB.nptI’	 was	amplified	 from	pUM24Cm	 (Ried	 and	Collmer,	 1987)	 via	 PCR	using	 primers	KmRSacBRF	and	 KmRSacBRR.	 Amplification	 with	 these	 primers	 ensured	 that	 the	 PCR	 product	 was	flanked	 with	 NheI	 restriction	 sites.	 The	 purified	 PCR	 product	 was	 cloned	 into	 the	pJET1.2/blunt	 vector.	 To	 create	 pIR706.sacB.nptI,	 the	 sacB/nptI	 cassette	 was	 digested	from	 pJET.sacB.nptI	 using	 NheI	 and	 cloned	 into	 the	 NheI	 site	 in	 pIR706.	 	 To	 create	pIR706.sacB.nptI’,	 the	 same	 steps	 as	 above	 were	 undertaken,	 however	 AfeI	 and	 EcoRV	were	 used	 to	 remove	 457	 bp	 of	 redundant	 sequence	 between	 sacB	 and	 nptI	 from	 the	pJET.sacB.nptI	 cloning	 vector,	 prior	 to	 insertion	 into	 pIR706.	 Sequencing	 analysis	confirmed	the	construction	of	both	constructs.		
5.2.1.5 Creation	 of	 the	 sacB	 chassis	 strain	 for	 the	 production	 of	 marker-less	
transformants	WT	 Synechocystis	 was	 transformed	 with	 pIR706.sacB.nptI	 and	 pIR706.sacB.nptI’.	Transformant	 colonies	 for	 both	 plasmids	 were	 seen	 after	 selection	 for	 kanamycin	resistance.	 Eight	 putative	 transformants	 were	 picked	 from	 each	 transformation	 and	restreaked	onto	BG-11	medium	supplemented	with	200	μg/ml	kanamycin.	Colonies	were	restreaked	four	times	to	ensure	all	copies	of	the	genome	contained	the	sacB/nptI	cassette.	PCR	performed	using	primers	IR706F	and	IR706R	on	putative	transformants	transformed	with	 pIR706.sacB.nptI	 or	 pIR706.sacB.nptI’	 confirmed	 the	 integration	 of	 the	 sacB/nptI	cassette	 (Figure	 5.4)	 The	 PCR	 also	 confirmed	 that	 the	 kanamycin	 resistant	 lines	 were	homoplasmic.	
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Figure	5.4	PCR	screening	for	successful	transformants	in	Synechocystis	containing	sacB.	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragment	 sizes	 for	 WT	
Synechocystis	 and	 successful	 6803.IR706.sacB	 and	 6803.IR706.sacB’	 strains.	 (B)	Colony	 PCR	 screening	 of	 putative	 transformants	 of	 6803.IR706.sacB.	 WT	
Synechocystis	(WT)	and	a	plasmid	preparation	of	pIR706.nptI.sacB	(+C)	were	used	as	controls.	Homoplasmic	 strains	 containing	 sacB	 confirmed	by	 the	 single	 band	 at	 4.7	kb.	 (C)	 Colony	 PCR	 screening	 of	 putative	 transformants	 of	 6803.IR706.sacB’.	 WT	
Synechocystis	(WT)	and	a	plasmid	preparation	of	pIR706.nptI.sacB’	(+C)	were	used	as	controls.	Homoplasmic	 strains	 containing	 sacB	 confirmed	by	 the	 single	 band	 at	 4.3	kb.		
5.2.1.6 Testing	the	expression	of	sacB	Growth	 ‘spot’	 tests	 were	 performed	 to	 test	 the	 sensitivity	 of	 strains	 containing	 sacB	towards	sucrose.	 Initial	spot	 tests	were	performed	with	 three	 isolated	transformants	 for	each	 strain	6803.IR706.sacB	 (#1,	2,	 7)	 and	6803.IR706.sacB’	 (#2,	4,	 6)	on	BG-11,	BG-11	supplemented	 with	 200	 μg/ml	 kanamycin	 and	 BG-11	 supplemented	 with	 5	 %	 (w/v)	
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Figure	X.	PCR	screening	for	successful	transformants	
in	Synechocys)s	containing	sacB.	
(A)	Schema,c	showing	the	binding	sites	and	
expected	fragment	sizes	for	WT	Synechocys8s	and	
successful	6803.IR706.sacB	and	6803.IR706.sacB’	
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sucrose.	WT	Synechocystis	 and	 strain	6803.AII.LS	were	grown	alongside	as	 controls.	On	BG-11	 supplemented	with	 sucrose,	 all	 6803.IR706.sacB	 (#1,	 2,	 7)	 and	 6803.IR706.sacB’	(#2,	4,	6)	transformant	lines	were	able	to	grow,	although	the	growth	of	6803.IR706.sacB_7	was	slightly	inhibited	in	comparison	to	the	others	(Figure	5.5A).	To	confirm	this	unexpected	result,	the	growth	‘spot’	test	was	repeated	with	an	additional	transformant	of	6803.IR706.sacB	(#1,	2,	7	and	8)	and	WT	Synechocystis	on	BG-11	and	BG-11	with	5%	(w/v)	sucrose.	Only	a	single	 transformant	6803.IR706.sacB_7	was	unable	 to	grow	in	the	presence	of	5%	sucrose	(Figure	5.5B),		The	PCR	results	(Figure	5.4)	confirm	sacB/nptI	integration	at	the	neutral	site,	however	the	results	of	the	growth	‘spot’	tests	(Figure	5.5)	demonstrate	that	the	expression	of	sacB	does	not	 cause	cell	death	 in	 the	presence	of	 sucrose	 in	most	of	 the	 transformants	 tested.	The	
sacB	–	sucrose	method	has	been	used	by	a	number	of	groups	using	the	same	sacBR/nptI	cassette	(Lea-Smith	et	al.,	2013)	so	the	result	is	unexpected.	
5.2.1.7 Sequencing	analysis	of	sacB		Sequencing	analysis	was	performed	to	 try	and	explain	why	6803.IR706.sacB_7	appeared	to	be	sensitive	to	sucrose,	but	the	others	strains	containing	sacB	were	not.	The	sacB	gene	was	 amplified	 from	 the	 genomic	 DNA	 of	 6803.IR706.sacB_1	 and	 6803.IR706.sacB_7	 via	PCR	 using	 NptI_outF	 and	 KmRsacBRR.	 Sequencing	 both	 sacB	 genes	 with	 6803_sacB_F,	6803_sacB_R	and	KmRsacBRR	confirmed	that	no	mutations	were	present	in	sacB	or	sacR	in	 either	 strain.	 The	 sequencing	 results	 therefore	 do	 not	 explain	 why	 the	 two	transformants	 produce	 different	 results	 on	 the	 growth	 ‘spot’	 tests	 and	 why	6803.IR706.sacB_1	is	able	to	grow	on	sucrose.	Owing	 to	 these	 results,	work	 on	 the	 sacB	 –	 sucrose	method	was	 put	 on	 hold	 to	 look	 at	alternative	methods	for	the	production	of	marker-less	transformants	in	Synechocystis	and	was	revisited	in	section	(5.2.6).		
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Figure	 5.5	 Growth	 ‘spot’	 tests	 checking	 sensitivity	 of	 Synechocystis	 sacB	 transformants	
towards	sucrose.	(A)	 6803.sacB.nptI	 and	 6803.sacB.nptI’	 transformants	 were	 grown	 alongside	 WT	
Synechocystis,	 (WT)	 and	 6803.AII.LS	 (LS)	 which	 acted	 as	 controls,	 on	 BG-11,	 BG-11	supplemented	 with	 200	 μg/ml	 kanamycin	 and	 BG-11	 supplemented	 with	 5%	 (w/v)	Sucrose.	 The	 photograph	 was	 taken	 after	 12	 days	 incubation.	 Kanamycin	 resistance	was	 seen	 in	 all	 6803.IR706.sacB	 and	 6803.IR706.sacB’	 transformants.	 All	6803.IR706.sacB	and	6803.IR706.sacB’	transformants	were	able	to	grow	in	presence	of	sucrose,	 6803.IR706.sacB_7	 to	 a	 lesser	 degree.	 (B)	 Four	 transformants	 of	6803.IR706.sacB	 and	 wild-type	 Synechocystis,	 WT	 6803,	 were	 spotted	 onto	 media	containing	BG-11	and	BG-11	supplemented	with	5%	(w/v)	sucrose.		A	photograph	was	taken	after	4	days	incubation.	Inhibition	of	growth	by	sucrose	is	only	seen	in	the	single	transformant	6803.IR706.sacB_7.		
5.2.2 Testing	 the	 feasibility	 of	 a	 codA	 –	 5-FC	 method	 for	 producing	 marker-less	
transformants.	Unable	to	use	the	sacB	–	sucrose	method,	an	alternative	system	for	producing	marker-less	transformants	was	investigated.	Previous	work	in	our	group	demonstrated	that	a	modified	cytosine	deaminase,	encoded	by	codA,	could	be	used	as	a	negative	selectable	marker	in	the	
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BG-11-Suc	(5%(w/v))	
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Figure	X.	Growth	‘spot’	tests	checking	sensi2vity	of	sacB	towards	
sucrose	in	Synechocys+s.		
6803.sacB.nptI	and	6803.sacB.nptI’	transformants	were	grown	
alongside	WT	Synechocys)s,	WT,	and	6803.AII.LS,	LS,	which	acted	as	
controls	on	BG-11	media,	BG-11	media	supplemented	with	200	μg/ml	
kanamycin	and	BG-11	media	supplemented	with	5%	(w/v)	Sucrose.	
Photograph	was	taken	aWer	12	days	incubaYon.	Kanamycin	resistance	
was	expressed	in	all	6803.IR706.sacB	and	6803.	IR706.sacB’	
transformants.	All	6803.IR706.sacB	and	6803.IR706.sacB’	transformants	
are	able	to	grow	in	presence	of	sucrose,	6803.IR706.sacB_7	to	a	lesser	
degree.		
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Figure	X.	Growth	‘spot’	tests	checking	the	expression	of	sacB	in	
successful	transformants	of	6803.IR706.sacB	
Four	transformants	of	6803.IR706.sacB	and	wild-type	Synechocys)s,	
WT	6803,	were	spo]ed	onto	media	containing	BG-11	media	and	
BG-11	media	supplemented	with	5%	(w/v)	sucrose.		Photograph	was	
taken	aWer	4	days	incubaYon.	InhibiYon	of	growth	by	sucrose	is	only	
seen	in	the	single	transformant	6803.IR706.sacB_7.		
A)	
B)	
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chloroplast	 of	Chlamydomonas	reinhardtii	 (Young	and	Purton,	2014).	A	 literature	 search	showed	 cytosine	 deaminase	 had	 not	 been	 used	 as	 a	 negative	 selectable	 marker	 in	
Synechocystis.	 Therefore,	 the	 use	 of	 codA	 as	 a	 negative	 selectable	 marker	 to	 produce	marker-less	 transformants	 in	 Synechocystis	was	 investigated.	 Figure	 5.6	 demonstrates	how	the	codA	–	5-FC	method	could	be	transferred	to	Synechocystis.		
	
Figure	 5.6	 Pipeline	 for	 the	 production	 of	 marker-less	 transformants	 using	 the	
expression	of	codA	in	Synechocystis.		In	the	first	transformation	step,	codA	alongside	a	kanamycin	resistance	gene	(KmR)	is	integrated	 into	 the	 genome	 of	 Synechocystis	 by	 homologous	 recombination.	 The	chassis	 strain	 is	 selected	 for	on	kanamycin.	The	second	 transformation	step	selects	for	marker-less	transformants	on	5-FC	for	the	loss	of	the	codA	gene.		
5.2.2.1 Endogenous	 codA	 is	 not	 suitable	 as	 a	 negative	 selectable	 marker	 in	
Synechocystis	A	search	of	 the	Synechocystis	 genome	using	CyanoBase	 indicated	 the	presence	of	 a	codA	gene	(ID	slr1237)	that	 is	predicted	to	encode	cytosine	deaminase	and	shares	29%	amino	acid	identity	with	the	characterised	cytosine	deaminase	from	E.	coli	K12.	
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Figure	X.	Pipeline	for	the	produc0on	of	marker-less	transformants	
using	the	expression	of	codA	in	Synechocys+s.		
In	the	ﬁrst	transforma>on	step	codA	alongside	a	kanamycin	
resistance	gene	is	integrated	into	the	genome	of	Synechocys)s	by	
homologous	recombina>on.	The	chassis	strain	is	selected	for	on	
kanamycin.	The	second	transforma>on	step	selects	for	marker-less	
transformants	on	5-ﬂuorocytosine,	5-FC,	for	the	loss	of	the	codA	
gene.	
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An	 initial	 growth	 ‘spot’	 test	 demonstrated	 that	 the	 growth	 of	 WT	 Synechocystis	 is	 not	inhibited	on	BG-11	with	different	concentrations	(0.1,	0.5	and	1	mg/ml)	of	5-FC	(results	not	 shown).	 Another	 growth	 ‘spot’	 test	 confirmed	 WT	 Synechocystis	 could	 grow	 in	 the	presence	of	2	mg/ml	5-FC	(Figure	5.7).	At	2	mg/ml	5-FC	the	growth	of	WT	Synechocystis	did	appear	slower,	which	suggests	that	the	endogenous	enzyme	may	be	active	but	the	substrate	specificity	towards	5-FC	may	not	be	 sufficient	 enough	 to	 cause	 cell	 death,	 since	 the	 main	 substrate	 for	 the	 enzyme	 is	cytosine.	
	
Figure	5.7	Growth	‘spot’	test	testing	the	sensitivity	of	WT	Synechocystis	towards	5-FC.		Wild-type	 Synechocystis	 is	 able	 to	 grow	 on	 BG-11	 and	 BG-11	 supplemented	with	 0.5	and	2	mg/ml	5-FC.	Photograph	taken	after	12	days	of	incubation.		The	 result	 demonstrated	 that	 the	 endogenous	 cytosine	 deaminase,	 encoded	 by	 slr1237,	does	 not	 confer	 enough	 sensitivity	 to	 5-FC	 to	 be	 used	 to	 produce	 marker-less	transformants.	 However,	 an	 alternative	 codA	 encoding	 a	 cytosine	 deaminase	 that	 is	optimised	to	accept	5-FC	could	be	used	in	Synechocystis.	
5.2.2.2 Expression	of	a	heterologous	codA	gene	in	Synechocystis	The	 expression	 of	 an	 alternative,	 synthetic	 codA	 gene,	 termed	 crCD	 (Young	 and	 Purton,	2014)	was	attempted	in	Synechocystis.	The	design	of	the	synthetic	crCD	gene	was	based	on	cytosine	deaminase	(NP_414871)	from	E.	coli	strain	K12	substrain	MG1655.	Three	amino	acid	 changes	 (V152A,	 F316C	and	D317G)	were	made	 to	optimise	 cytosine	deaminase	 to	accept	 5-FC	 (Fuchita	 et	 al.,	 2009).	 A	HA-tag	was	 inserted	 at	 the	 C-terminal	 end	 and	 the	final	gene	sequence	was	codon-optimised	 for	 the	Chlamydomonas	reinhardtii	 chloroplast	(Young	 and	 Purton,	 2014).	 A	 BLAST	 query	 comparing	 the	 amino	 acid	 sequence	 of	 the	native	codA	in	Synechocystis	to	crCD	showed	a	28%	identity	match	and	a	47%	similarity.	The	 crCD	 gene,	 referred	 hereafter	 as	 codA,	 was	 amplified	 from	 pRY127d	 (Young	 and	Purton,	2014)	using	primers	6803_codA_F	and	6803_codA_R.	Primers	were	designed	with	NdeI	 (6803_codA_F)	 and	 BamHI	 (6803_codA_R)	 restriction	 sites	 for	 cloning	 into	 the	
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BG-11	+	0.5	mg/ml	5-FC	
BG-11	+	2	mg/ml	5-FC	
10-1	 10-2	 10-3	 10-5	10-4	
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Figure	X.	Growth	‘spot’	test	tes-ng	the	sensi-vity	of	wild-type	
Synechocys)s	t wards	5-ﬂuorocytosine,	5-FC.		
Wild-type	Synechocys)s	is	able	to	grow	on	BG-11	media	and	
BG-11	media	supplemented	with	0.5	and	2	mg/ml	5-F.	
Photograph	taken	aIer	12	days	of	incuba6on.		
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pLAH.AII	 expression	vector.	 The	 codA	 fragment	was	digested	with	NdeI	 and	BamHI	 and	inserted	 into	 these	 restriction	 sites	 in	 pLAH.AII	 .	 PCR	 performed	 with	 primers	Ben.seq.ups.F	 and	 Out.GFP.R	 and	 sequencing	 with	 the	 same	 primers	 confirmed	 the	successful	insertion	of	codA	to	produce	pLAH.AII.codA	(Figure	5.8).	
	
Figure	5.8	Diagram	of	the	expression	plasmid	pLAH.AII.codA.		The	codA	gene	from	pRY127d	was	cloned	into	the	pLAH.AII	expression	plasmid	at	the	NdeI	 and	 BamHI	 restriction	 sites	 to	 produce	 pLAH.AII.codA.	 Cloning	 in	 pLAH.AII	enables	 genomic	 integration	of	 the	codA	 gene	 at	 the	psbAII	 site	under	 the	 control	 of	PpsbAII.			
Synechocystis	 was	 transformed	 with	 pLAH.AII.codA	 and	 transformants	 appeared	 after	selection	for	kanamycin	resistance.	16	putative	transformants	were	picked	and	restreaked	on	BG-11	 supplemented	with	 kanamycin	 (200	 μg/ml).	 A	 PCR	performed	 on	 8	 of	 the	 16	putative	 transformants	 with	 Ben.seq.ups.F	 and	 C.	 fragBR	 confirmed	 the	 replacement	 of	
psbAII	with	codA	to	produce	transformants	of	6803.AII.codA	(Figure	5.9).		
psbAII	upstream	
element	
psbAII	downstream	
element	
KmR	
pLAH.AII.codA	
PpsbAII	
codA	
NdeI	 BamHI	
Figure	X.	Schema'c	of	expression	plasmid	pLAH.AII.codA.	
Modiﬁed	codA	cloned	into	the	pLAH.AII	expression	
plasmid,	to	enable	integraDon	of	the	codA	gene	under	the	
control	of	the	psbAII	promoter	at	the	psbAII	site.		
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Figure	 5.9	 PCR	 screening	 for	 successful	 transformants	 in	 the	 Synechocystis	 containing	
codA.	(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis,	 pLAH.AII.codA	 plasmid	 and	 6803.AII.codA	 transformants.	 (B)	 PCR	screening	 of	 putative	 transformants	 of	 6803.AII.codA.	 WT	 Synechocystis	 (WT),	pLAH.AII.codA,	 (+C),	 and	no	DNA	 template,	 (-C),	were	used	 as	 controls.	Homoplasmy	was	confirmed	by	the	lack	of	a	band	at	1.9	kb.	
5.2.2.3 The	heterologous	codA	gene	can	be	used	as	a	negative	selectable	marker	in	
Synechocystis	A	growth	 ‘spot’	 test	was	performed	using	a	 single	6803.AII.codA	 transformant	on	BG-11	and	BG-11	supplemented	with	various	concentrations	of	5-FC	(0.5,	1	and	2	mg/ml).	The	6803.AII.codA	transformant	was	unable	 to	grow	 in	 the	presence	of	5-FC	but	was	able	 to	grow	in	the	absence	of	5-FC	(Figure	5.10).	WT	Synechocystis	was	grown	as	a	control	and	was	able	to	grow	in	the	presence	of	5-FC	at	0.5	mg/ml,	but	growth	was	restricted	at	higher	concentrations.		As	the	expression	of	cytosine	deaminase	in	the	presence	of	5-FC	leads	to	cell	death	(Figure	5.10),	 the	 results	 confirm	 the	 expression	 of	 codA	 under	 the	 PpsbAII	 in	 Synechocystis.	 The	
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Figure	X.	PCR	screening	for	successful	transformants	in	the	
Synechocys)s	containing	codA.	
(A)	S hemaQc	showing	the	binding	sites	and	expected	fragments	
sizes	for	WT	Synechocys.s,	pLAH.AII.codA	plasmid	and	successful	
6803.AII.codA	transformants.	(B)	Colony	PCR	screening	of	putaQve	
transformants	of	6803.AII.codA.	WT	Synechocys.s,	WT,	
pLAH.AII.codA,	+C,	and	no	DNA	template,	-C,	were	used	as	
controls.	Homoplasmic	strains	conﬁrmed	by	the	single	band	at	3.4	
kb.	
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optimised	cytosine	deaminase	can	be	used	as	a	negative	selectable	marker	in	Synechocystis	and	could	be	used	to	produce	marker-less	transformants	in	a	similar	method	to	sacB.		
	
Figure	 5.10	 Growth	 spot	 test	 checking	 the	 expression	 of	 codA	 in	 6803.AII.codA	
transformants.		WT	Synechocystis	(WT	6803)	and	a	successful	6803.AII.codA	transformant	were	grown	on	BG-11	and	BG-11	supplemented	with	0.5,	1,	and	2	mg/ml	5-FC.	Photographs	were	taken	after	5	days	of	incubation.	Growth	of	6803.AII.codA	is	inhibited	in	the	presence	of	5-FC.		
5.2.3 Creation	of	chassis	strain	of	Synechocystis	containing	codA	for	the	production	
of	marker-less	transformants	Once	the	feasibility	of	the	codA	-5-FC	method	had	been	demonstrated,	the	next	step	was	to	create	 the	chassis	strain,	as	shown	 in	Figure	5.6,	 containing	codA	alongside	an	antibiotic	resistance	gene,	at	the	chosen	neutral	site.		
5.2.3.1 Creation	of	pIR706.codA	The	codA	gene,	including	the	PpsbAII	promoter	was	amplified	together	with	the	kanamycin	resistance	 cassette,	 KmR,	 from	 pLAH.AII.codA	 via	 PCR	 using	 primers	 pLAH_codAF	 and	pLAH_codAR.	Both	primers	were	designed	to	produce	NheI	restriction	sites	at	the	ends	of	the	PCR	product	for	insertion	into	pIR706.	The	PCR	product	was	digested	with	NheI	and	cloned	into	the	NheI	site	in	pIR706	to	produce	pIR706.codA	(Figure	5.11).	PCR	performed	with	 pLAH_codAF	 and	 pLAH_codAR,	 and	 sequencing	 with	 primers	 IR706F,	 IR706R	 and	codAmidF	confirmed	the	construction	of	pIR706.codA.		
Dilu%on	factor	
100	 10-1	 10-2	 10-3	 10-4	
WT	6803	BG-11	
WT	6803	BG-11	+	0.5	mg/ml	5-FC	
WT	6803	BG-11	+	1	mg/ml	5-FC	
WT	6803	BG-11	+	2	mg/ml	5-FC	
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Figure	X.	Growth	spot	test	checking	the	expression	of	codA	in	
6803.AII.codA	transformants.		
WT	Synechocys)s,	WT	6803,	and	a	successful	6803.AII.codA	
transformants	were	grown	on	BG-11	media	and	BG-11	media	
supplemented	with	0.5,	1,	and	2	mg/ml	5-FC.	Photograph	was	
taken	aNer	5	days	of	incuba%on.	Growth	of	6803.AII.codA	inhibited	
in	the	presence	of	5-FC.		
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Figure	5.11	Diagram	of	expression	plasmid	pIR706.codA.	The	modified	 codA	 gene	 under	 the	 control	 of	 the	 PpsbAII	 was	 amplified	 alongside	 the	kanamycin	 resistance	 gene	 and	 cloned	 into	 the	 NheI	 site	 in	 pIR706	 to	 produce	 the	transforming	plasmid	pIR706.codA.		
5.2.3.2 Expression	of	codA	in	Synechocystis	at	neutral	site	
Synechocystis	 was	 transformed	 with	 pIR706.codA.	 Transformants	 were	 seen	 after	selection	 on	 kanamycin	 supplemented	media.	 Eight	 putative	 transformants	were	 picked	and	 restreaked	 twice	 onto	 BG-11	 supplemented	 with	 200	 μg/ml	 kanamycin.	 A	 PCR	performed	with	primers	IR706F	and	IR706R	confirmed	the	integration	of	codA	in	all	eight	putative	 transformants	 at	 the	 targeted	 neutral	 site	 to	 produce	 homoplasmic	6803.IR706.codA	 strains	 (Figure	 5.12).	 Transformants	 6803.IR706.codA_3,	6803.IR706.codA_4	and	6803.IR706.codA_6,	were	selected	for	further	analysis.		
IR706	
pIR706.codA	
NheI		HpaI	
codA	 KmR	
PpsbAII	
NdeI	NdeI	
FigureX.	Schema'c	of	expression	plasmid	pIR706.AII.codA.	
The	modiﬁed	codA	gene	was	ampliﬁed	along	with	the	psbAII	
promoter	and	kanamycin	resistance	casseDe	and	cloned	into	
the	NheI	site	in	pIR706	to	produce	the	transforming	plasmid	
pIR706.AII.codA	that	will	be	used	to	produc 	the	chassis	strain	
of	marker-less	transformants.	
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Figure	5.12	PCR	screening	for	successful	transformants	in	Synechocystis	containing	codA	
at	the	chosen	neutral	site.		(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 for	 WT	
Synechocystis	 and	 6803.IR706.codA	 transformants.	 (B)	 PCR	 screening	 of	 putative	transformants	of	6803.IR706.codA.	WT	Synechocystis	 (WT)	and	no	DNA	template	(-C)	were	used	as	controls.	Homoplasmic	strains	confirmed	by	the	single	band	at	3.4	kb.		
5.2.3.3 Western	 blot	 analysis	 confirms	 expression	 of	 codA	 in	 6803.IR706.codA	
strains	When	 Western	 blot	 analysis	 with	 anti-HA	 tag	 antibodies	 was	 performed	 on	 the	 crude	extract	of	three	transformants	of	6803.IR706.codA,	the	expression	of	codA	was	detected	in	all	transformants	(Figure	5.13).			
Figure	X.	PCR	screening	for	successful	transformants	in	Synechocys)s	
containing	codA	at	the	chosen	neutral	site.		
(A)	Schema2c	showing	the	binding	sites	and	expected	fragments	sizes	for	
WT	Synechocys)s	and	successful	6803.IR706.codA	transformants.	(B)	Colony	
PCR	screening	of	puta2ve	transformants	of	6803.IR706.codA.	.	WT	
Synechocys)s,	WT,	and	no	DNA	template,	-C,	were	used	as	controls.	
Homopla mic	strains	conﬁrmed	by	the	singl 	band	at 3.4	kb.		
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Figure	 5.13	 Western	 blot	 analysis	 showing	 the	 presence	 of	 HA	 tagged	 codA	 gene	 in	
successful	6803.IR706.codA	transformants	Western	blot	analysis	was	performed	with	samples	of	6803.IR706.codA	using	the	ECL	method	with	anti-HA	antibodies	and	ECL	anti-rabbit	 IgG	antibodies.	WT	Synechocystis	(WT)	was	used	as	a	negative	control.	The	expected	band	size	of	CodA	is	49	kDa,	as	seen	in	all	three	6803.IR706.codA	transformants.		
5.2.3.4 Growth	spot	test	confirms	that	expression	of	codA	confers	sensitivity	to	5-
FC	The	Western	blot	analysis	 (Figure	5.13)	confirmed	 the	expression	of	codA	 at	 the	neutral	site	 under	 the	 control	 of	 the	 PpsbAII.	 In	 order	 to	 confirm	 that	 this	 expression	 resulted	 in	sensitivity	 to	 5-FC	 a	 growth	 ‘spot’	 test	 was	 performed.	 The	 three	 6803.IR706.codA	transformants	 were	 able	 to	 grow	 on	 BG-11	 but	 were	 unable	 to	 grow	 on	 BG-11	supplemented	with	various	concentrations	of	5-FC	(0.25	and	0.5	mg/ml)	(Figure	5.14).	
Figure	X.	Western	blot	analysis	showing	the	presence	of	HA	
tagged	codA	gene	in	successful	6803.IR706.codA	transformants	
Western	blot	analysis	was	performed	with	samples	of	
6803.IR706.codA	and	anB-HA	anBbodies,	ECL	anB-rabbit	IgG	and	
ECL	method	was	used	for	detecBon.	WT	Synechocys)s,	WT,	was	
used	as	a	negaBve	control.	The	expected	band	size	is	49	kDa	(note	
the	protein	runs	higher	than	the	size).		
codA-HA	(49	kDa)	
WT	 3	 4	 6	
6803.IR706.codA 
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Figure	5.14	Growth	‘spot’	test	confirms	expression	of	codA	in	successful	transformants.		A	10-fold	 serial	 dilution	was	performed	on	 a	 culture	of	WT	Synechocystis	 (WT	6803)	and	 three	 successful	6803.IR706.codA	 transformants.	These	 strains	were	 then	grown	on	BG-11	and	BG-11	supplemented	with	0.25	and	0.5	mg/ml	5-FC.	Photographs	were	taken	after	5	days	of	 incubation.	Growth	of	 the	 three	6803.IR706.codA	transformants	was	inhibited	by	the	presence	of	5-FC.		
5.2.4 Developing	 a	 protocol	 for	 producing	 marker-less	 transformants	 with	 the	
chassis	strain,	6803.IR606.codA	The	 selection	 protocol	 used	 in	 the	 generation	 of	marker-less	 transformants	when	 using	negative	 selectable	 markers	 such	 as	 sacB	 differs	 to	 the	 protocol	 when	 using	 positive	markers	 such	 as	 antibiotic	 resistance	 markers	 (Liu	 et	 al.,	 2011).	 When	 selecting	 for	transformants	using	an	antibiotic	resistance	marker,	putative	transformants	that	contain	at	 least	 one	 copy	 of	 the	 resistance	 gene	 are	 able	 to	 survive.	 Further	 selection	 can	 be	performed	 on	 these	 colonies	 once	 selected	 to	 ensure	 all	 copies	 of	 the	 genome	 have	integrated	 the	 resistance	 gene.	 However,	with	 negative	 selection,	 if	 a	 single	 copy	 of	 the	negative	 selectable	marker	 remains,	 cell	 death	will	 occur	when	 the	 selective	pressure	 is	applied,	 there	 is	 no	 opportunity	 to	 lose	 the	 remaining	 copies	 of	 the	 marker.	 Therefore	
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Figure X.	Growth	‘spot’	test	conﬁrms	expression	of	E.	coli	codA
in	successful	transfor ants.		
A	serial	dilu%on	was	performed	on	a	culture	of	WT	Synechocys)s,	
WT	6803,	and	three	successful	6803.IR706.codA	transformants.	
These	strains	were	then	grown	on	BG-11	media	and	BG-11	media	
supplemented	in	0.25	and	0.5	mg/ml	5-FC.	Photograph	was	taken	
aQer	5	days	of	incuba%on.	Growth	of	the	three	successful	
6803.IR706. dA	tra sformants	is	inhibited	by	the	presence	of	5-
FC.	
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complete	 segregation	 of	 the	 mutant	 alleles	 needs	 to	 be	 achieved	 before	 the	 selective	pressure	can	be	applied.		The	 protocols	 used	 to	 produce	 marker-less	 transformants	 using	 the	 sacB	 –	 sucrose	method	 in	Synechocystis,	were	 therefore	used	as	a	 template	 for	developing	a	protocol	 to	produce	marker-less	transformants	using	codA	–	5-FC.		
5.2.4.1 	Unsuccessful	 attempts	 at	 producing	 marker-less	 transformants	 using	
6803.IR706.codA		Numerous	attempts	were	made	to	transform	6803.IR706.codA	with	pIR706.cat	to	produce	marker-less	 transformants	 containing	 cat	 at	 the	 neutral	 site.	 One	 attempt	 led	 to	 the	production	of	heteroplasmic	strains	of	Synechocystis	that	contained	copies	of	both	the	cat	gene	and	codA	gene	(Figure	5.15).	The	protocol	used	by	Liu	et	al.,	to	produce	marker-less	transformants	in	Synechocystis	using	the	sacB	–	sucrose	method,	was	used	on	this	occasion	(Liu	et	al.,	2011).	A	single	6803.IR706.codA	strain	(6803.IR706.codA	_6)	was	grown	to	an	OD730	of	1.5.	Cells	were	prepared	in	the	same	way	as	when	transforming	WT	Synechocystis	(see	 2.4.13	 or	 details).	 The	 amount	 of	 cells	 used	 in	 each	 transformation	 mix	 differed	between	the	two	methods,	instead	of	using	200	µl,	10	µl	was	used	for	each	transformation	mix.	Approximately	0.4	µg	of	pIR706.cat	was	added	before	the	mixture	was	incubated	at	30°C	for	4	hours.	To	each	mixture	2	ml	of	BG-11	was	added.	The	tubes	were	incubated	at	25°C	 in	 a	 shaking	 incubator	 for	 4	 days	 before	 1	ml	 and	 0.5	ml	 was	 plated	 onto	 BG-11	supplemented	with	0.25	mg/ml	5-FC.	These	plate	were	then	incubated	at	30°C.		Colonies	 appeared	 after	6	days.	Thirty	 colonies	were	picked	 and	 restreaked	onto	BG-11	supplemented	with	0.25	mg/ml	5-FC.	After	2	days,	eight	putative	transformants	began	to	grow.	 A	 PCR	 using	 primers	 IR706F	 and	 IR706R	 was	 performed	 on	 the	 DNA	 of	 these	putative	 transformants.	 The	 results	 suggested	 no	 marker-less	 transformants	 were	produced;	however,	some	transformants	(#	2,	8,	10,	12)	appeared	to	have	copies	of	both	the	 codA	 gene	 and	 the	 cat	 gene	 in	 their	 genome,	 i.e.	 their	 genomes	were	 heteroplasmic	(Figure	5.15).		These	 four	 heteroplasmic	 transformants,	 along	 with	 putative	 transformant	 18	 were	restreaked	onto	BG-11	medium	containing	0.5	mg/ml	5-FC	in	an	attempt	to	select	for	the	loss	 of	 the	 remaining	 copies	 of	 codA.	 After	 restreaking	 the	 heteroplasmic	 transformants	twice	 on	 0.5	 mg/ml	 5-FC,	 a	 PCR	 showed	 that	 only	 one	 (number	 10)	 of	 the	 four	‘heteroplasmic’	 strains	 still	 contained	 cat	 (Figure	 5.15).	 The	 presence	 of	 cat	 in	 the	remaining	‘heteroplasmic’	strain	was	then	investigated	by	streaking	the	strain	onto	BG-11	
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supplemented	 with	 chloramphenicol	 (34	 µg/ml),	 however	 the	 strain	 did	 not	 grow	suggesting	the	absence	of	the	cat	gene	in	this	transformant.		
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Figure	 5.15	 PCR	 screening	 of	 putative	 marker-less	 transformants	 containing	 both	
copies	of	codA	and	cat.		(A)	Schematic	of	the	primer	binding	sites	and	the	expected	sizes	of	6803.IR706.codA	and	 6803.IR706.cat	 (marker-less	 transformants).	 (B)	 PCR	 screening	 of	 putative	transformants.	 6803.IR706.codA	 (+C)	 and	 no	 DNA	 template	 (-C)	 used	 as	 controls.	Putative	transformants	2,	8,	10,	12	appear	to	have	copies	of	cat	 integrated	between	
slr1340	 and	 sll1255,	 but	 copies	 of	 codA	 remain,	 shown	 by	 the	 band	 at	 3.4	 kb.	 (C)	Another	 PCR	 screen	 after	 further	 selection	 on	 5-FC	 supplemented	 media.	 Same	controls	were	used,	along	with	putative	transformant	18.	Only	putative	transformant	10,	remained	heteroplasmic,	the	other	putative	transformants	appear	to	have	lost	the	
cat	gene.		
5.2.4.2 An	 extension	 of	 the	 region	 of	 homology	 results	 in	 marker-less	
transformants	As	attempts	to	produce	marker-less	transformants	with	pIR706.cat	were	unsuccessful,	the	idea	 of	 extending	 the	 region	 of	 homology	 in	 the	 transforming	 plasmid,	 pIR706.cat,	 was	
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considered.	 There	 is	 some	 evidence	 to	 suggest	 that	 increasing	 the	 region	 of	 homology	increases	 the	 transformation	 efficiency	 (Zang	 et	 al.,	 2007).	 Currently	 the	 regions	 of	homology	 between	 6803.IR706.codA	 and	 pIR706.cat	 are	 445bp	 and	 330bp	 but	 by	increasing	the	regions	of	homology	to	~1000bp,	ideally	the	transformation	efficiency	will	increase,	along	with	the	likelihood	of	producing	of	marker-less	transformants.		
5.2.4.2.1 Creation	of	pIR706.Ex	and	pIR706.Ex.Cat	to	test	the	production	of	marker-less	transformants	Primers,	 IR706.ExF	 and	 IR706.ExR,	were	 used	 to	 amplify	 approximately	 1000	 bp	 either	side	of	the	NheI	restriction	sites	in	the	neutral	site	to	generate	IR706.Ex	(Figure	5.16).	The	2	 kb	 fragment	 was	 then	 cloned	 into	 the	 pJET1.2/blunt	 cloning	 vector.	 A	 PCR	 using	 the	primers	 IR706.ExF	and	 IR706.ExR	and	DNA	sequencing	with	pJET	F	and	pJET	R	primers	confirmed	the	creation	of	pIR706.Ex	(Figure	5.16).	The	cat	gene	from	pARG1.3	was	digested	with	EcoRV	and	ZraI	and	cloned	into	pIR706.Ex	at	the	HpaI	site	to	generate	pIR706.Ex.cat.	A	PCR	performed	with	primers	IR706.ExF	and	IR706.ExR	 alongside	 sequencing	 with	 primers	 pJETF,	 pJETR,	 IR706F	 and	 IR706R	confirmed	the	creation	of	pIR706.Ex.cat.		
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Figure	5.16	Diagram	describing	the	extension	of	the	region	of	homology	and	the	construction	of	the	plasmids	with	the	extended	region	of	homology.		Primers	 IR706.ExF	 and	 IR706.ExR	 were	 designed	 to	 amplify	 approximately	 1000bp	 of	 homology	 either	 side	 of	 the	 gene	 insertion	 site.	 The	extended	 region	 of	 homology	 (IR706.Ex)	 was	 then	 used	 to	 construct	 pIR706.Ex	 and	 pIR706.Ex.cat	 required	 to	 produce	 marker-less	transformants.		
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5.2.4.3 Establishment	 of	 a	 method	 for	 the	 successful	 production	 of	 marker-less	
strains	of	Synechocystis	A	similar	protocol	to	one	that	produced	the	‘heteroplasmic	strains’	(5.2.4.1)	was	employed.	A	 single	 6803.IR706.codA	 transformant,	 6803.IR706.codA_3,	 was	 grown	 to	 an	 OD730	 of	0.85.	To	10	µl	of	cells,	1	µg	of	pIR706.Ex.cat	was	added.	A	control	mixture,	where	no	DNA	was	 added	 to	 the	 cells	 was	 also	 prepared.	 The	 cells	 were	 then	 incubated	 at	 30°C	 for	 5	hours	 before	 2	ml	 of	 BG-11	medium	was	 added	 to	 each	 transformation	mix.	 The	 tubes	were	 then	 placed	 in	 a	 30°C	 shaking	 incubator	 for	 4	 days	 before	 1ml	 and	 0.5	ml	 of	 the	transformation	mix	was	plated	onto	BG-11	supplemented	with	0.5	mg/ml	5-FC.	The	plates	were	then	incubated	at	30°C.		After	 7	 days	 colonies	 appeared,	 16	 putative	 transformants	 were	 picked	 and	 restreaked	onto	BG-11	supplemented	with	0.5	mg/ml	5-FC.	From	 the	16	putative	 transformants	11	grew	after	2	days.	PCR	using	primers	 IR706.Ex.F	and	 IR706.Ex.R	was	performed	on	5	of	these	putative	transformants;	one	transformant	(#13)	appeared	to	have	lost	the	codA	gene	and	gained	the	cat	gene	(Figure	5.17).	The	other	putative	transformants,	which	later	grew	on	5-FC,	were	 tested	by	PCR	 and	 another	 two	 transformants	 (#5	 and	#15)	 appeared	 to	have	replaced	codA	with	cat	(Figure	5.17).	One	line	(#3)	appeared	to	have	reverted	back	to	WT	Synechocystis	(3)	and	another	(#14)	produced	a	band	at	~2.8kb,	an	unexpected	size	(Figure	5.17).	Other	putative	transformants	still	contained	the	codA	gene.		It	should	be	noted	that	there	were	a	significant	number	of	colonies	present	on	the	control	plates,	 where	 no	 DNA	 was	 added	 to	 6803.IR706.codA.	 The	 number	 of	 colonies	 on	 the	control	 plates	 was	 approximately	 half	 the	 number	 of	 colonies	 on	 the	 plates	 with	 the	putative	transformants.		
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Figure	5.17	Screening	of	successful	marker-less	transformants	that	replaced	codA	with	
cat.		(A)	Schematic	of	the	primer	binding	sites	and	the	expected	sizes	of	WT	Synechocystis,	6803.IR706.codA	 and	 6803.IR706.cat	 (marker-less	 transformants).	 (B)	 PCR	screening	of	putative	transformants.	WT	Synechocystis	(WT)	and	no	DNA	template	(-C)	 were	 used	 as	 controls.	 Putative	 transformants	 5,	 15	 and	 13	 appeared	 to	 be	homoplasmic	 transformants	 containing	 cat	 with	 a	 single	 band	 at	 3.2	 kb.	 (C)	Photographs	of	WT	Synechocystis	and	the	putative	transformants	(same	as	the	ones	used	 in	 the	 PCR)	 5,	 11	 (-C),	 13,	 14	 and	 15	 streaked	 on	 BG-11	 and	 BG-11	supplemented	 with	 34	 μg/ml	 chloramphenicol	 to	 confirm	 expression	 of	 cat.	Photograph	taken	after	4	days	of	incubation.		
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Figure	X.	Screening	of	successful	marker-less	
transformants	that	have	loss	the	codA	gene	and	
contain	the	cat	gene.		
(A)	SchemaLc	of	the	primer	binding	sites	and	the	
expected	sizes	of	WT	Synechocys9s,	
6803.IR706.codA	and	6803.IR706.cat	(marker-less	
transformants.	(B)	Colony	PCR	screening	of	putaLve	
transformants.	WT	Synechocys9s,	WT,	and	no	DNA	
template,	-C,	used	as	controls.	PutaLve	
transformants	5,	15	and	13	appear	to	be	
homoplasmic	marker-less	transformants	with	a	
single	band	at	3.2	kb.	(C)	Photograph	of	WT	
Synechocys9s,	and	the	putaLve	transformants	
(same	as	the	ones	used	in	the	PCR)	5,	12	(-C),	13,	14	
and	15	streaked	on	BG-11	media	and	BG-11	media	
supplemented	with	34	μg/ml	chloramphenicol	to	
conﬁrm	expression	of	cat.	Photograph	taken	a\er	4	
days	of	incubaLon.		
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To	 confirm	 the	 replacement	 of	 codA	 with	 cat,	 lines	 #5,	 #13,	 and	 #15	 were	 picked	 and	restreaked	onto	BG-11	and	BG-11	that	was	supplemented	with	34	µg/ml	chloramphenicol.	Line	 #11,	 which	 still	 contained	 the	 codA	 gene	 (not	 seen	 in	 Figure	 5.17)	 and	 WT	
Synechocystis	 were	 grown	 as	 controls.	 Line	 #14	was	 also	 grown	 due	 to	 the	 similar	 size	product	 to	 marker-less	 transformants.	 Only	 lines	 #5,	 #13	 and	 #15	 could	 grow	 in	 the	presence	of	chloramphenicol,	confirming	the	 integration	of	cat	in	 these	transformants	 to	produce	 6803.IR706.cat.	 The	 production	 of	 6803.IR706.cat	 was	 also	 confirmed	 through	DNA	sequencing	analysis	of	the	cat	PCR	product	using	primers	IR706F	and	IR706R.		The	 production	 of	 6803.IR706.cat	 confirms	 that	 the	 production	 of	 marker-less	transformants	 using	 5-FC	 to	 select	 for	 the	 loss	 of	 codA	 is	 possible.	 To	 confirm	 that	 the	production	 of	 marker-less	 transformants	 was	 reproducible,	 another	 attempt	 using	 the	method	described	above	 showed	 that	 adding	2	µg	of	DNA	and	 shaking	 the	 cells	 at	25°C	instead	 of	 30°C	 for	 four	 days	 also	 resulted	 in	 the	 production	 of	 at	 least	 four	 successful	transformants	of	6803.IR706.cat	(results	not	shown).	As	before	there	was	a	high	number	of	colonies	on	the	control	plate:	the	number	of	colonies	on	control	plate	(30)	when	0.5	ml	was	plated	was	half	 the	number	of	putative	transformants	(67).	When	1	ml	 is	plated	the	number	 of	 colonies	 on	 the	 control	 plate	 (108)	 is	 similar	 to	 the	 number	 of	 putative	transformants	(115).	Of	the	six	putative	transformants	tested	only	two	still	contained	codA.	In	the	previous	test,	of	the	16	tested,	13	contained	the	codA	gene.	The	ability	to	grow	on	5-FC	is	most	likely	due	to	a	mutation	in	codA	that	overcomes	sensitivity	towards	5-FC.		Using	pIR706.Ex.cat	rather	than	pIR706.cat,	increasing	the	region	of	homology,	may	have	had	 the	 desired	 effect	 of	 producing	 of	 marker-less	 transformants,	 however	 as	 other	changes	were	made	 to	 the	 protocol,	 it	may	 not	 be	 the	 only	 factor	 in	 the	 success	 of	 the	method.		The	 production	 of	 marker-less	 transformants	 using	 pIR706.cat	 and	 pIR706.Ex.cat	 was	made	slightly	more	difficult	due	to	the	construction	of	the	transforming	plasmid.	The	cat	gene	was	cloned	at	the	HpaI	site	of	the	transforming	plasmid;	however,	codA	was	located	at	 the	NheI	 site.	This	misalignment	 results	 in	 three	 regions	of	homology	between	 IR706	(Figure	5.18).	If	homologous	recombination	does	occur,	marker-less	 transformants,	with	
cat	replacing	codA,	may	not	be	the	only	product.	A	strain	of	Synechocystis	containing	both	
codA	 and	cat	 at	 the	neutral	site	could	be	produced;	however,	selection	with	5-FC	should	ensure	this	transformant	is	selected	against	(Figure	5.18).	A	strain	that	no	longer	contains	
codA	 or	 cat	 that	 appears	 as	 WT	 Synechocystis	 could	 also	 be	 produced	 and	 would	 be	present	after	selection	with	5-FC	(Figure	5.18).		
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From	 the	PCR	results	other	products,	not	mentioned	above,	 could	also	be	produced,	 e.g.	line	 #14	 produced	 a	 band	 at	 ~2.8	 kb,	 which	 does	 not	 correlate	 to	 any	 of	 the	 possible	homologous	recombination	events	mentioned	above	(Figure	5.18).		
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Figure	5.18	Diagram	describing	the	various	homologous	recombination	events	that	are	possible	due	to	the	construction	of	the	pIR706.Ex.cat	plasmid.		There	 are	 three	 regions	 of	 homology	 that	 can	 lead	 to	 different	 homologous	 recombination	 events.	 For	 the	 production	 of	 marker-less	transformants,	the	insertion	of	cat	(purple	box)	is	required.	Transformants	with	both	codA	and	cat	are	possible	(blue	box),	as	are	transformants	with	neither	codA	nor	cat	(red	box).		
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5.2.5 Introduction	 of	 the	 limonene	 synthase	 gene	 at	 the	 neutral	 site	 using	 the	
marker-less	transformation	method	Demonstrating	 that	 the	codA	 –	5-FC	method	can	be	used	 to	 introduce	another	gene,	one	that	is	not	an	antibiotic	resistance	gene,	would	add	further	evidence	that	the	codA	 -	5-FC	method	can	produce	marker-less	transformants.	The	synthetic	limonene	synthase	gene,	LS,	described	in	Chapter	3	was	introduced	at	the	neutral	site	using	the	same	protocol	used	to	introduce	cat	into	Synechocystis.		
5.2.5.1 Creation	of	pIR706.Ex.LS	Primers,	AII.LS_F	and	AII.LS_R	were	used	to	amplify	LS	under	the	control	of	the	PpsbAII	from	pLAH.AII.LS.	 The	 primers	 introduced	 an	NheI	 restriction	 site	 upstream	 of	 the	 promoter	and	a	HpaI	restriction	site	downstream	of	LS.	By	cloning	the	gene	between	the	two	sites,	this	 potentially	 avoids	 the	 unwanted	 homologous	 recombination	 events	 that	 occurred	with	pIR706.Ex.cat	(Figure	5.19).	PCR	using	AII.LS_F	and	AII.LS_R	successfully	amplified	LS	under	the	control	of	the	PpsbAII.	
	
Figure	 5.19	 Diagram	 demonstrates	 insertion	 of	 LS	 between	 the	 HpaI	 and	 NheI	
restriction	sites.	With	only	two	regions	of	homology,	the	replacement	of	codA	and	KmR	with	LS	should	be	the	only	possible	gene	arrangement	in	transformants.		The	PCR	fragment	was	digested	with	NheI	and	HpaI	and	cloned	into	the	restriction	sites	in	pIR706.Ex.	 A	 PCR	using	 IR706F	 and	 IR706R	 and	DNA	 sequencing	with	 primers	 IR706F,	IR706R	and	LS.midF	confirmed	the	construction	of	pIR706.Ex.LS	(Figure	5.20).	
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Figure	5.20	Method	used	to	produce	pIR706.Ex.LS	The	LS	gene	under	the	control	of	 the	PpsbAII	promoter	was	amplified	from	pLAH.AII.LS	and	cloned	into	pIR706.Ex.LS.		
5.2.5.2 Transformation	 of	 pIR706.Ex.LS	 with	 6803.IR706.codA	 produces	marker-
less	transformants	containing	the	limonene	synthase	gene	Three	6803.IR706.codA	(#3,4	and	6)	transformants	were	grown	to	an	OD730	between	0.5-0.8	 to	 check	 they	 could	 all	 produce	 marker-less	 transformants.	 The	 codA-5-FC	 method	established	 (see	 2.4.14	 for	 details)	 was	 used	 to	 transform	 6803.IR706.codA	 with	pIR706.Ex.LS,	although	after	the	addition	of	DNA	cells	were	incubated	for	8	hours	at	30°C.		Colonies	appeared	after	9	days,	and	16	colonies	were	picked	from	each	6803.IR706.codA	transformation	 (48	 colonies	 in	 total)	 and	 restreaked	onto	BG-11	 supplemented	with	0.5	mg/ml	5-FC.	A	PCR	with	IR706.Ex.Flank.F	and	IR706.Ex.Flank.R	confirmed	that	of	the	48	colonies	 picked,	 14	 had	 replaced	 codA	 with	LS	 to	 produce	 6803.IR706.LS	 (Figure	 5.21).	Marker-less	 transformants	 were	 produced	 from	 each	 6803.IR706.codA	 transformant	tested	(Figure	5.21).	Successful	transformants	from	each	6803.IR706.codA	transformation	mix	were	chosen	for	further	analysis.	Table	5.2	summarises	the	results	of	the	PCR	on	all	48	putative	transformants.	Almost	three-quarters	of	 the	putative	transformants	still	contain	
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the	 codA	 gene.	 A	 few	 transformants	 produced	 products	 that	 did	 not	 correlate	 with	 the	expected	result	(Table	5.2).	Controls	 for	 each	 6803.IR706.codA	 transformation,	 where	 no	 DNA	 is	 added,	 were	prepared.	Table	5.3	summarises	the	number	of	colonies	that	were	present	on	these	plates	after	 9	 days.	 Similar	 to	 the	 experiments	 involving	 the	 production	 of	 marker-less	transformants	 containing	 cat,	 there	 are	 a	 significant	 number	 of	 colonies	 present	 on	 the	control	plates.		
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Figure	5.21	PCR	Screening	for	marker-less	transformants	of	Synechocystis	containing	LS.		(A)	 Schematic	 showing	 the	 primer	 binding	 site	 and	 expected	 fragments	 of	 WT	
Synechocystis,	 6803.IR706.codA	 and	 6803.IR706.LS.	 (B)	 PCR	 screening	 of	 successful	transformants	 containing	 LS.	 A	 single	 band	 at	 3.8	 kb	 indicates	 homoplasmic	 strains	containing	 LS.	 Putative	 transformants	 1-16	 are	 from	 the	 transformation	 of	6803.IR706.codA_3,	 17-32	 from	 6803.IR706.codA_4	 and	 33-48	 from	6803.IR706.codA_6.		WT	Synechocystis	(WT)	and	no	DNA	(-C)	were	used	as	controls.			
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Table	 5.2	 Summary	 of	 all	 the	 PCR	 screening	 results	 for	 marker-less	 transformants	
containing	LS.		After	 screening	 a	 total	 of	 48	 putative	 transformants	 (16	 from	 each	 of	 the	6803.IR706.codA	transformation	mixes),	14	appear	to	be	marker-less	transformants.		
		
Table	 5.3	 Summary	 of	 the	 number	 of	 colonies	 present	 after	 transformation	 of	
6803.IR706.codA	with	pIR706.Ex.LS	The	 number	 of	 colonies	 present	 on	 the	 control	 plates	 for	 the	 majority	 of	 the	transformation	 reactions	 is	 greater	 than	 half	 the	 number	 of	 colonies	 present	 on	 the	plates	containing	the	putative	transformants.	
	
Band	
size	
(kb)	
Puta1ve	
transformants	
number	
Total	number	
of	
transformants	
Expected	
transformant	
strain	
1.9	 17	 1	 Unknown	
2.4	 37,	41	 2	 Unknown	
3.8	 13,	16,	19,	20,	22,	
23,	26,	27,	29,	31,	
32,	34,	36,	38	
14	 6803.IR706.AII.LS	
4.7	 1-12,	14,	15,	18,	
21,	24,	25,	28,	30,	
35,	39,	40,	42-	48	
31	 6803.IR706.codA	
Table	X.	Summary	of	PCR	screening	results	for	marker-less	
transformants	of	Synechocys)s	containing	LS.		
ARer	screening	a	total	of	48	puta1ve	transformants	(16	each	
from	the	three	6803.IR706.codA	transformants	strains),	14	
appear	to	be	marker-less	transformants.		
	
Transforma)on	mixture		
	
Volume	
plated	(ml)	
Number	of	colonies	
6803.IR706.codA_3	+	no	
DNA	
0.5	 35	
1	 75	
6803.IR706.codA_3	+	
pIR706.Ex.LS	
0.5	 52	
1	 90	
6803.IR706.codA_4	+	no	
DNA	
0.5	 22	
1	 54	
6803.IR706.codA_4	+	
pIR706.Ex.LS	
0.5	 31	
1	 62	
6803.IR706.codA_6	+	no	
DNA	
0.5	 40	
1	 54	
6803.IR706.codA_6	+	
pIR706.Ex.LS	
0.5	 61	
1	 113	
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5.2.5.3 Confirming	the	absence	of	kanamycin	resistance	gene	The	marker-less	 selection	method	 is	 based	 on	 the	 loss	 of	 both	 codA	 and	nptI,	 and	 their	replacement	with	the	G.O.I.	Consequently,	successful	transformants	should	be	kanamycin	sensitive	as	well	at	5-FC	resistant.	To	test	this,	three	selected	6803.IR706.LS	transformants	(#13,	 19	 and	 34)	 and	 the	 6803.IR706.codA	 strains	 were	 grown	 on	 BG-11,	 BG-11	supplemented	 with	 kanamycin	 and	 BG-11	 supplemented	 with	 0.5	 mg/ml	 5-FC.	 As	expected	the	growth	‘spot’	tests	demonstrated	that	6803.IR706.codA	strains	were	able	to	grow	 in	 the	 presence	 of	 kanamycin	 but	 unable	 to	 grow	 in	 the	 presence	 of	 5-FC	 (Figure	5.22).	 The	 growth	 of	 the	 6803.IR706.LS	 transformants	 in	 the	 presence	 of	 5-FC	 and	inability	 to	grow	on	kanamycin	confirm	 the	 loss	of	 the	codA/KmR	 cassette	 (Figure	5.22).	These	 results	 along	 with	 the	 PCR	 results	 confirm	 the	 production	 of	 marker-less	transformants	with	the	limonene	synthase	gene	at	the	neutral	site.			
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Figure	5.22	Growth	‘spot’	test	confirms	the	loss	of	codA	and	kanamycin	resistance	gene	
in	successful	6803.AII.LS	transformants.	Three	6803.IR706.codA	and	three	6803.IR706.LS	transformants	were	grown	on	BG-11,	BG-11	supplemented	with	200	μg/ml	kanamycin	and	BG-11	supplemented	with	0.5	mg/ml	5-FC.	6803.IR706.sacB_1	was	used	as	a	control.	6803.IR706.codA	was	able	to	 grow	on	kanamycin	but	unable	 to	 grow	on	5-FC,	whilst	 the	6803.IR706.LS	were	unable	to	grow	on	kanamycin	but	were	able	to	grow	on	5-FC.	
5.2.5.4 Expression	of	limonene	synthase	is	detected	by	Western	blot	analysis		To	confirm	the	expression	of	LS,	Western	blot	analysis	was	performed	on	the	crude	extract	of	 three	 6803.IR706.LS	 (#13,	 19	 and	 34)	 transformants.	 LS	was	 detected	 using	 anti-HA	antibodies	in	all	three	6803.IR706.LS	transformants	with	a	band	at	65	kDa	present	that	is	absent	 in	 the	negative	 control,	 6803.AII,	 and	present	 in	 the	positive	 control,	 6803.AII.LS	(Figure	5.23).		
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Figure	X.	Growth	‘spot’	test	conﬁrms	the	loss	of	codA	and	
kanamycin	resistance	gene	in	successful	6803.AII.LS	
transformants.	
Three	6803.IR706.codA	and	three	6803.IR706.LS	transformants	
are	grown	on	BG-11	media,	BG-11	media	supplemented	with	
200	μg/ml	kanamycin	and	BG-11	media	supplemented	with	0.5	
mg/ml	5-FC.	6803.IR706.sacB_1	is	used	as	a	control.	
6803.IR706.codA	is	able	to	grow	on	kanamycin	but	unable	to	
grow	on	5-FC,	whilst	the	marker-less	transformants	are	unable	
to	grow	on	kanamycin	but	are	able	to	grow	on	5-FC.		
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Figure	 5.23	 Western	 blot	 analysis	 confirms	 the	 expression	 of	 LS	 in	 marker-less	
transformants	of	Synechocystis.		The	Western	blot	was	performed	with	whole	 cell	 extracts	and	anti-HA	and	anti-RbcL	antibodies,	 using	 the	 Odyssey®	 Infrared	 Imaging	 System	 for	 detection.	 The	 samples	were	run	on	a	10%	SDS-PAGE	gel.	The	expected	band	size	for	LS	is	65	kDa	and	53	kDa	for	 RbcL,	 which	 acted	 as	 loading	 control.	 Protein	 size	 was	 determined	 using	 the	PageRulerTM	Prestained	Protein	ladder	(Thermo	Scientific),	lane	L.	Strains	6803.AII	(-C)	and	6803.AII.LS	(+C),	were	grown	as	controls.		
5.2.6 Return	to	sacB:	expression	of	sacB	confers	sensitivity	to	sucrose.		After	 receiving	 information	on	how	 the	 sucrose	medium	should	be	prepared,	 the	 sacB	 –sucrose	 method	 was	 revisited	 to	 investigate	 why	 both	 6803.IR706.sacB	 and	6803.IR706.sacB’	strains	did	not	confer	sensitivity	to	sucrose.	
5.2.6.1 Growth	‘spot’	test	analysis	of	sacB		The	lack	of	mutations	in	the	sacB	gene,	suggested	that	there	must	be	another	explanation	as	 to	why	sacB	 expression	did	not	confer	sensitivity.	After	obtaining	a	clear	protocol	 for	using	 the	 sacB	 –	 sucrose	method	 (kindly	 provided	 from	 David	 Lea	 Smith,	 University	 of	Cambridge),	differences	with	the	preparation	of	the	media	used	in	the	earlier	growth	‘spot’	test	 (5.2.1.6)	were	observed.	 In	 the	protocol	 used	by	 the	Cambridge	Lab,	NaHCO3	 is	 not	present	 in	 the	BG-11	medium	with	sucrose	and	 the	5%	(w/v)	sucrose	 is	 filter	sterilised,	not	autoclaved.		Growth	 ‘spot’	 tests	were	 repeated	using	a	new	medium	based	on	 the	protocol	provided.	Three	6803.IR706.sacB	transformants,	WT	Synechocystis	and	6803.AII	 (used	as	controls)	were	grown	on	BG-11	(also	prepared	without	NaHCO3),	BG-11	with	kanamycin	and	BG11	with	5%	and	7.5%	(w/v)	sucrose.	The	three	6803.IR706.sacB	transformants	were	unable	to	grow	on	5%	or	7.5%	(w/v)	sucrose	(Figure	5.24)	but	were	able	to	grow	on	BG-11	and	BG-11	with	kanamycin.	WT	Synechocystis	and	6803.AII	grew	on	the	plate	containing	BG-11	with	5%	(w/v)	sucrose	but	struggled	to	grow	on	medium	containing	7.5%	(w/v)	sucrose.		Another	growth	‘spot’	test	was	performed	with	three	6803.IR706.sacB’	transformants,	WT	
Synechocystis	 and	 6803.AII	 (used	 as	 controls)	 on	 BG-11,	 BG-11	 supplemented	 with	 5%	
-C	L	 +C	
6803.IR706.AII.LS	
13	 19	 34	kDa	
~55	
LS-HA	(65	kDa)	
RbcL	(53	kDa)	
Figur 	X.	Western	blot	analysis	conﬁrms	the	expression	of	
limonene	synthase	at	the	neutral	site	in	marker-less	
transformants	of	Synechocys)s.		
Th 	w stern	blot	was	performed	with	whole	cel 	extracts	and	anQ-
HA	and	anQ-rbcL	anQbodies,	using	the	Odyssey®	Infrared	Imaging	
System	for	detecQon.	The	expected	band	size	for	limonene	
synthase	is	65	kDa	and	53	kDa	for	rbcL,	which	acted	as	a	posiQve	
control.	Protein	size	was	determined	using	the	PageRulerTM	
Prestained	Protein	ladder	(Thermo	ScienQﬁc).	
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(w/v)	sucrose	and	BG-11	supplemented	with	kanamycin.	The	results	of	these	 ‘spot’	tests	demonstrated	that	the	expression	of	sacB	 in	the	presence	of	sucrose	does	lead	to	the	cell	death	in	Synechocystis	as	expected.	The	sacB	-	sucrose	method	can	therefore	be	used	with	6803.IR706.sacB	and	6803.IR706.sacB’	to	produce	marker-less	transformants.		
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Figure	 5.24	 Growth	 spot	 tests	 testing	 the	 expression	 of	 sacB	 in	 6803.AII.sacB	 (A)	 and	
6803.IR706.sacB’	in	the	presence	of	sucrose.	(A)	Four	transformants	of	6803.IR706.sacB	were	grown	on	BG-11	(w/o	NaHCO3),	BG-11	supplemented	with	200	μg/ml	kanamycin	and	BG-11	(w/o	NaHCO3)	supplemented	with	 5%	 and	 7.5%	 (w/v)	 sucrose.	 6803.IR706.sacB	 strains	 were	 able	 to	 grown	 on	kanamycin	but	were	unable	grow	on	media	supplemented	with	5%	sucrose.	All	strains	were	unable	to	grow	on	media	supplemented	with	7.5	%	sucrose.		In	both	(A)	and	(B)	WT	Synechocystis	(WT	6803)	and	6803.AII	were	grown	as	controls.	Photographs	were	taken	 after	 7	 days	 incubation.	 (B)	 Three	 transformants	 of	 6803.IR706.sacB’	 were	grown	 on	 BG-11,	 BG-11	 supplemented	 with	 200	 μg/ml	 kanamycin	 and	 BG-11	 (w/o	NaHCO3)	supplemented	with	5%	(w/v)	sucrose.	6803.IR706.sacB’	strains	were	able	to	grown	on	kanamycin	but	were	unable	grow	on	media	(w/o	NaHCO3)	and	supplemented	with	5%	sucrose.	Photographs	were	taken	after	5	days	of	incubation.		
B
G
-1
1 
B
G
-1
1 
+ 
K
m
20
0  
WT6803 
6803.IR706.sacB’ 1 
6803.IR706.sacB’ 4 
6803.IR706.sacB’ 6 
6803.AII 
B
G
-1
1 
+ 
5 
%
 
(w
/v
) S
uc
* 
WT6803	
6803.IR706sacB	1	
6803.IR706.sacB	2	
6803.IR706.sacB	7	
6803.IR706.sacB	8	
6803.AII	
BG
-1
1	
(w
/o
	N
aH
CO
3)
	
BG
11
	+
	K
m
20
0 	
BG
-1
1	
+	
5	
%
	
(w
/v
)	S
uc
*	
BG
-1
1	
+	
7.
5	
%
	
(w
/v
)	S
uc
*	
Figure	X.	Growth	spot	tests	tes+ng	the	expression	of	
sacB	in	6803.AII.sacB(A)	and	6803.IR706.sacB’	in	the	
presence	of	sucrose.	
(A)	Three	transformants	of	6803.IR706.sacB	were	grown	
on	BG-11	media	(w/o	NaHCO3),	BG-11	media	
supplemented	with	200	μg/ml	kanamycin	and	BG-11	
media	(w/o	NaHCO3)	supplemented	with	5%	and	7.5%	
(w/v)	sucrose.	6803.IR706.sacB	strains	were	able	to	
grown	on	kanamycin	but	were	unable	grow	on	media	
(w/o	NaHCO3)	and	supplemented	with	5%	sucrose.	All	
strains	were	unable	to	grow	on	media	(w/o	
NaHCO3)supplemented	with	7.5	%	sucrose.			
In	both	(A)	and	(B)	WT	Synechocys)s,	WT	6803,		and	
6803.AII.only	were	grown	as	controls.	Photograph	was	
taken	aZer	7	days	incuba[on.	(B)	Three	transformants	of	
6803.IR706.sacB’	were	grown	on	BG-11	media,	BG-11	
media	supplemented	with	200	μg/ml	kanamycin	and	
BG-11	media	(w/o	NaHCO3)	supplemented	with	5%	(w/
v)	sucrose.	6803.IR706.sacB	strains	were	able	to	grown	
on	kanamycin	but	were	unable	grow	on	media	(w/o	
NaHCO3)	and	supplemented	with	5%	sucrose.	
Photograph	was	taken	aZer	5	days	of	incuba[on.		
A) 
B) 
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5.2.6.2 Production	of	marker-less	transformants	using	the	sacB	selection	All	 three	 strains	 of	 6803.IR706.sacB	 were	 grown	 to	 an	 OD730	between	 0.7	 and	 0.9	 and	transformed	 with	 pIR706.Ex.cat	 using	 a	 similar	 method	 used	 to	 successfully	 obtain	marker-less	transformants	using	codA	–	5-FC	method	(see	2.4.15	for	details).	After	14	days	only	two	colonies	grew.	PCR	performed	on	these	two	putative	transformants	showed	that	only	one	had	replaced	sacB	with	cat	 to	produce	6803.IR706.cat	 from	6803.IR706.sacB_1	(Figure	5.25).	As	 the	 other	 putative	 transformant	was	 able	 to	 grow	on	 sucrose,	 but	 still	contained	sacB,	this	could	be	due	to	a	mutation	in	sacB.			
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Figure	 5.25	 Screening	 of	marker-less	 transformants	 produced	 in	 Synechocystis	 using	
the	sacB	–	sucrose	method.		(A)	 Schematic	 showing	 the	 binding	 sites	 and	 expected	 fragments	 sizes	 of	 WT	
Synechocystis,	 6803.IR706.sacB	 and	 6803.IR706.cat.	 (B)	 Photograph	 of	 putative	transformants	 picked	 and	 restreaked	 onto	 BG-11	 supplemented	 with	 5%	 (w/v)	sucrose.	Only	putative	transformants	1	and	5	were	able	to	grow.	(C)	PCR	screening	of	putative	 transformants	 confirms	 the	 production	 of	 marker-less	 transformant	 in	transformant	5.	The	strain	appears	homoplasmic	as	there	is	a	single	band	at	3.3	kb.		
5.2.7 Comparison	of	the	two	marker-less	transformation	methods		To	 compare	 the	 two	 methods	 of	 producing	 marker-less	 mutants,	 liquid	 cultures	 of	6803.IR706.codA_3	and	6803.IR706.sacB_7	were	grown	to	an	OD730	of	approximately	1.2.	The	codA-5-FC	method	was	used	for	6803.IR706.codA_3	and	sacB	–	sucrose	method	was	used	for	6803.IR706.sacB_7.	A	control	transformation,	where	no	DNA	was	added	to	either	strain,	was	also	prepared.		After	11	days	no	colonies	were	seen	on	the	sucrose	plates,	suggesting	transformation	into	6803.IR706.sacB_7	was	unsuccessful.	Colonies	were	present	on	all	5-FC	plates,	 including	
6803.IR706.sacB	
	6.2	kb	
sll1255	slr1340	
3.3	kb	
sll1255	slr1340	
6803.IR706.cat	
(marker-less	
transformant)	
cat	
IR706.Ex.Flank	RIR706.Ex.Flank	F
IR706.Ex.Flank.F IR706.Ex.Flank	R
2.1	kb	
WT	Synechocys4s	 sll1255	slr1340	
IR706.Ex	RIR706.Ex	F
sacB	 nptI	
A) 
B) C) 
Figure	X.	Screening	of	marker-less	transformants	produced	in	
Synechocys)s	using	the	sacB	–	sucrose	method.		
(A)	SchemaIc	showing	the	binding	sites	and	expected	fragments	
sizes	 f	WT	Synechocys4s,	6803.IR706.sacB	and	6803.IR706.cat.	(B)	
Photograph	of	putaIve	transformants	picked	and	restreaked	onto	
BG-11	media	supplemented	with	5%	(w/v)	sucrose.	Only	putaIve	
transformants	1	and	5	were	able	to	grow.	(C)	PCR	colony	screening	
putaIve	transformants	conﬁrm	the	producIon	of	marker-less	
transformant	in	putaIve	transformant	5.	The	strain	is	homoplasmic	
as	there	is	a	single	band	at	3.3	kb.		
1 5 WT 
6.2 kb 
3.3 kb 
2.1 kb 
Putative transformants 
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the	no-DNA	negative	control	plates	(Table	5.4).	The	number	of	colonies	on	the	plate	with	putative	transformants	of	6803.IR706.cat	is	much	greater	than	the	number	of	colonies	on	the	control	plate.	However,	the	number	of	colonies	on	the	control	plate	is	greater	than	the	number	of	colonies	on	the	plate	with	putative	transformants	of	6803.IR706.LS	(Table	5.4).	Despite	 this,	 putative	 transformants	 for	 6803.IR706.cat	 and	 6803.IR706.LS	were	 picked	for	screening.		
Table	 5.4	 Summary	 of	 the	 number	 of	 colonies	 from	 the	 transformation	 of	
6803.IR706.codA	Colonies	were	counted	after	11	days	incubation.	*	Estimated	value.	
		To	improve	the	screening	process,	colonies	were	picked	and	suspended	in	BG-11,	before	‘spotting’	 onto	 BG-11,	 BG-11	 supplemented	 with	 0.5	 mg/ml	 5-FC	 and	 BG-11	 with	 200	
µg/ml	 kanamycin.	 Twenty-four	 colonies	 of	 6803.IR706.codA_3	 transformed	 with	pIR706.Ex.LS	and	32	colonies	of	6803.IR706.codA_3	transformed	with	pIR706.Ex.cat	were	screened	in	this	method.	After	three	days,	16	out	of	24	putative	transformants	appear	to	have	replaced	codA	with	LS	(Figure	5.26).	A	PCR	with	IR706.Flank.F	and	IR706.Flank.R	on	the	 first	 six	 successful	 transformants	 confirmed	 the	 results	 from	 the	 spot	 test	 (Figure	5.26).	 After	 seven	 days	 all	 32	 colonies	 of	 6803.IR706.codA_3	 transformed	 with	pIR706.Ex.cat	grew	and	showed	that	28	out	of	32	colonies	appear	 to	have	 lost	codA	and	gained	the	cat	gene	(Figure	5.27).	A	PCR	with	IR706.Flank.F	and	IR706.Flank.R	on	the	first	six	successful	transformants	confirmed	the	results	from	the	spot	test	(Figure	5.27).	
Transforma)on	mixture		
	
Volume	
plated	(ml)	
Number	of	colonies	
6803.IR706.codA	+	no	DNA	 0.5	 37	
1	 33	
6803.IR706.codA	+	
pIR706.Ex.cat	
0.5	 332*	
1	 101	
6803.IR706.codA	+	
pIR706.Ex.LS	
0.5	 25	
1	 4	
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Figure	5.26	Screening	of	marker-less	transformants	of	Synechocystis	containing	LS	using	
the	codA	–	5-FC	method.		(A)	Growth	‘spot’	test	of	24	putative	marker-less	transformants	grown	on	BG-11,	BG-11	supplemented	with	200	μg/ml	kanamycin	and	BG-11	supplemented	with	0.5	mg/ml	5-FC.	Photographs	were	taken	after	4	days	incubation.	Of	the	putative	transformants	that	grew,	 15	 out	 of	 23	 appear	 to	 be	marker-less	 transformants.	 (B)	 PCR	 screening	with	primers	IR706	Ex	Flank	F	and	IR706	Ex	Flank	R	of	the	first	six	putative	transformants	that	 appeared	 to	 be	marker-less	 transformants	 from	 the	 results	 of	 the	 growth	 ‘spot’	tests.		Homoplasmic	marker-less	transformants	of	Synechocystis	containing	the	LS	gene	are	seen	with	a	single	band	at	3.8	kb,	and	no	band	at	4.7	kb.	WT	Synechocystis	(WT)	and	a	no	DNA	template	(-C)	are	used	as	controls.	 	
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Figure	 5.27	 Screening	 of	 marker-less	 transformants	 of	 Synechocystis	 containing	 cat	
using	the	codA	–	5-FC	method.		(A)	Growth	‘spot’	test	of	32	putative	marker-less	transformants	grown	on	BG-11,	BG-11	 supplemented	 with	 200	 μg/ml	 kanamycin	 and	 BG-11	 supplemented	 with	 0.5	mg/ml	5-FC.	 Photograph	 taken	 after	6	days	 incubation.	 From	 the	 test	 28	out	 of	 32	transformants	 appear	 to	be	marker-less	 transformants	 containing	 the	cat	 gene.	 (B)	PCR	screening	with	primers	 IR706	Ex	Flank	F	and	 IR706	Ex	Flank	R	of	 the	 first	 six	putative	 transformants	 that	 appeared	 to	 be	 marker-less	 transformants	 from	 the	results	 of	 the	 growth	 ‘spot’	 tests.	 	 Homoplasmic	 marker-less	 transformants	 of	
Synechocystis	 containing	 the	 cat	 gene	 are	 seen	 with	 a	 single	 band	 at	 3.3	 kb.	 WT	
Synechocystis	(WT)	and	a	no	DNA	template	(-C)	are	used	as	controls.		
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Figure	X.	Screening	of	marker-less	transformants	of	
Synechocys)s	containing	cat	using	the	codA	–	5-FC	
method.		
(A)	Growth	‘spot’	test	of	32	puta>ve	marker-less	
transformants	grown	on	BG-11	media,	BG-11	media	
supplemented	with	200	μg/ml	kanamycin	and	Bg-11	
media	supplemented	with	0.5	mg/ml	5-FC.	
Photograph	taken	a_er	6	days	incuba>on.	From	the	
test	28	out	of	32	transformants	appear	to	be	marker-
less	transformants	containing	the	cat	gene.	(B)	PCR	
screening	with	primers	IR706	Ex	Flank	F	and	IR706	Ex	
Flank	R	of	the	ﬁrst	six	puta>ve	transformants	that	
appeared	to	be	marker-less	transformants	from	the	
results	of	the	growth	‘spot’	tests.		Homoplamsic	
marker-less	transformants	of	Synechocys,s	
containing	the	cat	gene	are	seen	with	a	single	band	
at	3.3	kb.	WT	Synechocys,s,	WT,	and	a	no	DNA	
template,	-C,	are	used	as	controls.		
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As	 the	 comparison	 between	 the	 two	 methods	 was	 not	 repeated	 and	 no	 transformants	using	 the	 sacB	 –	 sucrose	 method	 were	 produced,	 a	 valid	 comparison	 between	 the	 two	methods	would	be	difficult	to	make.	The	sacB	–	sucrose	method	is	an	established	method	that	 others	 have	 used	 to	 produce	marker-less	 transformants	 (Lagarde	 et	 al.,	 2000;	 Lea-Smith	et	al.,	2013;	Liu	et	al.,	2011;	Xu	et	al.,	2004);	however,	in	all	my	attempts	to	use	the	
sacB	–	sucrose	method,	only	a	single	marker-less	transformant	was	recovered,	suggesting	that	the	method	is	not	routine.	
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5.3 Discussion	and	Future	work	The	work	presented	 in	 this	 chapter	describes	 the	development	of	a	new	method	 for	 the	production	 of	marker-less	 transformants	 in	 Synechocystis.	 The	 results	 demonstrate	 that	the	expression	of	a	synthetic	cytosine	deaminase,	optimised	to	accept	5-FC	can	be	used	as	a	method	of	negative	selection	in	Synechocystis	when	strains	are	grown	in	the	presence	of	5-FC.	Furthermore,	the	expression	of	the	modified	codA	can	be	used	in	a	similar	manner	to	the	sacB-sucrose	method	for	the	production	of	marker-less	transformants.		The	 codA-5-FC	 method	 provides	 an	 alternative	 method	 to	 producing	 marker-less	transformants	in	Synechocystis	that	could	potentially	be	used	in	other	strains	that	are	able	to	 incorporate	 DNA	 by	 homologous	 recombination	 such	 as	 Synechococcus	 7942,	
Synechococcus	 7002,	 Synechococcus	 UTEX	 2973	 and	 Anabaena	 7120.	 The	 absence	 of	selectable	 markers	 in	 genetically	 engineered	 strains	 removes	 the	 potential	 risk	 of	 the	antibiotic	 resistance	 genes	 escaping	 into	 the	 environment,	 and	 increasing	 the	 rate	 of	antibiotic	 resistance	 in	 human	 diseases.	 The	 use	 of	 the	 system	 also	 enables	 multiple	rounds	 of	 transformations	 to	 a	 strain	 since	 the	 technology	 is	 not	 constrained	 by	 the	number	of	selectable	markers	available.		
5.3.1 The	sacB-sucrose	method	From	 the	 literature	 the	 sacB-sucrose	 method	 is	 the	 most	 commonly	 used	 technique	 to	produce	marker-less	transformants	in	Synechocystis	(Branco	dos	Santos	et	al.,	2014).	When	attempting	to	use	the	sacB-sucrose	method,	initially	all	but	one	Synechocystis	strain	containing	 sacB	 appeared	 to	 be	 insensitive	 to	 sucrose	 (Figure	 5.5).	 This	 result	 was	unexpected,	 as	 the	 same	 sacBR/nptI	 cassette	has	been	demonstrated	 to	be	 functional	 in	
Synechocystis	 (Lea-Smith	 et	 al.,	 2013).	 After	 preparing	 the	 media	 differently,	 all	
Synechocystis	 strains	 containing	 sacB	 were	 sensitive	 to	 sucrose	 as	 expected.	 The	unexpected	results	might	be	due	to	the	media	preparation,	as	sucrose	was	autoclaved	 in	the	 initial	 growth	 ‘spot’	 test	 but	 sterilised	 in	 the	 successful	 growth	 ‘spot’	 tests.	 At	 high	temperatures,	 above	 110°C,	 such	 as	 those	 seen	 during	 autoclaving,	 the	 hydrolysis	 of	sucrose	 to	glucose	and	 fructose	occurs,	 thereby	decreasing	 the	concentration	of	sucrose.	The	concentration	of	sucrose	may	have	been	too	low	to	have	a	toxic	effect	on	Synechocystis.	In	the	literature,	the	sacB-sucrose	method	works	in	Synechocystis	in	the	presence	of	4.5%	(w/v)	 sucrose,	 but	by	 autoclaving	 sucrose	 the	 concentration	may	have	 fallen	below	 this	(Liu	and	Curtiss,	2009;	Liu	et	al.,	2011).		
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Sodium	bicarbonate,	NaHCO3,	was	also	absent	in	the	media	containing	sucrose,	when	the	transformants,	 6803.IR706.sacB	 and	 6803.IR706.sacB’	 were	 unable	 to	 grow.	 Sodium	bicarbonate	 is	 usually	 added	 to	 BG-11,	 to	 provide	 an	 additional	 carbon	 source	 to	atmospheric	carbon	dioxide,	although	how	this	might	impact	on	SacB	activity	is	unclear.	Once	sensitivity	 to	 sucrose	was	established	 for	 the	chassis	 strains	of	Synechocystis	 these	could	 be	 used	 to	 produce	marker-less	 transformants.	 However,	 attempts	 to	 the	 use	 the	
sacB-sucrose	method	were	not	very	successful	with	only	a	single	transformant	containing	
cat	being	produced.		
5.3.2 The	codA-5-FC	method	The	 expression	 of	 the	 modified	 codA	 gene	 under	 the	 PpsbAII	 promoter	 leads	 to	 the	production	 of	 cytosine	 deaminase.	 In	 the	 presence	 of	 5-FC,	 the	 modified	 cytosine	deaminase	is	able	to	accept	5-FC	as	a	substrate	and	catalyses	its	conversion	into	5-FU.	The	presence	 of	 5-FU	 leads	 to	 the	 inhibition	 of	 protein	 and	 DNA	 synthesis,	 resulting	 in	 cell	death.	These	findings	allowed	the	development	of	a	novel	method	using	codA-5-FC	for	the	production	of	marker-less	transformants,	with	the	successful	introduction	of	both	cat	and	
LS	genes	into	the	non-coding	region	between	slr1340	and	sll1255.		
5.3.2.1 Comparison	 with	 sacB-sucrose	 method	 of	 producing	 marker-less	
transformants	Only	a	single	marker-less	transformant	(containing	cat)	was	achieved	in	all	 the	attempts	made	 using	 the	 sacB-sucrose	 method,	 whereas	 with	 the	 codA-5-FC	 method	 numerous	marker-less	 transformants	 were	 achieved	 (containing	 either	 cat	 or	 LS).	 When	 a	 formal	comparison	was	attempted	between	the	sacB-sucrose	method	and	the	codA-5-FC	method,	no	transformants	were	obtained	using	the	sacB-sucrose	method.	At	least	six	transformants	each	containing	cat	 and	LS	were	obtained	using	 the	codA-5-FC	method.	However,	 as	 the	experiment	 was	 not	 repeated,	 a	 fair	 comparison	 between	 the	 two	 methods	 cannot	 be	made.	In	the	literature	there	are	no	reported	problems	with	the	sacB-sucrose	method	but	this	may	be	down	to	only	reporting	positive	results.	One	advantage	of	using	the	codA-5-FC	method	 is	 that	 selection	 is	 not	 made	 on	 media	 containing	 sucrose,	 which	 is	 more	susceptible	to	contamination.		
5.3.2.2 Comparison	with	other	methods	of	producing	marker-less	transformants	The	validation	of	the	codA-5-FC	method	adds	to	a	growing	list	of	methods	that	can	be	used	to	 produce	 marker-less	 transformants.	 An	 advantage	 of	 the	 codA-5-FC	 method	 is	 the	absence	of	 a	 scar	 site	 seen	when	 recombinases	are	used	 to	 remove	antibiotic	 resistance	
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genes.	The	codA-5-FC	method	 could	be	used	 in	 strains	 that	 cannot	use	 the	 sacB-sucrose	method	successfully	to	select	for	marker-less	transformants.	
5.3.3 Future	work	
5.3.3.1 Optimisation	of	the	codA-5-FC	Other	 than	 the	 sacB-sucrose	 method,	 alternative	 methods	 of	 producing	 marker-less	transformants	have	not	been	widely	used.	For	the	codA-5-FC	method	to	become	a	routine	method	 in	 cyanobacterial	 laboratories	 other	 improvements	 could	 be	 made	 to	 the	methodology.		When	 using	 the	 codA-5-FC	method	 to	 introduce	 cat,	 there	was	 a	misalignment	with	 the	
codA/KmR	cassette,	which	resulted	 in	an	extra	region	of	homology	that	could	 lead	to	the	production	of	unwanted	gene	arrangements.	For	the	introduction	of	LS	the	misalignment	was	removed,	and	only	two	regions	of	homology	were	present;	however,	there	were	still	transformants	when	screened	that	produced	bands	of	unexpected	sizes	(Figure	5.21).		Extending	 the	 flanking	 regions	 required	 for	 homologous	 recombination	 appeared	 to	improve	 the	 transformation	 efficiency	 as	 transformants	 containing	 cat	 were	 achieved	using	 codA/5-FC,	which	was	not	 possible	 previously.	 There	 is	 some	 evidence	 to	 suggest	that	increasing	the	region	of	homology	increases	the	transformation	efficiency	(Zang	et	al.,	2007).	Work	 done	 previously	 in	 the	 Purton	 group	 demonstrated	 that	when	 performing	natural	transformation	in	Synechocystis	with	a	transforming	plasmid,	transformants	could	be	obtained	even	when	the	region	of	homology	upstream	and	downstream	is	a	little	as	30	bp.	The	work	also	showed	that	by	increasing	the	length	of	the	flanking	region,	the	number	of	transformant	colonies	recovered	was	increased	and	there	was	a	10-fold	increase	when	the	region	of	homology	was	 increased	 from	400	bp	 to	1000	bp	(Al-Haj,	2014).	Although	the	selection	method	employed	in	this	chapter	differed,	the	result	suggests	that	increasing	the	flanking	region	may	have	played	a	role	in	obtaining	successful	transformants.	A	search	of	 the	 literature	 suggests	 that	 flanking	 regions	 of	 at	 least	 500	 bp	 upstream	 and	downstream	are	normally	used	with	the	sacB-sucrose	method	(Lagarde	et	al.,	2000;	Lea-Smith	et	al.,	2013,	2014).			When	 performing	 a	 transformation,	 at	 least	 three	 successful	 transformant	 lines	 are	required	to	perform	triplicate	studies.	Screening	 large	number	of	 initial	 transformants	 is	relatively	quick	and	easy	by	comparing	the	growth	 ‘spot’	 test	of	 transformants	on	BG-11	and	BG-11	containing	kanamycin.	This	helps	circumvent	the	main	issue	with	the	codA-5-FC	method	–	the	high	frequency	of	false	positives	on	the	control	plate	where	no	DNA	has	been	 added.	 Indeed,	 there	 were	 occasions	 where	 more	 colonies	 were	 present	 on	 the	
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control	 plate	 than	 on	 the	 transformed	 plate.	 When	 this	 occurred	 previously	 (when	transforming	the	plasmid	with	pIR706.cat)	the	plates	were	dismissed	as	unsuccessful	but	this	might	not	have	been	the	case.		Although	marker-less	transformants	produced	using	codA-5-FC	is	possible	using	the	5-FC	method	(Figure	5.28),	future	work	should	focus	on	optimising	the	conditions	(i.e.	recovery	time	 before	 selection	 pressure	 is	 applied)	 to	 ensure	 marker-less	 transformants	 are	consistently	produced,	and	the	number	of	false	positives	is	reduced	to	a	minimum.		The	method	should	also	be	attempted	in	other	strains	of	cyanobacteria,	to	see	whether	the	technique	is	transferrable.	
5.3.3.2 Utilising	the	codA-5-FC	method	for	introducing	an	operon.	The	overall	goal	of	the	‘tools	development’	was	to	develop	a	pipeline	in	which	transgenic	operons	 could	 be	 introduced	 into	 a	 neutral	 genomic	 locus	 using	 a	marker-less	 strategy,	thereby	 establishing	 the	 methodology	 for	 metabolic	 engineering	 of	 Synechocystis.	 In	Chapter	6	 the	codA-5FC	method	 is	used	 to	 try	and	 introduce	a	biosynthetic	pathway	 for	the	production	of	(S)-styrene	oxide	in	Synechocystis.			
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Figure	5.28	Protocol	used	 to	produce	marker-less	 transformants	 in	Synechocystis	 using	
the	codA	–	5-FC	method.			 	
Draw	a	diagram	of	the	table	that	shows	the	method	for	
the	produc5on	of	marker-less	transformants	in	
Synechocys)s	using	the	codA	–	5-FC	method.		Grow	chassis	strain	(6803.IR706.codA)	to	an	OD730	of	0.5-1.2	
from	a	loop	full	of	cells	.		
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Calculate	volume	of	cells	(V1)	that	need	to	be	spun	down.	
	
Spin	cells	down	at	3000g	for	10	mins	
Wash	cells	with	2ml	fresh	BG-11	media	
Resuspend	the	cells	in	1ml	fresh	BG-11	media	
Aliquot	10	μl	for	each	transforma5on	
Add	1	μg	of	DNA	
Incubate	at	20-40	μE	in	the	30°C	for	5	hours	(no	shaking)	
	
Add	2ml	of	BG-11	media	
Incubate	at	40	μE	in	25°C	for	96	hours	(shaking)	
	
Plate	1ml	and	0.5	ml	onto	BG-11	+	0.5	mg/ml	5-FC	plates	
Incubate	at	50	μE	in	the	30°C	
C1V1	=	C2V2	
C1	=	OD730	×	1.15	×	108	cells.ml-1	
C2	=	4	×	108	cells/ml	
V2	=	1ml	
V1	=	(4	×	108	cells.ml-1	×	1ml)	÷	C1	
Colonies	should	appear	a_er	7-12	days	
Pick	colonies	and	resuspend	them	in	50	μl	BG-11	
‘Spot’	10	μl	onto	BG-11	media	and		BG-11	+	200	μg/ml	
kanamycin,	(Op5onal	-	BG-11	+	0.5mg/ml	5-FC	)			
Colony	PCR	screen	–	puta5ve	transformants	that	are	able	
to	grow	on	BG-11	media	but	unable	to	grow	on	BG-11	+	
200	μg/ml	kanamycin	
Does	volume	have	an	eﬀect?		
Does	OD730	have	a	huge	eﬀect	on	
success.		
Figure	X.	Outline	of	protocol	to	
select	for	marker-less	
transformants	in	Synechocys)s	
using	the	codA	–	5-FC	method.	
Whole	process,	from	culture	
growth	to	screening,	should	
take		approximately	3	weeks.		
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Chapter	6 Introducing	 a	 heterologous	 pathway	 into	
Synechocystis	for	the	production	of	(S)-styrene	oxide	
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6.1 Introduction	
6.1.1 	(S)	–	Styrene	oxide		(S)-Styrene	oxide	(C8H8O)	is	a	chiral,	aromatic	molecule	that	is	used	as	a	building	block	for	pharmaceuticals,	speciality	chemicals	and	cosmetics.	The	anthelminthic	drug,	 levamisole,	and	nematocides	are	made	 from	 (S)-styrene	oxide	 (McKenna	et	 al.,	 2013;	Mooney	et	 al.,	2006).	 (S)-Styrene	 oxide	 is	 traditionally	 produced	 from	 the	 partial	 oxidation	 of	 styrene	over	a	heavy	metal	catalyst,	however	there	 is	no	control	over	the	stereochemistry	of	 the	product,	and	further	processing	is	needed	to	 isolate	the	useful	(S)	enantiomer	(McKenna	et	al.,	2013).		The	natural	production	of	 styrene	oxide	has	been	observed	 in	numerous	bacteria.	 Some	bacteria	 in	 the	Pseudomonas	genus	are	capable	of	utilising	styrene	as	a	source	of	carbon	(Nishio	et	al.,	2001;	Nöthe	and	Hartmans,	1994;	Panke	et	al.,	1998;	Wubbolts	et	al.,	1994).	Styrene	monoxygenase	(SMO),	encoded	by	styAB,	can	catalyse	the	conversion	of	styrene	to	styrene	oxide,	although	the	enantiomer	produced	varies	from	different	strains	(Otto	et	al.,	2004;	 Panke	 et	 al.,	 1998).	 The	 styAB	 gene	 from	 Pseudomonas	 sp.	 Strain	 VLB120	 and	
Pseudomonas	 putida	 S12	 encode	 a	 SMO	 capable	 of	 producing	 (S)-styrene	 oxide	 in	 an	enantiomeric	excess	of	>99%	(Nöthe	and	Hartmans,	1994;	Panke	et	al.,	1998,	2000,	2002).	Both	 the	 industrial	 method	 and	 the	 use	 of	 a	 single	 enzyme	 catalyst	 are	 limited	 by	 the	amount	of	styrene.	Styrene	is	usually	produced	from	the	dehydrogenation	of	ethylbenzene,	derived	 from	 petroleum,	 in	 the	 presence	 of	 steam	 over	 a	 catalyst	 and	 the	 process	 of	production	is	very	energy	intensive	(Mooney	et	al.,	2006;	U.S	Department	of	Energy,	2002).	
6.1.2 Engineering	styrene	and	(S)-styrene	oxide	biosynthesis	in	E.	coli	In	 2011,	 McKenna	 and	 Nielsen	 engineered	 E.	 coli	 to	 produce	 styrene	 from	 glucose.	 By	utilising	 the	 endogenous	 production	 of	 L-phenylalanine	 (from	 glucose),	 styrene	 was	produced	 by	 expressing	 two	 enzymes,	 PAL2	 from	 Arabidopsis	 thaliana	 and	 FDC1	 from	
Saccharomyces	cerevisiae,	in	a	strain	of	E.	coli	that	over	produces	L-phenylalanine	(Figure	6.1)	(McKenna	and	Nielsen,	2011).	PAL2	acts	as	a	phenylalanine	ammonia	lyase	(PAL)	and	deaminates	L-phenylalanine	to	produce	trans-cinnamate	(tCa).	The	decarboxylation	of	tCa	to	styrene	is	performed	by	FDC1,	originally	labeled	as	a	ferulate	decarboxylase,	and	is	the	only	enzyme	shown	to	carry	out	this	reaction	(McKenna	and	Nielsen,	2011).			
	 209	
	
Figure	6.1	Pathway	introduced	into	E.	coli	for	the	production	of	(S)-styrene	oxide.		Modified	from	(McKenna	et	al.,	2013).	Genes	introduced	into	E.	coli	are	in	blue	and	tyrA,	already	present,	is	in	orange.			McKenna	 et	 al.	 built	 upon	 their	work	 and	 extended	 the	pathway	 to	 produce	 (S)-styrene	oxide	 by	 expressing	 StyAB	 from	 Pseudomonas	 putida	 S12,	 a	 two	 component	 SMO	(McKenna	 et	 al.,	 2013).	 StyA	 is	 a	 FAD-dependent	 hydroxylase	 and	 StyB	 is	 a	 NADH-FAD	oxidoreductase,	the	reaction	requires	FADH2,	which	is	regenerated	through	the	oxidation	of	NADH	(Otto	et	al.,	2004).	The	expression	of	PAL2,	FDC1	and	StyAB	 in	E.	coli	 led	 to	 the	production	 of	 0.97±0.03	 g/L	 (S)-styrene	 oxide	 after	 72	 hours	 (McKenna	 et	 al.,	 2013).	Production	 was	 further	 improved	 to	 1.32±0.03	 g/L	 after	 72	 hours	 by	 increasing	 the	amount	 of	 L-phenylalanine	 available,	 by	 deleting	 tyrA,	 which	 encodes	 an	 enzyme	 that	produces	tyrosine	from	chorismate	(also	require	for	phenylalanine	production)	(McKenna	et	al.,	2013).		
Proposed	pathway	for	the	produc1on	of	styrene	oxide	in	E.	coli	and	
Synechocys,s,	modiﬁed	slightly	from	the	one	in	the	McKenna	Paper	
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Figure	X.	Pathway	introduced	into	E	.coli	for	the	produc1on	of	
(S)-styrene	oxide.	
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The	production	of	(S)-styrene	oxide	has	not	yet	been	attempted	in	Synechocystis,	but	could	be	 a	 more	 sustainable	 method	 than	 E.	 coli,	 as	 the	 carbon	 source	 required	 would	 be	produced	from	photosynthesis.	
6.1.3 Aims	and	objectives	The	 aim	of	 this	 project	was	 to	 demonstrate	 the	use	 of	 the	molecular	 tools	 developed	 in	Chapter	 4	 and	 Chapter	 5,	 by	 introducing	 a	 trans-operon	 (separated	 by	 the	 IGs	 tested)	under	the	control	of	Pcpc560	and	PnrsB,	using	the	codA-5-FC	method	into	Synechocystis.	As	the	production	 of	 (S)-styrene	 oxide	 has	 not	 been	 attempted	 in	 Synechocystis	 and	 has	 been	successfully	made	 in	E.	coli	 by	 introducing	 four	genes,	 the	 same	pathway	was	 chosen	 to	utilise	the	molecular	tools	developed	so	far.		
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6.2 Results	
6.2.1 Toxicity	tests	To	 examine	 the	 possible	 effects	 of	 metabolite	 toxicity	 that	 could	 occur	 with	 the	introduction	 of	 the	 (S)-styrene	 oxide	 pathway	 into	 Synechocystis,	 tCa,	 styrene	 and	 (S)-styrene	oxide	were	added	exogenously	to	cultures	of	Synechocystis	to	test	their	effects	on	growth.	Toxicity	tests	were	performed	at	an	OD730	of	~0.1	and	~0.8.	Tests	starting	at	OD730:	~0.1	could	 be	 seen	 as	 representative	 of	 expression	 under	 the	 control	 of	 Pcpc560	 and	 at	 OD730:	~0.8	as	representative	of	expression	after	nickel-induction	using	the	PnrsB	promoter.	When	tCa,	styrene	and	(S)-styrene	oxide	was	added	to	a	culture	of	Synechocystis	with	an	OD730	of	0.8-0.9,	the	growth	of	Synechocystis	appeared	unaffected	by	the	addition	of	tCa	up	to	 concentrations	 of	 1	 g/L.	 Styrene	 appeared	 to	 be	 toxic	 towards	 Synechocystis	 at	concentrations	 of	 0.2	 g/L.	 After	 72	 hours,	 the	 addition	 of	 (S)-styrene	 oxide	 at	 0.5	 g/L	appeared	to	have	a	toxic	effect	on	the	cells	and	after	120	hours	the	same	effect	was	seen	at	0.2	g/L	(Figure	6.2).		When	a	culture	of	WT	Synechocystis	was	grown	to	an	OD730	of	~0.1,	Synechocystis	was	able	to	grow	in	the	presence	of	tCa	up	to	1	g/L.	 In	the	presence	of	styrene,	Synechocystis	was	unable	to	grow	in	0.4	g/L	and	growth	in	0.2	g/L	was	slower	than	at	lower	concentrations	of	 styrene.	 Synechocystis	 was	 able	 to	 grow	 in	 (S)-styrene	 oxide	 up	 to	 0.5	 g/L.	 In	 the	presence	of	1	g/L	(S)-styrene	oxide,	the	growth	of	Synechocystis	appears	to	be	inhibited	up	until	144	hours	after	addition	(Figure	6.3).	
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Figure	 6.2	 Photographs	 of	 toxicity	 tests	 taken	 after	 the	 addition	 of	 tCa,	 styrene	 and	
styrene	oxide	to	a	culture	of	WT	Synechocystis	with	a	starting	OD730	of	~0.8		(A)	 Addition	 of	 tCa	 to	 cells.	 (B)	 Addition	 of	 styrene	 to	 cells.	 	 (C)	 Addition	 of	 styrene	oxide	to	cells.			
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Figure	X.	Photographs	of	toxicity	tests	taken	a3er	the	addi5on	of	
tCa,	styrene	and	styrene	oxide	to	a	culture	of	WT	Synechocys*s	
with	a	star5ng	OD730	of	~0.8		
(A)	Addi8on	of	tCa	to	cells.	(B)	Addi8on	of	styrene	to	cells.		(C)	
Addi8on	of	styrene	oxide	to	cells.		
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Figure	 6.3	 Photographs	 of	 toxicity	 tests	 taken	 after	 the	 addition	 of	 tCa,	 styrene	 and	
styrene	oxide	to	a	culture	of	WT	Synechocystis	with	a	starting	OD730	of	~0.1		(A)	 Addition	 of	 tCa	 to	 cells.	 (B)	 Addition	 of	 styrene	 to	 cells.	 	 (C)	 Addition	 of	 styrene	oxide	to	cells.		The	results	of	the	toxicity	tests	suggests	that	styrene	and	styrene	oxide	are	toxic	towards	
Synechocystis,	 however	 the	 threshold	 is	 quite	 high	 and	 Synechocystis	 could	 produce	 (S)-styrene	 oxide	 between	 0.1	 and	 0.2	 g/L,	 which	 is	 a	 high	 yield	 for	 novel	 compounds	produced	in	Synechocystis.		If	the	production	of	(S)-styrene	oxide	in	Synechocystis	is	higher	than	 the	 toxicity	 limit	 then	 there	 is	 the	 potential	 to	 alleviate	 toxicity	 by	 growing	 the	culture	in	a	two-phase	system	with	bis(2-ethylhexyl)phthalate	(Panke	et	al.,	2002).		
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Figure	X.	Photographs	of	toxicity	tests	taken	a3er	the	addi5on	of	
tCa,	styrene	and	styrene	oxide	to	a	culture	of	WT	Synechocys*s	
with	a	star5ng	OD730	of	~0.1		
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6.2.2 Designing	the	SO	operon	The	biosynthetic	pathway	 introduced	 into	E.	coli	 led	 to	 the	 successful	production	of	 (S)-styrene	 oxide.	 Therefore,	 the	 same	 genes	 introduced	 were	 chosen	 for	 expression	 into	cyanobacteria.	 To	 test	 the	 molecular	 techniques	 developed	 in	 the	 earlier	 chapters,	 the	genes	 were	 designed	 as	 an	 operon,	 referred	 to	 as	 the	 styrene	 oxide	 (SO)	 operon,	 for	insertion	into	Synechocystis.	The	protein	sequence	of	PAL2	from	Arabidopsis	thaliana	(GenBank	Accession	AY133595),	FDC1	 from	 Saccharomyces	 cerevisiae	 (NP_010828.1)	 and	 the	 StyAB	 subunits	 from	
Pseudomonas	 putida	 S12	 (AJA17113.1	 and	 AJA17114.1)	 were	 used	 to	 design	 codon	optimised	 synthesis	 genes	 for	 Synechocystis	 using	 IDT’s	 Codon	 Optimization	 Tool	(https://www.idtdna.com/CodonOpt).	From	the	results,	 codon-optimised	sequences	 that	did	not	contain	NdeI	and	BamHI	restriction	sites	were	chosen.	An	NdeI	restriction	site	was	positioned	 immediately	 before	 the	 start	 codon	 for	 PAL2	 and	 BamHI	 was	 positioned	immediately	after	the	stop	codon	of	StyB.	The	functional	intergenic	regions	containing	RBS	that	were	 investigated	 in	Chapter	4	were	used	 to	 separate	 the	genes	within	 the	operon.	The	intergenic	region	IG4	was	used	to	separate	PAL2	and	FDC1	and	StyA	and	StyB	and	IG5	was	used	to	separate	FDC1	and	styA	(Figure	6.4).	Due	 to	 the	 large	size	of	 the	operon	(5.5	kb),	 it	was	split	 into	 two	parts	 for	synthesis.	An	SphI	 restriction	 site,	 approximately	 halfway	 in	 the	 operon,	 was	 selected	 as	 the	 site	 at	which	to	split	 the	operon	 into	SO_Part1	(2.9	kb)	containing	PAL2	and	part	of	FDC1	gene,	and	SO_Part2	(2.6	kb),	containing	the	rest	of	FDC1	and	styA	and	styB	(Figure	6.4).	The	SphI	site	 remains	 in	both	 fragments	with	a	BamHI	 restriction	 site	 immediately	after	 the	SphI	site	 in	 SO_Part1.	 GeneART	 synthesised	 SO_Part1	 and	 SO_Part2	 and	 cloned	 them	 into	 a	plasmid	 containing	 an	 ampicillin	 resistance	 marker	 to	 produce	 SO_Part1_pMA-T	 and	SO_Part2_pMA-T,	respectively	(See	Appendix).		
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Figure	6.4	Schematic	of	the	SO	operon	designed	for	introduction	into	Synechocystis.		The	entire	(S)-styrene	oxide	operon	(A),	was	split	into	two	parts:	styrene	oxide	Part	1	(B)	and	styrene	oxide	Part	2	(C)	for	synthesis	by	GeneART.	
6.2.3 Construction	of	expression	plasmids	containing	the	SO	operon		The	 creation	 of	 four	 different	 transgenic	 strains	 of	 Synechocystis	 containing	 the	 styrene	oxide	operon	was	planned	 to	study	 the	production	of	 (S)-styrene	oxide.	Two	of	 the	 four	strains	would	 contain	 the	 operon	 at	 the	psbAII	site,	 one	 under	 the	 control	 of	 the	 nickel	inducible	promoter,	PnrsB	and	 the	other	under	 the	Pcpc560.	To	create	 these	 two	strains	 the	expression	vectors,	pLAH.nrsB	and	pLAH.cpc	would	be	used,	respectively.	The	other	two	strains	 would	 express	 the	 operon	 under	 Pcpc560	 and	 PnrsB,	 but	 at	 neutral	 site	 between	
slr1340	and	 sll1255,	 used	 previously	 for	 producing	marker-less	 transformants	 using	 the	
codA-5-FC	method.	To	introduce	the	genes	at	this	neutral	site	the	pIR706.Ex	(see	5.2.4.2.1	for	 details)	 expression	 vector	was	modified	 to	 contain	 either	 the	 Pcpc560	 and	 PnrsB	 and	 a	cloning	site	for	the	SO	operon.		
6.2.3.1 Construction	of	pIR706.Ex.cpc	and	pIR706.Ex.nrsB	In	 order	 to	 introduce	 the	 SO	 operon	 into	 the	 neutral	 site	 between	 slr1340	 and	 sll1255	under	 the	 control	 of	 the	 Pcpc560	 and	 PnrsB,	 the	 pIR706.Ex	 expression	 vector	 needed	 to	 be	modified	to	introduce	the	promoters	and	a	cloning	site	for	the	SO	operon.	
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The	nrsB	promoter	 along	with	 the	NdeI	 and	BamHI	 restriction	 sites	was	 amplified	 from	pLAH.nrsB	with	primers	pLAH.nrsB.F	and	pLAH.pro.R.	The	PCR	product	was	then	cloned	into	pIR706.Ex	at	 the	HpaI	 site.	 Similarly,	 the	cpc560	 promoter	along	with	 the	NdeI	 and	BamHI	 restriction	 sites	 was	 amplified	 from	 pLAH.cpc	 with	 primers	 pLAH.Pcpc.F	 and	pLAH.pro.R	and	the	PCR	product	cloned	into	pIR706.Ex	at	the	HpaI	site.	PCR	performed	on	with	IR706F	and	IR706R	and	DNA	sequencing	confirmed	the	creation	of	both	new	cloning	vectors:	pIR706.Ex.nrsB	and	pIR706.Ex.cpc.	It	should	be	noted	that	HpaI	is	a	blunt	ended	restriction	site	and,	DNA	sequencing	results	confirmed	the	insertion	of	the	two	promoters	in	their	respective	plasmids	were	in	the	different	orientation	to	one	another.	
6.2.3.2 Joining	the	SO	operon	and	constructing	pIR706.cpc.SO		SO_Part1	(2.9	kb)	was	isolated	from	SO_Part1_pMA-T	using	NdeI	and	BamHI,	as	the	vector	backbone	produced	a	similarly	sized	band,	the	backbone	was	digested	with	ScaI.	SO_Part2	(2.6kb)	 was	 isolated	 from	 SO_Part2_pMA-T	 using	 SphI	 and	 BamHI,	 and	 again	 ScaI	 was	used	 to	 digest	 the	 backbone.	 SO_Part1	 was	 cloned	 into	 both	 pIR706.Ex.nrsB	 and	pIR706.Ex.cpc	 at	 the	 NdeI	 and	 BamHI	 sites.	 Construction	 of	 pIR706.Ex.nrsB.SO1	 and	pIR706.Ex.cpc.SO1	was	confirmed	by	digesting	with	NdeI	and	BamHI	(Figure	6.5).	
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Figure	 6.5	 Restriction	 digest	 to	 confirm	 construction	 of	 pIR706.Ex.cpc.SO1	 and	
pIR706.Ex.nrsB.SO1		(A)	Expected	sizes	for	the	pIR706.Ex.cpc.SO1	digest	with	NdeI	and	BamHI	were	2.9	kb	and	 5.6	 kb.	 Expected	 sizes	 for	 the	 pIR706.Ex.nrsB.SO1	 digest	 with	 NdeI	 and	 BamHI	were	 2.9	 kb	 and	 5.9	 kb.	 The	 sizes	 are	 correct	 for	 both	 plasmids.	 (B)	 Schematic	 of	expected	plasmids	pIR706.Ex.cpc.SO1	and	pIR706.Ex.nrsB.SO1	with	restriction	sites	of	NdeI	and	BamHI.		SO_Part2	 (2.6	 kb)	 was	 cloned	 between	 the	 SphI	 and	 BamHI	 sites	 of	 both	pIR706.Ex.nrsB.SO1	 and	 pIR706.Ex.cpc.SO1	 to	 produce	 pIR706.Ex.nrsB.SO	 and	pIR706.Ex.cpc.SO.	It	should	be	noted	that	E.	coli	colonies	carrying	putative	transformants	for	pIR706.Ex.nrsB.SO	appeared	blue	and	pIR706.Ex.cpc.SO	appeared	pink,	when	grown	in	liquid	media;	this	observation	is	further	discussed	at	the	end	of	this	chapter.		A	 digest	was	performed	with	BamHI,	NdeI	 and	 ScaI	 to	 confirm	 the	 construction	of	 both	pIR706.Ex.nrsB.SO	 and	 pIR706.Ex.cpc.SO,	 however	 the	 digest	 indicated	 a	 problem	 with	pIR706.Ex.nrsB.SO	 between	 the	 BamHI	 and	 ScaI	 restriction	 site	 (Figure	 6.6).	 This	 was	confirmed	 by	 sequencing	 analysis	 using	 primers	 nrsBseqF,	 SO_seq_1R,	 SO_seq_2F,	SO_seq_3R,	SO_seq_4F,	SO_seq_5F,	SO_seq_6R,	and	SO_seq_EndF.	Sequencing	analysis	also	
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confirmed	 the	construction	of	 the	SO	operon	 in	both	constructs.	Due	 to	 time	constraints	the	pIR706.Ex.nrsB.SO	was	not	recreated.		
	
Figure	 6.6	 Restriction	 digest	 to	 confirm	 the	 construction	 of	 pIR706.Ex.cpc.SO	 and	
pIR706.Ex.nrsB.SO.		(A)	Expected	sizes	for	pIR706.Ex.cpc.SO	digest	with	NdeI,	BamHI	and	ScaI	were	5.5,	2.7,	1.8	and	1.1	kb.	The	sizes	observed	on	the	gel	confirm	that	this	plasmid	is	as	expected.	Expected	 sizes	 for	 pIR706.Ex.nrsB.SO	 were	 5.5,	 2.7,	 2.6	 and	 0.5	 kb.	 The	 band	 sizes	observed	do	not	correspond	to	this	with	the	0.5	kb	band	absent	and	a	band	at	1.5	kb	present	 instead.	(B)	Schematic	of	expected	expression	plasmids	pIR706.Ex.cpc.SO	and	pIR706.Ex.nrsB.SO	with	restriction	sites	of	NdeI,	BamHI	and	ScaI.		
6.2.3.3 Construction	of	pLAH.nrsB.SO	and	pLAH.cpc.SO	The	 SO	 operon	was	 digested	 from	 the	 incorrectly	 constructed	 pIR706.Ex.nrsB.SO,	 using	NdeI	 and	BamHI	 and	 cloned	 into	pLAH.nrsB	 and	pLAH.cpc	 at	 the	 same	 restriction	 sites.	Putative	E.	coli	 transformants	 containing	pLAH.nrsB.SO	 and	pLAH.cpc.SO	were	 grown	 in	liquid	media	with	some	appearing	to	produce	a	blue	pigment,	as	seen	previously	in	E.	coli	strains	containing	pIR706.Ex.nrsB.SO.			
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Fig	X.	RestricGon	digest	to	conﬁrm	the	construcGon	of	
pIR706.Ex.cpc.SO	and	pIR706.Ex.nrsB.SO.		
(A)	Expected	sizes	for	pIR706.Ex.cpc.SO	digest	with	NdeI,	BamHI-HF	and	
ScaI	were	5.5,	2.7,	1.8	and	1.1	kb.	The	sizes	are	correct	for	this	plasmid.		
Expected	sizes	for	pIR706.Ex.nrsB.SO	were	5.5,	2.7,	2.6	and	0.5	kb.	The	
sizes	are	not	correct	with	the	0.5	kb	band	absent	and	a	band	at	1.5	kb	
present	instead.	(B)	SchemaGc	of	expected	expression	plasmids	
pIR706.Ex.cpc.SO	and	pIR706.Ex.nrsB.SO	with	restricGon	sites	of	NdeI,	
BamHI-HF	and	ScaI.		
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The	 plasmid	 extracted	 from	 two	 putative	 transformants	 of	 pLAH.cpc.SO	 –	 P1	 (normal	culture	 colour)	 and	 P4	 (Blue	 pigment	 present	 in	 medium)	 –	 were	 digested	 with	 XbaI,	BamHI	and	NdeI	together	with	a	putative	pLAH.nrsB.SO	transformant	–	N5	(Blue	pigment	present	 in	 medium).	 The	 results	 confirmed	 the	 insertion	 of	 the	 SO	 operon	 in	pLAH.cpc.SO_4	and	pLAH.nrsB.SO_5,	both	of	which	gave	a	blue	 coloration	 to	 the	 culture,	whereas	 for	 pLAH.cpc.SO_1	 the	 SO	 operon	 was	 absent	 (Figure	 6.7).	 The	 production	 of	indigo	 from	 these	 cell	 lines	 is	 the	most	 likely	 explanation	 for	 this	 result	 and	 is	 further	discussed	at	the	end	of	this	chapter.		
6.2.4 Creation	of	transgenic	strains	6803.AII.cpc.SO	and	6803.AII.nrsB.SO	WT	 Synechocystis	 was	 transformed	 with	 pLAH.nrsB.SO	 and	 pLAH.cpc.SO	 in	 order	 to	introduce	 the	 SO	 operon	 at	 the	 psbAII	 site.	 Colonies	 appeared	 after	 selection	 for	kanamycin	 resistance.	 A	 PCR	 performed	 on	 selected	 transformants,	 using	 primers	Ben.seq.up.F	and	C.frag.BR	confirmed	the	integration	of	the	SO	operon	in	6	of	the	8	tested	transformants	lines	of	6803.AII.cpc.SO	(Figure	6.8).	Integration	of	SO	operon	was	also	seen	in	 3	 of	 the	 8	 putative	 transformants	 of	 6803.AII.nrsB.SO	 at	 the	 psbAII	 site.	 	 All	 three	transformants	appeared	to	be	homoplasmic.			
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Figure	6.7	Confirmation	of	the	construction	of	plasmid	pLAH.cpc.SO	and	pLAH.nrsB.SO.		(A)	Photograph	of	selected	E.	coli	cultures	containing	different	plasmid	constructs.	That	for	pLAH.cpc.SO_1	appears	typical	of	an	E.	coli	culture	but	in	both	pLAH.cpc.SO_4	(P4)	and	pLAH.nrsB.SO_5	(N5)	a	blue	pigment	appears	to	be	produced.	(B)	Restriction	digest	of	 the	 plasmids.	 Expected	 sizes	 for	 pLAH.cpc.SO	 were	 5.5,	 3.7,	 and	 1.4	 kb.	 Expected	sizes	 for	 pLAH.nrsB.SO	were	 5.5,	 4,	 and	 1.4	 kb.	 The	 expected	 sizes	were	 seen	 in	 the	‘blue’	cultures,	P4	and	N5,	but	not	P1.	(C)	Schematic	of	pLAH.cpc.SO	and	pLAH.nrsB.SO	with	restriction	sites	of	NdeI,	BamHI	and	XbaI.			
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Fig	X.	ConﬁrmaNon	of	the	construcNon	of	expression	vectors	
pLAH.cpc.SO	and	pLAH.nrsB.SO.		
(A)	Photographs	of	selected	cultures,	pLAH.cpc.SO_1	appears	normal	
but	in	both	pLAH.cpc.SO_4	(P4)	and	pLAH.nrsB.SO_5	(N5)	a	blue	
pigment	appears	to	be	produced.	(B)	RestricNon	digest	of	the	the	
selected	expression	vectors.	Expected	sizes	for	pLAH.cpc.SO	were	5.5,	
3.7,	and	1.4	kb.	Expected	sizes	for	pLAH.nrsB.SO	were	5.5,	4,	and	1.4	
kb.	The	expected	sizes	were	seen	in	the	‘blue’	cultures	P4	and	N5	but	
not	P1.	(C)	SchemaNc	of	expected	expression	plasmids	pLAH.cpc.SO	
and	pLAH.nrsB.SO	with	restricNon	sites	of	NdeI,	BamHI-HF	and	XbaI.		
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Figure	6.8	PCR	screening	for	successful	transformants	in	Synechocystis	containing	the	SO	operon	at	the	psbAII	locus.	(A)	Schematic	showing	the	binding	sites	of	the	primers	and	expected	fragment	sizes	for	WT	Synechocystis,	6803.cpc.SO	and	6803.nrsB.SO.	(B)	PCR	screening	of	putative	transformants	of	6803.cpc.SO.	(C)	PCR	screening	or	putative	transformants	of	6803.nrsB.SO.	For	(B)	and	(C)	the	expected	sizes	for	WT	Synechocystis	was	1.9	kb,	6803.cpc.SO	was	8.0	kb	and	6803.nrsB.SO	was	8.3	kb.		WT	Synechocystis	(WT),	pLAH.AII.codA	(+C)	and	no	DNA	template	(-C)	were	used	as	controls.	All	successful	transformants	are	homoplasmic	with	an	absent	band	at	1.9	kb.			
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Figure	X.	PCR	screening	for	successful	transformants	in	Synechocys)s	containing	the	styrene	
oxide	operon	at	the	psbAII	locus.	
(A)	SchemaOc	showing	the	binding	sites	of	the	primers	and	expected	fragment	sizes	for	WT	
Synechocys1s,	6803.cpc.SO	and	6803.nrsB.SO.	(B)	Colony	PCR	screening	of	putaOve	
transformants	of	6803.cpc.SO.	(C)	Colony	PCR	screening	or	putaOve	transformants	of	
6803.nrsB.SO.	For	(B)	and	(c)	the	expected	sizes	for	WT	Synechocys1s	was	1.9	kb,	6803.cpc.SO	
was	8.0	kb	and	6803.nrsB.SO	was	8.3	kb.		WT,	pLAH.AII.codA,	+C,	and	no	DNA	template,	-C,	
were	used	as	controls.	All	correct	transformants	are	homoplasmic	strains	with	an	absent	band	
at	1.9	kb.		
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6.2.5 Creation	 of	 control	 strain,	 6803.IR706.cpc,	 and	 unsuccessful	 attempts	 at	
producing	marker-less	transformants	containing	the	SO	operon	Attempts	using	 the	codA-5-FC	method,	 established	 in	Chapter	5,	 to	produce	marker-less	transformants	 with	 the	 SO	 operon	 using	 pIR706.Ex.cpc.SO	 to	 transform	 the	 recipient	strain	 6803.IR706.codA	 proved	 unsuccessful.	 A	 transformation	 using	 pIR706.Ex.cpc.SO	and	pIR706.Ex.cpc	(to	produce	a	control	strain)	resulted	in	the	appearance	of	colonies	13	days	after	plating.	From	both	sets	of	plates,	32	colonies	were	picked	and	grown	onto	BG-11	 and	 BG-11	 supplemented	 with	 kanamycin.	 Of	 the	 32	 putative	 transformants	 of	6803.IR706.cpc.SO,	all	32	colonies	were	able	to	grow	in	the	presence	of	kanamycin.	This	indicates	that	the	codA/KmR	gene	cassette	was	not	replaced	by	the	SO	operon	(results	not	shown).		However,	the	creation	of	the	control	strain,	6803.IR706.cpc	was	successful.	From	the	32	colonies	picked,	five	colonies	were	unable	to	grow	onto	BG-11	supplemented	with	kanamycin	but	were	able	 to	grow	on	BG-11	only	 (Figure	6.9).	PCR	analysis	of	 these	 five	transformant	lines	confirmed	the	replacement	of	codA	with	the	Pcpc560	(Figure	6.9).		
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Figure	6.9	Screening	of	marker-less	transformants	of	Synechocystis	containing	the	Pcpc560	
at	the	neutral	site,	between	slr1340	and	sll1255.		(A)	Growth	 ‘spot’	 test	of	32	putative	marker-less	 transformants	grown	on	BG-11	and	BG-11	 supplemented	 with	 200	 μg/ml	 kanamycin.	 Photograph	 taken	 2	 weeks	 after	incubation.	From	the	32	colonies,	5	appear	to	be	marker-less	transformants	containing	the	 cpc560	 promoter.	 (B)	 Schematic	 showing	 the	 primer	 binding	 site	 and	 expected	fragments	 of	WT	 Synechocystis	 and	 6803.IR706.cpc.	 (C)	 PCR	 Screening	 primers	 with	IR706	Ex	Flank	F	and	IR706	Ex	Flank	R	of	the	five	putative	transformants.	All	of	those	tested	contain	the	cpc560	promoter	and	are	homoplasmic,	with	a	single	band	seen	at	2.7	kb.	WT	Synechocystis	(WT)	and	a	no	DNA	template	(-C)	are	used	as	controls.			
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Fig.	Screening	of	marker-less	transformants	of	Synechocys)s	
containing	the	cpc	promoter.		
(A)	Growth	‘spot’	test	of	32	puta8ve	marker-less	transformants	
grown	in	BG-11	media	and	BG-11	media	supplemented	with	200	
μg/ml	kanamycin.	Photograph	taken	2	weeks	a\er	incuba8on.	
From	the	32	colonies,	5	appear	to	be	marker-less	transformants	
containing	the	cpc560	promoter.	(B)	Schema8c	showing	the	
primer	binding	site	and	expected	fragments	of	WT	Synechocys)s	
and	6803.IR706.cpc.	(C)	PCR	Screening	primers	with	IR706	Ex	
Flank	F	and	IR706	Ex	Flank	R	of	the	puta8ve	transformants	that	
appeared	to	be	marker-less	transformants.	All	of	those	tested	
contain	the	cpc560	promoter	and	are	homoplasmic,	with	a	single	
band	seen	at	2.7	kb.	WT	Synechocys)s,	WT,	and	a	no	DNA	
template,	-C,	are	used	as	controls.		
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6.3 Discussion		In	 summary:	 i)	 toxicity	 tests	 were	 conducted	 for	 (S)-styrene	 oxide	 and	 the	 two	intermediates	 in	 its	 synthesis;	 	 ii)	 a	 synthetic	 operon	 for	 the	 production	 of	 (S)-styrene	oxide	was	designed	and	introduced	into	Synechocystis	at	the	psbAII	site	under	the	control	of	the	nrsB	and	cpc560	promoter.	However	production	of	(S)-styrene	oxide	has	yet	to	be	tested	 to	 validate	 the	 design	 of	 the	 operon.	 iii)	 Introduction	 of	 the	 SO	 operon	 into	 the	neutral	site	using	the	codA-5-FC	method	was	unsuccessful,	suggesting	more	work	needs	to	be	done	to	optimise	the	selection	method	when	trying	to	introduce	large	regions	of	foreign	DNA	such	as	the	SO	operon.		
6.3.1 Toxicity	tests	Exogenous	 addition	 of	 tCA,	 styrene	 and	 (S)-styrene	 oxide	 to	WT	 Synechocystis	 may	 not	cause	the	same	cell	response	seen	if	the	compound	was	produced	within	the	cell,	but	gives	an	 indication	 of	 their	 toxicity	 towards	 the	 cell.	 The	 results	 suggest	 that	 Synechocystis	 is	able	to	grow	in	the	presence	of	tCa	up	to	1	mg/L.	The	results	differ	slightly	for	styrene	and	styrene	 oxide	 when	 added	 to	 the	 cells	 at	 a	 low	 OD	 and	 at	 a	 higher	 OD.	 At	 a	 low	 OD,	
Synechocystis	was	able	 to	grow	 in	 the	presence	of	0.2	g/L	styrene	and	1	g/L	 (S)-styrene	oxide,	but	at	a	higher	OD	value	styrene	and	(S)-styrene	oxide	are	both	toxic	at	0.2	g/ml.	In	
E.	coli,	the	toxic	limits	were	0.8	g/L	for	tCa;	0.3	g/L	for	styrene	and	1.6	g/L	for	(S)-styrene	oxide	 (McKenna	 and	 Nielsen,	 2011;	 McKenna	 et	 al.,	 2013).	 So	 compared	 to	 E.	 coli,	
Synechocystis	can	tolerate	a	higher	concentration	of	tCa,	but	a	lower	concentration	of	(S)-styrene	oxide.	1.32	g/L	of	(S)-styrene	oxide	was	produced	in	E.	coli	after	the	introduction	of	 the	SO	operon,	which	 is	above	the	toxicity	 limit	seen	 in	Synechocystis	 (McKenna	et	al.,	2013).	 In	E.	 coli	 strains	where	 only	 the	 SMO	 is	 expressed	 and	 styrene	 is	 provided	 as	 a	substrate,	 12	 g/L	 of	 (S)-styrene	 oxide	 was	 produced	 when	 a	 two-phase	 system	 was	adopted	 with	 bis(2-ethylhexyl)phthalate	 (Panke	 et	 al.,	 2002).	 The	 addition	 of	 bis(2-ethylhexyl)phthalate	also	increased	the	production	of	styrene,	to	0.8	g/L,	in	E.	coli	strains	expressing	PAL2	and	FDC1	(McKenna	et	al.,	2014).	A	two-phase	system	could	also	be	used	in	 Synechocystis	 to	 alleviate	 the	 toxicity	 of	 (S)-styrene	 oxide	 and	 improve	 production,	however	the	yields	produced	in	Synechocystis	may	not	be	capable	of	competing	with	E.	coli.		In	E.	coli	there	is	a	correlation	between	toxicity	of	the	solvent	and	its	logKO/W	value,	which	is	 not	 seen	 in	 Synechocystis	 (McKenna	 and	 Nielsen,	 2011;	 McKenna	 et	 al.,	 2013).	 The	octanol-water	 partition	 coefficient	 (reported	 as	 logKO/W)	 of	 organic	 solvents	 often	correlates	with	the	antimicrobial	activity	of	the	solvent	therefore	it	is	used	as	an	indicator	of	 solvent	 toxicity	 towards	 bacteria.	 The	 logKO/W	 of	 (S)-styrene	 oxide	 (1.61)	 is	 less	 than	
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that	of	styrene	(3.05)	and	tCa	(2.13).	Usually	if	the	logKO/W	calculated	is	between	1.5	and	5,	the	 solvent	 is	 hydrophobic	 and	 likely	 to	 be	 toxic	 (Heipieper	 et	 al.,	 1994;	 Ramos	 et	 al.,	2002).	 Hydrophobic	 aromatics	 are	 thought	 to	 accumulate	 within	 the	 cytoplasmic	membrane,	disrupting	the	integrity	of	the	membrane,	causing	ions	to	leak,	a	change	in	pH	and	 the	 proton	 gradient	 (Knoshaug	 and	 Zhang,	 2008).	 The	 toxicity	 of	 tCa	 towards	
Synechocystis	 should	be	 tested	 further,	 as	 the	 concentration	 tested	 in	 these	 experiments	did	not	cause	cell	death	and	may	not	be	interacting	with	the	cells	to	have	an	effect	when	added	exogenously.		When	 (S)-styrene	 oxide	 production	 was	 detected	 in	 E.	 coli,	 the	 intermediates	 tCa	 and	styrene	 were	 not	 detected,	 suggesting	 that	 there	 is	 a	 rapid	 turnover	 of	 the	 products	(McKenna	et	al.,	2013).	 If	 this	 is	 the	case	 in	Synechocystis	then	the	toxicity	of	(S)-styrene	oxide	is	most	likely	to	have	a	toxic	effect	towards	the	cell,	compare	to	styrene	and	tCa.		
6.3.2 Production	of	indigo	The	 blue	 pigment	 produced	 in	 E.	 coli	 containing	 plasmids	 with	 the	 SO	 operon,	pLAH.nrsB.SO,	pLAH.cpc.SO,	pIR706.nrsB.SO	and	pIR706.cpc.SO	was	most	 likely	 indigo,	a	brilliant	 blue	 pigment	 used	 to	 dye	 fabrics	 such	 as	 cotton	 and	wool,	 and	was	 due	 to	 the	expression	of	styAB.	The	conversion	of	indole	into	indigo	in	E.	coli	by	monooxygenases	and	dioxygenases,	such	as	the	SMO	in	the	SO	operon	has	been	demonstrated	and	are	presented	in	Figure	6.10.	E.	coli	transformants	expressing	styAB	can	therefore	be	selected	for	on	LB	medium	 supplemented	with	 indole	 as	 blue	 colonies,	 indicating	 the	 production	 of	 indigo	(Panke	 et	 al.,	 1998).	 The	 absence	 of	 indole	 in	 the	medium,	may	 explain	why	 the	E.	 coli	colonies	 containing	 the	 SO	 constructs	 were	 unable	 to	 produce	 sufficient	 indigo	 to	 be	initially	seen	on	solid	medium.		The	results	suggests	that	styA	and	styB	are	transcribed,	although	it	is	not	known	whether	the	Synechocystis	promoters,	Pcpc560	and	PnrsB	are	functional	in	E.	coli,	or	whether	there	is	a	cryptic	promoter	in	the	upstream	flanking	region	of	styAB	within	the	SO	operon,	which	is	responsible.	RT-PCR	could	be	used	to	check	which	promoter	is	transcribing	styA	and	styB.	The	amount	of	 indigo	produced	in	the	E.	coli	strain	carrying	the	pLAH.cpc.SO,	appears	to	be	 greater	 than	 pLAH.nrsB.SO,	 which	 correlates	 with	 the	 higher	 activity	 of	 the	 Pcpc560	promoter	in	Synechocystis	(Figure	3.22).	On	one	occasion,	transformants	containing	pIR706.cpc.SO,	appeared	pink	in	colour,	which	could	 be	 the	 production	 of	 indirubin	 (also	 known	 as	 indigo	 red).	 One	 of	 the	 proposed	mechanisms	for	the	production	of	indirubin	is	presented	in	Figure	6.10.	Indirubin	can	also	be	produced	from	the	condensation	reaction	of	isatin	and	indoxyl.	Isatin	can	be	made	from	
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oxidation	 of	 indoxyl	 and	 2-hydroxylindole	 (Meyer	 et	 al.,	 2002;	 Rui	 et	 al.,	 2004).	 The	production	of	indirubin	has	been	detected	when	expressing	heterologous	oxygenases	in	E.	
coli	(Rui	et	al.,	2004).		The	 production	 of	 indigo	 has	 not	 been	 reported	 in	 Synechocystis	 and	 an	 assay	 could	 be	devised	 to	detect	 the	production	of	 indigo	by	supplementing	 the	media	with	 indole.	The	blue-green	 colouration	 of	 the	 cells	might	make	 indigo	detection	 in	 the	 cultures	 difficult,	however	 in	 E.	 coli	 the	 insolubility	 of	 indigo	 in	 the	 media	 may	 only	 require	 visual	confirmation.	 The	 production	 of	 indigo	 would	 confirm	 the	 function	 of	 styAB	 in	 the	 SO	operon.		
	
Figure	6.10	Possible	pathway	for	the	production	of	indigo	and	indirubin	in	recombinant	
E.	coli	expressing	styrene	monoxygenase	(SMO).		3-Hydroxyindole	is	also	known	as	indoxyl.	Modified	from	(Han	et	al.,	2013).		
6.3.3 Marker-less	transformants	containing	the	SO	operon	The	 few	 attempts	 undertaken	 to	 introduce	 the	 SO	 operon	 using	 the	 codA-5-FC	method	were	 unsuccessful,	 although	 the	 creation	 of	 the	 control	 strain	 6803.IR706.cpc,	 was	achieved.	 This	 possibly	 reflects	 the	 inefficiency	 of	 the	method	when	 trying	 to	 introduce	
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large	sections	of	foreign	DNA.	Furthermore,	the	protocol	used	in	the	previous	methods	for	the	successful	production	of	marker-less	transformants	used	1	μg	of	plasmid,	however	as	the	size	of	 the	plasmids	containing	 the	SO	operon	are	much	 larger	(more	 than	 twice	 the	size)	 more	 DNA	 may	 be	 needed	 to	 increase	 the	 likelihood	 of	 obtaining	 transformants.	Finally,	the	SO	operon	was	cloned	into	the	HpaI	site	of	pIR706.Ex,	as	with	cat	in	Chapter	5,	resulting	in	three	regions	of	homology	and	the	production	of	transformants	that	reverted	back	to	the	WT	strain	(see	Figure	5.18).	Further	work	is	therefore	needed	to	optimise	the	transformation	efficiency	of	the	method	and	to	reduce	the	number	of	false	positives	seen.	
6.3.4 Future	work		
6.3.4.1 Detecting	the	production	of	(S)-styrene	oxide	Due	to	time	constraints,	the	production	of	(S)-styrene	oxide	in	the	transformant	lines	has	yet	 to	 be	 determined.	 Production	 of	 (S)-styrene	 oxide	 in	 E.	 coli	 was	 detected	 in	 the	supernatant	via	HPLC	analysis	and	could	be	similarly	employed	to	detect	the	production	in	
Synechocystis.	 If	 (S)-styrene	 oxide	 or	 the	 intermediates	 are	 not	 detected	 then	 RT-PCR	could	be	used	 initially	 to	detect	whether	 the	 genes	 in	 the	operon	 are	being	 transcribed.	The	expression	of	each	gene	would	then	need	to	be	confirmed	by	Western	blot	analysis.	In	order	 to	 do	 this,	 expression	 tags	 will	 need	 to	 be	 redesigned	 into	 the	 construct	 and	retransformed	into	Synechocystis.		
6.3.4.2 Optimising	the	production	of	(S)-styrene	oxide	Once	(S)-styrene	oxide	has	been	detected	in	Synechocystis,	production	could	be	increased	by	 further	metabolic	 engineering	 to	 reduce	 the	 effect	 of	 any	 bottlenecks	 present	 in	 the	metabolic	pathway.	In	E.	coli	the	amount	of	(S)-styrene	oxide	produced	was	0.97±0.03	g/L	after	72	hours.	However,	this	was	increased	to	1.32±0.03	g/L	after	72	hours,	by	deleting	
tyrA	 which	 led	 to	 an	 increase	 in	 the	 amount	 of	 chorismate	 available,	 which	 in	 turn	increased	 the	pool	of	phenylalanine	available	 for	PAL2	(McKenna	et	 al.,	 2013).	Attempts	were	also	made	in	E.	coli	to	increase	the	pool	of	phenylalanine	by	deleting	trpE	(involved	in	 the	 synthesis	 of	 tryptophan)	 along	 with	 tyrA	 however	 the	 increase	 of	 phenylalanine	seen	with	the	deletion	of	tyrA	was	negated	by	the	deletion	of	trpE	(McKenna	et	al.,	2013).	A	similar	approach	could	be	done	in	Synechocystis	to	improve	the	amount	of	phenylalanine	present	for	PAL2.					
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Chapter	7 	Final	discussion	
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7.1 Summary	of	findings	As	energy	demands	increase,	photosynthetic	microorganisms	such	as	cyanobacteria	have	the	 potential	 to	 provide	 a	 ‘green’	 alternative	 for	 the	 production	 of	 biofuels	 and	 other	chemicals	 that	 are	 usually	 derived	 from	 finite	 fossil	 fuels.	 However,	 the	 levels	 of	 novel	compounds	 produced	 in	 engineered	 strains	 are	 a	 long	 way	 from	 industrial	 production	levels	and	yields	are	not	yet	economically	viable.	A	significant	limitation	with	engineering	cyanobacteria	 for	 the	 production	 of	 novel	 compounds	 is	 the	 lack	 of	 a	 suite	 of	 biological	parts	that	are	well	characterised,	and	allow	advanced,	metabolic	manipulation.	The	initial	aims	of	the	project	were	to	 investigate	metabolic	engineering	in	Synechocystis	using	limonene	as	a	test	product	that	has	commercial	value	as	a	fragrance	and	could	be	a	potential	 replacement	 for	 jet	 fuel,	 to	 develop	 and	 characterise	 new	 DNA	 parts,	 a	 new	genomic	insertion	site	and	a	marker-free	transformation	strategy	for	Synechocystis	and	to	use	these	tools	to	demonstrate	multigenic	engineering	by	introducing	a	synthetic	operon	for	the	production	of	a	novel	compound.	A	synthetic	LS	gene	was	successfully	expressed	 in	Synechocystis	under	 the	control	of	 the	three	promoters	(PpsbAII,	PnrsB	and	Pcpc560),	however	limonene	production	was	not	detected	in	 this	 study	 and	 further	 work	would	 be	 needed	 to	 understand	why	 this	 was	 the	 case.	During	the	course	of	the	project,	 limonene	production	in	different	cyanobacterial	species	was	achieved	by	three	separate	groups	(Davies	et	al.,	2014;	Halfmann	et	al.,	2014;	Kiyota	et	 al.,	 2014).	 Expression	 of	Mentha	 spicata	 LS	 in	 Synechocystis	 7002	 using	 a	 dodecane	overlay,	similar	to	the	system	attempted	in	this	study,	resulted	in	the	highest	production	of	limonene	(4	mg/L)	out	of	the	three	strains	(Davies	et	al.,	2014).	In	the	other	two	strains,	different	LS	genes	and	different	methods	of	capturing	limonene	were	used,	which	resulted	in	 lesser	 yields,	 even	 though	 some	 genes	 involved	 in	 the	 MEP	 pathway	 were	overexpressed	to	improve	the	amount	of	substrate	for	LS	(Halfmann	et	al.,	2014;	Kiyota	et	al.,	2014).		The	 newly	 discovered	 ‘super’-strong	 promoter,	 Pcpc560,	 was	 shown	 to	 be	 a	 stronger	promoter	 than	 PpsbAII,	 and	 PnrsB,	 and	 was	 used	 to	 express	 multiple	 genes	 in	 an	 operon.	Several	IGs	regions	were	tested	within	an	operon	and	gave	varying	levels	of	expression	of	the	 downstream	 gene.	 Furthermore,	 it	 was	 found	 that	 the	 absence	 of	 an	 IG	 region	 still	resulted	in	the	translation	of	the	downstream	gene.		An	 alternative	 method	 to	 the	 sacB-sucrose	 method	 for	 the	 production	 of	 marker-less	transformants	 was	 developed.	 Although	 the	 method	 requires	 some	 optimisation,	 the	production	 of	 marker-less	 transformants	 enables	 numerous	 rounds	 of	 transformations	
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unlimited	 by	 the	 number	 of	 available	 antibiotic	 resistance	 genes.	 The	method	 could	 be	used	 with	 other	 strains	 of	 cyanobacteria	 such	 as	 Synechococcus	 7942	 that	 are	 able	 to	insert	genes	into	their	genome	via	homologous	recombination.	An	 operon	was	 designed	 to	 produce	 (S)-styrene	 oxide	 and	was	 successfully	 introduced	into	 Synechocystis,	 using	 the	 IG	 regions	 designed	 in	 Chapter	 4.	 However,	 due	 to	 time	limitations	further	work	is	required	to	detect	the	production	of	(S)-styrene	oxide.		
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7.2 Challenges	 and	 opportunities	 to	 using	 cyanobacteria	 as	 a	
microbial	cell	factory		The	 production	 of	 novel	 compounds	 has	 been	 demonstrated	 in	 cyanobacteria	 at	 a	 lab-scale,	 however	 before	 these	 products	 can	 be	 produced	 at	 an	 industrial	 level	 there	 are	many	challenges	ahead.	In	this	section,	some	of	these	challenges	are	discussed.		
7.2.1 Improving	product	yield	The	 yields	 of	 novel	 compounds	 produced	 from	 engineered	 E.	 coli	 or	 S.	 cerevisiae	 are	significantly	greater	than	those	seen	in	cyanobacteria	(Liao	et	al.,	2016).	Out	of	the	three	cyanobacterial	 strains	 that	managed	 to	produce	 limonene	 the	 engineered	Synechococcus	7002	 produced	 the	most	 (4	mg/L)	 but	 the	 yield	was	 still	 approximately	 100	 times	 less	than	that	achieved	in	E.	coli	(400	mg/L)(Alonso-Gutierrez	et	al.,	2013;	Davies	et	al.,	2014).	Various	strategies	have	been	investigated	in	the	hope	of	 increasing	the	production	levels	in	cyanobacteria.		
7.2.1.1 Engineering	the	chassis		As	 photosynthesis	 is	 driving	 the	 production	 of	 novel	 compounds	 in	 engineered	cyanobacteria,	 improvements	 to	 the	 photosynthetic	 efficiency	 have	 the	 potential	 to	improve	 yield.	 Improving	 light	 harvesting	 and	 CO2	 fixation	 in	 cyanobacteria	 are	 all	strategies	that	have	been	investigated	in	cyanobacteria	(Jensen	and	Leister,	2014).		Expanding	the	solar	spectrum	used	in	photosynthesis	from	400-700	nm	to	750	nm	could	be	 a	method	 of	 extending	 the	wavelengths	 absorbed	 and	 improve	 light	 harvesting.	 This	could	 be	 achieved	 by	 introducing	 chlorophyll	 d	 found	 in	 Acaryochloris	 marina,	 and	 a	recently	 discovered	 chlorophyll	 f	 found	 in	Halomicronema	 hongdechloris,	 which	 absorb	light	in	the	infra-red	region.	This	could	increase	the	available	photons	for	photosynthesis	by	19%,	but	whether	 this	 could	help	 increase	biofuel	production	 is	unknown	(Chen	and	Blankenship,	2011).		As	aforementioned	 in	 the	 introduction,	RuBisCO	has	been	 the	 target	 for	many	studies	 to	enhance	 carbon	 fixation	 but	 there	 has	 been	 little	 research	 investigating	 alternative	strategies	(Durall	and	Lindblad,	2015).	Recently,	the	overexpression	of	RuBisCO,	and	a	few	genes	involved	in	the	Calvin-Bassham-Benson	cycle	resulted	in	improved	growth	rate	and	biomass	 accumulation	 in	 Synechocystis	 (Liang	 and	 Lindblad,	 2016).	 To	 improve	 carbon	uptake,	 the	 endogenous	 bicarbonate	 transporters	 found	 in	 Synechocystis	 were	overexpressed.	This	led	to	an	increase	in	HCO3−	uptake	and	resulted	in	increased	biomass	accumulation	(Kamennaya	et	al.,	2015).	These	 findings	should	encourage	 further	studies	
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to	 see	 the	 effect	 of	 improved	 carbon	 fixation	 and	 light	 harvesting	 on	 the	 production	 of	novel	compounds	in	cyanobacteria.		
7.2.1.2 Relieving	toxicity	
E.	coli	is	capable	of	producing	400	mg/L	limonene.	However,	if	limonene	is	to	be	produced	as	a	competitive	replacement	for	jet	fuel,	it	has	been	calculated	that	approximately	6.4	g/L	of	 limonene	 needs	 to	 be	 produced,	 which	 is	 0.76%	 (v/v).	 	 Since	 complete	 growth	inhibition	 is	seen	 in	E.	coli	with	0.025%	(v/v),	a	more	tolerant	strain	 is	needed	(Dunlop,	2011).	Recently,	the	oxidised	derivative	of	limonene,	limonene	hyperoxide,	was	identified	as	 the	 cause	 of	 the	 toxic	 effect	 seen	 in	 E.	 coli,	 rather	 than	 limonene.	 The	 toxicity	 of	limonene	 hyperoxide	 could	 be	 alleviated	 by	 a	 point	mutation	 in	 an	 alkyl	 hyperoxidase,	AhpC	(Chubukov	et	al.,	2015).	The	effect	of	limonene	hyperoxide	has	not	been	investigated	in	cyanobacteria	and	it	would	be	interesting	to	examine	whether	a	similar	effect	is	seen.	If	this	is	the	case	in	Synechocystis,	sll1621	is	predicted	to	encode	an	AhpC/TSA	family	protein	and	could	be	studied	further	to	see	whether	it	could	relive	toxicity.		Transcriptomic	 and	 proteomic	 analyses	 performed	 on	 Synechocystis,	 in	 the	 presence	 of	ethanol,	butanol	and	hexane,	have	helped	to	identify	genes	that	are	up-	or	down-regulated.	Potentially,	these	could	be	targeted	in	order	to	improve	tolerance	(Anfelt	et	al.,	2013;	Liu	et	al.,	2012;	Qiao	et	al.,	2012;	Tian	et	al.,	2013;	Wang	et	al.,	2012;	Zhu	et	al.,	2013).	For	both	butanol	and	ethanol	treatment	of	Synechocystis,	specific	response	regulators	(encoded	by	
sll0039	 and	 sll0794,	 respectively)	have	 been	 identified	 from	proteomic	 data	 as	 potential	targets	 (Niu	 et	 al.,	 2015;	 Song	 et	 al.,	 2014).	 Butanol	 tolerance	 was	 increased	 when	 the	general	stress	response	regulator	was	overexpressed	(Kaczmarzyk	et	al.,	2014).	Proteomic	and	 transcriptomic	 data	 following	 exposure	 to	 other	 novel	 compounds	 should	 be	investigated	to	identify	possible	targets	that	could	help	relieve	toxicity.		Finally,	 the	 expression	 of	 efflux	 pumps,	 a	 class	 of	 membrane	 transporters	 that	 use	 the	proton	motive	force	to	export	toxic	compounds	out	of	the	cell,	has	been	demonstrated	to	improve	tolerance	to	limonene	in	E.	coli	(Dunlop	et	al.,	2011).	The	use	of	efflux	pumps	to	improve	tolerance	has	not	been	well	researched	in	cyanobacteria	but	could	prove	useful,	not	just	in	alleviating	toxicity,	but	also	by	potentially	improving	yield.	
7.2.1.3 Diverting	carbon	flux	In	 Synechocystis	 approximately	 20	 times	 more	 carbon	 goes	 towards	 the	 synthesis	 of	carbohydrates	than	towards	the	synthesis	of	terpenoids	(Rosgaard	et	al.,	2012).	This	may	explain	why	limonene	is	not	produced	to	such	high	levels	in	cyanobacteria	in	comparison	
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to	E.	coli.	To	improve	the	production	of	limonene,	more	fixed	carbon	needs	to	be	rerouted	towards	the	MEP	pathway.		There	 are	 a	number	of	 examples	of	modifying	 competing	pathways	 in	order	 to	 increase	yield.	The	pathway	for	the	synthesis	of	3-hydroxybutyrate,	the	monomer	form	of	PHB,	was	introduced	 in	 Synechocystis	 and	 production	 was	 increased	 when	 the	 native	 competing	pathway,	 producing	 the	 polymer	 PHB,	 was	 removed	 (Wang,	 2013).	 From	 in	 silico	metabolic	 flux	 analysis,	 carbon	 flux	 through	 acetyl-CoA	 appeared	 to	 limit	 the	photoautotrophic	production	of	biofuels.	The	pool	of	 acetyl-CoA	available	was	 increased	by	expressing	a	phosphoketolase,	this	resulted	in	improved	production	of	butanol	(Anfelt	et	al.,	2015).			Various	 metabolic	 reconstructions	 have	 been	 made	 for	 Synechocystis,	 to	 improve	 the	understanding	of	the	metabolic	network	present	and	use	this	information	to	improve	the	production	of	novel	compounds	(Erdrich	et	al.,	2014;	Knoop	and	Steuer,	2015;	Montagud	et	 al.,	 2010,	 2011;	 Nogales	 et	 al.,	 2013).	 One	 of	 the	 first	 genome-scale	 models	 of	
Synechocystis	 predicted	 the	 effect	 of	 introducing	 an	 ethanol	 fermentation	 pathway	 on	growth	 and	 production	 levels	which	matched	 experimental	 data	 (Fu,	 2009).	 The	 use	 of	genome	 scale	 models	 can	 assist	 a	 more	 directed	 and	 efficient	 approach	 to	 metabolic	engineering.	 The	 majority	 of	 the	 models	 produced	 have	 been	 developed	 using	
Synechocystis.	However,	in	2014	the	first	genome	scale	model	for	Synechococcus	7942	was	produced	(Triana	et	al.,	2014)	and	there	have	also	been	attempts	to	model	the	nitrogen-fixing	genus	of	cyanobacteria,	Cyanothece	(Mueller	et	al.,	2013;	Saha	et	al.,	2012).	
7.2.2 Controlling	gene	expression	The	 metabolic	 engineering	 of	 a	 microorganism	 such	 as	 Synechocystis	 requires	 the	coordinated	 expression	 of	 multiple	 transgenes.	 As	 the	 ability	 to	 tightly	 control	 gene	expression	 is	 important	 when	 attempting	 to	 redesign	 the	 cellular	machinery,	 there	 has	been	 increasing	 interest	 in	 finding	 and	 characterising	 suitable	 promoters.	 Other	mechanisms	for	controlling	gene	expression	have	also	been	investigated.		
7.2.2.1 Promoters	
E.	 coli	 inducible	 promoters	 have	 been	 modified	 to	 improve	 their	 efficiency	 in	cyanobacteria,	but	this	has	been	to	varying	levels	of	success	(Heidorn	et	al.,	2011;	Huang	and	 Lindblad,	 2013).	 A	 range	 of	 promoters	 were	 developed	 with	 differing	 levels	 of	expression	 by	 altering	 the	 distance	 between	 the	 -10	 and	 -35	 polymerase	 sigma	 binding	units	 (Albers	 et	 al.,	 2015).	 The	 nickel	 inducible	 promoter	 can	 be	 used	 to	 turn	 on	expression	 of	 transgenes.	 However,	 the	 presence	 of	 low	 levels	 of	 nickel	 in	 any	medium	
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means	 that	 there	 is	 a	 degree	 of	 leaky	 expression	 even	 in	 the	 absence	 of	 added	 nickel.	Furthermore,	 the	use	of	heavy	metals	 for	 induction	 is	not	 ideal	when	scaling	production	(Abe	 et	 al.,	 2014).	 A	 green	 light	 inducible	 promoter	 has	 been	 developed	 and	 avoids	 the	issues	 associated	 with	 using	 a	 chemical	 inducer	 (Abe	 et	 al.,	 2014).	 However,	 when	production	 is	 up-scaled	 it	 would	 be	 limited	 to	 growth	 in	 photobioreactors,	 as	 cultures	would	need	to	grow	in	red	light	and	expression	is	not	completely	switched	off	in	red	light	(Abe	et	al.,	2014).		The	 discovery	 of	 Pcpc560	 has	 also	 shown	 the	 potential	 importance	 of	 TFBSs	 in	 the	expression	of	genes	in	cyanobacteria	(Zhou	et	al.,	2014).	The	lack	of	TFBSs	in	strong	E.	coli	promoters	 has	 been	 hypothesised	 as	 an	 explanation	 as	 to	why	 these	 promoters	 do	 not	perform	 as	well	 in	 cyanobacteria	 (Zhou	 et	 al.,	 2014).	 In	 future	work,	 by	 altering	 the	 14	predicted	 TFBSs	 within	 Pcpc560,	 a	 range	 of	 promoters	 could	 be	 produced	 with	 varying	strengths	of	expression.	Also,	when	designing	new	promoters,	native	positive	TFBSs	could	be	introduced	to	improve	the	strength	of	the	promoter.	
7.2.2.2 RNA	control	Riboswitches	are	mRNA	elements	that	can	be	used	to	regulate	post	transcriptional	steps	of	gene	 expression.	 Riboswitches	 comprise	 of	 an	 aptamer	 sequence	 often	 located	 in	 the	 5’	untranslated	region	(5’UTR)	of	mRNA	that	 is	 the	binding	site	 for	a	specific	 ligand.	When	the	 ligand	 is	 bound	 to	 the	 aptamer	 sequence	 this	 leads	 to	 a	 conformational	 change	 that	then	affects	the	expression	of	the	adjacent	gene	(Nakahira	et	al.,	2013).	Riboswitches	can	work	 to	 either	 affect	 translation	 initiation	 or	 attenuate	 transcriptional	 termination.	Theophylline-dependent	 riboswitches	 have	 been	 developed	 for	 Synechococcus	 7942,	
Synechocystis,	Anabaena	sp.	strain	PCC	7120	and	Leptolyngbya	sp.	strain	BL090	(Ma	et	al.,	2014;	 Nakahira	 et	 al.,	 2013;	 Ohbayashi	 et	 al.,	 2016).	 One	 theophylline-dependent	riboswitch	was	 very	 effective	 at	 repressing	 expression	 in	 the	 absence	 of	 the	 ligand	 and	was	 capable	of	 a	190-fold	 increase	 in	 the	presence	of	 the	 ligand	 (Nakahira	 et	 al.,	 2013).	Another	 advantage	 to	 using	 the	 riboswitches	 is	 the	 ability	 to	 tune	 the	 expression,	 by	altering	the	concentration	of	ligand.		Riboregulators	have	been	used	 in	cyanobacteria,	and	are	made	up	of	 two	components:	a	
cis-repressive	mRNA	(crRNA)	and	trans-activating	RNA	(taRNA).	The	crRNA	is	repressed	by	 its	 5’	 UTR,	 preventing	 the	 ribosome	 from	 binding	 to	 the	 RBS.	 The	 production	 of	 the	taRNA,	 results	 in	 the	 formation	 of	 a	 hybrid	 complex	 with	 the	 5’	 UTR	 of	 crRNA,	 which		exposes	the	RBS	site	to	enable	translation.	Recently,	a	scaffold	fused-riboregulator	from	E.	
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coli	was	 successfully	 adapted	 and	used	 in	Synechocystis	 as	 a	method	of	 controlling	 gene	expression	(Sakai	et	al.,	2015).		The	role	of	antisense	RNA	(asRNA)	in	cyanobacteria	is	thought	to	play	an	important	role	in	controlling	gene	expression.	Transcribed	from	the	antisense	strand	of	a	gene,	asRNAs	are	found	either	directly	antisense	to	the	gene	or	within	50	bp	upstream	or	downstream	(Kopf	and	 Hess,	 2015).	 In	 Synechocystis,	 one	 third	 of	 transcriptional	 start	 sites	 were	 on	 the	complementary	strand	of	866	genes	suggesting	an	important	functional	role	for	antisense	transcription	 (Mitschke	 et	 al.,	 2011).	 In	 Synechocystis,	 asRNAs	 may	 repress	 or	 induce	expression	of	genes	(Dühring	et	al.,	2006;	Sakurai	et	al.,	2012).	The	presence	of	asRNA	has	also	 been	 demonstrated	 in	 Anabaena	 sp.	 PCC	 7120	 (Hernández	 et	 al.,	 2006)	 and	 two	strains	 of	 Prochlorococcus	 (Voigt	 et	 al.,	 2014).	 AsRNA	 has	 been	 used	 to	 repress	 genes	expression	 in	Synechococcus	7942	and	Anabaena	7120	(Higo	et	al.,	2016;	Holtman	et	al.,	2005).	
7.2.2.3 Ribosome	binding	sites	From	this	study,	it	was	demonstrated	that	within	a	two-gene	operon	the	presence	of	a	RBS	was	not	required	for	translation	of	the	downstream	gene.	In	order	to	develop	RBS	tools	in	cyanobacteria	further	research	is	needed	to	understand	protein	translation	initiation	and	the	importance	of	the	SD	sequence	in	cyanobacteria,	especially	as	is	it	not	well	understood	and	most	information	is	based	on	what	is	known	from	E.	coli.	There	are	tools	such	as	the	RBS	Calculator	available	for	predicting	the	effect	of	a	RBS,	and	such	tools	are	effective	at	predicting	translation	in	E.	coli.	However,	in	Synechococcus	7002,	the	predicted	levels	did	not	correlate	well	with	the	experimental	data	(Markley	et	al.,	2015).	
7.2.3 Scaling	up	production	Although	cyanobacteria	have	been	successfully	engineered	to	produce	biofuels	and	other	chemicals	at	the	lab-scale	there	are	still	a	lot	of	challenges	that	need	to	be	overcome	before	commercialisation	 (Parmar	et	 al.,	 2011).	There	 are	 some	 technical	 challenges,	 regarding	cultivation	and	harvesting,	and	ecological	challenges	that	need	to	be	considered	to	ensure	the	environmental	benefits	of	using	cyanobacteria	are	achieved.	There	are	also	economic	challenges	related	to	the	cost	of	scaling	up	production	of	biofuels	(Parmar	et	al.,	2011).		Although	cyanobacterial	cultivation	would	not	use	as	much	land	as	crop	plants,	like	plants	they	 still	 need	 a	 source	 of	major	 nutrients	 such	 as	 phosphorus	 and	 nitrogen.	 There	 has	been	limited	research	using	strains	that	are	capable	of	nitrogen	fixing	for	the	production	of	biofuels,	which	would	circumvent	the	issues	of	using	nitrogen	fertilisers	produced	using	the	Haber-Bosch	process.	Another	consideration	is	that	strains	such	as	Synechocystis	and	
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Synechococcus	 7942	 are	 freshwater	 strains.	 However,	 large-scale	 cultivation	 puts	significant	demands	on	freshwater	leading	to	competition	with	drinking	water	and	water	used	 for	 crop	 irrigation.	 Ideally,	 more	 research	 should	 be	 done	 to	 find	 strains	 that	 are	capable	of	growing	in	wastewater	or	salt	water	(Nozzi	et	al.,	2013).		One	of	 the	main	problems	with	scaling	cyanobacterial	cultivation	 is	 light	delivery.	When	scaling	up,	self-shading	limits	the	depth	of	the	culture,	although	rapid	mixing	can	help	to	address	 this.	 Furthermore,	 only	 10-15%	 of	 light	 is	 thought	 to	 be	 available	 to	 cells	 for	photosynthesis	 (Nozzi	 et	 al.,	 2013).	 The	 growth	 of	 cyanobacteria	 using	 an	 open	 pond	system	 is	significantly	cheaper	 than	 in	closed	photobioreactors.	However,	 the	amount	of	biomass	 produced	 in	 an	 open	 pond	 is	 significantly	 lower	 and	 there	 are	 environmental	issues	over	 the	 escape	of	 engineered	 strains	of	 cyanobacteria	 (Sarsekeyeva	 et	 al.	 2015).	There	is	very	little	research	in	cyanobacteria	into	biocontainment	mechanisms,	to	prevent	the	release	of	any	mutagenic	strains	into	the	environment.	The	expression	of	a	DNA/RNA	nuclease	NucA	under	different	metal	 inducible	promoters	was	 investigated	as	a	possible	suicide	switch,	although	 further	research	and	 improved	 inducible	promoters	are	needed	to	develop	this	system	(Čelešnik	et	al.,	2016).		The	genetic	and	metabolic	networks	in	E.	coli	and	S.	cerevisiae	are	well	characterised	and	better	 understood	 in	 comparison	 to	 those	 of	 cyanobacteria.	 This	 has	 allowed	 the	development	of	a	wide	range	of	synthetic	biology	tools	available	to	carry	out	advanced	and	predictable	 genetic	 engineering	 (Scaife	 et	 al.,	 2015).	 The	main	 advantage	 cyanobacteria	have	over	E.	coli	and	S.	cerevisiae	is	the	ability	to	fix	CO2	and	in	some	cases	to	fix	N2,	rather	than	 requiring	an	exogenous	 source	of	 fixed	carbon	such	as	 sugars	or	organic	acids	and	fixed	nitrogen	such	as	nitrates,	nitrates,	ammonium	or	urea.	It	might	therefore	be	possible	to	use	a	mixed	cultivation	approach	to	couple	the	metabolic	engineering	benefits	of	the	E.	
coli	or	yeast	platforms	with	the	autotrophy	of	cyanobacteria.	Indeed,	there	has	been	some	research	investigating	the	growth	of	cyanobacteria	engineered	to	secrete	sugars	required	to	support	the	production	of	novel	compounds	in	E.	coli	(Niederholtmeyer	et	al.,	2010).	If	such	a	cyanobacterium	was	also	capable	of	fixing	nitrogen	it	could	also	be	used	to	provide	a	nitrogen	source.		
7.2.4 The	future	of	cyanobacterial	biotechnology	Over	 the	 next	 few	 years	 the	 research	 areas	 discussed	 below	 have	 the	 potential	 to	significantly	 advance	 the	 development	 of	 cyanobacterial	 engineering	 in	 a	 predictable	manner.			
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7.2.4.1 Chassis	strain	Cyanobacteria	 represent	 such	 a	 diverse	 phylum	 of	 species,	 and	 only	 a	 few	 strains	 have	been	studied	in	any	detail.	The	diversity	in	phenotypes	and	genotypes	can	be	utilised	for	various	 applications	 and	 the	 production	 of	 different	 novel	 compounds.	 However,	 one	problem	with	the	diversity	seen	in	cyanobacteria	is	the	biological	tools	developed	in	one	strain	 may	 not	 be	 transferrable	 across	 species	 without	 laborious	 evaluation	 and	modification.		Although	 research	 continues	 to	 improve	 the	 synthetic	 biology	 tools	 available	 for	cyanobacteria,	the	slower	growth	rates	of	model	cyanobacteria	compared	to	E.	coli	has	an	effect	 on	 the	 time	 it	 takes	 to	 produce	 transformant	 lines	 and	 develop	 and	 characterise	different	 tools.	 In	E.	coli	 this	process	may	only	take	a	 few	days,	whereas	 in	Synechocystis	this	 can	 take	 months.	 Synechococcus	 elongatus	 UTEX	 2973	 (Synechococcus	 2973)	 was	recently	 identified,	as	having	a	doubling	time	similar	to	that	of	S.	cerevisiae,	at	1.9	hours,	which	is	much	faster	than	Synechococcus	7942,	which	has	a	doubling	rate	of	4.9	hours	(Yu	et	al.,	2015).	DNA	can	be	introduced	by	conjugation	but	the	strain	cannot	yet	be	naturally	transformed,	 limiting	 its	 use	 (Wendt	 et	 al.,	 2016;	 Yu	 et	 al.,	 2015).	 Nevertheless,	 an	engineered	strain	of	Synechococcus	2973	successfully	produced	8.7	g/L	of	sucrose	over	21	days	(Song	et	al.,	2016).		So	 far,	 Synechococcus	 7002	 has	 not	 been	 utilised	 to	 the	 same	 extent	 as	 the	 freshwater	strains	Synechocystis	 or	Synechococcus	 7942.	However	as	a	marine	 strain,	Synechococcus	7002	 is	 attractive	 as	 an	 industrial	 platform,	 as	 it	 is	 capable	 of	 growing	 in	 high	 salt	concentrations,	high	 light	and	under	a	range	of	high	 temperatures	between	30	and	38°C	(Ruffing,	 2014).	 One	 of	 the	 limitations	with	 using	 this	 strain	 is	 the	 lack	 of	 genetic	 tools	available.	However,	there	have	been	recent	progress	with	the	construction	of	a	few	tools	that	 enable	 the	 control	 of	 gene	 expression	 and	 a	 method	 for	 selecting	 marker-less	transformants	(Begemann	et	al.,	2013;	Markley	et	al.,	2015;	Zess	et	al.,	2016).		
7.2.4.2 CRISPR/Cas9	and	CRISPRi	Clustered	 regularly	 interspaced	 short	 palindromic	 repeats	 (CRISPR)	 along	 with	 CRISPR	associated	proteins	(Cas	proteins)	provide	an	adaptive	immune	system	in	bacteria	against	invading	viruses	and	plasmids.	The	CRISPR	system	can	be	utilised	for	genome	editing	by	creating	double	stranding	breaks	at	a	specific	site,	which	can	be	used	 to	create	mutants,	deletions	or	introduce	DNA	(Jinek	et	al.,	2012).	The	use	of	CRISPR	in	cyanobacteria	is	still	in	 its	 infancy.	The	first	reported	use	of	 the	CRISPR/Cas9	system	was	earlier	this	year,	as	was	 used	 in	 Synechococcus	2973	 to	 generate	marker-less	mutants	 (Wendt	 et	 al.,	 2016).	
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During	this	study	it	was	shown	that	the	expression	of	cas9	was	toxic	to	the	cell,	unless	it	was	transiently	expressed,	which	may	explain	why	the	system	has	not	been	used	much	in	cyanobacteria	 (Wendt	 et	 al.,	 2016).	 	 The	 use	 of	 CRISPR/Cas9	 genome	 editing	 systems	could	progress	cyanobacteria	as	a	platform	further,	especially	 for	strains	where	efficient	genome	manipulation	via	homologous	recombination	is	lacking.	CRISPR	 interference	(CRISPRi)	 is	an	attractive	method	to	repress	gene	expression	at	 the	level	of	transcription	and	has	so	far	been	investigated	in	Synechocystis	and	Synechococcus	7002	(Gordon	et	al.,	2016;	Yao	et	al.,	2016).	In	Synechocystis,	CRISPRi	was	used	to	repress	the	formation	of	PHB,	known	to	compete	with	biofuels	for	acetyl-CoA,	and	is	also	capable	of	repressing	multiple	genes	at	the	same	time	(Yao	et	al.,	2016).	CRISPRi	could	therefore	be	 used	 to	 divert	 flux	 from	 competing	 pathways,	 without	 abolishing	 the	 pathways	completely	(Gordon	et	al.,	2016).	
7.2.4.3 Genetic	Circuits	By	designing	and	creating	genetic	circuits	within	cyanobacteria,	cells	can	be	programmed	to	 respond	 to	 a	 greater	 number	 of	 inputs	 (pH,	 temperature,	 light	 etc.)	 that	 can	 then	 be	used	to	increase	biological	control	(Wang	et	al.,	2011).	Synthetic	gene-regulatory	circuits	have	been	constructed	 in	E.	coli	 to	perform	logic	 functions,	with	the	AND	and	NOR	gates	(Figure	7.1)	tested	in	E.	coli	under	industrially	relevant	conditions	that	could	be	used	for	fermentation	 (Gardner	 et	 al.,	 2000;	Moser	 et	 al.,	 2012).	 Recently,	 a	 two-input	 AND	 gate	was	developed	 in	Synechocystis,	 responsive	 to	 low	oxygen	 and	high	 anhydrotetracycline	(Immethun	et	 al.,	 2016).	The	discovery	of	more	promoters	and	 riboswitches	will	 enable	the	creation	of	more	genetic	circuits	using	different	logic	gates	(i.e.	OR,	NOT,	XOR,	NAND)	(Figure	7.1)	that	could	provide	tighter	control	of	the	synthetic	biological	circuits.		
7.2.5 Final	thoughts	The	 potential	 of	 utilising	 cyanobacteria’s	 ability	 to	 use	 sunlight	 to	 fix	 carbon	 for	 the	production	 of	 novel	 compounds	 in	 engineered	 strains	 is	 significant.	 There	 are	 a	 lot	 of	challenges	ahead	regarding	scaling	up	however	 the	most	pressing	concern	over	 the	next	few	years	for	cyanobacteria	seems	to	be	ensuring	metabolic	pathways	can	be	introduced	and	controlled	in	a	predictable	manner.	By	developing	new	and	improved	biological	parts	and	molecular	techniques	that	are	transferrable	between	strains,	finding	new	strains	and	building	detailed	metabolic	models;	the	true	capabilities	of	cyanobacteria	can	be	explored.		Cyanobacteria	 can	 then	 be	 evaluated	 to	 see	 what	 novel	 compounds	 are	 best	 suited	 for	production	in	these	hosts	over	other	model	microorganisms.		
	 239	
	
Figure	7.1	Truth	tables	of	logic	gates	used	in	genetic	circuits.		A)	The	AND	gate	only	gives	an	output,	when	both	 inputs	 represented	by	A	and	B	are	present.	B)	The	NOR	gate	only	gives	an	output	when	both	inputs	are	absent.	C)	Truth	tables	of	NAND,	XOR,	OR	and	NOT	gates	that	could	be	utilised	in	a	genetic	circuit.		
		
		 				 	
A)	AND	Gate	 B)	NOR	Gate	
Input Out
A B
0 0 0
1 0 0
0 1 0
1 1 1
Input Out
A B
0 0 1
1 0 0
0 1 0
1 1 0
Input Out
A B
0 0 1
1 0 1
0 1 1
1 1 0
Input Out
A B
0 0 0
1 0 1
0 1 1
1 1 0
Input	
A
Out
0 1
1 0
Input Out
A B
0 0 0
1 0 1
0 1 1
1 1 1
C)	Other	Logic	Gates	
NAND XOR OR NOT
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Appendix	1:	Primer	List	
Primer	name	 Sequence	(5’	to	3’)		6803_codA_F	 CGC TCT CAT ATG TCT AAC AAC GC 6803_codA_R	 GCA TGC GGA TCC TTA TTA AGC G 6803_sacB_F	 TCT TCA AAC AGG AGG GCT GG 6803_sacB_R	 CGG TTA GCC ATT TGC CTG C AII.LS_F	 ATG CTA GCG CTT CGT GTA TAT TAA CTT CC AII.LS_R	 TCG TTA ACA GGT CGG GGA TCC TTA GG AL.KanR.4op.R	 CGG GGT ACC TCA ATT CAA TTC ATC AAG AL.ZmR.4op.F	 TAT AAC CAT ATG GCC AAG TTG ACC AGT GCC Ben	seq	ups	F	 CCC AGA ACT ATG GTA AAG GCG Ble_Fw	 GGC ATT AAT GGC CAA GTT GAC C Ble_IG0bp_Re	 AGT TCT TCT CCT TTA CTC ATT CAG TCC TGC TCC TCG 
GCC ACG Ble_IG1bp_Re	 AGT TCT TCT CCT TTA CTC ATC TCA GTC CTG CTC CTC 
GGC CAC G Ble_IG2_Re	 GGC AAA ATC CGG GGG GCT GGT CAA CTA GTA ATT ATC 
AGT CCT GCT CCT CGG  Ble_IG4_Re	 TCG ATT ACC TCC ACT ATT GCC ATC AGT CCT GCT CCT 
CGG Ble_IG5_Re	 TTT ATT CCT TTG CCT TTT AGT TCA GTC CTG CTC CTC 
GG C.FragBR	 ATA AAC CGC CTG ATA GGT GTT GG codAmidF	 TCG TTG AAA CAG TAG CTG C FO.kmF	 CCT TTT AAC AGC GAT CGC G FO.kmR	 GGA ATC GAA TGC AAC CGG GFP_0bp_F	 CGA TGT TCC AGA TTA CGC TTA AAT GAG TAA AGG AGA 
AGA AC GFP_1bp_F	 CGA TGT TCC AGA TTA CGC TTA ACA TGA GTA AAG GAG 
AAG AAC GFP_IG0bp_Fw	 GGC CGA GGA GCA GGA CTG AAT GAG TAA AGG AGA AGA 
AC GFP_IG1bp_Fw	 GGC CGA GGA GCA GGA CTG AGA TGA GTA AAG GAG AAG 
AAC GFP_IG2_Fw	 TAA TTA CTA GTT GAC CAG CCC CCC GGA TTT TGC CAT 
GAG TAA AGG AGA AGA AC  GFP_IG4_Fw	 GGC AAT AGT GGA GGT AAT CGA ATG AGT AAA GGA GAA 
GAA C GFP_IG5_Fw	 CTA AAA GGC AAA GGA ATA AAA CTA TGA GTA AAG GAG 
AAG AAC GFP_Re	 GGA GAT CTT ATT TGT AGA GCT CAT CC  IR706.Ex	F	 ACC AAG AGC AAC AAA GAC AGG IR706.Ex	R	 CTT ATC AAC AGG GAT TCC GG IR706.Ex.Flank.F	 CAT CCG AAT CTT TAA ACC C IR706.Ex.Flank.R	 GAA CCT TGG ATT TCA TCA GG IR706F	 TCA GCG TAC AGA TCA TTC GG IR706R	 GCT ATG TAC ACT GGC TAA GG KmRSacBRF	 TTT GCT AGC AAT TCG AGC TCG GTA CCC G KmRSacBRR	 AAA GCT AGC CCC ATC ACA TAT ACC TGC C LSmidF	 TGC CCG TGA ATT TGC CAC C 
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Primer	name	 Sequence	(5’	to	3’)		NptI_outF	 GGC CTC AAC ACG ATT TTA CG nrsBseqF	 CCG TCT CAT CTT CCA CCA GC Out.GFP.R	 AAC ACC TTC TTC ACG AGG CAG ACC Pcpc_ins_Fw	 TGG ACT CCC TCA GTT TAT CCG pJET	F	 TTT TAA CTT GGA GCA GGT TCC pJET	R	 GTT TTC ATG AGA GTC GAT TGC pLAH_codAF	 CGT GGC TAG CAA CTT CCT GTT ACA AAG C pLAH_codAR	 TAC AGC TAG CGT TAT GAG CCA TAT TCA ACG pLAH.nrsBR.F	 ATG CGA CTA CGG GCA AAG AGG pLAH.pcpc.F	 GCA CCT GTA GAG AAG AGT CC pLAH.pro.R	 TCG GGG ATC CTC TAG AGT CG Slr0611	F	 AAA TGA AAA CCA TTG CCC CGC C Slr0611	R	 CAA TCG TAG GGT AGG GAA GC splB_0bp_R	 GTT CTT CTC CTT TAC TCA TTT AAG CGT AAT CTG GAA 
CAT CG splB_1bp_R	 GTT CTT CTC CTT TAC TCA TCT TAA GCG TAA TCT GGA 
ACA TCG splB_F	 GCA TTA ATG AAC AAA AAC GTA GTT ATT AAA TCA TTA 
GC StyOx_End_F	 GTG TAG TCA ATT TGC CCC CAC C StyOx_seq1_R	 CCG GGT TGG CTA AGT ATT GC StyOx_seq2_F	 TTC TAG CAA CCC CTC CCT CG StyOx_seq3_R	 CCA AAG CAC AGT GCA AAG G StyOx_seq4_F	 TAA ACC CCA ACA CAT TCG CC StyOx_seq5_F	 AAC CCC AGC GAG CCT TAT GC StyOx_seq6_R	 AAA CTC ATG GTG ACA GCA CG 
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Appendix	2:	Plasmids	used	in	this	study	
		Plasmids	pLAH.nrsB	and	pLAH.AII	designed	and	created	by	Lamya	Al-Haj	(Al-Haj,	2014).	The	NdeI	and	BamHI	sites	are	present	for	inserting	the	G.O.I.	
psbAII	upstream	
element	
psbAII	downstream	
element	
KmR	
pLAH.nrsB	
PnrsB	
Ori	
G.O.I	
NdeI	 BamHI	
psbAII	upstream	
element	
psbAII	downstream	
element	
KmR	
pLAH.AII	
Ori	
G.O.I	
NdeI	 BamHI	
PpsbAII	
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	Plasmid	pLAH.cpc	created	by	Aaron	Lau	,	again	the	NdeI	and	BamHI	sites	are	present	for	inserting	the	G.O.I.	*Synthesised	by	GeneArt	
Plasmid	name	 Backbone	 Insert	ls_pMA-RQ*	 pMA-TRQ	 ls	 with	 a	 HA-tag	 sequence	 at	 the	 SfiI	restriction	sites.		pLAH.nrsB.LS	 pLAH.nrsB	 ls	 with	 a	 HA-tag	 sequence	 at	 the	 NdeI	and	BamHI	restriction	sites.		pLAH.AII.LS	 pLAH.AII	 ls	 with	 a	 HA-tag	 sequence	 at	 the	 NdeI	and	BamHI	restriction	sites.		pLAH.cpc.LS	 pLAH.cpc	 ls	 with	 a	 HA-tag	 sequence	 at	 the	 NdeI	and	BamHI	restriction	sites.	pJET.sds	 pJET1.2/blunt	 sds	 (sllr0611)	 gene	 amplified	 from	genomic	 WT	 Synechocystis	 at	 the	multiple	cloning	sites	(MCS).		pJET.sds::Km	3	 pJET.sds	 Kanamycin	 resistant	 cassette	 	 from	pUC4K	at	the	HincII	and	SmaI	site.	pJET.sds::Km	6		 pJET.sds		 Kanamycin	 resistant	 cassette	 	 from	pUC4K	 at	 the	 HincII	 and	 SmaI	 site.	Differs	 from	 	 pJET.sds::Km	 6	 as	kanamycin	 resistant	 cassette	 is	 in	 the	opposite	orientation.	pLAH.nrsB_cat	 pLAH.nrsB	 cat	 cassette	 from	 pARG1.3	 inserted	 at	the	DraI	restriction	site.	pJET.zsk	 pJET1.2/blunt	 Ble-IG1-aadA-IG2-aphA-6	amplified	from	4op	at	the	MCS.	pLAH.nrsB.zsk	 pLAH.nrsB_cat	 Ble-IG1-aadA-IG2-aphA-6	 from	 pJET.zsk	ligated	at	the	NdeI	and	Acc65I	site.	pLAH.ble.IG2.GFP	 pLAH.cpc	 ble-IG2-gfpuv	 PCR	 product	 is	 ligated	 at	the	NdeI	and	BamHI	site.	pLAH.ble.IG4.GFP	 pLAH.cpc	 ble-IG4-gfpuv	 PCR	 product	 is	 ligated	 at	the	NdeI	and	BamHI	site.	pLAH.ble.IG5.GFP	 pLAH.cpc	 ble-IG5-gfpuv	 PCR	 product	 is	 ligated	 at	the	NdeI	and	BamHI	site.	pLAH.ble.IG0bp.GFP	 pLAH.cpc	 ble-IG0bp-gfpuv	 PCR	 product	 is	 ligated	
psbAII	upstream	
element	
psbAII	downstream	
element	
KmR	
pLAH.cpc	
5102	bp	
Ori	
G.O.I	
NdeI	 BamHI	
Pcpc560	
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Plasmid	name	 Backbone	 Insert	at	the	NdeI	and	BamHI	site.	pLAH.ble.IG1bp.GFP	 pLAH.cpc	 ble-IG1bp-gfpuv	 PCR	 product	 is	 ligated	at	the	NdeI	and	BamHI	site.	pLAH.splB.IG0bp.GFP	 pLAH.cpc	 splB-IG0bp-gfpuv	 PCR	product	 is	 ligated	at	the	NdeI	and	BamHI	site.	pLAH.splB.IG1bp.GFP	 pLAH.cpc	 splB-IG1bp-gfpuv	 PCR	product	 is	 ligated	at	the	NdeI	and	BamHI	site.	pIR706	 pJET1.2/blunt	 IR706,	 neutral	 site,	 amplified	 from	 the	genomic	WT	Synechocystis	at	the	MCS	pIR706.cat	 pIR706	 cat	 cassette	 from	 pARG1.3	 inserted	 at	the	HpaI	site.	pJET.sacB.nptI	 pJET1.2/blunt	 nptI	 and	 sacB	 from	 pUM24Cm	 inserted	at	the	MCS.	pJET.sacB.nptI’	 pJET.sacB.nptI	 DNA	 between	 AfeI	 and	 EcoRV	 digested	out.	pIR706.sacB.nptI	 pIR706	 nptI	 and	 sacB	 from	 pJET.sacB.nptI	inserted	at	NheI	restriction	site.		pIR706.sacB.nptI’	 pIR706	 nptI	 and	 sacB	 from	 pJET.sacB.nptI’	inserted	at	NheI	restriction	site.		pLAH.AII.codA	 pLAH.AII	 codA	 with	 a	 HA-tag	 sequence	 amplified	from	pRY127d	 inserted	 at	 the	NdeI	 and	BamHI	restriction	sites.	pIR706.codA	 pIR706	 codA	with	 a	HA-tag	 sequence	 under	 the	control	 of	 PpsbAII	 inserted	 and	 the	kanamycin	 resistance	 cassette	 from	pLAH.AII.codA	at	the	NheI	site.		pIR706.Ex	 pJET1.2/blunt	 Extended	 neutral	 site,	 IR706.Ex,	amplified	 from	 the	 genomic	 WT	
Synechocystis	at	the	MCS	pIR706.Ex.cat	 pIR706.Ex	 cat	 cassette	 from	 pARG1.3	 inserted	 at	the	HpaI	site.	pIR706.Ex.LS	 pIR706.Ex	 ls	 with	 a	 HA-tag	 sequence	 under	 the	control	 of	 PpsbAII	 from	 pLAH.AII.LS	inserted	at	the	NheI	and	HpaI	site.	pIR706.Ex.cpc	 pIR706.Ex	 Pcpc560	 and	 the	 NdeI	 and	 BamHI	restriction	 sites	 from	pLAH.cpc	 inserted	at	the	HpaI	site.	pIR706.Ex.nrsB		 pIR706.Ex	 PnrsB	and	the	NdeI	and	BamHI	restriction	sites	from	pLAH.cpc	inserted	at	the	HpaI	site.	SO_Part1_pMA-T*	 pMA-T	 SO_Part1	 containing	 PAL2-IG4-FDC1	 up	to	SphI	RE	site.	SO_Part2_pMA-T*	 pMA-T	 SO_Part2	 containing	 FDC1	 after	 SphI-IG5-styA-IG4-styB.	pIR706.Ex.nrsB.SO1	 pIR706.Ex.nrsB	 SO_Part1	from	SO_Part1_pMA-T	inserted	at	the	NdaI	and	BamHI	restriction	sites.	pIR706.Ex.cpc.SO1	 pIR706.Ex.cpc	 SO_Part1	from	SO_Part1_pMA-T	inserted	at	the	NdeI	and	BamHI	restriction	sites.	pIR706.Ex.nrsB.SO	 pIR706.Ex.nrsB.SO1	 SO_Part2	from	SO_Part2_pMA-T	inserted	at	the	SphI	and	BamHI	restriction	sites.	pIR706.Ex.cpc.SO	 pIR706.Ex.cpc	 SO	 operon	 from	 pIR706.Ex.nrsB.SO	inserted	into	NdeI	and	BamHI	restriction	
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Plasmid	name	 Backbone	 Insert	sites.	pLAH.cpc.SO	 pLAH.cpc	 SO	 operon	 from	 pIR706.Ex.nrsB.SO	inserted	into	NdeI	and	BamHI	restriction	sites.	pLAH.nrsB.SO	 pLAH.nrsB	 SO	 operon	 from	 pIR706.Ex.nrsB.SO	inserted	into	NdeI	and	BamHI	restriction	sites.	
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Appendix	3:	Transgenic	strains	created	in	this	study	
Strain	name	(in	this	
study)	
Description	6803.nrsB.LS	 The	psbAII	promoter	and	gene	is	replaced	by	ls	with	a	HA-tag	sequence	under	the	control	of	the	PnrsB	and	a	kanamycin	resistance	cassette.		6803.AII.LS	 The	psbAII	gene	is	replaced	by	ls	with	a	HA-tag	sequence	under	the	control	of	the	PpsbAII	and	a	kanamycin	resistance	cassette.		6803.cpc.LS	 The	psbAII	promoter	and	gene	is	replaced	by	ls	with	a	HA-tag	sequence	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.		6803.nrsB.zsk	 The	psbAII	promoter	and	gene	is	replaced	by	ble,	aadA	and	aphA-6	under	the	control	of	the	PnrsB.	Resistant	to	zeocin,	spectinomycin	and	kanamycin	6803.ble.IG2.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	ble	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	ble	and	GFP	is	IG2.	Also	resistant	to	zeocin.	6803.ble.IG4.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	ble	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	ble	and	GFP	is	IG4.	Also	resistant	to	zeocin.			6803.ble.IG5.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	ble	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	ble	and	GFP	is	IG5.	Also	resistant	to	zeocin.			6803.ble.0bp.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	ble	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	ble	and	GFP	is	IG0bp.	Also	resistant	to	zeocin.			6803.ble.1bp.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	ble	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	ble	and	GFP	is	IG1bp.	Also	resistant	to	zeocin.			6803.splB.0bp.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	splB	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	splB	and	GFP	is	IG0bp.	Also	resistant	to	zeocin.			6803.splB.1bp.GFP	 The	psbAII	promoter	and	gene	is	replaced	by	splB	and	gfp	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.	Between	splB	and	GFP	is	IG1bp.	Also	resistant	to	zeocin.			6803.IR706.sacB	 The	selected	neutral	region	between	slr1340	and	sll1255	at	the	NheI	site	has	sacB	and	nptI	expressed	under	their	own	promoter.	Resistant	to	kanamycin.			6803.IR706.sacB’	 The	selected	neutral	region	between	slr1340	and	sll1255	at	the	NheI	site	has	sacB	and	nptI	expressed	under	their	own	promoter.	Differs	from	6803.IR706.sacB	as	a	predicted	transposon	was	removed	between	sacB	and	nptI.		Resistant	to	kanamycin.			6803.AII.codA	 The	psbAII	gene	is	replaced	by	codA	with	a	HA-tagged	sequence	under	the	control	of	PpsbAII	and	a	kanamycin	resistance	cassette.	6803.IR706.codA	 The	selected	neutral	region	between	slr1340	and	sll1255	at	the	NheI	site	has	codA	under	the	control	of	the	psbAII	and	a	kanamycin	resistance	cassette.		6803.IR706.cat	 The	selected	neutral	region	between	slr1340	and	sll1255	at	the	HpaI	site	has	cat	under	the	control	of	its	own	promoter.	Resistance	
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Strain	name	(in	this	
study)	
Description	to	chloramphenicol.			6803.IR706.LS	 Replacing	the	region	between	the	NheI	and	HpaI	site,	found	within	the	neutral	region	slr1340	and	sll1255,	is	ls	with	a	HA-tag	sequence	under	the	control	of	the	PpsbAII.	Marker-less	strains.	6803.AII.cpc.SO	 The	psbAII	promoter	and	gene	is	replaced	by	the	PAL2,	FDC1,	styA	and	styB	under	the	control	of	the	Pcpc560	and	a	kanamycin	resistance	cassette.		6803.AII.nrsB.SO	 The	psbAII	promoter	and	gene	is	replaced	by	the	PAL2,	FDC1,	styA	and	styB	under	the	control	of	the	PnrsB	and	a	kanamycin	resistance	cassette.		6803.IR706.cpc	 The	selected	neutral	region	between	slr1340	and	sll1255	at	the	HpaI	site	has	no	gene-of-interest	under	the	control	of	Pcpc560.			
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Appendix	4:	DNA	Constructs	Synthetic	LS	gene	sequence	Genes:	
ls	HA	epitope	tag	TAA	–	Stop	codon	
	Restriction	sites:	NdeI	BamHI		
CATATGACCGAACGGCGTTCCGGCAATTACAATCCCTCCCGGTGGGATGTGAACTTTATTCAAT
CCTTGTTGTCCGATTACAAAGAAGATAAACACGTTATTCGTGCCTCCGAATTGGTGACCTTGGT
GAAAATGGAATTGGAAAAAGAAACCGATCAAATTCGGCAGCTGGAATTGATTGATGATTTGCAA
CGGATGGGCTTGTCCGATCATTTTCAGAACGAATTTAAAGAAATTTTGTCCTCCATTTATTTGG
ATCATCATTATTACAAAAATCCCTTTCCCAAAGAAGAACGGGATTTGTATTCCACCTCCTTGGC
CTTTCGGTTGTTGCGGGAACATGGCTTTCAAGTGGCCCAAGAAGTGTTTGATTCCTTTAAAAAC
GAAGAAGGGGAATTTAAAGAATCCCTGTCCGATGATACCCGTGGCTTGTTGCAATTGTATGAAG
CCTCCTTTTTGTTGACCGAAGGCGAAACCACCTTGGAAAGTGCCCGTGAATTTGCCACCAAATT
TTTGGAAGAAAAAGTGAATGAAGGCGGTGTGGATGGCGATTTGTTGACCCGGATTGCCTATTCC
TTGGATATTCCCTTGCATTGGCGGATTAAACGTCCCAATGCTCCCGTGTGGATTGAATGGTATC
GGAAACGTCCCGATATGAATCCCGTGGTGTTGGAATTGGCCATTTTGGATTTGAATATTGTGCA
GGCCCAGTTTCAAGAAGAATTGAAAGAATCCTTTCGGTGGTGGCGGAATACCGGCTTTGTGGAA
AAATTGCCCTTTGCCCGTGATCGGTTGGTGGAATGTTATTTTTGGAATACCGGCATTATTGAAC
CCCGTCAACATGCCAGTGCCCGTATTATGATGGGCAAAGTGAATGCCTTGATTACCGTGATTGA
TGACATTTACGATGTGTATGGCACCTTGGAAGAACTGGAACAATTTACCGATTTGATTCGGCGT
TGGGACATTAATTCCATTGATCAATTGCCCGATTACATGCAATTGTGTTTTTTGGCCCTGAACA
ACTTTGTGGATGATACCTCCTATGACGTGATGAAAGAAAAAGGCGTGAATGTGATTCCCTATTT
GCGGCAATCCTGGGTGGATTTGGCCGATAAATACATGGTGGAAGCCCGTTGGTTTTATGGCGGT
CATAAACCCAGTTTGGAAGAATATTTGGAAAATTCCTGGCAGTCCATTTCCGGTCCCTGTATGT
TGACCCATATTTTTTTTCGGGTGACCGACTCCTTTACCAAAGAAACCGTGGATTCCTTGTACAA
ATATCATGATTTGGTGCGGTGGTCCTCCTTTGTGTTGCGGTTGGCCGATGATTTGGGCACCTCC
GTGGAAGAAGTGAGTCGGGGTGATGTGCCCAAATCCTTGCAATGTTATATGTCCGATTATAATG
CCTCCGAAGCCGAAGCCCGTAAACATGTGAAATGGTTGATTGCCGAAGTGTGGAAAAAAATGAA
TGCCGAACGGGTGTCCAAAGATTCCCCCTTTGGCAAAGATTTTATTGGCTGTGCCGTGGATTTG
GGTCGGATGGCCCAATTGATGTATCATAATGGTGATGGCCATGGCACCCAACATCCCATTATTC
ATCAACAAATGACCCGGACCTTGTTTGAACCCTTTGCCTATCCCTATGATGTGCCCGATTATGC
CTAAGGATCC Synthetic	SO	operon	gene	sequence	Genes:	
PAL2	
FDC1	
StyA	
StyB	TAA	–	Stop	codon		
	Intergenic	Regions:	IG4	IG5	
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Restriction	sites:	NdeI	BamHI	SacI		
CATATGGACCAAATCGAGGCCATGTTGTGTGGGGGGGGCGAAAAGACCAAAGTAGCGGTCACCA
CCAAGACTCTCGCGGACCCTTTGAACTGGGGGTTGGCCGCAGATCAGATGAAGGGCAGCCACTT
AGATGAGGTTAAAAAAATGGTGGAGGAATATCGCCGGCCTGTAGTAAACCTCGGCGGAGAAACC
CTGACTATTGGACAAGTGGCAGCAATTAGCACGGTGGGCGGTAGTGTGAAAGTGGAGCTAGCCG
AAACCTCCCGAGCCGGTGTGAAGGCTAGCTCCGACTGGGTGATGGAAAGTATGAATAAGGGAAC
CGATAGCTATGGTGTAACAACCGGCTTCGGGGCGACCAGTCACCGGCGAACCAAGAATGGCACC
GCTCTCCAAACGGAATTGATCCGCTTCTTAAATGCTGGAATTTTTGGGAACACCAAAGAAACCT
GCCATACACTGCCTCAATCTGCAACCCGGGCGGCCATGCTCGTGCGAGTCAACACTCTACTGCA
GGGTTACAGTGGCATTCGGTTTGAGATTTTAGAAGCCATCACTTCCTTGCTCAATCACAACATC
TCTCCCAGTCTCCCGCTCCGCGGAACTATCACTGCCTCCGGCGATCTGGTTCCCCTGTCCTATA
TTGCTGGCCTGCTAACCGGTCGTCCAAATTCTAAAGCCACGGGCCCTGATGGCGAAAGTTTGAC
AGCCAAAGAAGCATTTGAGAAAGCGGGTATTAGTACAGGTTTCTTTGATTTGCAGCCGAAGGAG
GGCCTGGCCCTCGTGAACGGCACCGCGGTTGGCAGTGGGATGGCGTCTATGGTTCTATTTGAAG
CCAATGTGCAAGCGGTGCTCGCGGAAGTTTTATCCGCGATTTTTGCCGAAGTGATGTCCGGTAA
ACCCGAATTCACAGACCATTTAACCCACCGATTGAAACATCATCCGGGCCAGATTGAAGCCGCC
GCCATTATGGAACACATTCTAGATGGTAGCAGTTATATGAAGCTAGCCCAAAAGGTCCATGAGA
TGGCTCCCCTGCAGAAACCGAAACAAGATCGCTATGCTCTACGTACCTCCCCCCAGTGGTTAGG
TCCGCAAATCGAGGTGATCCGGCAAGCCACAAAAAGTATCGAACGCGAAATCAATTCTGTTAAC
GATAATCCCTTGATCGACGTGTCCCGTAATAAAGCCATCCACGGTGGTAATTTTCAAGGGACTC
CCATTGGGGTGTCTATGGACAACACCCGGCTCGCCATTGCCGCGATTGGCAAGTTAATGTTCGC
CCAATTTTCCGAATTAGTCAATGATTTTTACAACAACGGCCTCCCATCTAATTTAACTGCTTCT
AGTAACCCATCCCTGGATTACGGCTTCAAGGGCGCCGAGATTGCCATGGCCTCCTATTGTAGCG
AACTACAATATCTGGCCAATCCTGTGACTTCCCATGTTCAATCCGCGGAACAACATAACCAGGA
TGTGAATAGCCTGGGTTTAATCAGTAGTCGCAAGACATCTGAAGCAGTTGACATTCTAAAATTA
ATGAGCACAACATTCCTGGTAGGAATCTGTCAGGCTGTAGATCTCCGGCATTTGGAAGAAAATT
TACGTCAAACCGTGAAAAATACCGTTAGTCAGGTAGCGAAGAAAGTATTGACCACCGGGATTAA
TGGCGAGTTGCATCCCTCTCGATTTTGTGAAAAAGACCTGCTGAAGGTGGTAGACCGGGAACAG
GTTTTTACATACGTAGACGATCCCTGTTCCGCTACATACCCACTCATGCAACGGTTGCGCCAAG
TGATTGTTGATCATGCGCTGTCCAATGGTGAAACTGAGAAGAACGCTGTTACTTCTATTTTCCA
AAAAATTGGGGCCTTTGAGGAGGAACTGAAAGCCGTATTGCCTAAAGAAGTTGAAGCTGCTCGC
GCCGCGTATGGTAATGGTACGGCCCCCATTCCCAATCGCATTAAAGAATGTCGGTCTTATCCCC
TGTACCGGTTTGTCCGCGAAGAACTAGGAACGAAATTATTAACCGGTGAGAAGGTGGTCTCCCC
TGGCGAAGAATTTGATAAAGTCTTTACCGCCATGTGCGAAGGCAAACTCATTGATCCGTTGATG
GACTGTCTAAAGGAATGGAACGGAGCACCTATTCCTATTTGTTAATGGCAATAGTGGAGGTAAT
CGAATGCGAAAGTTGAACCCTGCACTAGAATTTCGGGATTTTATCCAAGTTCTGAAAGATGAGG
ATGATTTGATCGAAATTACGGAAGAAATTGACCCCAATTTGGAAGTCGGTGCCATTATGCGAAA
AGCCTACGAGAGCCACTTGCCAGCTCCATTGTTTAAGAATCTAAAAGGTGCCAGCAAGGACCTA
TTCTCTATTTTAGGCTGCCCCGCCGGTCTACGCTCTAAAGAAAAAGGGGATCATGGTCGGATTG
CCCATCACTTAGGTCTGGACCCTAAAACCACAATTAAGGAAATTATTGACTATCTGTTGGAATG
CAAAGAAAAAGAACCGTTGCCGCCTATCACAGTGCCCGTCAGCAGTGCCCCGTGCAAAACCCAT
ATTTTAAGTGAAGAAAAAATTCACCTGCAATCTCTACCGACCCCGTATTTGCACGTTTCCGATG
GGGGGAAATACTTACAAACCTATGGCATGTGGATTCTACAGACTCCCGATAAAAAATGGACCAA
TTGGTCTATTGCTCGGGGTATGGTCGTGGATGATAAACATATTACGGGTTTAGTAATTAAACCT
CAACACATCCGCCAGATTGCCGATTCCTGGGCCGCAATTGGTAAAGCTAATGAAATTCCCTTTG
CTCTATGTTTTGGTGTGCCACCCGCTGCCATTTTGGTGAGTTCCATGCCCATCCCGGAAGGTGT
ATCCGAGTCCGATTACGTAGGGGCTATCTTGGGTGAATCCGTGCCAGTTGTGAAGTGTGAGACC
AACGATTTAATGGTCCCGGCTACTAGTGAGATGGTCTTTGAAGGGACCCTGTCCTTGACAGATA
CGCACTTAGAAGGGCCGTTTGGTGAAATGCACGGCTACGTCTTTAAGTCCCAAGGTCATCCTTG
TCCCTTATATACCGTTAAAGCTATGTCTTATCGCGACAATGCGATCTTGCCCGTGAGTAATCCT
GGTTTATGCACTGACGAGACGCATACTCTGATCGGCTCCCTCGTTGCCACCGAAGCTAAGGAGC
TCGCAATTGAAAGCGGCCTCCCGATCTTGGATGCCTTTATGCCGTATGAAGCGCAAGCCTTGTG
GCTGATCCTCAAAGTCGATTTAAAAGGCCTGCAAGCCTTGAAAACGACACCAGAGGAGTTTTGT
	 268	
AAGAAAGTGGGTGATATCTACTTCCGTACTAAGGTTGGGTTTATTGTTCATGAAATTATTCTAG
TCGCCGATGATATTGACATTTTCAATTTTAAAGAGGTTATCTGGGCTTACGTGACGCGGCACAC
TCCCGTAGCCGATCAAATGGCTTTTGACGATGTGACTAGTTTTCCTCTCGCCCCCTTTGTGTCT
CAAAGCTCCCGTAGTAAGACTATGAAAGGCGGCAAATGTGTGACCAATTGCATTTTTCGTCAAC
AATACGAACGGTCCTTTGACTATATCACGTGTAACTTCGAGAAAGGTTATCCTAAGGGTCTGGT
GGATAAAGTGAATGAAAACTGGAAACGGTACGGGTACAAGTAAACTAAAAGGCAAAGGAATAAA
ACTATGAAAAAGCGCATCGGCATCGTGGGAGCGGGAACCGCCGGCTTGCATTTGGGCTTGTTCC
TGCGTCAGCATGATGTGGATGTCACGGTGTATACCGATCGTAAACCCGATGAATACAGCGGCTT
GCGGCTATTAAATACCGTAGCGCACAATGCCGTTACAGTCCAGCGAGAAGTCGCTCTAGATGTT
AACGAATGGCCTTCCGAAGAATTTGGCTATTTTGGACATTATTACTATGTGGGTGGGCCACAGC
CTATGCGCTTTTATGGCGATTTGAAAGCCCCCAGTCGAGCAGTGGATTATCGCTTGTACCAGCC
CATGCTGATGCGGGCACTGGAGGCTCGCGGTGGAAAATTTTGCTATGATGCTGTCAGCGCGGAA
GACTTAGAAGGCCTGTCTGAGCAATACGATTTACTCGTAGTGTGCACCGGGAAATACGCTCTGG
GCAAAGTCTTTGAGAAGCAGTCCGAGAACAGTCCGTTTGAGAAGCCTCAGCGTGCTCTATGTGT
TGGATTATTTAAAGGCATTAAAGAAGCCCCGATTCGAGCCGTGACCATGTCTTTTAGTCCGGGG
CATGGAGAACTAATCGAAATTCCCACATTAAGCTTTAATGGAATGAGTACCGCGCTAGTTTTGG
AAAATCATATTGGCTCTGACCTAGAGGTCCTGGCCCACACAAAATACGACGATGACCCGCGCGC
CTTTCTAGATTTGATGTTAGAAAAACTAGGAAAACATCATCCCTCTGTCGCCGAACGCATTGAT
CCTGCCGAATTCGATCTAGCTAATAGCTCCTTGGATATCTTGCAGGGAGGAGTTGTGCCGGCCT
TTCGAGATGGGCACGCGACCTTGAACAACGGTAAAACTATTATCGGCCTAGGTGATATTCAAGC
CACCGTCGATCCGGTTCTGGGGCAAGGCGCGAATATGGCGTCTTATGCAGCCTGGATTTTAGGG
GAAGAAATTCTAGCGCATTCTGTATATGATCTACGCTTTAGTGAACATTTAGAACGGCGGCGGC
AAGATCGCGTTCTGTGTGCCACTCGGTGGACCAACTTTACCTTAAGCGCGCTGTCTGCTCTGCC
CCCAGAATTCCTAGCCTTTCTCCAAATTTTATCTCAAAGTCGAGAAATGGCCGATGAATTTACC
GACAATTTCAACTATCCTGAACGACAGTGGGACCGCTTCTCTTCCCCTGAACGCATTGGACAAT
GGTGCAGTCAGTTTGCACCCACCATTGCTGCCTAATGGCAATAGTGGAGGTAATCGAATGACCT
TAAAAAAAGATATGGCTGTCGACATTGATAGTACCAATTTTCGTCAAGCAGTGGCTTTATTCGC
TACGGGTATCGCTGTTCTAAGCGCCGAGACAGAAGAGGGCGATGTGCATGGCATGACTGTTAAT
AGCTTCACAAGCATTAGTCTCGACCCACCTACTGTTATGGTGAGTTTGAAATCCGGCCGAATGC
ATGAATTGTTGACTCAAGGAGGGCGTTTCGGTGTGTCTTTGCTCGGTGAAAGCCAGAAAGTGTT
TAGTGCCTTCTTCTCCAAGCGGGCAATGGACGACACACCACCCCCCGCCTTCACTATCCAAGCC
GGATTGCCAACGTTACAGGGAGCCATGGCTTGGTTTGAATGTGAAGTCGAAAGCACTGTGCAAG
TTCATGATCACACCTTGTTTATTGCCCGTGTCAGCGCTTGTGGCACCCCGGAAGCCAACACACC
TCAACCCTTGCTCTTCTTTGCCTCCCGCTATCATGGTAATCCCTTGCCCCTGAACTAAGGATCC 							
